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UPDATE STATEMENT 
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*Legislative Background 
The toxicological profiles are developed in response to the Superfund Amendments and Reauthorization 
Act (SARA) of 1986 (Public law 99-499) which amended the Comprehensive Environmental Response, 
Compensation, and Liability Act of 1980 (CERCLA or Superfund).  This public law directed ATSDR to 
prepare toxicological profiles for hazardous substances most commonly found at facilities on the 
CERCLA National Priorities List and that pose the most significant potential threat to human health, as 
determined by ATSDR and the EPA.  The availability of the revised priority list of 275 hazardous 
substances was announced in the Federal Register on November 17, 1997 (62 FR 61332).  For prior 
versions of the list of substances, see Federal Register notices dated April 29, 1996 (61 FR 18744); April 
17, 1987 (52 FR 12866); October 20, 1988 (53 FR 41280); October 26, 1989 (54 FR 43619); October 17, 
1990 (55 FR 42067); October 17, 1991 (56 FR 52166); October 28, 1992 (57 FR 48801); and February
28, 1994 (59 FR 9486).  Section 104(i)(3) of CERCLA, as amended, directs the Administrator of ATSDR 
to prepare a toxicological profile for each substance on the list. 
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QUICK REFERENCE FOR HEALTH CARE PROVIDERS 
Toxicological Profiles are a unique compilation of toxicological information on a given hazardous 
substance. Each profile reflects a comprehensive and extensive evaluation, summary, and interpretation 
of available toxicologic and epidemiologic information on a substance.  Health care providers treating 
patients potentially exposed to hazardous substances will find the following information helpful for fast 
answers to often-asked questions. 
Primary Chapters/Sections of Interest 
Chapter 1: Public Health Statement: The Public Health Statement can be a useful tool for educating 
patients about possible exposure to a hazardous substance.  It explains a substance’s relevant 
toxicologic properties in a nontechnical, question-and-answer format, and it includes a review of 
the general health effects observed following exposure. 
Chapter 2: Relevance to Public Health: The Relevance to Public Health Section evaluates, interprets, 
and assesses the significance of toxicity data to human health. 
Chapter 3: Health Effects: Specific health effects of a given hazardous compound are reported by type 
of health effect (death, systemic, immunologic, reproductive), by route of exposure, and by length 
of exposure (acute, intermediate, and chronic).  In addition, both human and animal studies are 
reported in this section. 
NOTE: Not all health effects reported in this section are necessarily observed in the clinical 
setting. Please refer to the Public Health Statement to identify general health effects observed 
following exposure. 
Pediatrics: Four new sections have been added to each Toxicological Profile to address child health 
issues: 
Section 1.6 How Can (Chemical X) Affect Children?
 
Section 1.7 How Can Families Reduce the Risk of Exposure to (Chemical X)?
 
Section 3.7 Children’s Susceptibility
 
Section 6.6 Exposures of Children 

Other Sections of Interest: 
Section 3.8 Biomarkers of Exposure and Effect 
Section 3.11 Methods for Reducing Toxic Effects 
ATSDR Information Center 
Phone: 1-888-42-ATSDR or (404) 498-0110 Fax: (770) 488-4178
 E-mail: atsdric@cdc.gov Internet: http://www.atsdr.cdc.gov 
The following additional material can be ordered through the ATSDR Information Center: 
Case Studies in Environmental Medicine: Taking an Exposure History—The importance of taking an 
exposure history and how to conduct one are described, and an example of a thorough exposure 
history is provided.  Other case studies of interest include Reproductive and Developmental 
Hazards; Skin Lesions and Environmental Exposures; Cholinesterase-Inhibiting Pesticide 
Toxicity; and numerous chemical-specific case studies. 
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Managing Hazardous Materials Incidents is a three-volume set of recommendations for on-scene 
(prehospital) and hospital medical management of patients exposed during a hazardous materials 
incident. Volumes I and II are planning guides to assist first responders and hospital emergency 
department personnel in planning for incidents that involve hazardous materials.  Volume III— 
Medical Management Guidelines for Acute Chemical Exposures—is a guide for health care 
professionals treating patients exposed to hazardous materials. 
Fact Sheets (ToxFAQs) provide answers to frequently asked questions about toxic substances. 
Other Agencies and Organizations 
The National Center for Environmental Health (NCEH) focuses on preventing or controlling disease, 
injury, and disability related to the interactions between people and their environment outside the 
workplace. Contact: NCEH, Mailstop F-29, 4770 Buford Highway, NE, Atlanta, 
GA 30341-3724 • Phone: 770-488-7000 • FAX: 770-488-7015. 
The National Institute for Occupational Safety and Health (NIOSH) conducts research on occupational 
diseases and injuries, responds to requests for assistance by investigating problems of health and 
safety in the workplace, recommends standards to the Occupational Safety and Health 
Administration (OSHA) and the Mine Safety and Health Administration (MSHA), and trains 
professionals in occupational safety and health.  Contact: NIOSH, 200 Independence Avenue, 
SW, Washington, DC 20201 • Phone: 800-356-4674 or NIOSH Technical Information Branch, 
Robert A. Taft Laboratory, Mailstop C-19, 4676 Columbia Parkway, Cincinnati, OH 45226-1998 
• Phone: 800-35-NIOSH. 
The National Institute of Environmental Health Sciences (NIEHS) is the principal federal agency for 
biomedical research on the effects of chemical, physical, and biologic environmental agents on 
human health and well-being.  Contact: NIEHS, PO Box 12233, 104 T.W. Alexander Drive, 
Research Triangle Park, NC 27709 • Phone: 919-541-3212. 
Referrals 
The Association of Occupational and Environmental Clinics (AOEC) has developed a network of clinics 
in the United States to provide expertise in occupational and environmental issues.  Contact: 
AOEC, 1010 Vermont Avenue, NW, #513, Washington, DC 20005 • Phone:  202-347-4976 
• FAX: 202-347-4950 • e-mail: AOEC@AOEC.ORG • Web Page:  http://www.aoec.org/. 
The American College of Occupational and Environmental Medicine (ACOEM) is an association of 
physicians and other health care providers specializing in the field of occupational and 
environmental medicine.  Contact: ACOEM, 55 West Seegers Road, Arlington Heights, 
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1 TIN AND TIN COMPOUNDS 
1. PUBLIC HEALTH STATEMENT 

This public health statement tells you about tin and tin compounds and the effects of exposure to 
them.  
The Environmental Protection Agency (EPA) identifies the most serious hazardous waste sites in 
the nation. These sites are then placed on the National Priorities List (NPL) and are targeted for 
long-term federal clean-up activities.  Tin and organotin compounds have been found in at least 
214 and 8, respectively, of the 1,662 current or former NPL sites.  Although the total number of 
NPL sites evaluated for these substances is not known, the possibility exists that the number of 
sites at which tin and organotin compounds are found may increase in the future as more sites are 
evaluated. This information is important because these sites may be sources of exposure and 
exposure to these substances may harm you. 
When a substance is released either from a large area, such as an industrial plant, or from a 
container, such as a drum or bottle, it enters the environment.  Such a release does not always 
lead to exposure. You can be exposed to a substance only when you come in contact with it.  
You may be exposed by breathing, eating, or drinking the substance, or by skin contact. 
If you are exposed to tin and tin compounds, many factors will determine whether you will be 
harmed.  These factors include the dose (how much), the duration (how long), and how you 
come in contact with them.  You must also consider any other chemicals you are exposed to and 
your age, sex, diet, family traits, lifestyle, and state of health. 
1.1 WHAT ARE TIN AND TIN COMPOUNDS?
Tin is a soft, white, silvery metal that is insoluble in water.  Tin metal is used to line cans for 
food, beverages, and aerosols. It is present in brass, bronze, pewter, and some soldering 
materials.
2 TIN AND TIN COMPOUNDS 
1. PUBLIC HEALTH STATEMENT 
Tin is a metal that can combine with other chemicals to form various compounds.  When tin is 
combined with chlorine, sulfur, or oxygen, it is called an inorganic tin compound.  Inorganic tin 
compounds are found in small amounts in the earth's crust.  They are also present in toothpaste, 
perfumes, soaps, coloring agents, food additives, and dyes. 
Tin also can combine with carbon to form organotin compounds.  These compounds are used in 
making plastics, food packages, plastic pipes, pesticides, paints, wood preservatives, and rodent 
(rats and mice) repellants. 
There can be tin metal as well as inorganic and organic tin compounds in the air, water, and soil 
near places where they are naturally present in the rocks, mined, manufactured, or used.  In 
general, organic tin compounds are from human-made sources and do not occur naturally in the 
environment.  The time each tin compound stays in air, water, or soil differs from compound to 
compound. 
Further information on the properties and uses of tin and its compounds and how they behave in 
the environment is found in Chapters 4, 5, and 6. 
1.2 	 WHAT HAPPENS TO TIN AND TIN COMPOUNDS WHEN THEY ENTER THE 
ENVIRONMENT? 
Tin is a component of many soils.  Tin may be released in dusts from wind storms, roads, and 
farming activities.  Gases, dusts, and fumes containing tin may be released from smelting and 
refining processes, burning of waste, and burning of fossil fuels (coal or oil). Particles in the air 
containing tin may be transported by wind or washed out of the air by rain or snow.  Tin binds to 
soils and to sediments in water and is generally regarded as being relatively immobile in the 
environment.  Tin cannot be destroyed in the environment.  It can only change its form or 
become attached or separated from particles in soil, sediment, and water.  
Organic tin compounds stick to soil, sediment, and particles in water.  Organic tin compounds 
can be degraded (by exposure to sunlight and by bacteria) into inorganic tin compounds.  In 
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water, organic tin compounds are mostly attached to particles in water.  Organic tin compounds 
may also settle out of the water into sediments and may remain unchanged for years.  Organic tin 
compounds may be taken up into the tissues of animals that live in water containing these 
compounds.  
1.3 HOW MIGHT I BE EXPOSED TO TIN AND TIN COMPOUNDS?
Tin is present in the air, water, soil, and landfills and is a normal part of many plants and animals 
that live on land and in water. Tin is also present in the tissues of your body. There is no 
evidence that tin is an essential element for humans. 
Since tin is naturally found in soils, it will be found in small amounts in foods.  Tin 
concentrations of vegetables, fruits and fruit juices, nuts, dairy products, meat, fish, poultry, 
eggs, beverages, and other foods not packaged in metal cans are generally less than 2 parts per 
million (ppm) (1 ppm = 1 part of tin in a million parts of food by weight).  Tin concentrations in 
pastas and breads have been reported to range from less than 0.003 to 0.03 ppm.  You can be 
exposed to tin when you eat food or drink juice or other liquids from tin-lined cans.  Canned 
food from lacquered tin-lined cans contains less than 25 ppm of tin since the lacquer prevents the 
food from reacting with the tin.  Food from unlacquered tin-lined cans contains up to 100 ppm of 
tin since the reaction of the food with the can causes some of the tin to dissolve in the contents of 
the can. Greater than 90% of tin-lined cans used for food today are lacquered.  Only light 
colored fruit and fruit juices are packed in unlacquered tin-lined cans, since tin helps maintain 
the color of the fruit. Tin concentrations in food also increase if food is stored in opened cans. 
Stannous fluoride, a tin-containing compound, is added to toothpaste. 
You can also be exposed to higher-than-normal levels of tin if you work in a factory that makes 
or uses tin. Because tin compounds have many uses, you can be exposed by breathing in tin 
dusts or fumes or getting tin compounds on your skin.  Tin compounds can also be spilled 
accidentally.  If you live near a hazardous waste site, you could be exposed by breathing dusts, 
touching materials, or drinking water contaminated with tin. 
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Humans are usually exposed to tin at far less than 1 ppm from air and water.  The amounts in air 
and water near hazardous waste sites could be higher. 
Young children sometimes eat soil during play.  While most soil contains about 1 ppm tin, some
soils may contain as much as 200 ppm tin.  Assuming that children eat 200 mg of soil per day, 
exposure to tin from eating soil would be low. 
You may be exposed to organic tin compounds (mainly butyltin compounds) by eating seafood 
from coastal waters or from contact with household products that contain organotin compounds, 
(polyurethane, plastic polymers, and silicon-coated baking parchment paper).  Organic tin 
compounds have been detected in drinking water in Canada where pipes made of polyvinyl 
chloride (PVC), which contain organic tin compounds, are used in the distribution of drinking 
water. 
Additional information on how you can be exposed to tin compounds is given in Chapter 6. 
1.4 HOW CAN TIN AND TIN COMPOUNDS ENTER AND LEAVE MY BODY? 
Tin can enter your body when you eat contaminated food or drink contaminated water, when you 
touch or eat soil that has tin in it, or when you breathe tin-containing fumes or dusts.  Tin 
compounds can enter your body from nearby hazardous waste sites by exposure to contaminated 
air, water, and soil. When you eat tin in your food, very little leaves the gastrointestinal tract and 
gets into your bloodstream.  Most tin travels through the intestines and leaves your body in the 
feces. Some leaves your body in the urine.  If you breathe air containing tin dust or fumes, some
of the tin could be trapped in your lungs, but this does not affect your breathing if it is a small 
amount.  If you swallow some metallic tin particles, they will leave your body in the feces.  Very 
little tin can enter the body through unbroken skin.  Your body can rid itself of most inorganic tin 
in weeks, but some can stay in your body for 2–3 months.  Inorganic tin compounds leave your 
body very quickly; most are gone within a day.  Very small amounts of tin stay in some tissues 
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Further information on how tin enters and leaves your body is given in Chapter 3. 
1.5 HOW CAN TIN AND TIN COMPOUNDS AFFECT MY HEALTH?
Scientists use many tests to protect the public from harmful effects of toxic chemicals and to find 
ways for treating persons who have been harmed. 
One way to learn whether a chemical will harm people is to determine how the body absorbs, 
uses, and releases the chemical.  For some chemicals, animal testing may be necessary.  Animal 
testing may also help identify health effects such as cancer or birth defects.  Without laboratory 
animals, scientists would lose a basic method for getting information needed to make wise 
decisions that protect public health. Scientists have the responsibility to treat research animals 
with care and compassion.  Scientists must comply with strict animal care guidelines because 
laws today protect the welfare of research animals. 
Because inorganic tin compounds usually enter and leave your body rapidly after you breathe or 
eat them, they do not usually cause harmful effects.  However, humans who swallowed large 
amounts of inorganic tin in research studies suffered stomachaches, anemia, and liver and kidney 
problems.  Studies with inorganic tin in animals have shown similar effects to those observed in 
humans.  There is no evidence that inorganic tin compounds affect reproductive functions, 
produce birth defects, or cause genetic changes.  Inorganic tin compounds are not known to 
cause cancer. 
Inhalation (breathing in), oral (eating or drinking), or dermal exposure (skin contact) to some
organotin compounds has been shown to cause harmful effects in humans, but the main effect 
will depend on the particular organotin compound.  There have been reports of skin and eye 
irritation, respiratory irritation, gastrointestinal effects, and neurological problems in humans 
exposed for a short period of time to high amounts of certain organotin compounds.  Some
neurological problems have persisted for years after the poisoning occurred.  Lethal cases have 
been reported following ingestion of very high amounts. Studies in animals have shown that 
certain organotins mainly affect the immune system, but a different type primarily affects the 
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nervous system.  Yet, there are some organotins that exhibit very low toxicity.  Exposure of 
pregnant rats and mice to some organotin compounds has reduced fertility and caused stillbirth, 
but scientists still are not sure whether this occurs only with doses that are also toxic to the 
mother. Some animal studies also suggested that reproductive organs of males may be affected.  
There are no studies of cancer in humans exposed to organotin compounds.  Studies of a few 
organotins in animals suggest that some organotin compounds can produce cancer.  On the basis 
of no data in humans and questionable data from a study in rats, EPA has determined that one 
specific organotin, tributyltin oxide, is not classifiable as to human carcinogenicity; that is, it is 
not known whether or not it causes cancer in humans.  
More information on the health effects of tin in humans and animals is found in Chapter 3. 
1.6 HOW CAN TIN AND TIN COMPOUNDS AFFECT CHILDREN? 
This section discusses potential health effects in humans from exposures during the period from
conception to maturity at 18 years of age. 
Children can be exposed to tin compounds (inorganic or organic) in the same manner as adults:  
through the diet or by contact with contaminated soil at or near hazardous waste sites where 
these compounds are found.  Some children eat significant amounts of dirt (a behavior called 
pica), which may lead to increased exposure if the soil is contaminated.  In addition, children can 
be exposed if family members work with tin compounds and bring home tin residues in their 
clothing or tools. 
There are no studies on health effects in children exposed to tin compounds.  However, it is 
reasonable to assume that children would exhibit the same type of health effects observed in 
exposed adults. We do not know whether children are more susceptible to the effects of 
exposure to tin and tin compounds than adults.  There are no reports of adverse developmental 
effects in humans exposed to tin or its compounds, or of inorganic tin in animals.  Studies in 
animals have shown that organotin compounds can cross the placenta and reach the fetus.  
Exposure of rodents to some organotins during pregnancy has produced birth defects in the 
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newborn animals.  The results of several studies suggest that this may occur only at high 
exposure levels that cause maternal toxicity, but further research is needed to clarify this issue. 
One study found that rats whose mothers were exposed to tributyltin during pregnancy showed 
altered performance in some neurological tests conducted when they were young adults. 
Another study, also with tributyltin, found that exposure during gestation, lactation, and post-
lactation affected some developmental landmarks in female rats.  There are no reports of tin or 
tin compounds in human breast milk, and there is no direct evidence in animals of transfer of 
these compounds to the young through nursing. 
More information regarding children’s health and tin and related compounds can be found in 
Section 3.7. 
1.7 	 HOW CAN FAMILIES REDUCE THE RISK OF EXPOSURE TO TIN AND TIN 
COMPOUNDS? 
If your doctor finds that you have been exposed to substantial amounts of tin and tin compounds, 
ask whether your children might also have been exposed.  Your doctor might need to ask your 
state health department to investigate. 
Children living near waste sites containing tin and tin compounds are likely to be exposed to 
higher than normal environmental levels of tin through breathing, touching soil, and eating 
contaminated soil.  You should discourage your children from eating dirt. Make sure they wash 
their hands frequently and before eating.  Discourage your children from putting their hands in 
their mouths.  Some toothpastes and other dental products contain stannous fluoride, a tin 
containing compound.  Children should be watched carefully when using these products and 
should not swallow these products. 
Because tin is naturally found in the environment at low levels, we cannot avoid being exposed 
to it. The major route of exposure to tin is from eating or drinking canned products.  Reducing 
the amount of canned products you eat or drink may reduce your exposure to tin.  Since tin 
concentrations in food increase if food is stored in opened cans, you can reduce your exposure by 
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storing unused portions of canned foods in a separate container. You may be exposed to organic 
tin compounds by eating seafood from areas that may be contaminated with organic tin 
compounds or from contact with household products that contain organotin compounds 
(polyurethane, plastic polymers, and silicon-coated baking parchment paper).  Reducing the 
amount of seafood that you eat from areas that may be contaminated with organic tin compounds 
and reducing contact with household products that contain organic tin compounds may reduce 
your exposure to organic tin compounds.  If you are accidentally exposed to large amounts of tin 
or tin compounds, consult a physician immediately. 
1.8 	 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN 
EXPOSED TO TIN AND TIN COMPOUNDS? 
There are tests to measure tin and organotin compounds in your blood, urine, feces, and body 
tissues. Normally, small amounts of tin are found in the body because of the daily exposure to 
small amounts in the food.  Therefore, the available tests cannot tell you when you were exposed 
or the exact amount of tin to which you were exposed, but can help determine if you were 
exposed to an amount of tin or tin compounds unusually high in the near past.  This information 
can be used to locate the source of exposure. 
Tests for tin and related compounds are not routinely performed at a doctor’s office because they 
require special equipment, but the doctor can take samples and send them to a testing laboratory. 
Further information on how tin can be measured in exposed humans is presented in Chapter 7. 
1.9 	 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO 
PROTECT HUMAN HEALTH? 
The federal government develops regulations and recommendations to protect public health. 
Regulations can be enforced by law. The EPA, the Occupational Safety and Health 
Administration (OSHA), and the Food and Drug Administration (FDA) are some federal 
agencies that develop regulations for toxic substances. Recommendations provide valuable 
9 TIN AND TIN COMPOUNDS 
1. PUBLIC HEALTH STATEMENT 
guidelines to protect public health, but cannot be enforced by law.  The Agency for Toxic 
Substances and Disease Registry (ATSDR) and the National Institute for Occupational Safety 
and Health (NIOSH) are two federal organizations that develop recommendations for toxic 
substances. 
Regulations and recommendations can be expressed as “not-to-exceed” levels, that is, levels of a 
toxic substance in air, water, soil, or food that do not exceed a critical value that is usually based 
on levels that affect animals; they are then adjusted to levels that will help protect humans. 
Sometimes these not-to-exceed levels differ among federal organizations because they used 
different exposure times (an 8-hour workday or a 24-hour day), different animal studies, or other 
factors. 
Recommendations and regulations are also updated periodically as more information becomes 
available. For the most current information, check with the federal agency or organization that 
provides it. Some regulations and recommendations for tin and tin compounds include the 
following: 
Several government agencies and the Congress have acted to protect human health by regulating 
tin compounds.  The EPA has limited the use of certain organotin compounds in paints.  OSHA 
has established workplace exposure limits of 0.1 milligrams per cubic meter of air (mg/m3) for 
organotin compounds and 2 mg/m3 for inorganic tin compounds, except oxides.  NIOSH 
recommends workplace exposure limits of 2 mg/m3 for inorganic tin compounds, except for tin 
oxides, and 0.1 mg/m3 for organotins, except tricyclohexyltin hydroxide.  NIOSH states that a 
concentration of tricyclohexyltin hydroxide of 25 mg/m3 should be considered as immediately 
dangerous to life or health. The FDA regulates the use of some organic tin compounds in 
coatings and plastic food packaging. The FDA also has set limits for the use of tin, as stannous 
chloride, as an additive for food. 
Additional information on governmental regulations and guidelines regarding tin and compounds 





10 TIN AND TIN COMPOUNDS 
1. PUBLIC HEALTH STATEMENT 
1.10 WHERE CAN I GET MORE INFORMATION? 
If you have any more questions or concerns, please contact your community or state health or 
environmental quality department, or contact ATSDR at the address and phone number below. 
ATSDR can also tell you the location of occupational and environmental health clinics.  These 
clinics specialize in recognizing, evaluating, and treating illnesses that result from exposure to 
hazardous substances. 
Toxicological profiles are also available on-line at www.atsdr.cdc.gov and on CD-ROM. You 
may request a copy of the ATSDR ToxProfilesTM CD-ROM by calling the toll-free information 
and technical assistance number at 1-888-42ATSDR (1-888-422-8737), by e-mail at 
atsdric@cdc.gov, or by writing to: 
Agency for Toxic Substances and Disease Registry 

  Division of Toxicology 

1600 Clifton Road NE 

  Mailstop F-32 

  Atlanta, GA 30333 

  Fax: 1-770-488-4178 

Organizations for-profit may request copies of final Toxicological Profiles from the following: 
National Technical Information Service (NTIS) 

5285 Port Royal Road 

  Springfield, VA 22161 

  Phone: 1-800-553-6847 or 1-703-605-6000 
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2.1 	 BACKGROUND AND ENVIRONMENTAL EXPOSURES TO TIN AND TIN 
COMPOUNDS IN THE UNITED STATES 
Tin is a naturally occurring element.  It is a silver-white, malleable, and somewhat ductile metal.  The 
earth's crust contains about 2–3 ppm tin, comprising 0.0006% of the earth's crust.  Major uses of tin 
include cans and containers, electrical, construction, and transportation.  Industrially important tin 
compounds can be categorized as inorganic (those without a tin-carbon bond) and organic (those having a 
tin-carbon bond). Inorganic tin compounds are used in the glass industry, and also serve as the base for 
the formulation of colors, as catalysts, and in perfumes and soaps.  The major commercial applications for 
organotin compounds are as polyvinyl chloride (PVC) heat stabilizers, biocides, catalysts, agrochemicals, 
and glass coatings. 
Tin may be released to the environment from natural and anthropogenic sources.  Tin is a component of 
many soils and tin and inorganic tin compounds may be released by weathering and agricultural activities.  
Releases of tin to the environment may also occur from the production and use of tin and tin compounds.  
Tin is generally regarded as being relatively immobile in the environment.  In general, organotin 
compounds are released to the environment through their production and use.  Tributyltin and triphenyltin 
enter the environment directly from their use as antifouling paints and as pesticides.  To a lesser extent, 
organotin compounds may also enter the environment by leaching from consumer products and from the 
disposal of products containing organotin compounds in landfills.  Organotin compounds are generally
found to partition to soils and sediments.  
Occupational exposure to tin may be significant in some industrial environments.  Ambient 
environmental levels of tin are generally quite low, except in the vicinity of pollution sources.  Human 
exposure to tin may occur by inhalation, ingestion, or dermal absorption.  Dermal absorption is a 
significant route of occupational exposure for certain organotin compounds.  The average daily tin intake 
of an adult in the United States was estimated at 4.003 mg (4 mg from food and 0.003 mg from air), and 
with undetectable levels contributed by drinking water.  The most important source for exposure to tin is 
from food, especially canned food products.  Tin-lined cans used to package food are the most important 
contributor to dietary tin intake.  There was a significant correlation between the amount of canned food 
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canned foods will be exposed to higher amounts of tin than people eating more fresh foods.  Tin 
concentrations in foods will depend on whether they are packaged in lacquer tin-lined cans or 
unlacquered cans. Mean tin concentrations ranging from <1 to 1,000 mg/kg have been found in foods 
packaged in unlacquered or partially lacquered cans, while the average tin concentration in foods in 
lacquered cans has been reported to be 0–6.9 mg/kg.  More than 90% of tin-lined cans used for food today
are lacquered.  Only light colored fruit and fruit juices are packed in unlacquered cans, since tin helps 
maintain the color of the product. 
Data on human exposure to organotin compounds are more limited.  Potential exposure for the general 
population to organotin compounds would be expected to exist for butyltin compounds, phenyltin 
compounds, and di- and monomethyltin, according to available monitoring data. In a market basket study
in Japan, daily intakes of tributyltin and triphenyltin in Japan were estimated to be 6.9 and 5.4 μg, 
respectively, in 1991 and 6.7 and 1.3 μg, respectively, in 1992, with 95% of the daily intakes of tributyltin 
and triphenyltin coming from the fish, mollusks, and crustaceans food group.  Mono- and dimethyltin and 
mono- and dibutyltin compounds have been detected in drinking water in Canada where PVC pipes, 
containing these organotin compounds, are used in the distribution of drinking water.  It has been 
demonstrated that butyltin compounds in siliconized baking parchment can be transferred to food baked 
on this type of baking parchment.  Organotin compounds were found in household dust in a United 
Kingdom study.  Monitoring data were not found to indicate whether the general population is exposed to 
other organotin compounds, such as trimethyltin and triethyltin. 
2.2 SUMMARY OF HEALTH EFFECTS 
Most of the information on the health effects of inorganic and organic tin in humans comes from studies 
of individuals exposed at work, volunteers exposed to controlled amounts, and accidental or intentional 
exposures. Except for the studies in volunteers, exposure characterization in the reports on humans is 
generally lacking.  Numerous studies have been conducted on the effects of tin and related compounds in 
a variety of animal species (primarily rodents) mostly following ingestion by the oral route.  
Humans chronically exposed to inorganic tin (e.g., stannic oxide dust or fumes) manifest a benign form of 
pneumoconiosis known as stannosis, which involves mainly the lower respiratory system.  
Gastrointestinal effects, such as nausea, vomiting, and diarrhea have been reported in subjects ingesting 
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evidence that inorganic tin affects reproduction or development in humans or that it is a neurotoxin, 
immunotoxin, mutagenic, or carcinogenic agent in humans.  A relatively limited number of studies in 
animals have not clearly established potential target organs for inorganic tin toxicity. Of the effects 
described, hematological signs of anemia and gastrointestinal distension appear to be best identified as 
tin-related. No adverse reproductive or developmental effects of inorganic tin were reported in a small 
number of studies available.  Tin affects the metabolism of other metals such as copper, zinc, and iron; 
therefore, if the pharmacokinetics of these metals is altered, it is difficult to ascertain whether a specific 
effect is caused by exposure to tin itself or is due to fluctuations in tissue levels of other metals.  
Bioassays for carcinogenicity of inorganic tin have been negative. 
Cases of lethality have been reported after acute inhalation exposure to a mixture of vapors of trimethyltin 
and dimethyltin organotins and after acute oral ingestion of trimethyltin.  In addition, approximately
100 deaths occurred in France in 1954 following ingestion of a proprietary drug that seemed to have been 
contaminated with ethyltin triiodide, triethyltin iodide, or tetraethyltin.  Deaths occurred after exposure to 
an estimate dose of 3 g triethyltin iodide over a period of 6–8 weeks.  Those affected showed neurological 
signs and symptoms such as headache, photophobia, altered consciousness, and convulsions. These 
appeared about 4 days after intoxication and, in individuals who recovered, continuous headaches and 
weakness persisted for at least 4 years.  Additional cases of accidental or intentional acute inhalation, oral, 
or dermal intoxication with trimethyltin or triphenyltin also have included adverse neurological effects 
that persisted for a long time (years in some cases) after the poisoning episode.  Organotins also are 
known to be skin and eye irritants in humans. 
There are no studies that evaluated whether organotin compounds cause developmental or reproductive 
alterations in humans or cancer.  Limited inhalation data from intermediate-duration studies in animals 
indicate that organotins can produce lung alterations, irritation of the respiratory airways, skin, and eyes, 
and liver and kidney effects.  In contrast to the limited inhalation database, an extensive oral database 
indicates that trimethyltin and triethyltin compounds are primarily neurotoxic, whereas tributyltin, 
dibutyltin, and dioctyltin are essentially immunotoxic.  Hepatic and hematological effects also have been 
described in animals treated orally with organotins.  Triphenyltin, dibutyltin, and tributyltin, when 
administered during pregnancy, have induced developmental and reproductive effects in rodents.  
However, it remains unclear whether these effects occur only at doses that induce maternal toxicity.  
Studies of genotoxic activity of organotin compounds have given mixed results depending on the specific 
compound and test system.  Dibutyltin acetate, triphenyltin hydroxide, and tributyltin oxide have been 
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carcinogenicity in Fischer-344 rats and B6C3F1 mice, whereas the results for tributyltin oxide in Wistar 
rats were considered questionable by the EPA and led to a carcinogenic classification of “not classifiable 
as to human carcinogenicity” or, to a group of substances for which there is “inadequate information to 
assess carcinogenic potential,” according to updated guidelines.  Additional studies with higher doses of 
triphenyltin hydroxide in Wistar rats and NMRI mice showed increased incidence of pituitary cancer in 
female rats and of liver cancer in female mice. 
A greater detailed discussion of immunological, neurological, reproductive/developmental, and 
hematological effects of tin and compounds follows.  The reader is referred to Section 3.2, Discussion of 
Health Effects by Route of Exposure, for additional information on other health effects. 
Immunological and Lymphoreticular Effects.    There are no studies that evaluated whether 
environmental concentrations of tin or organotin compounds alter immunocompetence in humans.  
However, acute exposure of rats to higher concentrations (generally >2 mg/kg/day) of tributyltins and 
other organotins have caused immune alterations. The effect is characterized by reduced thymus weight 
and size and lymphocyte depletion.  Dialkyltins appear to directly interfere with proliferation of 
thymocytes, a cytostatic effect, whereas tributyltin oxide has a direct and selective toxic action on 
lymphocytes in the thymus.  Long-term studies with tributyltin oxide in rats have demonstrated alterations 
in parameters of specific and nonspecific resistance at the relatively low dose level of 0.25 mg/kg/day.  
Although no adverse immunological effects have been described in humans exposed to tin and 
compounds, the high sensitivity exhibited by the rat thymus and the impairment in resistance to infection 
suggest that similar responses might occur in humans exposed to these chemicals at high concentrations 
or for long periods of time. 
Neurological Effects. While adverse neurological effects have been described in animals following 
oral exposure to various organotin compounds, triethyltins and trimethyltins are by far the most potent 
neurotoxins of the organotins and have been the most extensively studied in experimental animals.  The 
results from animal studies have confirmed the findings reported in cases of accidental or intentional 
exposure to trimethyltin and triethyltin in humans.  Triethyltin produces brain and spinal cord swelling, 
which is characterized by accumulation of fluid between myelin layers, splitting of the myelin sheets, and 
formation of intramyelin vacuoles.  This was observed in fatal cases that occurred from a massive 
accidental intoxication episode in France in 1954 and similar results have been reproduced in animal 
studies exposed to doses t1 mg/kg/day. Individuals affected in the French case showed neurological 
signs and symptoms such as headache, photophobia, altered consciousness, and convulsions. These 
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appeared about 4 days after intoxication and, in individuals who recovered, recurrent headaches and 
weakness persisted for at least 4 years.  Studies in animals have confirmed the reversibility of some of the 
neurological effects.  Trimethyltin produces neuronal necrosis, particularly in the hippocampus and other 
structures in the limbic system, and this has been demonstrated in humans and in animals.  Studies in 
animals have described neuronal necrosis in the neocortex, pyriform cortex, hippocampal formation, basal 
ganglia, brain stem, spinal cord, and dorsal root ganglia after single doses of t1 mg/kg.  The 
morphological changes that occur in the brain translate into behavioral alterations, such as aggression 
(both in humans and in animals), memory loss, and unresponsiveness.  Some neurological symptoms can 
last for years.  No population group has been identified that has undergone long-term exposure to low 
levels of trimethyltin or triethyltin, and no monitoring data are available to evaluate current exposures of 
the general population, but it is unlikely that adverse neurological effects would occur in humans exposed 
to environmental levels of organotins. 
Reproductive/Developmental Effects.    There are no data regarding reproductive/developmental 
effects of inorganic or organic tin compounds in humans.  Two early studies found no adverse 
reproductive/developmental effects of inorganic tin in rodents.  Much of the information available 
regarding reproductive/developmental effects of organotins in animals comes from studies conducted in 
the 1990s. Numerous studies have been conducted with tributyltin, triphenyltin, and dibutyltin which 
have been shown to cause pregnancy failure, preimplantation loss, postimplantation loss, resorptions, and 
fetal death. The highest incidence of resorptions and postimplantation losses occurred when the 
chemicals were administered on gestation days 7–9. Doses that induced these effects were generally
>3 mg/kg/day.  Implantation loss has been attributed to a suppression of uterine decidualization caused by
decreased levels of serum progesterone.  Organotins have also proved to be embryotoxic and teratogenic, 
including in studies in vitro using cultured rat embryos.  The most commonly seen malformation was cleft 
palate and other facial malformations. For dibutyltin dichloride, the highest incidence of malformations 
occurred when dosing on gestation day 8.  A key issue in evaluating reproductive/developmental effects 
has been to ascertain whether the effects occur secondary to maternal toxicity or occur in the absence of 
maternal toxicity (generally assessed by clinical observations and alterations in body weight gain).  Thus 
far, a conclusive answer has not been provided.  Male rats exposed to 10 mg tributyltin/kg/day for 10 days
had histologic alterations in the seminal vesicles and epididymis and reduced sperm counts, but except for 
these findings, reproductive effects of organotins in males have not been well studied.  Two 
multigeneration studies in rats with tributyltin chloride showed slight alterations in developmental 
landmarks in male and female animals suggesting a possible endocrine modulatory role for this
compound in laboratory rats.  Results from studies in vitro show that some organotins can alter the 
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activities of enzymes involved in the synthesis of sex hormones in mammals, which can alter the 
androgens/estrogens balance and affect sexual maturation. However, further studies are necessary to 
establish the relevancy of these findings to human exposures. 
Hematological Effects. No data were located regarding hematological effects of inorganic tin or 
organotins in humans.  Tin affects the metabolism of a number of essential minerals such as iron, copper, 
zinc, calcium, and selenium by mechanisms that are not totally clear, but which could involve altered 
absorption and/or retention. Studies in animals have shown that excess dietary tin reduces serum iron and 
copper levels. Thus, as expected, feeding a diet with excess tin to rats produced signs of anemia, which 
was reversed by enriching the diet with iron and/or copper.  It is reasonable to assume that individuals 
with low levels of iron or copper may be at risk of developing signs of anemia if at the same time they
consume excessive amounts of tin. 
Organotin compounds have produced hematological effects in laboratory animals.  In a 13-week study
with dibutyltin dichloride in rats, the most sensitive end point was hemoglobin concentration which was 
depressed at a dose of 5.7 mg/kg/day, but not at 3.4 mg/kg/day. Long-term studies with tributyltin oxide 
in rats also have produced decreased hemoglobin concentrations.  Since there was an indication of 
increased young erythrocytes and decreased serum iron concentrations, it was suggested that exposure to 
tributyltin oxide disrupts hemoglobin synthesis by interfering with iron uptake or by promoting iron loss.  
Exposure of rats to dioctyltin dichloride also reduced hemoglobin concentration in rats in a 6-week 
dietary study.  Whether signs of anemia occur in humans exposed to environmental levels of organotin 
compounds is not known and, although plausible, this seems unlikely due to their relatively low 
environmental levels.   
2.3 MINIMAL RISK LEVELS 
Estimates of exposure levels posing minimal risk to humans (MRLs) have been made for tin and tin 
compounds.  An MRL is defined as an estimate of daily human exposure to a substance that is likely to be 
without an appreciable risk of adverse effects (noncarcinogenic) over a specified duration of exposure.  
MRLs are derived when reliable and sufficient data exist to identify the target organ(s) of effect or the 
most sensitive health effect(s) for a specific duration within a given route of exposure.  MRLs are based 
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acute, intermediate, and chronic duration exposures for inhalation and oral routes.  Appropriate 
methodology does not exist to develop MRLs for dermal exposure. 
Although methods have been established to derive these levels (Barnes and Dourson 1988; EPA 1990), 
uncertainties are associated with these techniques.  Furthermore, ATSDR acknowledges additional 
uncertainties inherent in the application of the procedures to derive less than lifetime MRLs.  As an 
example, acute inhalation MRLs may not be protective for health effects that are delayed in development 
or are acquired following repeated acute insults, such as hypersensitivity reactions, asthma, or chronic 
bronchitis. As these kinds of health effects data become available and methods to assess levels of 
significant human exposure improve, these MRLs will be revised. 
Inhalation MRLs 
No inhalation MRLs were derived for inorganic tin or organic tin compounds since adequate experimental 
data were not available by this route of exposure. 
Oral MRLs 
Inorganic Tin. Acute oral data for inorganic tin were limited to an early reproductive/developmental 
study in rodents exposed during gestation (FDA 1972) and a study in which rats and mice were given 
either a single dose of stannous chloride or were treated for 14 days (NTP 1982).  The NTP studies were 
pilot studies of limited scope designed primarily to establish dose levels to be tested in longer-term
studies. Although the FDA (1972) study provided adequate information on embryotoxicity and 
teratogenicity of tin chloride, it is unknown whether sensitive end points for inorganic tin, such as 
hematological parameters, were affected in the dams because no evaluations were conducted.  The 
intermediate-duration database is based on a limited number of studies, but a 13-week study in rats 
provided sufficient information for derivation of an intermediate oral MRL for tin (De Groot et al. 1973).
No chronic-duration MRL was derived for inorganic tin because the lowest dose tested, 0.7 mg Sn/kg/day
as stannous chloride, reduced survival in rats in a 42-month drinking water study (Schroeder et al. 1968). 
An MRL of 0.3 mg/kg/day has been derived for intermediate-duration oral exposure (15– 
364 days) to inorganic tin. 
The intermediate-duration MRL was based on a NOAEL of 32 mg Sn/kg/day (as stannous chloride) for 
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The diet provided doses of approximately 0, 9.5, 32, 95, and 315 mg/kg/day.  End points monitored 
included survival, body weight, food intake, hematology (hemoglobin, hematocrit, total erythrocytes, total 
and differential leukocytes), serum chemistry (transaminases, alkaline phosphatase, bilirubin), urinalysis, 
organ weights (nine organs), and gross and microscopic pathology.  Tin in the standard diet was not 
determined, but the concentrations of calcium, phosphorus, iron, copper, and zinc were known.  The 
highest dietary level tested caused reduced food consumption and abdominal distension on week 1.  At 
week 8, loss of body weight occurred in males and females and one male died.  At week 9, another three 
males died and the group was discontinued.  Rats in the 95 mg/kg/day group showed poor appetite and 
abdominal distension the first 2 weeks; this was associated with decreased food consumption, but they
continued growing.  At termination, no significant differences in body weight were seen.  Food 
consumption was also low in the 32 mg/kg/day group but only for week 1.  Hemoglobin concentration 
was significantly reduced starting at week 4 in the 95 and 315 mg/kg/day groups (about 12 and 20%, 
respectively), and at week 4 in the 32 mg/kg/day males (3% reduction).  Terminal hemoglobin and 
hematocrit were significantly reduced only in high-dose treated males (6 and 4%, respectively).  Tin had 
no noticeable effect on osmotic resistance of the erythrocytes or on the number of reticulocytes.  Serum
alkaline phosphatase was significantly decreased at termination in both sexes, but there was no significant 
effect on transaminases or in bilirubin concentration.  Terminal urine samples were unremarkable, as were 
relative organ weights. Rats from the high-dose group (315 mg/kg/day) that had to be terminated early
showed distended intestines, slight edema of the pancreas, and grayish-brown livers.  The high-dose rats 
had moderate testicular degeneration, severe pancreatic atrophy, spongy white matter in the brain, acute 
bronchopneumonia, enteritis, and liver changes characterized by homogeneous appearance of the liver 
cell cytoplasm and mild proliferation of the bile duct epithelium.  In the 95 mg/kg/day group, treatment-
related effects included bile duct epithelium proliferation and homogeneous cytoplasm at termination.  
Applying an uncertainty factor of 100 (10 for animal to human extrapolation and 10 for human 
variability) to the NOAEL of 32 mg/kg/day yields an intermediate-duration MRL of 0.3 mg/kg/day for 
inorganic tin.  The 95 mg/kg/day dose level is considered a minimal LOAEL based on the unknown 
biological significance of a 12% reduction in hemoglobin concentration. 
Derivation of oral MRLs was considered for the following organotin compounds: tributyltin, triethyltin, 
trimetyltin, triphenyltin, dibutyltin, and dioctyltin.  These are the organotins that have been subject to the 
most studies.  Of these, relevant and adequate information was found only for tributyltin, for which an 
intermediate-duration MRL and a chronic-duration MRL were derived, and for dibutyltin, for which an 
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Dibutyltin. One of the lowest-observed-adverse-effect levels (LOAELs) for acute oral exposure to 
dibutyltin was 3.8 mg/kg/day for a reproductive effect in rats, a significant increase in postimplantation 
loss per litter, a serious LOAEL (Ema and Harazono 2000).  The highest NOAEL below that LOAEL was 
2.5 mg/kg/day for developmental effects in rats (Ema et al. 1991b), which is very near the serious 
LOAEL. The chronic-duration database was limited to the NCI (1978a) study in which a relatively low 
dose, 6.7 mg/kg/day caused significant early mortality in rats.  An intermediate-duration oral MRL was 
derived for dibutyltin dichloride. 
An MRL of 0.005 mg/kg/day has been derived for intermediate-duration oral exposure (15– 
364 days) to dibutyltin dichloride. 
The intermediate-duration oral MRL of 0.005 mg/kg/day for dibutyltin dichloride is based on a LOAEL 
of 5 mg/kg/day for immunological effects in rats (Seinen et al. 1977b).  Groups of male weanling Wistar 
rats were fed diets containing 0, 50, or 150 ppm of the test material (>98% pure) for 4–6 weeks.  Based 
on a body weight of 0.2 kg, it can be estimated that these levels provided doses of dibutyltin dichloride of 
approximately 0, 5, and 15 mg/kg/day (EPA 1988e).  End points examined included body weight and 
parameters of humoral and cellular immune responses.  The humoral immune response was assessed by
measuring antibody formation against SRBC and E. coli lipopolysaccharide.  The cellular immune 
response was assessed by examining allograft rejection.  Final body weight after 4 weeks of exposure was 
not significantly altered relative to controls, but it was 28% lower than controls in the high-dose group 
after 6 weeks of exposure. Allograft rejection time was significantly delayed in the high-dose group 
relative to controls. In the tests for humoral response, the number of antibody-producing cells per million 
spleen cells was not affected, but the number per whole spleen was significantly decreased in a dose-
related manner.  This response was associated with a decreased hemagglutination titer in the high-dose 
group.  The antibody titers against E. coli lipopolysaccharide were slightly but not significantly lower in 
treated groups than in controls. The dose of 5 mg/kg/day is the study LOAEL based on the reduction in 
hemagglutinating antibodies against SRBC.  Applying an uncertainty factor of 1,000 (10 for animal to 
human extrapolation, 10 for use of a LOAEL, and 10 for species variability) to the LOAEL of 
5 mg/kg/day yields an intermediate-duration oral MRL of 0.005 mg/kg/day for dibutyltin dichloride. 
Dioctyltin. Only one acute-duration study was available that provided limited information on systemic 
effects and on effects on the immune system (Seinen et al. 1977a).  Intermediate-duration studies focused 
mainly on the immune system and a relatively low dose tested, approximately 7 mg/kg/day, caused 
significantly mortality in guinea pigs after 4–5 weeks of treatment (Seinen et al. 1977b).  No chronic-
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Triphenyltin.  Most acute-duration studies provide information on reproductive and developmental 
effects and NOAELs and LOAELs are around 3–6 mg/kg/day.  A dose level of 4.7 mg/kg/day was a 
serious reproductive LOAEL in rats (Ema et al. 1997b). An intermediate-duration study reported high 
lethality (100%) in rats at approximately 23 mg/kg/day, but did not report whether deaths occurred at 
lower dose levels tested (NCI 1978b). That study also reported that the lowest dose tested, approximately
5 mg/kg/day, caused 25% reduction in body weight gain, a serious effect.  High lethality was observed in 
rats in a chronic-duration study with the lowest dose level tested, 0.4 mg/kg/day (Tennekes et al. 1989b).  
A study in dogs, available in summary form only, found no significant effects of triphenyltin hydroxide 
on a wide range of end points at doses of up to 0.62 mg/kg/day in the diet for up to 52 weeks (Sachsse et 
al. 1987).  
Triethyltin.  Most dose levels of triethyltin caused serious effects (primarily neurological) both in acute 
and intermediate duration oral studies.  The highest NOAEL in an acute study was 2 mg/kg/day for 
neurological effects in a study by Snoeij et al. (1985), but that same dose level was a serious LOAEL for 
body weight in rats in that same study and caused ataxia and paralysis in a different study (Magee et al. 
1957).  The highest intermediate LOAEL was 0.66 mg/kg/day for body weight in rats (Purves et al. 
1991), but 1.4 mg/kg/day was lethal to rats (Smith 1973) and 0.7–0.8 mg/kg/day were serious 
neurological LOAELs (Eto et al. 1971; Purves et al. 1991; Reiter et al. 1980). No chronic-duration 
studies were located. 
Trimethyltin.  Most acute- and intermediate-duration studies of trimethyltin described serious 
neurological effects occurring at the lowest dose levels tested.  The highest acute-duration NOAEL was 
0.7 mg/kg/day for neurological effects in rats (Snoeij et al. 1985), but 1 mg/kg/day was a serious 
neurological LOAEL (self-mutilating and aggressive behavior) in rats (Bouldin et al. 1981).  Doses 
2 mg/kg/day were lethal (Brown et al. 1984; Nolan et al. 1990; Snoeij et al. 1985).  In the few 
intermediate-duration studies available, the lowest LOAEL was 0.05 mg/kg/day for impaired performance 
of rat pups in a learning task, but there was no dose-response relationship (Noland et al. 1982).  No 
chronic-duration studies were located. 
Tributyltin. The lowest LOAEL in acute-duration studies was 1 mg/kg/day and caused hyperactivity and 
dysfunction of spatial learning performance in adult rats whose mothers were exposed during pregnancy; 
no other dose levels were tested (Gardlung et al. 1991).  This developmental effect is considered serious, 
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for reduction in maternal serum thyroxine levels in a developmental study in rats (Adeeko et al. 2003).  
Since no other maternal end points were monitored in the study, it seems inappropriate to use this 
NOAEL as basis for an acute oral MRL for tributyltin.  Another relatively low dose, 2.5 mg/kg/day for 
6 days, caused significant weight loss in rats, a serious effect (Yallapragada et al. 1991).  Intermediate-
and chronic-duration oral MRLs were derived for tributyltin. 
An MRL of 0.0003 mg/kg/day has been derived for intermediate-duration oral exposure (15– 
364 days) to tributyltin oxide. 
The intermediate-duration oral MRL of 0.0003 mg/kg/day for tributyltin oxide is based on a NOAEL of 
0.025 mg/kg/day for immunological effects in rats (Vos et al. 1990).  Groups of male Wistar rats were fed 
a diet containing 0, 0.5, 5, or 50 ppm tributyltin oxide (95.3% pure) for 4.5–6 months.  This diet provided 
approximately 0, 0.025, 0.25, and 2.5 mg/kg/day of the test material.  Parameters of specific resistance 
evaluated included immunoglobulin M (IgM) and immunoglobulin G (IgG) response to ovalbumin and 
delayed-type hypersensitivity (DTH) response to ovalbumin and tuberculin after 6 months of treatment; 
resistance to Trichinella spiralis infection after 5.5 months; mitogenic response of thymus and spleen 
cells after 4.5 months; and surface marker analysis of mesenteric lymph nodes after 6 months.  Parameters 
of nonspecific resistance examined included clearance of Listeria monocytogenes from the spleen after 
injection at 5 months and natural cell-mediated cytotoxicity of spleen and peritoneal cells after 
4.5 months.  Neither body weight nor spleen weight were significantly altered after 4.5 months of 
treatment, but thymus weight was reduced by 17% relative to controls in the high-dose group.  Neither the 
IgM nor IgG response to ovalbumin and T. spiralis was altered after 5.5 months of exposure.  The 
immunoglobulin E (IgE) responses to T. spiralis, as determined by the passive cutaneous anaphylaxis 
reaction, was suppressed in a dose-related manner (significant in the mid- and high-dose groups).  The 
DTH reactions to ovalbumin and tuberculin were not significantly altered after 6 months of dosing.  There 
was an increase in the number of larvae T. spiralis in muscle after infection in the mid- and high-dose 
groups after 5.5 months of exposure to the test material.  No significant effect was observed on the 
response of spleen cells to T- and B-mitogens after 4.5 months.  The cell surface marker analysis of 
mesenteric lymph node cells showed a reduction in the relative count of T-lymphocytes and an increase in 
the percentage of B-lymphocytes in the mid- and high-dose groups after 6 months of treatment.  The in 
vivo clearance of L. monocytogenes was impaired in the high-dose group after 5 months of treatment.  
Treatment with tributyltin oxide did induce a consistent effect on the natural killer cell activity of spleen 
and peritoneal cells after 4.5 months of exposure (decreased with low dose, increased with mid dose, and 
decreased with high dose).  Based on the depression of IgE titers and increased T. spiralis in muscle after 
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0.025 mg/kg/day.  Applying an uncertainty factor of 100 (10 for animal to human extrapolation and 10 for
intraspecies variability) to the NOAEL yields an intermediate-duration oral MRL of 0.0003 mg/kg/day. 
An MRL of 0.0003 mg/kg/day has been derived for chronic-duration oral exposure (365 days or 
more) to tributyltin oxide. 
The chronic-duration oral MRL of 0.0003 mg/kg/day for tributyltin oxide is based on a NOAEL of 
0.025 mg/kg/day for immunological effects in rats (Vos et al. 1990).  Groups of male Wistar rats were fed 
a diet containing 0, 0.5, 5, or 50 ppm tributyltin oxide (95.3% pure) for 18 months.  This diet provided 
approximately 0, 0.025, 0.25, and 2.5 mg/kg/day of the test material.  Parameters of specific resistance 
evaluated included IgM and IgG response to sheep red blood cells (SRBC) after 16 months; IgM and IgG 
response to ovalbumin and DTH response to ovalbumin and tuberculin after 15 months of treatment; 
resistance to T. spiralis infection after 16.5 months; mitogenic response of thymus and spleen cells after 
16.5 months; and surface marker analysis of mesenteric lymph nodes after 18 months.  Parameters of 
nonspecific resistance examined included clearance of L. monocytogenes from the spleen after injection at 
17 months and natural cell-mediated cytotoxicity of spleen and peritoneal cells after 16 months.  No 
information was provided regarding body weight or weigh of the thymus and spleen weights at 
termination.  Exposure to tributyltin oxide did not affect the primary IgM or the secondary response to 
SRBC after 16 months of dosing.  Neither the IgM nor IgG response to ovalbumin and T. spiralis were 
altered after 15 months of exposure, but the IgE responses to T. spiralis, as determined by the passive 
cutaneous anaphylaxis reaction, were suppressed in a dose-related manner (significant in the mid- and 
high-dose groups). The DTH reactions to ovalbumin and tuberculin were not significantly altered after 
16 months of dosing.  There was an increase in the number of larvae T. spiralis in muscle after infection 
in the mid- and high-dose groups after 16.5 months of exposure to the test material.  No significant effect 
was observed on the response of spleen cells to T- and B-mitogens after 16 months.  The cell surface 
marker analysis of mesenteric lymph node cells showed a reduction in the relative count of 
T-lymphocytes and an increase in the percentage of B-lymphocytes in the mid- and high-dose groups 
after 18 months of treatment.  The in vivo clearance of L. monocytogenes was impaired in the high-dose 
group after 17 months of treatment.  Treatment with tributyltin oxide for 16 months significantly reduced 
the natural killer cell activity of spleen and peritoneal cells, but there was no clear dose-response 
relationship. Based on the depression of IgE titers and increased T. spiralis in muscle after 16.5 months 
of exposure to tributyltin oxide, the study LOAEL is 0.25 mg/kg/day and the NOAEL is 
0.025 mg/kg/day.  Applying an uncertainty factor of 100 (10 for animal to human extrapolation and 10 for
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3.1 INTRODUCTION 
The primary purpose of this chapter is to provide public health officials, physicians, toxicologists, and 
other interested individuals and groups with an overall perspective on the toxicology of ton and tin 
compounds.  It contains descriptions and evaluations of toxicological studies and epidemiological 
investigations and provides conclusions, where possible, on the relevance of toxicity and toxicokinetic 
data to public health. 
A glossary and list of acronyms, abbreviations, and symbols can be found at the end of this profile. 
Because there is such a large number of inorganic tin and organotin compounds, only the most widely
studied compounds and those that present the greatest potential for human exposure have been selected 
for the discussion of health effects. In addition to primary studies, review articles and government reports 
are occasionally provided in order to assist the reader in understanding more fully the toxicology of the 
tin compounds. 
3.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE 
To help public health professionals and others address the needs of persons living or working near 
hazardous waste sites, the information in this section is organized first by route of exposure (inhalation, 
oral, and dermal) and then by health effect (death, systemic, immunological, neurological, reproductive, 
developmental, genotoxic, and carcinogenic effects).  These data are discussed in terms of three exposure 
periods: acute (14 days or less), intermediate (15–364 days), and chronic (365 days or more). 
Levels of significant exposure for each route and duration are presented in tables and illustrated in 
figures. The points in the figures showing no-observed-adverse-effect levels (NOAELs) or lowest­
observed-adverse-effect levels (LOAELs) reflect the actual doses (levels of exposure) used in the studies. 
LOAELs have been classified into "less serious" or "serious" effects.  "Serious" effects are those that 
evoke failure in a biological system and can lead to morbidity or mortality (e.g., acute respiratory distress 
or death). "Less serious" effects are those that are not expected to cause significant dysfunction or death, 
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considerable amount of judgment may be required in establishing whether an end point should be 
classified as a NOAEL, "less serious" LOAEL, or "serious" LOAEL, and that in some cases, there will be 
insufficient data to decide whether the effect is indicative of significant dysfunction.  However, the 
Agency has established guidelines and policies that are used to classify these end points.  ATSDR 
believes that there is sufficient merit in this approach to warrant an attempt at distinguishing between 
"less serious" and "serious" effects.  The distinction between "less serious" effects and "serious" effects is 
considered to be important because it helps the users of the profiles to identify levels of exposure at which 
major health effects start to appear. LOAELs or NOAELs should also help in determining whether or not 
the effects vary with dose and/or duration, and place into perspective the possible significance of these 
effects to human health. 
The significance of the exposure levels shown in the Levels of Significant Exposure (LSE) tables and 
figures may differ depending on the user's perspective.  Public health officials and others concerned with 
appropriate actions to take at hazardous waste sites may want information on levels of exposure 
associated with more subtle effects in humans or animals (LOAELs) or exposure levels below which no 
adverse effects (NOAELs) have been observed.  Estimates of levels posing minimal risk to humans 
(Minimal Risk Levels or MRLs) may be of interest to health professionals and citizens alike.
Levels of exposure associated with carcinogenic effects (Cancer Effect Levels, CELs) of tin compounds 
are indicated in Table 3-5 and Figure 3-5.  
A User's Guide has been provided at the end of this profile (see Appendix B).  This guide should aid in 
the interpretation of the tables and figures for Levels of Significant Exposure and the MRLs. 
3.2.1 Inhalation Exposure 
Little information has been published regarding the effects of inhaled inorganic tin or organotin
compounds on human health.  Reports of human occupational exposures often involve multiple chemicals 
and lack details on actual exposure concentrations and conditions.  Some reports of humans must also be 
regarded as anecdotal. The older animal literature (from the 1950s) includes inhalation studies that are 
lacking in description of methods and in reporting of experimental findings. However, it is still possible 
to characterize some aspects of tin toxicity due to inhalation of inorganic tin and organotin compounds.  
Exposure levels of the inhaled organotin compounds are expressed as milligrams per cubic meter (mg/m3) 
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covalent bond between the tin and the organic moiety.  There are no data for specific inorganic tin 
compounds.  Calculations of parts per million (ppm) values are included where appropriate.  Table 3-1 
and Figure 3-1 summarize available quantitative information on health effects that have been observed in 
animals after inhalation exposure to tributyltins.  Exposure levels are expressed as ppm in Table 3-1 and 
Figure 3-1. A table and figure are not presented for inorganic tin compounds due to limitations of the 
available studies. 
3.2.1.1 Death 
Inorganic Tin Compounds.  No studies were located regarding lethality in humans or animals after 
inhalation exposure to inorganic tin compounds. 
Organotin Compounds. Deaths have been reported in humans following exposure to organotins.  One of
six workers died 12 days following exposure to a mixture of half dimethyltin and half trimethyltin 
chloride vapor that occurred during the cleaning of a caldron at a chemical plant.  Maximum exposure 
was a total of 1.5 hours over a 3-day working period (Rey et al. 1984).  No estimates of exposure levels 
were given. The symptoms preceding death included excretion of high levels of tin in the urine, 
respiratory depression, and coma.  More uncertain is the report of a female worker who died following a 
drenching with triphenyltin chloride, diphenyltin dichloride, and other unidentified compounds.  No 
estimates of exposure levels were given. Death was apparently caused by renal failure 12 days after 
exposure (NIOSH 1976). No other studies were located regarding lethality in humans after inhalation 
exposure to organotin compounds. 
A 4-hour LC50 of 77 mg/m3 for tributyltin oxide (as total particles) was described by Schweinfurth and 
Gunzel (1987) in a summary of acute studies; the LC50 for particles with a diameter of <10 μm was 
65 mg/m3. The summary also indicates that a concentration of 20 mg/m3 of an aerosol of tributyltin oxide 
was lethal to guinea pigs within 1 hour of exposure.  Lethality in mice was observed following single or 
repeated daily exposures to a butyltin mixture (81.2% tributyltin bromide and 3.7% dibutyltin dibromide) 
together with other unidentified compounds (15.1%) (Igarashi 1959).  The concentration was 5.65 mg
tin/m3 (1.16 ppm) as the butyltin mixture for different durations of exposure.  The tributyltin bromide 
concentration was 1.1 ppm and that for dibutyltin bromide was 0.06 ppm.  For a 2-day, 8-hour/day
exposure, approximately 80–90% of the exposed mice died.  Despite the observation of other signs of 
toxicity (see Section 3.2.1.2) the exposure of the mice to multiple compounds confound the interpretation 














































Hepatic 0.42 (blood congestion) 
Renal 0.42 (glomerular swelling, 













6 hr/d Resp 0.3 (lung hyperemia, catarrhal bronchitis) 
Gohlke et al 1969 
TBT 
Hepatic 0.3 (minor fatty 
degeneration) 
Ocular 0.3 (inflamed eyes, nostrils) 
4 Rat 
(NS) 
80 d Resp 0.39 (bronchitis edema) Iwamoto 1960 
TBT 
Cardio 0.39 (myocardial atrophy) 
Hepatic 0.39 (atrophy, necrosis) 
Renal 0.39 (swelling and congestion) 



















































80 d 0.39 Iwamoto 1960 
TBT 
a The number corresponds to entries in Figure 3-1. 
Cardio = cardiovascular; d = day(s); Derm = dermal; hr = hour(s); LC50 = lethal concentration, 50% kill; LOAEL = lowest-observed-adverse-effect level; NOAEL = 
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In rats exposed nose-only for 29–32 days for 4 hours to doses of 0, 0.03 (vapor), 0.16 (vapor), or 
2.8 (aerosol) mg/m3 of tributyltin oxide 5 days/week for 21–24 treatments, the mortality in the high-dose 
group was 5/10 males and 6/10 females (Schweinfurth and Gunzel 1987); no toxicity was noticed in the 
groups exposed to vapors.  Little detail was presented in this brief summary. 
3.2.1.2 Systemic Effects 
No studies were located regarding cardiovascular, hematological, or musculoskeletal effects in humans or 
animals after inhalation exposure to inorganic tin or organotin compounds. 
The highest NOAEL values and all reliable LOAEL values for systemic effects in each species and 
duration category are recorded in Table 3-1 and plotted in Figure 3-1. 
Respiratory Effects. 
Inorganic Tin Compounds. Stannic oxide dust or fumes produce a benign form of pneumoconiosis, 
known as stannosis, in humans (Cutter et al. 1949; Dundon and Hughes 1950; Pendergrass and Pryde 
1948).  The workers exhibiting this pulmonary condition had industrial exposures ranging from 15 to 
20 years.  No exposure levels were included in the case reports.  In all cases, chest x-rays of the workers 
showed discrete opaque shadows throughout the lungs, attributed to stannic oxide deposits.  However, 
there was no impairment of pulmonary function or systemic disease.  It also has been reported that x-rays
of tin foundry workers confirmed more than 150 cases of stannosis by 1959 (Stewart and Lassiter 2001). 
No studies were located regarding respiratory effects in animals after inhalation exposure to inorganic tin 
compounds. 
Organotin Compounds. Respiratory depression requiring artificial ventilation occurred in three of six 
chemical workers.  The exposure duration was a total of 1.5 hours over a 3-day working-period to a 
mixture containing half dimethyltin and half trimethyltin chloride (Rey et al. 1984).  Although the two 
surviving workers, who were the most severely affected, developed permanent neurological disabilities, 
respiratory problems did not persist. 
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Tributyltin oxide has been implicated in producing irritation of the upper respiratory tract and chest 
irritation, tightness, and pain in workers using a rubber material containing tributyltin oxide.  Exposure 
conditions were not described. No changes were observed in pulmonary function tests (NIOSH 1976). 
Wax and Dockstader (1995) reported that all members of a family of five (two adults and three children) 
complained of sore throat, burning nose, and wheezing 24 hours after a room in their home had been 
painted with a paint containing tributyltin oxide for mildew control.  Cough and difficulty in breathing, 
characterized by inspiratory discomfort, were observed in a man a few hours after inhaling an unspecified 
amount of powdered trimethyltin chloride (Saary and House 2002).  Shortness of breath and chest 
discomfort was still present 20 days after the exposure. 
Inflammatory changes consisting of hyperemia and bronchitis were observed in the respiratory system of 
rabbits exposed to 4–6 mg/m3 (0.30–0.45 ppm) tributyltin chloride for 95 days (Gohlke et al. 1969).
Histopathology, consisting of severe bronchitis and vascular and alveolar edema, was seen in rats exposed 
to 2 mg tin/m3 (0.41 ppm) as a mixture of tributyltin bromide (0.39 ppm), dibutyltin dibromide 
(0.02 ppm), and hydrocarbon impurities for 80 days (Iwamoto 1960).  Since these were terminal 
histopathological evaluations only, it is not known whether the changes were reversible or would have 
produced functional impairment in the animals if exposure had continued. 
Information summarized by Schweinfurth and Gunzel (1987) indicate that a single 4-hour exposure of 
rats to aerosols of tributyltin oxide produced signs of irritation such as nasal discharge, lung edema and 
congestion. 
Gastrointestinal Effects.    
Inorganic Tin Compounds. No studies were located regarding gastrointestinal effects in humans or in 
animals after inhalation exposure to inorganic tin compounds. 
Organotin Compounds. Very limited information is available in humans.  Wax and Dockstader (1995) 
reported that nausea and vomiting occurred among all the members of a family of five who were exposed 
at home to tributyltin oxide contained in paint for mildew control.  Saary and House (2002) reported that 
a man who inhaled powdered trimethyltin chloride complained of substernal and epigastric burning with 
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Hematological Effects. 
Inorganic Tin Compounds.  No studies were located regarding hepatic effects in humans or in animals 
after inhalation exposure to inorganic tin compounds. 
Organotin Compounds. Data concerning hepatic effects of organotins in humans and animals are 
limited. 
Autopsy of a chemical worker who died following exposure to a combination of methyltin salts (see 
Section 3.2.1.1) revealed massive fatty degeneration of liver cells and necrosis (Rey et al. 1984).  
Fatty degeneration was observed at necropsy in animals killed after a 95-day exposure period to 4– 
6 mg/m3 (0.30–0.45 ppm) tributyltin chloride (Gohlke et al. 1969).  Histopathology, consisting of atrophy 
and slight necrosis of the liver, was seen in rats exposed to 2 mg tin/m3 (0.41 ppm) as a mixture of 
tributyltin bromide (0.39 ppm), dibutyltin dibromide (0.02 ppm), and hydrocarbon impurities for up to
80 days as part of a study of reproductive function (Iwamoto 1960).  Atrophy of the liver cells increased 
with exposure duration in the females.  Some recovery was apparent if exposure to tin was stopped prior 
to sacrifice. The longer the duration of exposure, the less complete the recovery. 
Renal Effects. 
Inorganic Tin Compounds.  No studies were located regarding renal effects in humans and animals after 
inhalation exposure to inorganic tin compounds. 
Organotin Compounds. Data concerning renal effects of organotins in humans and animals are limited.  
Autopsy of the one chemical worker who died following exposure to the combination of the methyltin 
salts (see Section 3.2.1.1) revealed shock kidneys (i.e., proximal tubule degeneration), which represents 
serious tubule damage (Rey et al. 1984).  The other five exposed men had high tin concentrations in the 
urine with the highest levels occurring in the most severely affected.  
Inhalation exposure of mice to a concentration of 5.65 mg tin/m3 (1.16 ppm) as a mixture of tributyltin 
bromide (1.1 ppm), dibutyltin dibromide (0.06 ppm), and hydrocarbon impurities for 7 hours/day over 
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degenerative changes in the glomeruli, convoluted tubules, and collecting tubules as well as extra-
medullary hematopoiesis.  More extensive kidney pathology was observed in rats exposed to 2 mg tin/m3 
(0.41 ppm) as a mixture of tributyltin bromide (0.39 ppm) and dibutyltin dibromide (0.02 ppm) for 
2 hours/day for 80 days.  Kidney damage consisted of extensive congestion and swelling of the renal 
tubular epithelium (Iwamoto 1960). 
Dermal Effects.    
Inorganic Tin Compounds.  Contact with inorganic tin salts produces mild irritation of the skin and 
mucous membranes (WHO 1980).  However, no specific studies were located regarding dermal effects in 
humans and animals after inhalation exposure to inorganic tin compounds. 
Organotin Compounds. No studies were located regarding dermal effects in humans after inhalation 
exposure to organotin compounds.  Occupational exposure produces such effects as discussed in 
Section 3.2.3.1. 
Dermal effects were observed during inhalation studies in mice that were exposed to a butyltin mixture 
(30 parts tributyltin bromide to 1 part dibutyltin dibromide) and consisted of reddening of the skin and 
dilatation of the blood vessels of the nose, feet, and tail (Igarashi 1959).  These effects may have been 
caused by direct contact with the chemical. 
Ocular Effects.    
Inorganic Tin Compounds. No information was located regarding ocular effects in humans following 
exposure to inorganic tin compounds. 
Organotin Compounds. Inflamed eyes and nasal mucous membranes were observed in the last month of 
a 95-day inhalation study of tributyltin chloride in female rats (Gohlke et al. 1969).  The animals were 
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3.2.1.3 Immunological and Lymphoreticular Effects 
No studies were located regarding immunological effects in humans or animals after inhalation exposure 
to inorganic tin or organotin compounds.  However, some lymph node atrophy was observed in rats 
exposed to a butyltin mixture for 14 days (Iwamoto 1960). 
3.2.1.4 Neurological Effects 
Inorganic Tin Compounds. No studies were located regarding neurological effects in humans or in 
animals after inhalation exposure to inorganic tin compounds. 
Organotin Compounds. A study by Rey et al. (1984) provides some information on neurobehavioral 
changes in humans after exposure to organotin compounds (dimethyltin dichloride and trimethyltin 
chloride). The study describes the cases of six chemical workers exposed to methyltins primarily by
inhalation who experienced headache, tinnitus, deafness, impaired memory, disorientation, 
aggressiveness, psychotic and other severe neuropsychiatric behavior, syncope, and loss of consciousness 
as symptoms of exposure; one subject died.  The two surviving workers with the highest urinary tin levels 
exhibited fixed neurological effects which were not resolved more than 6 years after exposure.  The 
remaining three survivors returned to work, but had memory loss, which persisted for 6 months.  Similar 
cases have been reported by other investigators. Fortemps et al. (1978) reported that two chemists who 
had been intermittently exposed to vapors of dimethyltin dichloride and trimethyltin chloride for about 
3 months abruptly developed a status of mental confusion with generalized epileptic seizures.  Before the 
acute episode, the subjects had complained of headaches, pain in various organs, and psychological 
disturbances such as memory defects, vigilance loss, insomnia, anorexia, and disorientation.  Both 
patients recovered completely following removal from exposure.  Ross et al. (1981) examined 22 male 
workers 1 month following exposure to trimethyltin spillage (presumable inhalation and dermal exposure 
occurred) and compared the frequency of neurological symptoms between those who suffered high 
exposure with those with lower exposure. Those highly exposed showed a significantly higher incidence 
of nonspecific symptoms such as forgetfulness, fatigue and weakness, loss of motivation, and specific 
symptoms such as bouts of depression and attacks of rage and temper compared to those with lower 
exposure. Some symptoms persisted for at least 3 years following the accident.  Yanofsky et al. (1991) 
and Feldman et al. (1993) described the case of a 23-year-old male who was accidentally exposed to 
vapors of a trimethyltin compound and 72 hours later exhibited delirium, spatial disorientation, 
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considerably elevated concentrations of trimethyltin when tested 3 weeks following the accident.  Five 
months after the accident, the man experienced complex partial seizures that required him to take 
anticonvulsant medication for 7 years.  Four years after exposure, tests revealed persistent memory
defects, cognitive dysfunction, and dysphoria.  Saary and House (2002) described the case of a man who 
worked in a chemistry laboratory and inhaled an undetermined amount of powdered trimethyltin chloride 
on a single occasion.  Within 3 hours of exposure he felt agitated and he later developed a headache, 
dizziness, and twitching of the right eye and cheek.  Two months after exposure, he continued 
experiencing twitching of his eyelids and arms and complained of suffering short-term memory problems 
and difficulty retaining new information.  
No relevant studies were located regarding neurological effects in animals after inhalation exposure to 
organotin compounds.  It was reported that no histopathological changes were observed in the brains of 
mice following a 6-day inhalation exposure to 2.12 mg tin/m3 (0.44 ppm) as a mixture of tributyltin 
bromide (0.42 ppm), dibutyltin dibromide (0.02 ppm), and hydrocarbon impurities (Igarashi 1959). 
3.2.1.5 Reproductive Effects 
Inorganic Tin Compounds.  No studies were located regarding reproductive effects in humans or animals 
after inhalation exposure to inorganic tin compounds. 
Organotin Compounds. No studies were located regarding reproductive effects in humans after 
inhalation exposure to organotin compounds. 
A study in rats was conducted to assess reproductive effects of a mixture of tributyltin bromide (81.2%) 
with other compounds such as dibutyltin dibromide (Iwamoto 1960).  The rats were exposed to 2 mg
tin/m3 (0.41 ppm) for acute- and intermediate-duration exposures (equivalent to 0.39 ppm tributyltin 
bromide and 0.02 ppm dibutyltin dibromide).  Pregnancy rates were markedly reduced after 4 weeks to 
3 months of exposure, but returned to near control rates when exposure was discontinued.  Histo­
pathological evaluations were made in separate studies of different exposure durations (14–80 days) 
followed by recovery periods.  No changes were seen in males, but atrophy of the glandular uterus was 
observed as early as 14 days of exposure in females.  All effects were reversed during the recovery
period. Although a mixture of butyltin compounds was used and the results were not clearly reported, 
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3.2.1.6 Developmental Effects 
No studies were located regarding developmental effects in humans or animals after inhalation exposure 
to inorganic tin or organotin compounds. 
3.2.1.7 Cancer 
No studies were located regarding cancer effects in humans and animals after inhalation exposure to 
inorganic tin or organotin compounds. 
3.2.2 Oral Exposure 
In contrast to the limited information on the inhalation toxicity of tin compounds (Section 3.2.1), there are 
considerable more data regarding the effects of oral exposure to organotin compounds, particularly in 
animal studies.  Although there is less information concerning health effects produced by oral exposure to 
inorganic tin compounds, the data from animal studies allow some characterization of health effects of 
these compounds.  Dosages are expressed as milligrams of tin per kilogram of body weight per day (mg 
tin/kg/day) as the specific inorganic tin compound fed or administered orally.  Table 3-2 and Figure 3-2 
summarize available quantitative information on health effects that have been observed in animals after 
oral exposure to inorganic tin compounds.  Similar information for organotin compounds is given in 
Tables 3-3 through 3-8 and Figures 3-3 through 3-8.  In order to be consistent with most studies in the 
literature, dosages are expressed as mg/kg/day of the specific organotin compound rather than as a tin 
equivalent. 
3.2.2.1 Death 
Inorganic Tin Compounds.  No studies were located regarding lethality in humans after oral ingestion of 
inorganic tin compounds. 
In animals, the lowest oral dose that produced deaths in rats following a single gavage administration was 
473 mg/kg body weight stannous chloride (NTP 1982).  However, all rats survived doses up to 
















































378 (1/5 males and 1/5 
females









1229 (males and females 
gained less weight than 




































































































































DeGroot et al. 1973 
SnCl2 
DeGroot et al. 1973 
Sn3(PO4)2 
Gastro 98 325 (slightly distended small 
and large intestine) 





33 98 (30% decreased body 











































Table 3-2 Levels of Significant Exposure to Inorganic Tin - Oral (continued) 
Exposure/ 
Duration/ 























































32 95 (14% reduced food 
consumption on week 2) 


































































































































Table 3-2 Levels of Significant Exposure to Inorganic Tin - Oral (continued) 
Exposure/ 
Duration/ 










































275 DeGroot et al. 1973 
SnSO4 
275 
28 83 (decreased hemoglobin 
and hematocrit) 
83 275 (slightly decreased 




28 83 (16% decreased body 
weight gain and 
decreased food intake in 
males) 
220 DeGroot et al. 1973 
SnC4-H406 
22 66 (decreased hemoglobin 
and hematocrit) 




22 66 (11% decreased body 



























































Cardio 285 DeGroot et al. 1973 
SnC204 
Hemato 29 86 (decreased hemoglobin 
and hematocrit) 




Bd Wt 29 86 (18-25% decreased body 
weight gain and 











































Table 3-2 Levels of Significant Exposure to Inorganic Tin - Oral	 (continued) 
Exposure/ 
Duration/ 


























ReferenceNOAEL Less Serious	 Serious 
(mg/kg/day)	 (mg/kg/day) (mg/kg/day) Chemical Form 
315	 DeGroot et al. 1973 
SnCl2 





















390	 DeGroot et al. 1973 
SnS 






































































Gastro 7.9 M (increased intestinal 
length) 
Janssen et al. 1985 
SnCl2 
Hemato 7.9 M (decreased hemoglobin 
concentration) 







Cardio 2457 NTP 1982 
SnCl2 









157 (11.7% decreased body 






Hemato 10 F (transient hemolytic 
anemia) 





































































































0.7 (decreased longevity in 
females by 11%) 









































Table 3-2 Levels of Significant Exposure to Inorganic Tin - Oral	 (continued) 
Exposure/ 
Duration/ 













































Less Serious	 Serious 
(mg/kg/day)	 (mg/kg/day) 
0.7	 (fatty degeneration) 
0.7	 (tubular degeneration, 
vacuolization) 
0.7	 (11-16% decreased body 





























































Bd Wt 0.7 Schroeder et al. 1968 
SnCl2 
a The number corresponds to entries in Figure 3-2. 
b Used to derive an intermediate-duration oral minimal risk level (MRL) of 0.3 mg/kg/day; the MRL was derived by dividing the NOAEL by an uncertainty factor of 100 (10 for animal 
to human extrapolation and 10 for human variability). 
Cardio = cardiovascular; d = day(s); Derm = dermal; (F) = feed; (GW) = gavage in water; Gastro = gastrointestinal; Hemato = hematological;  LOAEL = 
lowest-observed-adverse-effect level; M = males; mo = month(s); NOAEL = no-observed-adverse-effect level; SnC2O4 = stannous oxalate; SnC4H4O6 = stannous tartrate; 
Sn(C18H33O2)2 = stannous oleate; SnCl2 = stannous chloride; SnO2 = stannic oxide; Sn2O7N2 = stannous nitrate; Sn3(PO4)2 = stannous orthophosphate; SnS = stannous sulfide; 
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7.5 F (5 out 12 pregnant rats 
died) 







23 (4 females and 2 males 
died 
in second week) 








Gastro 50 (distention of stomach) Barnes and Magee 1958 
DBT 






Bd Wt 20 F (reduced body weight 
gain) 
40 F (significant body weight 
loss) 




































































Hepatic 7.7 23 (proliferation of bile duct 
epithelium; periportal 
fibrosis) 
Seinen et al. 1977a 
DBT 






Hepatic 18.3 M (increased serum AST 
and ALT activities) 












Hepatic 58.6 M (liver necrosis) Ueno et al. 2003b 
DBT 


















Hepatic 30 M (bile duct necrosis) 
7.7 (over 50% reduced 
relative thymus weight; 
lymphocyte depletion in 
lymphoid organs) 
Jang et al. 1986 
DBT 











































































5 F 7.5 F (increased resorptions, 
dead fetuses, and 
postimplantation loss) 







20 F (increased resorptions, 
dead fetuses, and 
postimplantation loss) 







7.6 F (reduced fertility rate; 
increased 
pre-implantation loss) 














10 F 15 F (increased incidence of 
dead or 
resorbed fetuses) 






























































7.6 (significantly reduced 













2.5 5 (increased incidence of 
external and skeletal 
malformations) 







20 (increased incidence of 
malformations) 







5 10 (slight increase in 
malformations) 







5 10 (increased external and 
skeletal malformations) 

















































































Endocr 5.7 F 






Hepatic 17.5 M (increased heme 
oxygenase activity, 
decreased activity of 
microsomal enzymes) 








Hepatic 30 M Seinen et al. 1977a 
DBT 
Renal 30 M 







Bd Wt 30 M 
b 
5 M (depressed humoral 
response against SRBC) 























































































6.65 M (52% survival at 
termination 
compared to 85% in 
controls) 









19.76 F (86% survival compared 






































































Bd Wt 19.76 
a The number corresponds to entries in Figure 3-3. 
b Used to derive an intermediate-duration oral minimal risk level (MRL) of 0.005 mg/kg/day; The MRL was derived by dividing the LOAEL by an uncertainty factor of 1000 (10 for the 
use of a LOAEL, 10 for animal to human extrapolation and 10 for human variability). 
Bd Wt = body weight; Cardio = cardiovascular; d = day(s); Endocr = endocrine; (F) = feed; F = Female; Gastro = gastrointestinal; gd = gestational day; (GO) = gavage in oil; hemato = 























































Figure 3-3 Levels of Significant Exposure to Dibutyltins - Oral 









4r 7r 7r 
1r 6r 16r 22r 
9m 8r 
19r 
10 18r 19r 23r 24r 
9m 
3r 7r 7r 13r 17r 20r15r 





















  Cancer Effect Level-Animals
 LOAEL, More Serious-Animals
LOAEL, Less Serious-Animals
  NOAEL - Animals
  Cancer Effect Level-Humans
 LOAEL, More Serious-Humans
LOAEL, Less Serious-Humans
  NOAEL - Humans
 LD50/LC50
Minimal Risk Level















































Figure 3-3 Levels of Significant Exposure to Dibutyltins - Oral (Continued) 










27m 27m 27m 27m 29m 30m 
26r 
10 























  Cancer Effect Level-Animals
 LOAEL, More Serious-Animals
LOAEL, Less Serious-Animals
  NOAEL - Animals
  Cancer Effect Level-Humans
 LOAEL, More Serious-Humans
LOAEL, Less Serious-Humans
  NOAEL - Humans
 LD50/LC50
Minimal Risk Level































































Figure 3-3 Levels of Significant Exposure to Dibutyltins - Oral (Continued) 
Chronic (≥365 days) 
Systemicmg/kg/day 
100 
32m 34m 34m 34m 34m 34m 34m 34m 34m 
10 



















  Cancer Effect Level-Animals
 LOAEL, More Serious-Animals
LOAEL, Less Serious-Animals
  NOAEL - Animals
  Cancer Effect Level-Humans
 LOAEL, More Serious-Humans
LOAEL, Less Serious-Humans
  NOAEL - Humans
 LD50/LC50
Minimal Risk Level















































































7.7 (over 35% reduction in 
relative thymus weight; 
lymphocyte depletion in 
lymphoid organs) 









7 F (10 of 16 deaths on 
weeks 4-5) 


































































Resp 5.3 F 16 F (gross changes 
suggesting chronic 
respiratory disease) 
Seinen and Willems 1976 
DOT 














Hemato 100 F 500 F (14% reduction in mean 
hemoglobin 
concentration). 










































Table 3-4 Levels of Significant Exposure to Dioctyltins - Oral	 (continued) 
Exposure/ 
Duration/ 
a FrequencyKey to Species (Route)Figure (Strain) 
6 Gn Pig 4 wk 
(Hartley) ad libitum 
(F) 
Immuno/ Lymphoret 
7 Rat 6 wk 
ad libitum(Wistar) 
(F) 
8 Rat	 4-6 wk 
ad libitum(Wistar) 
(F) 
9 Mouse	 8 wk 
1 x/wk(BALB/c) 
(GO) 



















8 M (abdominal edema) 
4 M (13% reduced final body 
weight) 
5 M (impaired cell-mediated 
immunity; lymphocyte 
depletion from thymus) 

















Seinen et al. 1977a 
DOT 
Seinen and Willems 1976 
DOT 
Seinen et al. 1977b 
DOT 
Miller et al. 1986 
DOT 





















































7 F Seinen et al. 1977b 
DOT 
a The number corresponds to entries in Figure 3-4. 
Bd Wt = body weight; Endocr = endocrine; (F) = feed; F = Female; Gastro = gastrointestinal; (GO) = gavage in oil; hemato = hematological; Immuno = immunological; LOAEL = 













































Figure 3-4 Levels of Significant Exposure to Dioctyltins - Oral 














































  Cancer Effect Level-Animals
 LOAEL, More Serious-Animals
LOAEL, Less Serious-Animals
  NOAEL - Animals
  Cancer Effect Level-Humans
 LOAEL, More Serious-Humans
LOAEL, Less Serious-Humans
  NOAEL - Humans
 LD50/LC50
Minimal Risk Level



















































Figure 3-4 Levels of Significant Exposure to Dioctyltins - Oral (Continued) 




100 5m 9m 
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  Cancer Effect Level-Animals
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  NOAEL - Animals
  Cancer Effect Level-Humans
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LOAEL, Less Serious-Humans
  NOAEL - Humans
 LD50/LC50
Minimal Risk Level



















































































Endocr 50 M (hyperglicemia and 
hypertriglyceridemia) 







Endocr 50 M (increased serum 
glucose and triglycerides) 








6.7 M 20 M (19% reduction in thymus 
weight) 








3.1 F 4.7 F (infertility and 
preimplantation loss) 







3.1 F 6.3 F (increased resorptions, 
dead fetuses, and 
postimplantation loss) 







3.1 F 4.7 F (reduced uterine weight 
and serum progesterone) 






































































3 F 6 F (fetal resorption) 
3.1 4.7 (reduced fetal body 
weight) 
Noda et al. 1991b 
TPT 







6.3 9.4 (decreased body weight 
of live fetuses) 






















60 (10/10 died) 








































































Hepatic 8.7 M 17.4 M (hypertrophy of smooth 
endoplasmic reticulum) 
Dacasto et al. 1994 
TPT 
Renal 8.7 M 17.4 M (slight vacuolization of 
tubular epithelium) 
Bd Wt 1.7 M 8.7 M (more than 10% 
reduction in final body 
weight) 
17.4 M (more than 20% 







1.25 M (changes in immune 
response) 








8.7 M 17.4 M (depletion of lymphocytes 
in thymic cortex) 









0.4 F (51% survival vs. 75% in 
controls) 







































































Tennekes et al. 1989a 
TPT 




















































































Cardio 6.2 F Tennekes et al. 1989b 
TPT 
Gastro 6.2 






0.4 F (bile duct proliferation) 
Endocr 0.4 F (cystoid lesions and 
hyperplasia of the 
pituitary) 
Ocular 6.2 





Cardio 6.2 Tennekes et al. 1989b 
TPT 
Hemato 0.4 1.3 (significant decrease in 
hemoglobin and 
hematocrit in females; 
increased prothrombin 
time in males) 
Hepatic 
Renal 6.2 
0.4 F (bile duct proliferation) 






































































































































(mg/kg/day) (mg/kg/day) (mg/kg/day) Chemical Form 
NOAEL Less Serious	 Serious 










































































































0.3 M (reduction in serum 
immunoglobulins IgG1, 
IgG2a, IgG2C, IgA, and 
increase in IgM) 












15.24 (decreased levels of 
serum immunoglobulins) 


































Table 3-5 Levels of Significant Exposure to Triphenyltins - Oral	 (continued) 
a



























0.3 M (Leydig cell hypertrophy 
and tubular atrophy) 









1.6 CEL (pituitary tumors) 
5.2 F CEL (testicular tumors) 
15.24 F CEL (hepatocellular 
carcinoma) 
Tennekes et al. 1989b 
TPT 
Tennekes et al. 1989b 
TPT 
Tennekes et al. 1989a 
TPT 
a The number corresponds to entries in Figure 3-5. 
Bd Wt = body weight; Cardio = cardiovascular; CEL = cancer effect level; d = day(s); Endocr = endocrine; (F) = feed; F = Female; Gastro = gastrointestinal; Gd = gestational day; 
(GO) = gavage in oil; (GW) = gavage in water; hemato = hematological; Immuno = immunological; LOAEL = lowest-observed-adverse-effect level; M = male; NOAEL = 
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3 M (4/10 rats died after third 
dose) 








Bd Wt 0.7 M (13% reduction in final 
body weight) 
2 M (30% reduction in final 
body weight) 







Bd Wt 1 M 3 M (significant body weight 
loss) 















3 M (significant disruption of 
normal spontaneous 
activity) 
0.5 M (body weight loss) Yallapragada et al. 1991 
TET 







2 (ataxia, paralysis of hind 
limbs) 








































































1 M (reduced grip strength 
and startle 
responsiveness) 















1 M 1.5 M (hind limb paralysis) 
2 (4/6 rats died during the 
third week) 
Yallapragada et al. 1991 
TET 













Bd Wt 0.66 M 
1.4 (death) Smith 1973 
TET 






Bd Wt 0.8 M (50% decrease in body 
weight) 

































































Eto et al. 1971 
TET 
0.7 (brain edema; changes in 







Graham and Gonatas 1973 
TET 
2.8 (motor dysfunction, 
splitting of peripheral 
myelin sheaths and 







Purves et al. 1991 
TET 







Reiter et al 1980 
TET 
0.4 M (diminished maze activity 
and startle response) 






Richman and Bienkamper 
1984 
TET 
4.2 M (hind limb paralysis 
followed by recovery; 
demyelination in spinal 
cord and peripheral 
nerves) 
a The number corresponds to entries in Figure 3-6. 
Bd Wt = body weight; d = day(s); (F) = feed; (GO) = gavage in oil; (GW) = gavage in water; LOAEL = lowest-observed-adverse-effect level; M = male; mo = month(s); NOAEL = 





































Figure 3-6 Levels of Significant Exposure to Triethyltins - Oral 
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Figure 3-6 Levels of Significant Exposure to Triethyltins - Oral (Comtinued) 
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7 M (4 out 10 rats died) 
Reference 
Chemical Form 






5 (fatal seizures after 4 
doses) 













2 M (2/10 deaths, none in 
controls) 






4 F (death within 4 days of 
dosing) 






3.75 M (4/11 died within 3 days 
of dosing) 






3 F (death within 2-7 days of 
dosing) 
































































Nolan et al. 1990 
TMT 







Renal Opacka and Sparrow 1985 
TMT 
3 M (slightly dilated proximal 
tubules and impaired 
organ function) 
10 M (marked proximal tubule 






Renal Robertson et al. 1987 
TMT 
12.25 M (severe kidney tubule 
damage) 







Bd Wt Yallapragada et al. 1991 
TMT 
1.5 M (reduced body weight 
gain) 







Bouldin et al. 1981 
TMT 






Chang and Dyer 1983 
TMT 
6 M (morphological damage 






























































Chang et al 1983 
TMT 
7.5 M (neuronal damage; 







Ishida et al. 1997 
TMT 

















Nishimura et al. 2001 
TMT 
9 M (aggressive behavior and 







0.7 M Snoeij et al. 1985 
TMT 
2 M (neuronal degeneration 







Tsutsumi et al. 2002 
TMT 

































































0.75 M (hyperexcitability; 
reduced brain calmodulin 
activity) 






3 M (neuronal damage; 
mainly hippocampal, 
fascia dentata) 












3 M (ataxia; neuronal 
degeneration in brain 
areas) 






3 F (tremors, prostration, 
hippocampal 
degeneration) 






3.5 (prostration, tremors and 
ataxia; histopathological 
changes in the CNS) 







































































0.8 (aggressive behavior; cell 
necrosis in the 
hippocampus, pyriform 
cortex, amygdala, and 
olfactory tuberculum) 







1 (tremors and seizures in 
pups; neuronal necrosis 
in hippocampus) 









0.05 M (significant decrease in 
extinction learning ability) 
Noland et al. 1982 
TMT 
a The number corresponds to entries in Figure 3-7. 
Bd Wt = body weight; d = day(s); (F) = feed; F = Female; (G) = gavage; (GO) = gavage in oil; (GW) = gavage in water; LD50 = lethal dose, 50% kill; LOAEL = 








































Figure 3-7 Levels of Significant Exposure to Trimethyltins - Oral 
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Figure 3-7 Levels of Significant Exposure to Trimethyltins - Oral (Continued) 
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37.5 M (6/50 died) 
Reference 
Chemical Form 












194 M (LD50 in aqueous 
suspension) 







27 F (3/40 pregnant mice died, 
none in controls) 







149.6 M (2-week LD50; 172 
mg/kg in females) 










Endocr 0.25 F 2.5 F (reduced serum 
thyroxine) 
Adeeko et al. 2003 
TBT 







Bd Wt 5 F 10 F (20% decrease in body 
weight gain) 




















































































































58.6 M (increased serum AST 
and ALT activities) 
5 F	 (18% reduction in body 
weight gain) 




30 M (body weight loss 48 
hours 
after dosing) 
2.5 M (significant weight loss) 
58.6 M (liver necrosis) 
Reference 
Chemical Form 
Raffray and Cohen 1993 
TBT 
Ueno et al. 2003b 
TBT 
Yallapragada et al. 1991 
TBT 
Baroncelli et al. 1995 
TBT 
Karrer et al. 1995 
TBT 
Ueno et al. 1995 
TBT 
Ueno et al. 2003b 
TBT 









































































Hepatic 29.6 (bile duct dilation and 
inflammatory damage) 
Takagi et al. 1992 
TBT 







30 M (significant decrease in 
relative and absolute 
thymus weight) 







1.25 M 2.5 M (enhanced primary 
immune response to 
SRBC; significant 
decrease in thymus 
weight) 







2.5 M 5 M (enhanced immune 
response to SRBC 
immunization; reduced T 
cells) 







2 M 6.7 M (lymphocyte depletion in 
the thymus) 


































































37.5 M (agressive behavior; 
seizures) 






6.3 M (decreased dark-phase 
spontaneous motor 
activity) 








1.5 M 2.5 M (slight tremors and 
weakness) 



















25 F (significant increase in 
resorptions and 
post-implantation loss) 







100 F (significant increase in 
post-implantation loss) 



































































8.1 F 16.3 F (significant increase in 
pregnancy failure) 







8 F 16 F (increased fetal deaths 
and resorptions) 








5 M 10 M (histologic alterations of 
seminal vesicles and 
epididymis) 














5 F (increased early 
parturitions 
and number of 
resorptions) 








23.4 F 35 F (decreased number of 
implantations 
and living fetuses) 












































































Faqi et al. 1997 
TBT 







5 F Crofton et al. 1989 
TBT 








Ema et al. 1995 
TBT 
25 (significant increase in 
incidence of clef palate 
when TBTC was given 






Ema et al. 1997a 
TBT 
100 (significant increase in 







Gardlung et al. 1991 
TBT 







8.1 16.3 (significantly reduced 
fetal weight) 



































































8 16 (significant increase in 
cleft palate incidence) 







20 F 40 F (approximately 21% 
lower fetal weight) 






10 F 20 F (significant increase in 
postnatal mortality) 








11.7 F (cleft plate and other 
bone abnormalities) 

















incidence of cleft palate) 
(unspecified number of 
deaths on week 3) 
Faqi et al. 1997 
TBT 



































































Hemato 0.16 M Karrer et al. 1992 
TBT 







Endocr 3 M 6 M (33% increase in adrenal 
relative weight and 26% 
of the hypophysis) 
Funahashi et al. 1980 
TBT 









Endocr 2.5 F 10 F (decreased serum T4 
and T3) 
Adeeko et al. 2003 
TBT 







Hepatic 2.5 M Bressa et al. 1991 
TBT 

































































Hepatic 16 (cholangitis with biliary 
retention) 
Carthew et al. 1992 
TBT 
Bd Wt 16 M (27% reduced final body 







Endocr 1 M (decreased serum insulin 
levels) 
4 M (decreased thyroxine, 
thyroid stimulating 
hormone and insulin; 
increased leutinizing 
hormone) 







Hemato 0.25 (decreased mean 
corpuscular volume, 
eosinophils) 
4 (abnormalities in all 
hematological 
components) 
Krajnc et al 1984 
TBT 
Hepatic 1 4 (slight atrophy of 
hematocytes) 
16 (liver necrosis and bile 
duct hyperplasia) 
Bd Wt 1 4 (10% lower final body 
weight) 































































































Bd Wt 25 M 
0.5 M (partial atrophy of 
mesenteric lymph nodes) 
Konno et al. 2001 
TBT 







16 (22-28% reduced relative 
thymus weight) 








3 M (30% decreased relative 
thymus weight) 




































































Krajnc et al 1984 
TBT 
0.25 1 (17% decrease thymus 
weight) 







Smialowicz et al. 1989 
TBT 
5 M (significant reduction in 
thymus weight; reduced 
lymphoproliferative 
response to mitogen Con 
A). 
10 M (approximately 45% 
reduction 






Van Loveren et al 1990 
TBT 







Vandebriel et al. 1998 
TBT 








Verdier et al. 1991 
TBT 
0.5 5 (slight impairment in host 







Vos et al. 1990 
TBT 
b 
0.025 M 0.25 M (altered parameters of 









































Table 3-8 Levels of Significant Exposure to Tributyltins - Oral	 (continued) 
a





































10 20 (post-implantation loss; 
decreased litter size) 























0.25 M (increased anogenital 
distance) 






0.025 0.25 (decreased pup's liver 
and thymus weight) 







































Table 3-8 Levels of Significant Exposure to Tributyltins - Oral	 (continued) 
a































2 F (slight reduction in pup 
weight gain; reduced 
serum LH concentration) 






2 M (reduced postnatal 
weight gain and 
decreased prostate 
weight) 






2 F 10 F (alterations in 
developmental landmaks; 
reduced birth weight) 






0.4 M 2 M (decreased pup weight in 
F1 generation on Pnd 14 
and 21) 






0.25 2.5 (mild to moderate thymus 
atrophy) 









































































Wester et al. 1990 
TBT 
Cardio 2.5 F 
Gastro 2.5 F 
Hemato 0.25 F 2.1 M (decreased hemoglobin 
and hematocrit after 12 
months) 
Musc/skel 2.5 F 
Hepatic 0.25 F 2.1 M (29% increase in 
absolute liver weight; 
increased serum liver 
transaminases) 
Renal 0.19 M 2.1 M (29% increase in 
absolute kidney weight) 
Endocr 0.19 M 2.1 M (decreased thyroid 
follicular epithelial cell 
height) 
Bd Wt 0.19 M 2.1 M (decreased body weight 








0.025 M 0.25 M (altered parameters of 
both specific and 
nonspecific 
immunocompetence) 





















































2.1 M (significant changes in 
serum immunoglobulin 
levels) 
Wester et al. 1990 
TBT 
a The number corresponds to entries in Figure 3-8. 
b Used to derive an intermediate-duration minimal risk level (MRL) of 0.0003 mg/kg/day; The MRL was derived by dividing the NOAEL by an uncertainty factor of 100 (10 for animal 
to human extrapolation and 10 for human variability). 
c Used to derive a chronic-duration minimal risk level (MRL) of 0.0003 mg/kg/day; The MRL was derived by dividing the NOAEL by an uncertainty factor of 100 (10 for animal to 
human extrapolation and 10 for human variability). 
Bd Wt = body weight; d = day(s); Endocr = endocrine; (F) = feed; F = Female; (G) = gavage; Gastro = gastrointestinal; Gd = gestational day; (GO) = gavage in oil; (GW) = gavage in 
water hemato = hematological; LD50 = lethal dose, 50% kill; LOAEL = lowest-observed-adverse-effect level; M = male; mo = month(s); NOAEL = no-observed-adverse-effect level; 

































































Figure 3-8 Levels of Significant Exposure to Tributyltins - Oral 
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Figure 3-8 Levels of Significant Exposure to Tributyltins - Oral (Continued) 
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Figure 3-8 Levels of Significant Exposure to Tributyltins - Oral (Continued) 
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Figure 3-8 Levels of Significant Exposure to Tributyltins - Oral (Continued) 
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Figure 3-8 Levels of Significant Exposure to Tributyltins - Oral (Continued) 
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112 TIN AND TIN COMPOUNDS 
3. HEALTH EFFECTS 
dose producing death following a single gavage administration was 378 mg tin/kg as stannous chloride 
(NTP 1982). All mice survived the 14-day feeding of the compound up to dietary levels of 
2,457 mg/kg/day.  These studies were performed in order to set doses for the chronic bioassay of stannous 
chloride in rats and mice (see Section 3.2.2.8). 
In intermediate-duration studies (4 or 13 weeks), rats were fed various inorganic tin compounds.  A single 
female (1/10) died during week 11 with after receiving doses of 795 mg tin/kg/day as stannous chloride.  
A total of four males receiving doses of 315 mg/kg/day died during weeks 8 and 9 leading to 
discontinuation of this dose (De Groot et al. 1973). 
The results of the chronic bioassays showed somewhat lower survival of high-dose male rats (63 mg
tin/kg/day as stannous chloride) compared to the controls.  In mice, survival of control males was affected 
more than the dosed groups (82 and 164 mg tin/kg/day), but survival of the female dosed groups was 
affected less than the controls (NTP 1982).  No explanation was provided for the apparent lower survival 
among control male mice. 
Reliable LOAEL values for lethality in animals in each duration category are recorded in Table 3-2 and 
plotted in Figure 3-2. 
Organotin Compounds. The oral administration of a proprietary drug, Stalinon, resulted in the deaths of 
about 100 people in France from an estimated 1,000 who had been treated for osteomyelitis, anthrax, and 
acne. Most of the 10 or more accounts of this 1954 tragedy are published in the French literature, but a 
summary can be found in WHO (1980).  The primary ingredients in Stalinon were diethyltin diodide 
(15 mg/capsule) and linoleic acid (100 mg/capsule).  It has been proposed that the deaths were caused by
triethyltin iodide, which was present as an impurity from the manufacturing process.  An estimate of 
70 mg of triethyltin has been calculated as the toxic dose for humans ingesting this compound over an 
8-day period (Barnes and Stoner 1959).  A review by Boyer (1989) states that deaths occurred after 
exposure to an estimate dose of 3 g triethyltin iodide over a period of 6–8 weeks.  However, many
confounding variables in the reporting of this poisoning episode weaken the validity of these estimates.  
Kreyberg et al. (1992) described the case of a woman who ingested an unknown amount of trimethyltin 
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Lethal doses for monoorganotins ranging from 1,500 to more than 6,000 mg/kg have been reported for 
rodents suggesting that these compounds have relatively low toxicity (Pelikan and Cerny 1970). 
Acute-duration studies with dibutyltins have described lethal doses in rats between 20 and 50 mg/kg 
administered by gavage (Alam et al. 1993; Barnes and Magee 1958).  In a 2-week dietary study, a dose of 
approximately 23 mg/kg/day was lethal to 6 out of 20 rats during the second week of the study (Seinen et 
al. 1977a). In a developmental study, daily gavage doses of 7.5 mg/kg/day administered on gestation 
days (Gds) 7–15 killed 5 out of 12 rats with a mean time of 8 days (Ema et al. 1991b).  Long-term
treatment (78-week study) with dibutyltin diacetate significantly decreased survival in rats and mice at the 
termination of the study (NCI 1978a).  A dose of 7 mg dioctyltin dichloride/kg/day in the food was lethal 
to 10 out of 16 guinea pigs after 4–5 weeks of treatment (Seinen et al. 1977b). 
In male albino rats, the oral LD50 for tributyltin oxide was 148 mg/kg when the chemical was 
administered by gavage in corn oil and 194 mg/kg when administered as an aqueous suspension (Elsea 
and Paynter 1958). Three consecutive daily doses of 37.5 mg of tributyltin oxide/kg killed 6 out of 
50 rats (Elsabbagh et al. 2002). In pregnant mice, a dose of 27 mg/kg of tributyltin oxide administered 
during gestation was lethal to 3 out of 40 mice; no deaths occurred in controls (Faqi et al. 1997).  Takagi 
et al. (1992) calculated a 2-week LD50 of approximately 150 mg/kg for tributyltin chloride in male 
hamsters and 172 mg/kg in females. 
Numerous studies provide information on the lethal effects of trimethyltins.  In general, lethal doses, 
mostly in acute-duration studies, are below 10 mg/kg.  For example, Brown et al. (1979) calculated an 
oral LD50 of 12.6 mg/kg in rats following a single gavage dose; most deaths occurred 2–5 days after 
dosing.  Other studies have reported lethal single doses in rats of 5 mg/kg (Bouldin et al. 1981) and 
7 mg/kg (Alessandri et al. 1994).  In a 2-week dietary study, doses of 2 mg/kg/day were lethal to 2 out of 
10 rats and doses of 6.7 mg/kg/day killed 10/10 rats in a few days (Snoeij et al. 1985).  Three female 
hamsters that received a single dose of 4 or 5 mg/kg showed whole body tremors and were almost 
moribund when killed 4 days after dosing (Brown et al. 1984).  In the same study, a single dose of 
3.75 mg/kg of trimethyltin chloride killed 4 out of 11 marmoset monkeys within 3 days of dosing (Brown 
et al. 1984). Single doses of 3–4 mg/kg were lethal to gerbils within a few days of treatment (Brown et al. 
1984; Nolan et al. 1990). 
Triethyltins are also highly toxic.  In a 2-week study, doses of 6.7 mg/kg/day in the diet were lethal to 
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2-week study, rats were gavaged with triethyltin bromide in water twice/week and a dose of 3 mg/kg 
killed 4 out of 10 rats after the third dose (Squibb et al. 1980).  Four out of six rats died during the third 
week on a diet that provided 2 mg/kg/day of triethyltin hydroxide (Magee et al. 1957) and in an 11-week 
drinking water study with triethyltin sulfate in rats at dose levels of 1.4 mg/kg/day; deaths occurred after 
4 weeks (Smith 1973). 
An extensive listing of LD50 values for organotin compounds in several animal species can be found in 
Smith (1978) and WHO (1980). 
Reliable LOAEL values for lethality, and LD50 values in each species and duration category are recorded 
in Tables 3-3 through 3-8 and plotted in Figures 3-3 through 3-8. 
3.2.2.2 Systemic Effects 
No studies were located regarding musculoskeletal, or ocular effects in humans or animals after oral 
exposure to inorganic tin or organotin compounds. 
The highest NOAEL values and all reliable LOAEL values for systemic effects in each species and 
duration category are recorded in Table 3-2 and plotted in Figure 3-2 for inorganic tin compounds.  
Similar information is given in Tables 3-3 through 3-8 and Figures 3-3 through 3-8 for organotin 
compounds. 
Respiratory Effects. 
Inorganic Tin Compounds. No studies were located regarding respiratory effects in humans or in 
animals after oral exposure to inorganic tin compounds. 
Organotin Compounds. No histopathological alterations were observed in the lungs, bronchi, and 
trachea from rats and mice fed diets that provided up to 6.7 and 19.8 mg/kg/day of dibutyltin diacetate, 
respectively, for 78 weeks (NCI 1978a) or up to 3.8 and 9.8 mg/kg/day, respectively, of triphenyltin 
hydroxide for 78 weeks (NCI 1978b).  Beagle dogs dosed with up to 0.62 mg triphenyltin 
hydroxide/kg/day for up to 52 weeks did not show any gross or microscopic alterations in the respiratory
tract (Sachsse et al. 1987).  Similar results were reported for rats dosed with up to 2.5 mg/kg/day of 
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in rats, Seinen and Willems (1976) reported that rats dosed with approximately 16 mg/kg/day had grayish 
areas in the lungs at termination, suggesting chronic respiratory disease, and that three rats that died early
in the study showed severe pneumonic alterations.  No further relevant information was located. 
Cardiovascular Effects. 
Inorganic Tin Compounds.  No studies were located regarding cardiovascular effects in humans after 
oral exposure to inorganic tin compounds. 
In a feeding study in rats, at dietary levels ranging from <10 to 315 mg/kg/day as stannous chloride for 
13 weeks, relative heart weights of males were higher than those of controls (De Groot et al. 1973).  This 
effect was not dose-dependent and there were no associated histopathological findings.  By itself, the 
significance of the observation is not clear. In a 4-week exposure to the same doses, there were no 
changes in heart weights (De Groot et al. 1973). 
Organotin Compounds. No studies were located regarding cardiovascular effects in humans after oral 
exposure to organotin compounds. 
No gross or microscopic alterations were observed in the heart of rats dosed with up to 5.7 mg dibutyltin 
dichloride/kg/day for 90 days (Gaunt et al. 1968).  In a chronic-duration study, no histopathological 
alterations were observed in the hearts of rats and mice fed diets that provided up to 6.7 and 
19.8 mg/kg/day of dibutyltin diacetate, respectively, for 78 weeks (NCI 1978a).  Similar findings 
regarding the heart were reported in chronic-duration studies with triphenyltin hydroxide in rats and mice 
dosed with up to 6.2 and 20 mg/kg/day, respectively, for 78–106 weeks (NCI 1978b; Tennekes et al. 
1989a, 1989b).  Also, no cardiovascular effects were reported in dogs administered up to 0.62 mg
triphenyltin hydroxide/kg/day for up to 52 weeks (Sachsse et al. 1987). 
Dietary treatment of rats with up to 16 mg dioctyltin dichloride/kg/day for 6 weeks (Seinen and Willems
1976) or up to 2.5 mg tributyltin oxide/kg/day for 106 weeks (Wester et al. 1990) did not induce gross or 
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Gastrointestinal Effects.    
Inorganic Tin Compounds.  There are several accounts of people who experienced gastrointestinal 
effects such as diarrhea, gastrointestinal pain, nausea, or gastroenteritis after ingestion of various foods 
stored in tin cans (WHO 1980, 2003).  Doses ranged from 250 to 1,000 mg tin/kg body weight.  Recent 
studies by Boogaard et al. (2003) showed that tin levels up to approximately 270 ppm in canned food 
caused no adverse effects in healthy humans. 
Data from studies in animals show that inorganic tin compounds can cause adverse gastrointestinal 
effects. Slightly distended small and large intestines were observed at necropsy of rats fed for 4 weeks 
diets containing 315–325 mg tin/kg/day as either stannous chloride or stannous orthophosphate.  
However, there were no histopathological changes (De Groot et al. 1973). In a 13-week study by the 
same investigators, doses of 95 mg Sn/kg/day as stannous chloride caused abdominal distension in rats 
during the first 2 weeks of the study, doses of 32 mg/kg/day caused no significant effects.  Rats dosed 
with 315 mg/kg/day, which had to be terminated prematurely, showed distended intestines and slight
ascites. 
In another study, effects on the morphology and on absolute and relative weights of the gastrointestinal 
tract were evaluated after feeding rats dietary levels of 7.9 and 15.9 mg tin/kg/day stannous chloride for 
4 weeks. Feed restriction was also studied in an attempt to distinguish between tin effects and the effects 
of decreased food intake and poor growth (Janssen et al. 1985).  Increased relative weights of the 
stomach, cecum, and colon were observed at the lowest tin dose, but were apparently caused by
diminished food intake since these changes were present in the pair fed controls as well as in the tin 
exposed animals. On the other hand, increases in the weight and length of the small intestines were 
observed to be independent of food consumption and thus a consequence of the exposure to stannous 
chloride. There was also an increase in the villus length, a decrease in the number of villi per unit 
surface, an increase in villus cell turnover, and changes in villi morphology in the intestines of the treated 
rats. Although similar changes of the intestinal villi were reported in another study (Dreef-van der 
Meulen et al. 1974), there are not enough data at this time to verify the intestinal changes as adverse. 
Mice fed 311–2,457 mg tin/kg/day as stannous chloride for 13 weeks showed gross distention of the 
cecum and reddened gastric mucosa at necropsy but no compound-related histopathological changes 
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no such changes were observed in rats fed 32 or 63 mg tin/kg/day or mice fed 82 or 164 mg tin/kg/day as 
stannous chloride during a 105-week study (NTP 1982). 
Organotin Compounds. Limited information is available regarding gastrointestinal effects in humans 
after oral exposure to organotin compounds.  Nausea and vomiting were reported in more than 70% of the 
individuals intoxicated presumably with triethyltin in a massive accidental poisoning episode in France in 
1954 (WHO 1980). Abdominal pain, diarrhea, nausea, and vomiting have been reported in cases of oral 
intoxication with triphenyltin (Lin and Hsueh 1993; Lin et al. 1998; Wu et al. 1990). 
Stomach distention was observed in rats 24 hours after a single dose of 50 mg dibutyltin dichloride/kg 
(Barnes and Magee 1958). The duodenum was also examined in many rats, but no changes were evident.  
Chronic studies with dibutyltin diacetate in rats and mice did not report any significant alterations in the 
gastrointestinal tract from rats or mice dosed with up to 6.7 and 19.8 mg/kg/day of the test material, 
respectively, for 78 weeks (NCI 1978a). 
Histopathological evaluation of the gastrointestinal tract (at six different levels) from rats dosed with up 
to approximately 16 mg dioctyltin dichloride/kg/day did not reveal any significant alterations (Seinen and 
Willems 1976). 
Single doses of 500 mg/kg of various tributyltin salts (chloride, acetate, benzoate, oleate) produced 
hemorrhages in the digestive tract of mice (Pelikan and Cerny 1968).  Similar gross changes in the 
gastrointestinal tract were seen in another study in mice treated with much higher doses (4,000 mg/kg) of 
monobutyltin trichloride and other monobutyltin salts (Pelikan and Cerny 1970).  No gastrointestinal 
alterations were observed in rats treated with up to 2.5 mg tributyltin oxide/kg/day for 106 weeks (Wester 
et al. 1990). 
No treatment-related alterations in the gastrointestinal tract were reported in rats, mice, and dogs in 
chronic-duration studies with triphenyltin hydroxide (NCI 1978b; Sachsse et al. 1987; Tennekes et al. 
1989a, 1989b).  Rats were dosed with up to 6.2 mg/kg/day and mice were dosed with up to 20 mg/kg/day;
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Hematological Effects. 
Inorganic Tin Compounds.  No studies were located regarding hematological effects in humans after oral 
exposure to inorganic tin compounds. 
Data from 4-week feeding studies in rats showed some hematological changes (De Groot et al. 1973).  A 
significant increase was observed in the hematocrit of male, but not in female, rats fed a dietary level of 
395 mg tin/kg/day as stannous sulfide.  Both sexes of rats fed tin at dietary levels ranging from 68 to 
325 mg tin/kg/day as the chloride, orthophosphate, sulfate, oxalate, and tartrate showed anemia.  The 
signs of anemia were decreased hematocrit, total erythrocytes, and hemoglobin levels.  Lower mean 
corpuscular volume and hemoglobin concentrations were seen at the highest doses (225–325 mg
tin/kg/day).  In 13-week studies, stannic oxide produced no hematological changes in rats (De Groot et al. 
1973). However, dietary levels of 7.9 mg tin/kg/ as stannous chloride produced decreased 
hematological values in rats with 4-week exposures (Janssen et al. 1985).  It is possible that the mineral 
content of the diet had an effect on the results of these studies since the no effect levels (22–440 mg
Sn/kg/day) for hematological effects in studies with diets adequate in copper and iron (De Groot et al. 
1973; Dreef-van der Meulen et al. 1974) exceeded the LOAEL (7.9 mg/kg/day) from the work by Janssen 
et al. (1985) with diets that contained only one fifth as much iron and copper.  Iron and copper are key
nutrients in hematopoiesis; deficiencies in these elements are associated with microcytic anemias 
characterized by low hemoglobin and hematocrit values.  It is suggested that the poor iron and copper 
nutrition in the Janssen et al. (1985) work was a predisposing factor, which amplified the adverse effects 
of tin on hematological parameters.  This hypothesis is supported by studies in which the dietary
concentrations of copper, tin, and iron were varied (De Groot 1973).  High levels of copper and iron (well 
above dietary requirements) added to semipurified diets containing up to 75 mg/kg/day tin almost 
completely prevented hematological changes.  Transient hemolytic anemia also was reported in rabbits 
treated daily by gavage with 10 mg tin/kg (as stannous chloride), the only dose tested, for 4 months 
(Chmielnicka et al. 1993).  However, no information was provided in that study regarding the trace 
mineral composition of the diet.  The NOAEL of 32 mg/kg/day for tin, as stannous chloride, in the 
13-week study by De Groot et al. (1973) was used to derive an intermediate-duration oral MRL for 
inorganic tin. 
Organotin Compounds. No studies were located regarding hematological effects in humans after oral 
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Treatment of Fischer-344 rats with 5–6 mg dibutyltin dichloride/kg/day in the diet for up to 13 weeks 
produced a slight, but significant decrease in hemoglobin concentration in females after 6 weeks and in 
males after 13 weeks (Gaunt et al. 1968).  This decrease was not associated with reductions of other 
erythrocyte parameters or with a reticulocytosis.  Lower doses of approximately 3 mg/kg/day caused no 
significant effect. Differential leukocyte counts were not altered by treatment with dibutyltin dichloride.  
Decreased hemoglobin and hematocrit values, lowered mean corpuscular volume and hemoglobin mass, 
and decreased leucocytes were observed in rats fed a diet that provided approximately 4 and 
16 mg/kg/day tributyltin oxide for 4 weeks (Krajnc et al. 1984).  Erythrocytes were reduced, and 
spherocytes and Howell-Jolly body-containing erythrocytes were increased in the 16 mg/kg/day group 
only.  However, a study in Sprague-Dawley rats found no significant alterations in a complete set of 
hematological parameters following treatment with approximately 5 mg tributyltin oxide/kg/day for 
28 days (Verdier et al. 1991).  The reason for the discrepancy between these two studies is unknown.  In a 
2-year bioassay in Wistar rats, hematological determinations were made in weeks 13 and 53, and at 
termination (Wester et al. 1990).  Significant hematological effects restricted to the high-dose males 
(dosed with approximately 2.1 mg/kg/day) were seen only at 12 months, and consisted of decreased 
hemoglobin, hematocrit, and mean corpuscular hemoglobin levels, and mean corpuscular volume (also at 
3 months.  In females, there was an indication of increased young erythrocytes at 3 and 12 months, but the
doses were not indicated.  Leucocytes were decreased in high-dose males (24 months) and females 
(12 and 24 months).  In a 22-week gavage study in Cynomolgus monkeys, treatment with doses of 
tributyltin oxide of 0.16 mg/kg/day (only dose level tested) decreased total leukocytes in weeks 8–10 at 
weeks 16–20 (Kerrer et al. 1992).  The biological significance of this finding is unknown. 
In a 6-week dietary study with dioctyltin dichloride in male and female Wistar rats, hematological 
investigations conducted on blood collected at termination included hemoglobin concentration and total 
and differential leukocyte counts (Seinen and Willems 1976).  Doses of approximately 16 mg/kg/day
significantly decreased hemoglobin concentration in males, but there was no effect on total or differential 
leukocyte counts; the NOAEL for hemoglobin concentration was approximately 5.3 mg/kg/day.  A study 
in female Balb/c mice treated by gavage with 500 mg dioctyltin dichloride/kg once per week for 8 weeks 
reported a 14% reduction in hemoglobin concentration at termination but no significant alterations in red 
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Triphenyltin hydroxide at a dose of 1.3 mg/kg/day caused a transient decrease in hemoglobin and 
hematocrit values at 26 and 52 weeks in female rats, but not in the males (Tennekes et al. 1989b).  These 
changes were not apparent at 78 and 104 weeks (Tennekes et al. 1989b), nor were they seen in dogs given 
the same compound at doses of approximately 0.62 mg/kg/day for up to 42 weeks (Sachsse et al. 1987). 
Musculoskeletal Effects. 
Inorganic Tin Compounds.  No studies were located regarding musculoskeletal effects in humans or 
animals following oral exposure to inorganic tin compounds. 
Organotin Compounds. No studies were located regarding musculoskeletal effects in humans following 
oral exposure to organotin compounds.  Treatment of rats with up to 16 mg dioctyltin dichloride/kg/day
for 6 weeks did not induce histopathological alterations in skeletal muscle (Seinen and Willems 1976).  
No treatment-related alterations in skeletal muscles were observed in a 104-week study in rats dosed with 
up to 6.2 mg triphenyltin hydroxide/kg/day or in mice dosed with up to 9.8 mg triphenyltin 
hydroxide/kg/day (Tennekes et al. 1989a, 1989b).  Beagle dogs dosed with up to 0.62 mg triphenyltin 
hydroxide/kg/day for up to 52 weeks showed no gross or microscopic alterations in skeletal muscle or in 
the sternum bone (Sachsse et al. 1987).  Similar findings were reported in a 106-week study with 
tributyltin oxide in rats dosed with to 2.5 mg/kg/day of the chemical (Wester et al. 1990).  
Hepatic Effects. 
Inorganic Tin Compounds.  No studies were located regarding hepatic effects in humans after oral 
exposure to inorganic tin compounds. 
Hepatic effects have been observed following intermediate and chronic oral exposure of rats. Data from a 
4-week feeding study in Wistar rats showed some histopathological changes (De Groot et al. 1973).  Both 
sexes fed tin as the chloride, orthophosphate, sulfate, oxalate, and tartrate had histopathological changes 
in the liver. The cytoplasm exhibited a clear homogeneous appearance, which suggested a disappearance 
of the cellular organelles and impaired cell function at the highest dietary level of 226–325 mg/kg/day and 
to a lesser extent at a level of 68–98 mg tin/kg/day (the doses varied with the tin compound used).  A 
slight but definite oval cell type hyperplasia of the bile ducts was also apparent.  Changes in organ 
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part, to the reduced food intake and resultant impaired weight gain.  These changes were apparent in the 
animals with the poorest weight gains. 
In a 13-week study in Wistar rats, histopathological changes were observed in the livers of both sexes at a 
dietary level of 315 mg tin/kg/day as stannous chloride, but in only a few rats at 95 mg tin/kg/day
(De Groot et al. 1973).  The changes were a homogeneous appearance of the cell cytoplasm and mild 
proliferation of the bile duct epithelium.  Organ weights were not affected.  In another 13-week study,
similar changes were seen in the livers of rats fed a diet that was gradually increased to a final level of 
252 mg tin/kg/day as stannous chloride (Dreef-van der Meulen et al. 1974). 
No hepatic effects were reported in Fischer-344 rats and B6C3F1/N mice fed stannous chloride for either 
14 days or 13 weeks (NTP 1982).  The highest dietary levels were 236 mg tin/kg/day as stannous chloride 
for rats and 2,457 mg tin/kg/day for mice.  Considering the extremely high doses used, it is surprising that 
hepatic changes were not observed. 
Limited hepatic changes were seen following chronic oral exposure of rats and mice to stannous chloride.  
In a drinking water study at 0.7 mg tin/kg/day as stannous chloride for life, 80 rats were evaluated for 
hepatic and other health effects (Schroeder et al. 1968).  There was a significant increase in fatty 
degeneration of the liver in the tin-exposed rats.  Thirty-eight percent of the control rats had liver lesions, 
whereas 68% of the tin-exposed rats had liver lesions. Degeneration and necrosis, as well as fatty
changes moderate to severe, were found in 55% of the control rats with lesions and in 65% of the tin-
exposed rats with lesions. Although similar hepatic effects were reported in the 105-week chronic 
bioassay of stannous chloride in rats and mice, the findings were not dose-related and comparable in 
treated and control animals (NTP 1982). 
Organotin Compounds. Liver impairment, as judged by increased serum levels of transaminases, was 
described in two cases of acute oral intoxication with triphenyltin (Lin et al. 1998; Wu et al. 1990).  
Hepatitis also was reported in three subjects who ingested between 20 and 50 grams of a preparation 
containing 45% triphenyltin acetate (Lin and Hsueh 1993).  No further relevant information was located. 
Hepatic and bile duct effects were observed following acute and intermediate oral exposures of animals to 
organotin compounds.  A single dose of dibutyltin dichloride of 50 mg/kg produced inflammation of the 
common bile duct of Wistar rats (Barnes and Magee 1958).  Severe hepatic injury occurred in rats 
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some rats in 6–10 days.  The main features of the bile-duct injury included thickening, inflammation, and 
dilatation of the proximal duct.  Histologically, the epithelium of the wall was replaced by granulomatous 
tissue. In cases in which the bile duct was perforated, severe peritonitis and fatty necrosis were seen.  
Multiple yellow infarcts developed in lobes of the liver, followed by inflammation of the portal blood 
vessels. In some cases, there was complete necrosis of the bile ducts.  In rats examined 6–12 months after 
receiving the three doses of dibutyltin, the bile duct was shorter and thicker than normal and there was 
wall fibrosis in the adjacent pancreas, and in the portal tracts of the liver.  Seinen et al. (1977a) noticed 
proliferation of the bile duct epithelium and periportal fibrosis in Wistar rats fed a diet that provided 
approximately 23 mg/kg/day of dibutyltin dichloride for 2 weeks; doses of 7.7 mg/kg/day caused no 
significant effect. Bile duct necrosis also was seen in Syrian hamsters treated with a single dose of 
30 mg/kg (Jang et al. 1986).  Bile duct necrosis also occurred in mice, but not in rabbits or guinea pigs 
(20–50 mg/kg dose ranges) (Barnes and Magee 1958).  No adverse hepatic effects (histopathology and 
serum transaminases) were reported in Fischer-344 rats dosed with up to 5.7 mg dibutyltin 
dichloride/kg/day for 90 days (Gaunt et al. 1968).  In variance with the findings of bile duct necrosis in 
mice reported by Barnes and Magee (1958), Seinen et al. (1977a) did not observe histological changes in 
the liver from Swiss mice dosed with dibutyltin dichloride in doses of up to 30 mg/kg/day for 4 weeks; 
however, it is unclear whether the bile duct was examined. No microscopic alterations were reported in 
the liver from Fischer-344 rats or B6C3F1 mice treated with dibutyltin diacetate in doses of up to 6.7 and 
20 mg/kg/day, respectively, for 78 weeks (NCI 1978a).
A significant increase in serum levels of ornithine carbamyl transferase (used as index of hepatotoxicity) 
was observed in albino mice gavaged once with 58 mg tributyltin chloride/kg (Ueno et al. 1994).  The 
increase was first apparent 24 hours after dosing. Parallel experiments with dibutyltin dichloride and 
monobutyltin trichloride showed that the hepatotoxicity potency followed the order: dibutyltin ! 
tributyltin ! monobutyltin (Ueno et al. 1994).  Monobutyltin was not hepatotoxic.  Further studies by the 
same group of investigators showed that the liver toxicity of tributyltin chloride could be prevented by
pretreatment of the mice with the cytochrome P-450 inhibitor SKF-525 (Ueno et al. 1995, 1997).  
Conversely, pretreatment with the P-450 inducer phenobarbital (PB) increased the toxicity of tributyltin 
chloride. These results suggest that the liver toxicity of tributyltin is due to a metabolite, most likely
dibutyltin.  Comparative studies with tributyltin and dibutyltin in mice and guinea pigs showed the mice 
to be much more sensitive to the hepatotoxicity of tri- and dibutyltin dichloride than guinea pigs (Ueno et 
al. 2003a), and this was correlated with differential inhibition of mitochondrial respiration in the two 
species. Additional experiments suggested that the difference in susceptibility between mice and guinea 
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mice containing higher levels of sulfhydril groups relative to guinea pigs.  In a three species comparison, 
the susceptibilities followed the order: mice ! rats ! guinea pigs (Ueno et al. 2003b).  Kinetic studies 
showed that the differences in susceptibility appeared to be partly due to differences in metabolism of 
tributyltin and in the distribution of dibutyltin within cell organelles.  In hepatocytes of mice treated with 
dibutyltin chloride, 41% of the dibutyltin was found in organelles compared to 27% in rats and 9% in 
guinea pigs (Ueno et al. 2003b). 
A single dose of 29.6 mg tributyltin chloride/kg (lowest dose tested) induced bile duct changes in Syrian 
hamsters consisting of adhesion in the liver, pancreas, and duodenum, and severe inflammation (Takagi et 
al. 1992).  In a separate experiment, following a single dose of 44.4 mg/kg of tributyltin, the maximum
concentrations of tributyltin and dibutyltin appeared in the liver 1 day after treatment and rapidly
decreased thereafter. The concentration of dibutyltin was 10 times higher than that of tributyltin 1 day
after dosing (Takagi et al. 1992).  By day 14, neither compound could be detected in the liver, and 
aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-guanosine triphosphate 
(GTP), and alkaline phosphatase activities were not significantly different than control.  These results 
suggest that dibutyltin has an important role in the hepatotoxicity of tributyltin.  In a 4-week feeding 
study in Wistar rats, doses of approximately 16 mg tributyltin oxide/kg/day induced hepatic changes 
consisting of liver necrosis and bile duct hyperplasia (Krajnc et al. 1984).  Slight atrophy of the 
hepatocytes was seen at 4 mg/kg/day and no significant alterations were seen at 1 mg/kg/day. Consistent 
with these observations, no microscopic changes were observed in the livers of Sprague-Dawley rats 
treated with 5 mg tributyltin oxide/kg/day for 28 days (Verdier et al. 1991).  Cholangitis with biliary
retention was reported in Fischer-344 rats dosed with tributyltin oxide at 16 mg/kg/day for 6 weeks 
(Carthew et al. 1992). In a 2-year bioassay with tributyltin oxide in Wistar rats, liver effects were 
restricted to high-dose rats (2.1 mg/kg/day) and consisted of slight bile duct changes (hyperplasia, cellular 
hypertrophy, minimal mononuclear cell infiltration) observed at 12 months, increased serum AST and 
ALT activities at 24 months, and an approximate 30% increase in absolute liver weight at termination; no 
histopathologic alterations were seen at 24 months (Wester et al. 1990).  The NOAEL was 
0.25 mg/kg/day. 
No hepatotoxicity was seen in dogs exposed through the diet to up to 0.62 mg triphenyltin 
hydroxide/kg/day for up to 52 weeks (Sachsse et al. 1987).  Hypertrophy of the smooth endoplasmic 
reticulum was reported in New Zealand rabbits exposed to approximately 17.4 mg triphenyltin 
acetate/kg/day via the diet for 70 days (Dacasto et al. 1994a).  A dose-related trend towards portal 
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triphenyltin hydroxide for 52 and 104 weeks; there was no corresponding increase in liver weight 
(Tennekes et al. 1989b). The dose-related trend was stronger in females (p<0.0005) than in males 
(p<0.005).  However, no liver pathology was reported in Fischer-344 rats dose with the same compound 
in doses of up to 3.8 mg/kg/day for 78 weeks (NCI 1978b).  In NMRI mice, this same compound was 
associated with a 35–40% increase in relative liver weight and nodular hyperplasia at doses of 
15.2 mg/kg/day for males and 20.2 mg/kg/day for females but not at lower doses (Tennekes et al. 1989a).  
No significant liver alterations were reported in B6C3F1 mice in the 78-week bioassay with triphenyltin 
hydroxide (NCI 1978b). 
Studies with dioctyltin dichloride showed no significant histopathologic alterations in the livers from rats 
treated in the diet with doses of approximately 23 mg/kg/day for 2 weeks (Seinen et al. 1977a) or 
16 mg/kg/day for 6 weeks (Seinen and Willems 1976), or in guinea pigs treated with 8 mg/kg/day for 
4 weeks (Seinen et al. 1977a).  No significant changes in liver weight were reported in mice gavaged with 
up to 500 mg/kg/day once per week for 8 weeks, but no other liver end points were evaluated (Miller et 
al. 1986). 
Renal Effects. 
Inorganic Tin Compounds.  No studies were located regarding renal effects in humans after oral 
exposure to inorganic tin compounds. 
Histopathological changes in the kidneys were reported in Wistar rats that received dietary levels up to 
approximately 315 mg tin/kg/day as stannous chloride for 13 weeks (De Groot et al. 1973).  The changes 
included large protein-like droplets in renal tubular epithelial cells.  This appears to be a common finding 
in the strain of rats used in this study and did not appear to be related to tin exposure.  The authors also 
mentioned the absence of calcareous deposits in the high-dose level female rats.  This appears to be an 
unusual finding since these deposits are commonly seen with the species of rats used in the study. 
However, the toxicological significance of these kidney findings is not clear. 
In another 13-week study, Wistar rats that were fed the compound up to a maximum level of 252 mg
tin/kg/day as stannous chloride showed increased relative kidney weights (Dreef-van der Meulen et al. 
1974).  The protein-like droplets and calcareous deposits, which are common in the rat strains used, were 
present in the controls but were absent in the tin-fed animals.  The absence of calcareous deposits in the 
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compound toxicity is unclear.  The organ weight change itself, in the absence of histopathological or other 
effects, is usually not considered a toxic effect. 
Renal changes have been evaluated following chronic oral exposure of rats and mice to stannous chloride 
and the studies were described under Hepatic Effects.  Vacuolar changes in the proximal convoluted 
tubules of the kidney were significantly increased in rats administered stannous chloride, compared with 
controls (Schroeder et al. 1968). However, in 14-day, 13-week, and 105-week studies of stannous 
chloride in rats and mice, no treatment-related nonneoplastic renal changes were reported (NTP 1982). 
Organotin Compounds. Acute nephropathy was reported in three subjects who ingested between 20 and 
50 grams of a preparation containing 45% triphenyltin acetate (Lin and Hsueh 1993).  No further 
information was located regarding renal effects in humans after oral exposure to organotin compounds. 
Treatment of rats with up to 5.7 mg dibutyltin dichloride/kg/day for 90 days (Gaunt et al. 1968) or mice 
with up to 30 mg dibutyltin dichloride/kg/day (Seinen et al. 1977a) for 4 weeks did not induce any
significant gross or microscopic alterations in the kidneys.  Also, no significant renal effects were 
reported in rats or mice dosed with up to 6.7 or 19.8 mg dibutyltin diacetate/kg/day, respectively, for 
78 weeks (NCI 1978a). 
Rats dosed with up to approximately 23 mg dioctyltin dichloride/kg/day for 2 weeks showed no 
significant histopathological alterations in the kidneys at termination (Seinen et al. 1977a).  However, 
treatment with approximately 16 mg/kg/day for 6 weeks produced signs of slight impairment of renal 
function (decreased specific gravity of the urine, increased BUN), but no histopathologic alterations were 
noticed (Seinen and Willems 1976). No significant alterations were observed in the kidneys from guinea 
pigs treated with up to 8 mg dioctyltin dichloride/kg/day for 4 weeks (Seinen et al. 1977a).  
Administration of a single dose of 4,000 mg/kg of tributyltin laureate to mice caused gross renal changes 
observed at necropsy 24 hours later (Pelikan and Cerny 1970).  The kidneys were light red and slightly
enlarged, and histopathological findings included steatosis of the renal cortical tubular epithelium and 
hyperemia of the renal medulla.  In an intermediate-duration study, treatment of rats with doses of 
2.5 mg/kg/day of tributyltin chloride in the diet for 30 days did not cause any gross kidney alterations 
(Bressa et al. 1991). A significant increase (29–33%) in absolute kidney weight was observed in male
and female rats dosed with approximately 2 mg tributyltin oxide/kg/day for 2 years (Wester et al. 1990).  
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concentration capacity, but microscopic examination of the kidneys did not reveal any significant 
treatment-related alterations.  
The renal effects of trimethyltin chloride were examined in male Wistar rats (Opacka and Sparrow 1985).  
Gavage administration of single doses (3, 6, or 10 mg/kg) of the tin compound significantly increased 
urine production over an observation period of 3 days; this effect was dose-related.  Water consumption 
was significantly increased in the high-dose group beginning the first 24 hours after dosing.  
Histopathological examinations of the kidneys showed changes ranging from slight vacuolization of the 
proximal tubular cells with loss of brush borders at 3 mg/kg to extensive vacuolar degeneration with 
tubular dilation and evidence of regeneration in the 10 mg/kg dose-group.  Severe nephrotoxicity was also 
reported in Long-Evans rats treated once with a dose of approximately 12 mg trimethyltin chloride/kg 
(Robertson et al. 1987). This dose was lethal to 16 out of 43 rats.  Examination of the kidneys from
surviving animals showed hyaline droplet inclusions, attenuated brush border, basolateral vacuolization, 
and eosinophilic granular casts in the proximal tubule cells.  These lesions could be detected as early as 
2 days after dosing and were partially reversed during the 14-day observation period following treatment.  
Maximum severity was observed 7–11 days after treatment. 
Triphenyltin hydroxide did not induce morphological or functional alterations in the kidney from rats, 
mice, or dogs given doses of 0.6–20 mg/kg/day for up to 104 weeks (NCI 1978b; Sachsse et al. 1987;
Tennekes et al. 1989a, 1989b). 
Endocrine Effects. 
Inorganic tin compounds.  No studies were located regarding endocrine effects in humans following 
exposure to inorganic tin compounds.  
In a study in rats, there were no treatment-related alterations in the gross or microscopic appearance of the 
thyroid following dietary administration of up to 315 mg tin/kg/day as stannous chloride for 13 weeks 
(De Groot et al. 1973).  No further relevant information was located. 
Organotin compounds.  No information was located regarding endocrine effects in humans following 
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Treatment of rats with up 5.7 mg dibutyltin dichloride/kg/day for 13 weeks did not induce any significant 
alterations in absolute or relative weight of the pituitary, thyroid, or adrenals or gross or microscopic 
appearance of these organs (Gaunt et al. 1968). Similar findings were reported for the adrenals of mice 
treated with up to 30 mg dibutyltin dichloride/kg/day for 4 weeks (Seinen et al. 1977a).  Chronic-duration 
studies with dibutyltin diacetate also found no significant histopathological alterations in endocrine 
glands from rats and mice treated with doses of up to 6.7 and 19.8 mg/kg/day, respectively, for 78 weeks 
(NCI 1978a). 
Dietary exposure of rats to up to 23 mg dioctyltin dichloride/kg/day for 2 weeks had no significant effect 
on the weight or morphological appearance of the adrenals (Seinen et al. 1977a).  Similar lack of effects 
was reported in the adrenals, thyroid, and pituitary glands from rats exposed to doses of up to 
16 mg/kg/day via the diet for 6 weeks (Seinen and Willems 1976).  In contrast, guinea pigs exposed for 
4 weeks to 8 mg/kg/day showed a 50% increase in relative adrenal weight, suggesting that an increase of 
glucocorticoids may have been indirectly responsible for the thymus atrophy observed in this study
(Seinen et al. 1977a). No significant effects were seen at 4 mg/kg/day. 
Administration of a single gavage dose of 60 mg tributyltin oxide/kg to Wistar rats had no significant 
effect on the weight of the adrenals (Raffray and Cohen 1993).  Treatment of male Fischer-344 rats with a 
single dose of 100 mg/kg of tributyltin oxide increased serum cortisol levels and induced adrenal 
hypertrophy (Funahashi et al. 1980).  It also caused changes consistent with activation of both secretion 
and synthesis of ACTH, and to subsequent adrenal hypertrophy.  Serum levels of thyroxine (T4) and 
thyrotrophin (TSH) were markedly reduced, but the intensity of TSH cells staining was increased, 
suggesting that tributyltin oxide inhibited TSH release, which caused thyroid hypofunction.  Since the 
decrease in circulating T4 was much more pronounced than that of TSH, Funahashi et al. (1980) 
suggested that tributyltin oxide has a direct effect on the thyroid.  Most acute effects appeared to be 
reversible within 14 days.  Treatment of rats with 6 mg/kg/day for 26 weeks increased adrenals and 
hypophysis weight and caused signs of thyroid hypofunction (Funahashi et al. 1980).  In a study by
Krajnc et al. (1984), Wistar rats were fed diets that provided approximately 0, 1, or 4 mg tributyltin 
oxide/kg/day for 6 weeks.  Treatment with 4 mg/kg/day significantly decreased serum levels of T4 and 
TSH, whereas luteinizing hormone (LH) was significantly increased.  Both exposure levels decreased 
insulin levels in serum; however, the results of a glucose tolerance test were unremarkable, suggesting 
that the decrease in serum insulin may have been due to a marked decrease in feed intake.  No significant 
changes were measured in concentrations of follicle-stimulating hormone (FSH) and corticosterone. 
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4 mg/kg/day, but release of both LH and FSH were enhanced.  Light microscopy revealed flattening of 
the epithelial lining of the thyroid follicles at 4 mg/kg/day, but not at lower doses.  In the pituitary,
treatment with 4 mg/kg/day tributyltin oxide reduced the number of TSH-immunoreactive cells and the 
staining intensity, increased the number of cells staining for LH, and had no significant effect in the 
staining for GH-, FSH-, or ACTH-producing cells.  Krajnc et al. (1984) concluded that their results 
suggested that treatment with tributyltin oxide for 6 weeks did not stimulate the pituitary-adrenal axis.  In 
a 2-year dietary study with tributyltin oxide in Wistar rats, no significant alterations were observed at 
12 and 24 months in serum levels of TSH, LH, FSH, insulin, T4, or free thyroxine (FT4) with a dose level 
of up to 2.1 mg/kg/day (Wester et al. 1990).  However, decreased thyroid follicular epithelial cell height 
was observed at 12 and 24 months.  Treatment of pregnant rats with t10 mg tributyltin chloride/kg/day on 
Gds 0–19 significantly reduced serum T4 and T3, and treatment with t2.5 mg/kg/day on Gds 8–19 
significantly reduced only T4 (measurements were conducted on Gd 20) (Adeeko et al. 2003). 
No significant gross or microscopic alterations were seen in the adrenal, thyroid, and parathyroid glands 
of dogs dosed with up to 0.62 mg triphenyltin hydroxide/kg/day in the diet for up to 52 weeks (Sachsse et 
al. 1987).  Triphenyltin hydroxide caused dose-related cystoid changes in the pars intermedia of the 
pituitary gland from male and female Wistar rats administered this compound for 52 or 104 weeks at 
doses of 0.3–6.2 mg/kg/day (Tennekes et al. 1989b).  At the highest dose, up to 40% of the males and 
80% of the females were affected at 52 weeks. At the end of 104 weeks, 72.3% of the high dose males 
and 55.6% of the females exhibited the cystoid changes.  The lower incidence in females at 104 weeks 
was related to a high early mortality from fatal pituitary adenomas (see Section 3.2.2.7).  However, no 
significant histopathological alterations were observed in endocrine organs from male or female 
Fischer-344 rats treated with up to 3.8 mg/kg/day of the test material in the diet for 78 weeks (NCI 
1978b). Also, chronic treatment of mice with up to 20 mg triphenyltin oxide/kg/day did not result in 
histopathological alterations in endocrine glands (NCI 1978b; Tennekes et al. 1989a). 
Studies conducted by Ohhira and coworkers showed that administration of a single dose of 50 mg of 
triphenyltin chloride/kg produced transient hyperglycemia and hypertriglyceridemia in hamsters but not 
in rats (Ohhira and Matsui 1996).  Kinetic studies showed that hamsters accumulated significantly more 
triphenyltin in the pancreas than did rats, and peak levels of triphenyltin in the pancreas correlated well 
with peak levels of glucose in plasma. Additional studies by these investigators showed that pretreatment 
of hamsters with the cytochrome P-450 inducer phenobarbital (PB) suppressed the diabetogenic effects of 
triphenyltin compared to PB-untreated hamsters (Ohhira et al. 1999).  Pretreatment with the CYP1A and 
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pretreatment with PB in preventing the organotin-induced hyperglycemia and hypertriglyceridemia.  On 
the other hand, pretreatment with the P-450 inhibitor, SKF-525A, increased the diabetogenic effects of 
triphenyltin (Ohhira et al. 2000).  Overall, these findings suggested that the hyperglycemic toxicity of 
triphenyltin is due primarily to accumulation of the parent compound, triphenyltin, in the pancreas. 
Dermal Effects.    
Inorganic Tin Compounds.  No studies were located regarding dermal effects in humans or animals after 
oral exposure to inorganic tin compounds. 
Organotin Compounds. No studies were located regarding dermal effects in humans after oral exposure 
to organic tin compounds. 
Administration of dibutyltin diacetate to rats (6.7 mg/kg/day) and mice (19.8 mg/kg/day) for 78 weeks did 
not cause any significant alteration in the skin (NCI 1978a).  Similar findings were reported in rats dosed 
with up to 16 mg dioctyltin dichloride/kg/day for 6 weeks (Seinen and Willems 1976). 
No skin alterations were observed in rats dosed with up to 3.8 mg dibutyltin diacetate/kg/day for 
78 weeks or in mice dosed with up to 9.8 mg/kg/day for the same duration (NCI 1978b).  In female mice, 
a dose of 20.2 mg/kg/day triphenyltin hydroxide administered for 80 weeks was associated with dermal 
sores and burn-like lesions, and was sometimes accompanied by hair loss (Tennekes et al. 1989a).  These 
lesions were present primarily in the cervical area of the back, but were also identified on the head, ears, 
forelimb, and abdomen.  Males were affected to a much lesser extent than the females.  No skin lesions 
were associated with the chronic administration of triphenyltin hydroxide to rats or dogs (Sachsse et al. 
1987; Tennekes et al. 1989b). 
Ocular Effects.    
Inorganic Tin Compounds. No studies were located regarding ocular effects in humans or animals after 
oral exposure to inorganic tin compounds. 
Organotin Compounds. No studies were located regarding ocular effects in humans after oral exposure 
to organic tin compounds.  The only information available in animals is that no ophthalmologic 








130 TIN AND TIN COMPOUNDS 
3. HEALTH EFFECTS 
with up to 20.2 mg/kg/day of the same compound for 80–104 weeks and examined at 6, 12, and 
18 months (Tennekes et al. 1989a, 1989b).  Dogs dosed with up to 0.62 mg triphenyltin hydroxide/kg/day 
for up to 2 weeks also exhibited no gross or histologic alterations in the eyes (Sachsse et al. 1987). 
Body Weight Effects.    
Inorganic Tin Compounds.  Reductions in body weight, food intake, and water consumption were 
observed in oral studies of inorganic tin compounds.  Decreases in body weights and reduced food intake 
were recorded in studies in which stannous chloride and other inorganic tin (7.9 mg tin/kg/day)
compounds were administered to rats for acute and intermediate durations (De Groot et al. 1973; Janssen 
et al. 1985). This was usually accompanied by reduced food consumption.  However, these parameters 
were comparable between control and treated rats fed stannous chloride during chronic studies (NTP 
1982; Schroeder et al. 1968).  The findings appear to suggest direct action of some inorganic tin 
compounds on growth and food intake after acute- and intermediate-duration dosing but not during 
chronic dosing. When assessing effects of inorganic tin on growth, it is important to monitor the status of 
some essential minerals such as zinc, since reduced growth is a common symptom of zinc deficiency and 
excess dietary tin reduces zinc absorption (Greger and Johnson 1981; Johnson and Greger 1982). 
Organotin Compounds. Reduced body weight gain and even body weight loss have been reported in 
numerous studies with organotins following various exposure durations.  In some cases, but not all, 
information on food and water consumption was also provided.  Rats treated once daily for 3 days with 
40 mg dibutyltin laureate/kg/day lost weight, and a dose level of 20 mg/kg/day significantly reduced body 
weight gain (Khaliq et al. 1991).  In a 2-week dietary study in rats, a dose level of 23 mg/kg/day of 
dibutyltin dichloride reduced final body weight by 20%, a lower dose of 7.7 mg/kg/day was without 
significant effect (Seinen et al. 1977a). No significant effect on body weight was reported in a 90-day
dietary study in rats dosed with up to 57 mg/kg/day of dibutyltin dichloride (Gaunt et al. 1968).  Mice 
treated for 4 weeks with up to 30 mg/kg/day of dibutyltin dichloride also showed no treatment-related 
effects on body weight (Seinen et al. 1977a).  Chronic-duration studies with dibutyltin diacetate did not 
report significant differences in body weight between treated and control groups of rats and mice treated 
with up to 6.7 and 19.8 mg/kg/day, respectively, for 78 weeks (NCI 1978a). 
Doses of 23 mg/kg/day of dioctyltin dichloride for 2 weeks reduced final body weight in rats by
approximately 12% relative to controls; the NOAEL was 7.7 mg/kg/day (Seinen et al. 1977a).  A 7–9% 
reduction in final weight was seen in a 6-week dietary study in rats that received doses of up to 
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16 mg/kg/day of dioctyltin dichloride (Seinen and Willems 1976).  Since food consumption was 
practically unaffected, the authors suggested that the treatment slightly lowered food efficiency.  Guinea 
pigs seemed more susceptible to treatment with dioctyltin dichloride since a 4-week treatment with 
8 mg/kg/day caused a 43% reduction in final body weight and half that dose reduced it by 13% (Seinen et 
al. 1977a). 
Single-dose studies with tributyltin oxide and chloride reported reduced weight gain and weight loss that 
became noticeable 48 hours following doses of 30–50 mg/kg (Ema et al. 1991a; Raffray and Cohen 
1993).  Significant weight loss was also reported in rats following 6 days of treatment with 2.5 mg/kg/day
of tributyltin bromide (Yallapragada et al. 1991).  A single dose of 100 mg/kg of tributyltin chloride 
produced a 13% reduction in body weight in hamsters 2 weeks after dosing (Takagi et al. 1992).  
Intermediate-duration studies with tributyltins have reported alterations in body weight in the range of 
2.5–16 mg/kg/day (Bressa et al. 1991; Funahashi et al. 1980; Krajnc et al. 1984).  In a 106-week study, 
body weights of rats were unaffected up to week 67, at which time, body weights of high-dose males 
(2.1 mg/kg/day) began to decrease (Wester et al. 1990); no quantitative data were provided.  
Acute studies with triethyltin reported weight loss with doses 0.5 mg/kg/day (Yallapragada et al. 1991), 
and significant weight loss was reported in an intermediate-duration study with doses of 0.8 mg/kg/day in 
drinking water (Reiter et al. 1980). The lowest dose of trimethyltin that caused weight loss in rats in an 
acute study was 2.5 mg/kg/day (Yallapragada et al. 1991). 
Intermediate-duration studies with triphenyltins reported a 25% reduction in body weight gain in rats 
following 7 weeks on a diet that provided 5 mg/kg/day of triphenyltin hydroxide (NCI 1978b).  Rabbits 
also experienced a significant reduction in final weight gain following 70 days of treatment with 
approximately 17 mg triphenyltin acetate/kg (Dacasto et al. 1994a).  Triphenyltin hydroxide was also 
associated with reduced body weight in male NMRI mice following 80 weeks on a diet that provided 
15.2 mg/kg/day of the chemical (Tennekes et al. 1989a).  No significant alterations in body weight gain 
were reported in dogs dosed with up to 0.62 mg triphenyltin hydroxide/kg/day for up to 52 weeks 
(Sachsse et al. 1987).  
3.2.2.3 Immunological and Lymphoreticular Effects 
Inorganic Tin Compounds.  No studies were located regarding immunological effects in humans after 
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The only information available regarding effects in animals is that from a study by De Groot et al. (1973), 
which observed no significant histological alterations in the thymus and spleen from rats fed a diet that 
provided up to 440 mg Sn/kg/day as stannous oxide or up to 315 mg Sn/kg/day as stannous chloride for 
13 weeks. 
Organotin Compounds. No studies were located regarding immunological effects in humans after oral 
exposure to organotin compounds. 
Numerous studies have shown that the lymphoreticular system, specifically the thymus, is the main target 
for some organotin compounds.  For example, in Wistar rats fed diets that provided approximately 7.7 mg
of dibutyltin dichloride/kg/day (the lowest dose tested) for 2 weeks, there was approximately a 50% 
reduction in relative thymus weight accompanied by lesser reductions in the relative weight of the spleen 
and popliteal lymph nodes (Seinen et al. 1977a).  All treated rats showed marked lymphocyte depletion in 
the thymus, particularly the thymic cortex, but no signs of cell destruction could be seen.  Rats dosed with 
23 mg/kg/day showed almost complete depletion of lymphocytes.  In addition to the thymus, lymphocyte 
depletion was evident in thymus-dependent areas of the spleen and popliteal nodes.  Similar results were 
obtained with dioctyltin dichloride (Seinen and Williams 1977a).  A 4-week dosing with dioctyltin 
dichloride followed by an 8-week period on a control diet showed that the effects on the thymus were 
completely reversed within 2 weeks after treatment ceased.  Similar experiments conducted with 
diethyltin dichloride and dipropyltin dichloride showed similar but less pronounced effects.  In contrast, 
dimethyltin dichloride, didodecyltin dibromide, dioctadecyltin dibromide, monooctyltin trichloride, 
trioctyltin chloride, and tetraoctyltin did not induce atrophy of the lymphoid organs (Seinen et al. 1977a).  
Functional changes occurring in conjunction with the loss thymus weight and cellularity included a 
depression in the humoral response to immunization with sheep red blood cells (SRBC) in rats dosed with 
approximately 5 mg of dibutyltin dichloride/kg/day for 4–6 weeks and a significant delay in an allograft 
response at 15 mg/kg/day (Seinen et al. 1977b).  Rats treated similarly with a 5 mg/kg/day dioctyltin 
dichloride exhibited a depressed delayed-type hypersensitivity (DTH) to tuberculin, a cell-mediated 
immunity parameter.  Seinen et al. (1977b) also showed that the immune effects were more pronounced in 
rats exposed in the developmental phase of the lymphoid system.  The immune effects of these organotin 
compounds were not induced by stress-related release of glucocorticoids, since adrenalectomy did not 
prevent the reduction in thymus weight (Seinen and Willems 1976).  In addition, relative adrenal weight 
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(Seinen and Willems 1976).  The findings of Seinen et al. (1977b) with dibutyltin dichloride in rats were 
used as basis for derivation of an intermediate-duration oral MRL for dibutyltin dichloride. 
In contrast to rats, the immune functions of Swiss mice were unaffected by exposure to up to 
approximately 30 mg dibutyltin dichloride/kg/day for 4 weeks (Seinen et al. 1977a), and neither were the 
immune functions of guinea pigs treated with approximately 7 mg dioctyltin dichloride/kg/day for 5– 
7 weeks (Seinen et al. 1977b).  However, exposure of Hartley guinea pigs to higher doses of dioctyltin 
dichloride for 4 weeks caused a reduction of the size of the thymus and its relative weight by about 37% 
compared with controls, and a marked depletion of lymphocytes in the thymic cortex (Seinen et al. 
1977a). Treatment of Balb/c mice with a much higher dose of 500 mg dioctyltin dichloride/kg by gavage 
once per week for 8 weeks caused a reduction in relative thymus weight of approximately 67% relative to 
controls, and no significant changes occurred at 100 mg/kg (Miller et al. 1986).
Snoeij et al. (1985) studied the effects of a series of triorganotins in Wistar rats fed the compounds in the 
diet for 2 weeks. At doses of approximately 20 mg/kg/day, tripropyltin chloride, tributyltin chloride, and 
triphenyltin chloride induced a reduction in relative thymus weight of 47, 61, and 19%, respectively, 
relative to controls, and caused reduction of cellularity in the thymus.  These effects were completely
reversed within 2 weeks.  Trihexyltin chloride was less effective, whereas trioctyltin chloride was 
ineffective. Trimethyltin chloride and triethyltin chloride were primarily neurotoxic (see Section 3.2.2.4). 
In a 70-day dietary study in New Zealand rabbits, a dose of approximately 17.4 mg triphenyltin 
acetate/kg/day caused blurring of the demarcation between cortex and medulla of the thymus and 
depletion of lymphocytes in the cortex (Dacasto et al. 1994a).  Also, lymph nodes showed decreased 
cellularity in the thymic-dependent areas. 
A chronic-duration dietary study with dibutyltin dichloride did not report histopathological alterations in 
lymphoid tissues of Fischer-344 rats and B6C3F1 mice following treatment with doses of up to 6.7 and 
19.8 mg/kg/day, respectively, for 78 weeks (NCI 1978a, 1978b).  Long-term studies with triphenyltin 
hydroxide reported a reduction in serum immunoglobulins in Wistar rats following treatment with a dose 
of 0.3 mg/kg/day and higher for 52 weeks (Tennekes et al. 1989b), and in NMRI mice following 
administration of 15.2 mg/kg/day for 80 weeks (Tennekes et al. 1989a).  No histopathological effects 
were observed in lymphoid tissues from Fischer-344 rats or B6C3F1 mice administered up to 3.8 and 
9.8 mg of triphenyltin hydroxide/kg/day, respectively, for 78 weeks (NCI 1978a, 1978b), or in dogs dosed 
with up to 0.62 mg/kg/day for 52 weeks (Sachsse et al. 1987).  No tests of immunocompetence were 
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Several additional acute- and intermediate-duration studies with tributyltin hydroxide (and also oxide) 
have reported decreased weight in lymphoid organs (Bressa et al. 1991; Carthew et al. 1992; Funahashi et 
al. 1980; Krajnc et al. 1984; Raffray and Cohen 1993; Smialowicz et al. 1989, 1990; Vandebriel et al. 
1998; Vos et al. 1990).  Other immune parameters such as the primary immune response to SRBC and 
lymphoproliferative responses to stimulation with mitogens were affected by exposure to tributyltin oxide 
(Smialowicz et al. 1989, 1990).  Furthermore, comparative 3-week studies in adult and preweanling 
Fischer-344 rats showed that younger animals were more sensitive to the immunosuppressive effects of 
tributyltin oxide than mature rats (Smialowicz et al. 1989).  A 4.5–6-month dietary study in male Wistar 
rats showed that doses of 0.25 mg tributyltin oxide/kg/day, or higher, altered both parameters of specific 
resistance and nonspecific resistance (Vos et al. 1990).  Neither the IgM nor the IgG response to 
ovalbumin and T. spiralis were altered after 5.5 months, but the IgE responses to T. spiralis was 
suppressed in a dose-related manner (significant at 0.25 mg/kg/day).  The DTH reactions to ovalbumin 
and tuberculin were not significantly altered after 6 months of dosing.  There also was an increased 
number of larvae of T. spiralis in muscle after infection at 0.25 mg/kg/day after 5.5 months of exposure 
to the test compound.  There was no significant effect on the response of spleen cells to T- and 
B-mitogens after 4.5 months of treatment.  The cell surface marker analysis of mesenteric lymph node 
cells showed a reduction in the relative count of T-lymphocytes and an increase in the percentage of 
B-lymphocytes at 0.25 mg/kg/day after 6 months.  The in vivo clearance of L. monocytogenes was 
impaired at 2.5 mg/kg/day after 5 months of treatment.  Treatment with tributyltin oxide for 4.5 months 
had no significant effect on natural killer cell activity of spleen and peritoneal cells.  No significant effects 
were seen at 0.025 mg/kg/day and this dose, the study NOAEL, was used to derive an intermediate-
duration oral MRL for tributyltin oxide.  The same tests conducted after groups of rats had been on the 
experimental diets for 15–16.5 months yielded similar results and a LOAEL was defined at 
0.25 mg/kg/day for depression of IgE titers and increased T. spiralis larvae in muscle after 16.5 of dosing; 
the NOAEL was 0.025 mg/kg/day and was used to derive a chronic-duration oral MRL for tributyltin 
oxide. 
In another 2-year study of tributyltin oxide in Wistar rats, doses of 2.1–2.5 mg/kg/day significantly 
increased serum immunoglobin A (IgA) after 12 and 24 months in males and females, decreased IgG in 
females after 3 and 13 months, and increased IgM after 3, 12, and 24 months (Wester et al. 1990).  There 
were no histopathological changes in the thymus or lymph nodes, but the spleen showed decreased 
hemosiderin content after 12 months of exposure in males and females.  No significant effects were seen 
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The highest NOAEL values and all reliable LOAEL values for immunological effects in each species and 
duration category are recorded in Tables 3-3 through 3-8 and plotted in Figures 3-3 through 3-8 for 
organotin compounds. 
3.2.2.4 Neurological Effects 
Inorganic Tin Compounds.  No studies were located regarding neurological effects in humans after oral 
exposure to inorganic tin compounds. 
In the studies of systemic and other effects of inorganic tin compounds in animals (Sections 3.2.2.1 and 
3.2.2.2), clinical signs of neurotoxicity or behavioral changes were not noted.  However, central nervous 
system effects in animals consisting of ataxia, muscular weakness, and depression have apparently been 
associated with oral exposure to the inorganic compounds (WHO 1980).  Histopathological examinations 
of rats fed levels of 315 mg tin/kg/day as stannous chloride for 8–9 weeks revealed a spongy state of the 
white matter of the brain (De Groot et al. 1973).  However, the treatment of these animals was terminated 
at 9 weeks because of the number of rats that were dead or moribund.  It is, accordingly, difficult to 
determine if the tissue changes observed were due to a direct effect of tin on the brain or were secondary
to the poor health of the animals.  There were no other neurological changes reported and the meaning of 
the finding is not clear. 
Organotin Compounds. Death and intoxication resulting from the Stalinon incidents are described in 
Section 3.2.2.1.  Stalinon contained diethyltin diodide and an undetermined amount of triethyltin iodide.  
It has been proposed that the effects were caused by triethyltin iodide, which was present as an impurity
from the manufacturing process (WHO 1980).  Symptoms in the affected persons appeared suddenly,
about 4 days following ingestion of the drug, and included vertigo, intense headache, photophobia, altered 
consciousness, visual impairment, and convulsions. Sensory disturbances, hypoflexia, and loss of 
sphincter control were common observations.  Deaths occurred after 4–10 days as the result of deep 
coma, or more frequently, acute intracranial hypertension.  Autopsies revealed diffuse edema in central 
nervous system white matter (Foncin and Gruner 1979).  Kreyberg et al. (1992) described the 
neuropathological effects associated with a fatal case of trimethyltin intoxication.  A few hours after the 
intoxication, the patient experienced tinnitus, lightheadedness, aggression, and episodes of 
unresponsiveness.  The patient died of multiorgan failure six days after consumption of the chemical.  
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spinal ganglia.  There was recent neuronal necrosis in the fascia dentata of the hippocampus and spinal 
ganglia, and also in the pyramidal cell layer of the hippocampus, cerebral cortex, basal ganglia, and 
Purkinje cell layer of the cerebellum.  Kreyberg et al. (1992) noted that some of these changes could have 
been caused by an anoxic episode shortly before death.  Ultrastructurally, there was marked accumulation 
of lysosomal dense bodies and disorganization of the granular endoplasmic reticulum in the neurons.  
Acute intoxication with an unknown amount of triphenyltin produced severe ataxia, dysmetria, 
nystagmus, and blurring of vision in a 23-year-old male (Wu et al. 1990).  Twelve days later, the patient 
developed disturbance of consciousness and confusion that lasted for 2 months.  Electrophysiological 
tests revealed a delayed sensorimotor polyneuropathy due to axonal degeneration and demyelination.  Lin 
et al. (1998) described an additional case of triphenyltin intoxication in a 19-year-old female who 
presented with spontaneous involuntary movement of the hands, facial twitching, diplopia, drowsiness, 
giddiness, vertigo, bidirectional nystagmus, impairment of calculations ability, and disorientation to 
people, time, and places.  No seizures occurred, but 12 days after the poisoning episode the 
electroencephalogram (EEG) showed mild cortical dysfunction.  Follow-up of the patient showed 
complete recovery within a year. 
The effects associated with oral exposure of animals to triorganotins, particularly trimethyltin and 
triethyltin, have been described in a number of studies conducted mostly in rats.  End points that have 
been monitored include neurochemistry, neurophysiology, and behavior.  While the main target of both 
trimethyltins and triethyltin is the nervous system, exposure to trimethyltin is characterized by neuronal 
necrosis, particularly in the hippocampus, whereas triethyltin treatment causes primarily intramyelinic 
edema.  Rats dosed in the food with approximately 2 mg triethyltin oxide/kg/day (only dose level tested) 
for 2 weeks had ataxia and paralysis of the hind limbs (Magee et al. 1957).  Necropsy revealed swelling in 
the brain and spinal cord with compression of structures.  Microscopic examination revealed interstitial 
edema of the white matter in all sections of the central nervous system; neurons of the brain and spinal 
cord seemed not to be affected.  Rats that survived the treatment for 2 weeks followed by doses of 
1 mg/kg/day for 6 weeks and then 4 months on a normal diet did not show evidence of the characteristic 
edema or obvious loss of myelinated fibers.  Similar results were reported by in Osborne-Mendel rats 
dosed with approximately 2.8 mg triethyltin sulfate/kg/day in the drinking water for 22 days (Graham and 
Gonatas 1973). Signs of motor dysfunction were evident between the 10th and 17th day of intoxication.  
There was also greater involvement of the anterior than the posterior nerve roots, both of which showed 
more intramyelinic vacuole formation and splitting than did the sciatic nerve.  Older rats appeared more 
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sulfate/kg/day in the water for 3 months caused mild brain edema as early as day 10 (Eto et al. 1971).  
After 30 days, there was a noticeable decrease in the amount of stainable myelin.  In the treated rats, the 
yield of myelin per brain was reduced by half, but the isolated myelin appeared morphologically normal.  
Analysis of whole brains showed decreased proteolipid protein and total lipid, particularly galactolipids.  
Eto et al. (1971) hypothesized that treatment with triethyltin causes nonspecific chemical abnormalities in 
the myelin sheath undergoing secondary degeneration.  Some Wistar rats treated with approximately
1.4 mg triethyltin sulfate/kg/day in the water developed weakness and paralysis after 4 weeks of treatment 
and some died (Smith 1973).  Necropsy showed edema of the brain and spinal cord. 
In a 2-week dietary study with several trialkyltin compounds in male Wistar rats, Snoeij et al. (1985) 
observed that triethyltin chloride and trimethyltin chloride were neurotoxic (cerebral edema and neuronal 
necrosis, respectively), whereas tripropyltin chloride, tributyltin chloride, and triphenyltin were mainly
immunotoxic (see Section 3.2.2.4), trihexyltin chloride was slightly immunotoxic, and trioctyltin chloride 
was not toxic at the doses tested. 
In addition to examination of the morphological effects of triethyltin, behavioral testing has also been 
conducted. In male CD rats, no toxic signs were seen during treatment with 1 mg triethyltin 
bromide/kg/day twice per week (1, 2, or 3 mg/kg/day) for 2 weeks (Squibb et al. 1980).  However, grip 
strength (hindlimb and forelimb) was significantly reduced during the second week of treatment at 
2 mg/kg even during a week free of treatment.  Four weeks after treatment ceased, limb strength had 
returned to normal (1 and 2 mg/kg).  Startle responsiveness was significantly reduced at 1 and 2 mg/kg, 
beginning the first week of treatment, but recovered in the posttreatment period.  Two weeks after start of 
treatment, all treated groups showed edema of the white matter in the central nervous system but none 
was seen in the sciatic nerve. There appeared to be no neuronal damage.  Partial recovery of the lesions 
was seen 4 weeks after treatment ceased.  In another drinking water study, repeated doses of triethyltin 
bromide (0.4–0.8 mg/kg/day) produced performance decrements in a series of behavioral toxicity tests in 
rats (Reiter et al. 1980). The effects were rapid in onset, but were reversible 1 month after exposure was 
discontinued. Such findings correlate well with effects on the myelin sheath (i.e., demyelination). 
The neurotoxicity of trimethyltin has been examined in numerous acute-duration studies and in a smaller 
number of intermediate-duration studies.  Bouldin et al. (1981) conducted a detailed analysis of the 
morphological effects of trimethyltin hydroxide in adult and neonatal Long-Evans rats.  Both groups were 
dosed with 1 mg/kg, the adults once a day for 14 days, and the neonates once every other day for 26 days.  
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spontaneous tremors and seizures, and were reactive to noise but were not aggressive.  The major finding 
in both groups was neuronal necrosis in the neocortex, pyriform cortex, hippocampal formation, basal 
ganglia, brain stem, spinal cord, and dorsal root ganglia.  The neurons of the hippocampal formation and 
pyriform cortex were most vulnerable to the effects of trimethyltin.  Bouldin et al. (1981) also observed 
that acute high doses affected preferentially neurons of the fascia dentata, whereas longer-term low doses 
affected the neurons of Ammon’s horn.  Ultrastructurally, the changes were characterized by cytoplasmic 
accumulations of dense-core vesicles and tubules, autophagic vacuoles, and polymorphic dense bodies 
both in acute and chronic intoxications in both mature and immature rats.  Light- or electron-microscopy
provided no evidence of neuronal necrosis in the hippocampal formation or pyriform cortex of neonatal or 
adult rats exposed to dimethyltin, diethyltin, tripropyltin, tributyltin, tricyclohexyltin, or triphenyltin 
(Bouldin et al. 1981). 
Chang et al. (1983) conducted a comparative study in two strains of rats (Long-Evans and Sprague-
Dawley) and mice (Balb/c and C57BL/6).  All groups were dosed once, mice with 3 mg/kg and rats with 
7.5 mg/kg trimethyltin chloride.  Mice showed signs of intoxication earlier than rats and more prominent 
hippocampal lesions than rats.  Long-Evans rats showed signs of intoxication earlier than Sprague-
Dawley rats (3 days vs. 5 days).  Furthermore, while mice showed most lesions in the hippocampal fascia 
dentata, rats showed more prominent neuronal damage in the olfactory cortex and hippocampal Ammon’s 
horn. Trimethyltin also has been shown to induce neuronal damage in sensory neurons of the central and 
peripheral nervous system (Chang and Dyer 1983).  These investigators found that a single gavage dose 
of 6 mg/kg of trimethyltin chloride produced extensive damage in the retina, inner ear, pyriform cortex, 
olfactory tubercle, and dorsal root ganglia of rats.  Inner ear damage was already evident 72 hours after 
dosing and extensive destruction was apparent 15–30 days after treatment.  Small neurons in the olfactory
cortex (pyriform cortex and olfactory tubercle) also degenerated rapidly after treatment with trimethyltin.  
Fifteen days after exposure, there was extensive destruction of the pyriform cortex and olfactory cortex.  
No necrotic changes were seen in the dorsal root ganglia, but electron microscopy showed accumulation 
of lysosomes and formation of myeloid bodies both in the cell bodies and axons.  Hypertrophy and 
hyperplasia of the neuronal mitochondria were seen 30 days after treatment; these changes were thought 
to represent a compensatory response. 
The neurological effects of trimethyltin also have been studied in other species.  Brown et al. (1984) 
conducted studies with trimethyltin chloride in hamsters, marmosets, and gerbils. Hamsters receiving a 
single dose of 4 or 5 mg/kg showed whole-body tremors and were almost moribund when sacrificed at 
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also in the pyriform cortex, amygdala, neocortex, and various brain stem nuclei.  Motor neurons of the 
cervical spinal cord were also involved.  The brains of hamsters treated with 1 mg/kg once per week for 
5 weeks were normal and those of animals treated similarly for 7 weeks showed neuronal degeneration 
confined to the hippocampus.  The marmoset monkeys were gavaged with single doses (3–4.5 mg/kg) or 
two doses (3 plus 3 mg/kg or 3 plus 1.5 mg/kg) of trimethyltin chloride.  Signs of poisoning at 24 hours 
included fine tremor, diarrhea, and salivation.  Two days later, these signs increased to whole body
tremor, ataxia, agitation, aggression, and loss of appetite.  A dose of 3.75 mg/kg caused prostration at 2– 
3 days with continuous body tremors and myoclonic jerks of the head and body. No convulsions were 
seen. One monkey at 3 mg/kg was moribund on day 4, four at 3.75 mg/kg on days 2–3, and one at 
4.5 mg/kg on day 1.  Two monkeys given 3 mg/kg survived to days 35 and 45.  The monkeys that died 
early showed neuronal necrosis and chromatolysis primarily in the hippocampus but also in the pyriform
cortex, amygdala, neocortex, various brain stem nuclei, and retina.  Some signs of histopathological 
alterations were still present in the two monkeys that survived 35 and 45 days.  No lesions were seen in 
the lumbar spinal ganglia or sciatic nerve.  Gerbils were gavaged with single doses between 3 and 
12 mg/kg of trimethyltin chloride.  All dose levels caused lethality.  Clinical signs included whole body
tremors, prostration, and convulsions.  Histopathologic examinations showed neuronal necrosis and 
chromatolysis primarily in the hippocampus but also in the pyriform cortex, amygdala, neocortex, and 
various brain stem nuclei.  In two animals given 3 mg/kg that survived to 7 and 18 days, the pyramidal 
cells in the hippocampus were normal. 
Less information is available for other organotins.  For example, Wistar rats treated once with 6.3 mg
tributyltin chloride/kg (the lowest dose level tested) showed no overt signs of toxicity (Ema et al. 1991a).  
Diurnal activity was higher than in controls on days 1–4 in the groups receiving the highest dose 
(50 mg/kg).  Spontaneous motor activity during the dark phase was significantly decreased, but returned 
to normal 4 days after dosing.  Also, the acquisition of conditioned avoidance responses was significantly
impaired at 25 mg/kg.  An additional acute study reported that a daily dose of 2.5 mg tributyltin 
bromide/kg for 6 days induced slight tremors and weakness in Sprague-Dawley rats; doses of 1.5 mg/kg 
caused no adverse effects (Yallapragada et al. 1991).  Administration of 37.5 or 75 mg tributyltin 
oxide/kg/day for 3 days to rats induced significant reductions in serotonin, dopamine, and noradrenaline 
in whole brain preparations (Elsabbagh et al. 2002).  In general, the reductions were dose-related. 
ATPase activities also were significantly reduced.  Histopathological examination of the brains showed 
hyperemic meningeal and cerebral blood vessels.  There were focal hemorrhages in vacuolated 
myelinated fibers and some neurones showed chromatolysis and others necrosis.  The purkinje cells 
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bioassay with tributyltin oxide, no histopathologic alterations were observed in the brain and spinal cord 
from Wistar rats administered dietary doses of up to 2.5 mg/kg/day (Wester et al. 1990). 
Rats treated acutely with 20 mg dibutyltin laureate/kg/day for 3 days showed decreased motor activity
and learning, but that dose also caused lethality (Alam et al. 1993).  In 78-weeks dietary studies with 
dibutyltin chloride, there was no evidence of adverse gross or microscopic alterations in the brains of 
Fischer-344 rats and B6C3F1 mice dosed with up 6.7 and 19.8 mg/kg/day, respectively (NCI 1978a).  No 
neurological effects have been observed in chronic-duration studies with triphenyltin hydroxide in rats 
and mice (NCI 1978b), and dogs (Sachsse et al. 1987). 
The highest NOAEL values and all reliable LOAEL values for neurological effects in each species and 
duration category are recorded in Tables 3-3 through 3-8 and plotted in Figures 3-3 through 3-8 for 
organotin compounds. 
3.2.2.5 Reproductive Effects 
Inorganic Tin Compounds.  No studies were located regarding reproductive effects in humans after oral 
exposure to inorganic tin compounds. 
Limited information was found on effects in animals.  No reproductive effects (number of corpora lutea 
and of implantation and resorption sites) were reported in rats, mice, and hamsters administered up to 
31 mg tin/kg/day (as stannous chloride) during gestation (Gds 6–15 for rats and mice, Gds 6–10 for 
hamsters) (FDA 1972).  Exposure of rats during Gds 0–20 to up to approximately 45 mg tin/kg/day (as 
sodium pentachlorostannite) or 56 mg tin/kg/day (as tin fluoride) in the diet had no significant effect on 
the number of resorptions or placental weight (Theuer et al. 1971).  In a 13-week study in rats, dietary
levels ranging from 1.5 to 9.2 mg tin/kg/day as stannous chloride caused testicular degeneration 
(De Groot et al. 1973).  Histopathological degeneration was seen in a few animals that were treated for 
9 weeks with 315 mg/kg/day and then sacrificed because of their moribund physiological state.  The 
biological significance of the findings is unclear. 
Organotin Compounds. No studies were located regarding reproductive effects in humans after oral 
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The reproductive effects of some organotin compounds have been studied mostly in rats, although some
information in mice is also available.  In most studies in rats, the pregnant dams were dosed at various 
times during pregnancy and sacrifices were conducted on Gd 20.  Treatment of pregnant Wistar rats with 
doses of 7.5 mg dibutyltin dichloride/kg/day on Gds 7–15 significantly increased the number of 
resorptions and dead fetuses per litter and the percentage of postimplantation loss (Ema et al. 1991b). 
These dose levels also caused rats mortality.  Doses of 5 mg/kg/day produced no significant maternal or 
reproductive effects.  In a similar study, doses of 15 mg dibutyltin diacetate/kg/day administered on Gds 
7–17 significantly increased the incidence of dead or resorbed fetuses, but a lower dose of 10 mg/kg/day
was without significant reproductive effects (Noda et al. 1992). Maternal thymus weight was reduced by
54% with a dose of 5 mg/kg/day and body weight was significantly reduced at 15 mg/kg/day, suggesting 
that the adverse reproductive effects observed at 15 mg/kg/day may have been secondary to maternal 
toxicity and that thymic involution, while a sensitive index of maternal toxicity, may be unrelated to the 
manifestation of reproductive effects.  In a more recent study with dibutyltin dichloride administered on 
Gds 6–15, the highest dose tested, 10 mg/kg/day, was maternally toxic (reduced weight gain and food 
consumption), but did not significantly affect any reproductive parameter, (i.e., total implantations, mean 
implantations/litter, total early resorptions, mean early resorptions/litter, total late resorptions, and mean 
late resorptions/litter) (Farr et al. 2001).  Further studies of Ema and coworkers showed that adminis­
tration of dibutyltin dichloride on Gds 7–9 induced more resorptions and postimplantation losses than 
when given on Gds 10–12 or 13–15 (Ema et al. 1992).  Furthermore, within that 3-day period, Gd 8 was 
the day of highest susceptibility.  Treating rats with 3.8 mg dibutyltin chloride/kg/day on Gds 4– 
7 significantly increased the percentage of postimplantation losses/litter and doses of 7.6 mg/kg/day on 
Gds 0–3 increased the number and percentage of preimplantation losses (Ema and Harazono 2000).  In a 
subsequent study, Ema et al. (2003) reported that subcutaneous administration of progesterone partially
prevented the preimplantation losses induced by dibutyltin and hypothesized that a decline in 
progesterone is a primary mechanism for the implantation failure induced by dibutyltin.  Results from
further studies by the same group of investigators suggested that the early embryonic loss induced by 
dibutyltin is due to inhibition of uterine decidualization, which is caused by inhibition of the development 
of uterine sensitivity due to decreased serum progesterone levels (Harazono and Ema 2003). 
In long-term studies, female Fischer-344 rats fed diets that provided approximately 3.33 and 
6.65 mg/kg/day dibutyltin diacetate showed inflammation and hyperplasia of the uterus (NCI 1978a).  
The frequency with which these changes were observed was greater in the low-dose group than in the 
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microscopic examination; therefore, these findings must be regarded as inconclusive.  No significant 
alterations in reproductive organs from B6C3F1 mice were seen in a 78-week bioassay (NCI 1978a). 
Studies with tributyltins have provided results similar to those with dibutyltins.  Increased fetal deaths and 
resorptions were seen in rats dosed with 16 mg tributyltin acetate/kg/day on Gds 7–17 (Noda et al. 
1991a); this dose levels also caused maternal toxicity (reduced food consumption and body weight gain 
and 28% reduction in thymus weight).  A significant increase in resorptions and in the incidence of 
postimplantation loss was seen in rats dosed with 25 mg tributyltin chloride/kg/day (the lowest dose 
tested) on Gds 7–9 relative to controls and to treatments on Gds 10–12 or 13–15 (Ema et al. 1995b).  In a 
subsequent study from the same group, Gd 9 was identified as the most susceptible for postimplantation 
loss to occur compared to Gds 7, 8, 10–15 (Ema et al. 1997a).  In another study, a significant increase in 
pregnancy failure occurred when dosing with 16.3 mg/kg/day on Gds 0–3, whereas a much higher dose, 
65.1 mg/kg/day, was needed to cause pregnancy failure if treatment was done on Gds 4–7 (Harazono et 
al. 1998).  A more recent study reported decreased fertility, increased postimplantation loss, and 
decreased litter size in rats treated with 20 mg tributyltin chloride/kg/day on Gds 0–19; no such effects 
were seen at 10 mg/kg/day (Adeeko et al. 2003). 
In four studies of similar design in mice (treatment for at least 10 days during gestation) (Baroncelli et al. 
1990, 1995; Davis et al. 1987; Faqi et al. 1997), the LOAEL for tributyltins was 5 mg/kg/day for 
increased early parturitions and resorptions (Baroncelli et al. 1995).  A study that evaluated a different 
type of reproductive parameter showed that treatment of male ICR mice with 10 mg tributyltin oxide/kg 
2 times/week for 4 weeks significantly reduced sperm counts to about 70% of controls (Kumasaka et al. 
2002).  In addition, light microscopy of the testis revealed disorganized seminiferous tubules with 
vacuolization of Sertoli cells and some loss of germ cells.  No effects were seen on spermatogonia, 
spermatocytes, spermatids, Leydig cells, and the basement membrane of the seminiferous tubules; the 
study NOAEL was 2 mg/kg/day. 
Daily administration of tributyltin chloride (5–20 mg/kg/day) to 35-day-old male rats did not significantly
alter the weights of the testes, epididymis, or prostate, but doses of 10 and 20 mg/kg/day significantly
decreased seminal vesicle weight in a dose-related manner (Yu et al. 2003a). Doses of 10 and 
20 mg/kg/day did not produce morphological alterations in the testes or prostate, but did so in seminal 
vesicles and epididymis.  In rats that underwent the same treatment but were examined 5 weeks after the 
last dose, the 20 mg/kg/day dose of tributyltin chloride significantly reduced sperm counts recovered from
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at 10 and 20 mg/kg/day.  In general, sperm motility was not significantly altered by treatment with 
tributyltin. 
In 2-generation reproductive studies with tributyltin chloride in male and female Wistar rats, the highest 
dose tested, 10 mg/kg/day, had no significant effect on the fertility index of females (females with 
delivery/females copulated) of either the parental generation (P) or the F1 generation (Ogata et al. 2001)
or on the copulation index or the fertility index of F1 males (Omura et al. 2001).  In a 2-year bioassay with 
tributyltin oxide in Wistar rats, no histopathological alterations were observed in the ovaries, uterus, 
testis, or prostate (Wester et al. 1990). 
Studies with triphenyltins in which pregnant rats were dosed during most of the pregnancy (Gd 5–17) 
reported significant increases in resorptions at dose levels of 13 mg/kg/day (only dose level tested) 
(Chernoff et al. 1990) and 6 mg/kg/day (Noda et al. 1991b); a NOAEL of 3 mg/kg/day was identified in 
the latter study. Dosing rats with 4.7 mg/kg/day on Gds 0–3 induced pregnancy failure, preimplantation 
loss and a decrease in the number of implantations per female (Ema et al. 1997b).  However, pregnancy
failure occurred only at 12.5 mg/kg/day and increased implantations losses only at 25 mg/kg/day when 
the rats were treated on Gds 4–6. It was suggested that preimplantation losses are caused by changes in 
the development of uterine receptivity induced by triphenyltin (Ema et al. 1999b).  Similar to findings 
with other alkyltins, the most vulnerable dosing period for resorptions and postimplantation losses to 
occur was Gds 7–9 relative to Gds 10–12 or 13–15 (Ema et al. 1999a).  Transient reduced fertility was 
reported in male rats treated with approximately 5 mg triphenyltin hydroxide/kg/day for up to 64 days
(Gaines and Kimbrough 1968).  However, because changes in food consumption closely followed the 
gradual change in fertility and the recovery, it appeared that the decrease in food intake was responsible 
for the reduced fertility.
Male rats fed triphenyltin hydroxide at doses of 5.2 mg/kg/day for 2 years displayed a dose-related 
increase in Leydig cell hyperplasia (p<0.0005) and tubular atrophy (p=0.004) of the testes (Tennekes 
et al. 1989b), which was not seen in either rats dosed with up to 9.8 mg/kg/day or mice dosed with up to 
3.75 mg/kg/day for 78 weeks (NCI 1978b).  Administration of up to 0.62 mg triphenyltin 
hydroxide/kg/day in the diet for up to 52 weeks to male and female dogs did not produce any significant 
gross or microscopic changes in the reproductive organs (Sachsse et al. 1987). 
The effects of diphenyltin also have been studied.  Administration of t16.5 mg diphenyltin 
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24.8 mg/kg/day also decreased the pregnancy rate (Ema et al. 1999c).  Results from a subsequent study
showed that the early pregnancy failure was due to suppressed uterine decidualization and reduced serum
progesterone levels (Ema and Miyawaki 2002). 
No significant alterations in reproductive parameters were observed in rats treated with up to 400 mg
monobutyltin trichloride/kg/day on Gds 7–17 (Noda et al. 1992b).
The highest NOAEL values and all reliable LOAEL values for reproductive effects in each species and 
duration are recorded in Tables 3-3 through 3-8 and plotted in Figures 3-3 through 3-8 for organotin 
compounds. 
3.2.2.6 Developmental Effects 
Inorganic Tin Compounds.  No studies were located regarding developmental effects in humans after 
oral exposure to inorganic tin compounds. 
Limited information is available from studies in animals.  Treatment of rats, mice, and hamsters with up 
to 31 mg tin/kg/day by gavage in water during gestation (Gds 6–15 for mice and rats, Gds 6–10 for 
hamsters) has no significant effect on fetal weight, the number of live of dead fetuses, and the incidence 
of external and internal malformations (FDA 1972).  Administration of up to approximately 56 mg
tin/kg/day (as tin fluoride) or 45 mg tin/kg/day (as sodium pentachlorostannite) to rats on Gds 0–20 had 
no significant effect on average fetal weight or the number of live fetuses per litter (Theuer et al. 1971). 
Organotin Compounds. No studies were located regarding developmental effects in humans after oral 
exposure to organotin compounds. 
Several organotins have been evaluated for potential developmental effects in animals.  A dose of 5 mg
dibutyltin dichloride/kg/day administered by gavage to pregnant Wistar rats on Gds 7–15 significantly 
increased the incidence of external and skeletal malformations but not of internal malformations (Ema et 
al. 1991b). Cleft jaw and ankyloglossia were the most frequent malformations.  A lower dose of 
2.5 mg/kg/day did not cause any significant effect.  Since adjusted maternal weight and food consumption 
during pregnancy were not affected at 5 mg/kg/day, it would appear that the developmental effects 
occurred in the absence of maternal toxicity.  In a similar study in Wistar rats dosed on Gds 7–17, Noda et 
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5 mg/kg/day.  Neither maternal weight not food consumption were significantly altered at 10 mg/kg/day, 
but maternal thymus weight was significantly reduced at 5 mg/kg/day suggesting that for dibutyltin, a 
known immunotoxicant (see Section 3.2.2.3), maternal changes in thymus weight may be a better 
predictor of embryotoxicity and teratogenicity than changes in body weight.  In a third study of similar 
design, Farr et al. (2001) observed a slight increase in malformations at 10 mg/kg/day, a dose level that 
also reduced maternal weight gain and food consumption, and decreased thymus weight; 5 mg/kg/day
was the maternal and developmental NOAEL. 
Studies have been conducted to determine the period of highest susceptibility during gestation.  For 
example, Ema et al. (1992) dosed rats with dibutyltin dichloride (20 mg/kg/day) at various times during 
gestation, after Gd 6, and noticed that the highest incidence of malformations occurred when dosing on 
Gd 8. No teratogenicity was evident when the rats were treated on Gds 10–12 or 13–15.  Fetal weights 
were most severely decreased when dosing on Gds 7–9.  In a more recent study, Ema and Harazono 
(2000) reported that doses of up to 15.2 mg dibutyltin dichloride/kg/day administered on either Gds 0– 
3 or 4–7 caused no external malformations. 
Doses of 16 mg tributyltin acetate/kg/day administered to pregnant Wistar rats on Gds 7–17 significantly
increased the incidence of external malformations, particularly cleft palate and also reduced maternal 
weight gain and food consumption, and thymus weight by about 28% (Noda et al. 1991a).  The 
developmental NOAEL was 8 mg/kg/day, but even a lower dose, 4 mg/kg/day, reduced maternal thymus 
weight. A dose of 25 mg tributyltin chloride/kg/day administered on Gds 13–15 caused more external 
malformations in rats (particularly cleft palate) than when given on Gds 10–12 (Ema et al. 1995b).  
Single-day treatments from Gd 7 onward showed that the most vulnerable periods for increased external 
malformations were Gds 11, 12, 13, and 14; a smaller increase also occurred when dosing on Gd 8 (Ema
et al. 1997a).  As with dibutyltin, doses of up to 16.3 mg tributyltin chloride administered on Gds 0–3 or 
4–7 did not cause malformations (Harazono et al. 1998).  Doses of tributyltin chloride up to 10 mg/kg/day
administered on Gds 8–19 did not significantly affect fetal weight, anogenital distance (male and female 
pups), or sex ratio, and caused no external malformations (Adeeko et al. 2003). However, 
0.25 mg/kg/day and higher doses given on Gds 0–19 significantly increased anogenital distance in male 
pups and t10 mg/kg/day increased the percentage of unfused ossification centers in the sternebrae 
(Adeeko et al. 2003). 
In a 2-generation reproductive toxicity study in female Wistar rats designed to examine the reproductive 
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significantly decreased the percentage of live pups and the birth weight of female pups (Ogata et al. 
2001).  Gestational body weight was significantly reduced in the high-dose parental (P) and F1 
generations. There were no gross malformations.  The day of eye opening was significantly delayed in 
the high-dose F2 pups. Body weights of F1 and F2 high-dose pups were significantly lower than controls 
for both pre- and postweaning.  Anogenital distance was significantly increased in F1 and F2 females on 
postnatal days (Pnds) 1 and 4 with the high-dose and on Pnd 1 in mid-dose F1. The day of vaginal 
opening was significantly delayed (6 days) in the high-dose F1 and F2 groups.  Analysis of the estrous 
cycles between Pnds 71 and 92 showed no alterations in F1, but the number of cycles was significantly
decreased in the high-dose F2. Also, the percentage of normal cycles was decreased in the high-dose F1 
and F2 rats. The NOAEL was 2 mg/kg/day.
A study of similar design was conducted to evaluate the development of reproductive parameters in male 
Wistar rats (Omura et al. 2001).  The doses tested were 0.4, 2, and 10 mg/kg/day.  Body weight was 
significantly reduced in the high-dose F1 pups on Pnds 1, 4, 14, and 21 and in the mid-dose F1 pups on 
Pnds 14 and 21.  Body weight was also reduced in the high-dose F2 pups on Pnds 1, 4, 14, and 21.
Anogenital distance and day of testes descent (measured on Pnds 1 and 4) was not significantly altered in 
F1 or F2 males. The day of eye opening was significantly delayed in the mid- and high-dose F1 males and 
in the high-dose F2 pups. Postnatal body weight gain, but not food consumption, was significantly 
depressed in the high-dose F1 and F2 pups. Effects on the weight of the sex organs included: decreased 
absolute testis weight in all F1 groups (dose-related); decrease absolute epididymis weight in the low- and 
high-dose F1 groups; decrease absolute testis and epididymis weight in the high-dose F2 groups and in 
relative prostate weight in the mid- and high-dose F2 groups. The only sperm parameters that were 
significantly altered were sperm count in the high-dose F2 rats and spermatid count in high-dose F1 rats 
and the mid- and high-dose F2 rats. Histological examination of the testes revealed minimal alterations in 
the high-dose F1 groups, but more frequent and severe effects in F2 groups, which were considered 
abnormal and consisted of vacuolization of the seminiferous epithelium, spermatid retention, and delayed 
spermiation.  Serum testosterone was increased and estradiol was decreased in the high-dose F1; serum
estradiol was decreased, and luteinizing hormone (LH) was increased in the high-dose F2. Based on 
decreased pups weight on Pnds 14 and 21, the authors established the developmental LOAEL at 
2 mg/kg/day and the NOAEL at 0.4 mg/kg/day.  The changes in sex organ weight were not considered 
biologically significant. 
Tributyltin chloride has also been shown to cause neurodevelopmental effects in rats.  Treatment of 
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hyperactivity in the offspring when tested on Pnds 60–70 and impaired learning in a radial arm maze test 
on Pnds 65–68 (Gardlung et al. 1991).  No obvious maternal toxicity was noticed and there were effects 
on the physical development of the offspring.  No significant effects were seen on open-field activity
(Pnds 120–125) or on performance on a swim-maze test (Pnds 66–70).  Also, in rats sacrificed on Pnds 
60–70, no significant alterations were found in the levels of noradrenaline in the frontal and occipital 
cortex, hippocampal formation, and cerebellum; levels of serotonin and metabolites in the frontal cortex, 
striatum, olfactory tubules, hippocampus, mesencephalon, and cerebellum; and levels of dopamine and its 
metabolites in the striatum, olfactory tubules, and mesencephalon.  Trihexyltin chloride, which was also 
tested in the study, was much less effective than tributyltin. 
Cooke et al. (2004) and Tryphonas et al. (2004) evaluated systemic and immunological parameters in rats 
that were exposed to tributyltin chloride in utero (Gds 8–21), through the mother’s milk, and directly as 
young adults until the age of 90 days.  The doses tested were 0.025, 0.25, and 2.5 mg/kg/day. Neither 
body weights nor food consumption was affected in the dams.  No effects were observed on litter size, 
pup's weight at birth, sex ratio, or survival until weaning.  Growth of the treated pups after weaning was 
slightly reduced (<10%) relative to controls and analysis of food consumption and weight gain showed 
that male pups converted feed into weight gain less effectively than females.  No effects were seen on the 
weights of pup's brain, kidney or adrenals, but there was a decrease in absolute and relative liver weight 
in 60-day-old females at 0.025 and 2.5 mg/kg/day, a decrease in absolute and relative liver weight in 
90-day-old males at 2.5 mg/kg/day, decrease in absolute spleen weight in 30-day-old males at 
2.5 mg/kg/day and in relative spleen weight in 60-day-old females at 2.5 mg/kg/day, a decrease in relative 
thymus weight in 60-day-old females at 0.25 and 2.5 mg/kg/day and in absolute thymus weight in 30-day­
old males at 2.5 mg/kg/day.  No consistent treatment-related gross or microscopic lesions were observed 
in dams and pups.  Clinical chemistry changes of potential biological importance included a decrease in 
serum amylase in 90-day-old males at 0.25 and 2.5 mg/kg/day and decreased T4 also in 90-day-old males 
at 2.5 mg/kg/day.  Based on the changes in pup's organ weights and in clinical chemistry parameters, the 
0.25 mg/kg/day dose is a LOAEL and 0.025 mg/kg/day a NOAEL.  The reduced weight gain of the pups 
is not considered adverse because the difference with controls was less than 10%.  
In the study of immunological parameters (Tryphonas et al. 2004), the only significant change in serum
immunoglobulin levels that appeared dose-related was an increase in IgG at 0.25 and 2.5 mg/kg/day in
90-day old males.  Flow cytometric analysis of splenocytes showed a significant increase mean percent 
and absolute NK cell numbers in high-dose 30-day-old males and females, a decrease in the percentage, 
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of NK cells in 90-day-old males.  The anti-SRBC IgM response was not affected by exposure to 
tributyltin.  No significant alterations were observed in the lymphoproliferative activity of splenocytes in 
response to mitogen stimulation.  The delayed-type hypersensitivity response (DTH) was not affected in 
60-day-old females, but 90-day-old males showed a significant trend toward a decrease in DTH response 
with increasing dosis of tributyltin.  The assays for L. monocytogenes infectivity and NK cell activity did 
not give dose-related responses.  Cytokine levels in serum were not affected.  Gross examination of 
lymphoid tissues was unremarkable.  The most consistent histological finding was mild to moderate 
cortical atrophy of the thymus, characterized by decreased numbers of cortical lymphocytes at 
2.5 mg/kg/day at all ages. 
In mice, doses of 11.7 mg tributyltin oxide/kg/day on Gds 6–15 induced cleft palate and other bone 
abnormalities and also decreased weight gain in the pregnant mice (Davis et al. 1987).  Similar findings 
were reported by Faqi et al. (1997) following dosing the mice on Gds 6–17 with 27 mg/kg/day, a dose 
level that also caused maternal toxicity. The developmental and maternal NOAEL was 13.5 mg/kg/day.  
Doses of up to 20 mg tributyltin oxide/kg/day did not increase the incidence of malformations in pups 
from dams treated on Gds 6–15, but significant early pup mortality occurred with this dose level 
(Baroncelli et al. 1995).  That same dose level did not significantly alter hematological parameters in the 
dams, neonates, or pups on Pnds 7, 14, and 21 (Karrer et al. 1995).  Absolute and relative thymus weight 
was reduced in pups on Pnd 7 and increased on Pnd 21 relative to controls; spleen weight was not 
affected by treatment. 
Experiments conducted with triphenyltin chloride in Wistar rats showed that doses of up to 
12.5 mg/kg/day administered on either Gds 7–9, 10–12, or 13–15 did not significantly increase the 
incidence of malformations, but fetal weight was decreased at 9.4 mg/kg/day when dosed on Gds 13– 
15 (Ema et al. 1999a).  No significant effect was seen on the incidence of malformations in doses up to 
25 mg/kg/day administered on Gds 4–6 or up to 6.3 mg/kg/day on Gds 0–3; fetal weight was decreased 
with doses of 4.7 mg/kg/day administered on Gds 0–3 (Ema et al. 1997b).  An unpublished study reported 
that fetal weights were slightly depressed (11%) in the offspring of New Zealand white rabbits that were 
administered 0.9 mg triphenyltin hydroxide/kg/day by gavage on Gds 6–18 (Rodwell 1987).  Delayed 
ossification of the hyoid bone was also present, but there were no teratogenic effects.  Food consumption 
and maternal weight gain were also significantly reduced at this dose level.  The maternal and 
developmental NOAEL was 0.3 mg/kg/day.  No other study in rabbits was identified that could have been 
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In a study with diphenyltin dichloride, treatment of rats with 16.5 mg/kg/day and higher doses on Gds 0–3 
significantly decreased the body weight of the live fetuses, but no significant effect was seen with doses 
of 8.3 mg/kg/day (Ema et al.1999c).  Treatment with up to 33 mg/kg/day did not alter the sex ratio or 
induce external malformations. 
Monobutyltin trichloride did not induce maternal or developmental effects in rats administered the 
compound on Gds 7–17 in doses of up to 400 mg/kg/day (Noda et al. 1992). 
Trimethyltin chloride (0.05, 0.16, 0.34 mg/kg/day) altered extinction learning ability in 11-day-old rat 
pups from rats treated for a period that included 14 days premating, gestation, and lactation (Noland et al. 
1982). This specific effect (altered extinction learning ability) was dose-related, but no dose-response 
was evident for other behavioral tests.  Tests with monomethyltin trichloride (3.7, 12.5, and 
37 mg/kg/day) were inconclusive. 
All reliable NOAEL and LOAEL values for developmental effects in each species and duration category
are recorded in Tables 3-3 through 3-8 are plotted in Figures 3-3 through 3-8 for organotin compounds. 
3.2.2.7 Cancer 
Inorganic Tin Compounds.  No studies were located regarding cancer effects in humans after oral 
exposure to inorganic tin compounds. 
A carcinogenesis bioassay for stannous chloride was conducted in male and female Fischer-344 rats and 
B6C3F1/N mice (NTP 1982).  Diets containing 32 or 63 mg tin/kg/day as stannous chloride were fed to 
rats and 82 or 164 mg tin/kg/day to mice for 105 weeks.  Aspects of the toxicity of stannous chloride 
observed during prechronic studies completed prior to the bioassay have been presented in 
Sections 3.2.2.1 and 3.2.2.2.  Tumors occurred at increased incidences in the dosed groups in the 
bioassay.  These included C-cell adenomas of the thyroid in low-dose male rats, lung adenomas in the 
high-dose male rats, and hepatocellular adenomas and carcinomas and histiocytic lymphomas in both 
low- and high-dose female mice.  However, the authors concluded that the incidences of the tumors 
relative to the histological control rat and mouse data were similar and were not clearly related to 
administration of stannous chloride.  The possibility that the C-cell tumors in the thyroid may have been 
related to stannous chloride feeding was not ruled out since the incidence in the low-dose group, but not 
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reservation, the conclusion from the NTP (1982) data was that stannous chloride was not carcinogenic for 
male or female rats or mice. 
An earlier chronic oral study that evaluated the carcinogenic potential of sodium chlorostannate must be 
regarded as flawed for several reasons.  The rats were fed on irregular dose schedules and most of the 
animals developed pneumonia (Roe et al. 1965).  After 1 year, three malignant tumors were identified in 
30 rats. Long-term chronic studies of stannous chloride in rats and mice were conducted using a single 
low-dose exposure and limited pathology studies (Schroeder and Balassa 1967; Schroeder et al. 1968).  
The authors concluded that stannous chloride was not carcinogenic. 
Organotin Compounds. No studies were located regarding cancer effects in humans after oral exposure 
to organotin compounds. 
A carcinogenesis bioassay for dibutyltin diacetate was conducted in male and female Fischer-344 rats and 
B6C3F1 mice (NCI 1978a).  Rats were fed diets that provided approximately 0, 3.33, or 6.65 mg 
dibutyltin diacetate/kg/day for 78 weeks followed by a period of no compound administration for 
26 weeks. Mice also were fed diets that provided approximately 0, 9.9, or 19.8 mg/kg/day for 78 weeks 
followed by a period of no compound administration for 14 weeks.  There were no significant increased 
tumor incidence in treated groups of rats and mice compared to their respective controls.  However, 
accidental loss of tissues from the uterus from 17 of the 50 high-dose female rats precluded a complete 
evaluation of neoplasms in this organ.  Apparently, there were no historical control data available at the 
time for evaluation of background versus experimental findings. The general conclusion was that 
dibutyltin diacetate was not carcinogenic for male rats and male or female mice under the experimental 
conditions of the study.  The loss of the tissues prevented reaching a conclusion with regard to the 
relationship between dibutyltin diacelate and the occurrence of uterine neoplasms in female rats. 
Another organotin compound, triphenyltin hydroxide, was tested in a bioassay using male and female
Fischer-344 rats and B6C3F1 mice (NCI 1978b).  The regimen included dietary feeding for 78 weeks 
followed by a 26-week observation period.  Dosage levels were approximately 0, 1.88, and 
3.75 mg/kg/day as triphenyltin hydroxide for rats and 0, 4.88, and 9.75 mg/kg/day for mice.  Survival was 
affected in male mice, but no other effects were observed in the mice or the rats.  The incidence of tumors 
seen in treated animals was comparable to controls.  Historical control data were apparently not available 
at the time for evaluation of background versus experimental findings.  The general conclusion was that 
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triphenyltin hydroxide was not carcinogenic for male and female rats and mice under the experimental 
conditions of the study. 
In contrast to these results, longer-term studies on the carcinogenicity of triphenyltin hydroxide in Wistar 
rats and NMRI mice, using higher maximum doses, produced tumors in both species (Tennekes et al. 
1989a, 1989b).  In rats administered doses of 0.3–6.2 mg/kg/day triphenyltin hydroxide in the diet, there 
was a dose-related increase in pituitary adenomas in the exposed females at 104 weeks.  Although the 
incidence of this lesion was high in the control animals (64.4%), it was even greater in the exposed 
animals, especially at the two highest dose levels (76.8 and 93.1%, respectively).  There was also a dose-
related decrease in survival for the females that was related to tumor incidence.  Only 23% of the females 
receiving the highest dose were alive at the termination of the study as opposed to 80% of the males. 
The number of males with testicular Leydig cell tumors was increased in animals exposed to 
5.2 mg/kg/day triphenyltin hydroxide for 104 weeks (16.7 as opposed to 1.7% in the controls). 
Tumors were also present in mice given diets containing 0.9–20.2 mg/kg/day triphenyltin hydroxide.  
After sacrifice at 80 weeks, examination of the tissue revealed an increased incidence of hepatocellular 
adenomas in both sexes. These tumors were consistent with the nodular hyperplasia seen in the livers of 
the treated animals.  As was the case with the rat study, the females appeared to be more sensitive to tin 
treatment than the males.  There was a decrease in survival for the females at the highest dose.  Only 50% 
of the females receiving this dose were alive at the termination of the study as opposed to 70% of the 
males in the same dose group and 74% of the female control animals.  The difference between the high-
dose treated females and control females was statistically significant. 
A 2-year bioassay was conducted with tributyltin oxide in male and female Wistar rats (Wester et al. 
1990).  The rats were fed a diet that provided 0, 0.019, 0.19, or 2.1 mg/kg/day of tributyltin oxide for 
males and 0, 0.025, 0.25, or 2.5 mg/kg/day for females.  In high-dose males, survival at termination was 
40 vs. 60% in controls; in females, it was 54 vs. 74% in controls.  There was a significant increase in total 
pituitary tumors in males and females from the low- and high-dose groups, but not in the mid-dose 
groups. Also, the total pheochromocytomas (adrenal gland) were significantly increased in high-dose 
males and females. In addition, the number of parathyroid adenomas was significantly increased in high-
dose males. Wester et al. (1990) stated that the increase incidence of some tumors may have been due to 
hormonal or immunological changes.  They further noted that because there is a high spontaneous 
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of a dose-effect relationship, the significance of the increased incidence is questionable.  Based on no 
human data and questionable data in rats, EPA (IRIS 2005) placed tributyltin oxide in Group D, not 
classifiable as to human carcinogenicity or, according to updated guidelines (EPA 2003g), in a group for 
which there is inadequate information to assess carcinogenic potential. 
3.2.3 Dermal Exposure 
Except for dermal/ocular effects (Section 3.2.3.2) there is no information that describes health effects in 
humans or animals after dermal exposure to inorganic tin or organotin compounds.  Table 3-9 summarizes 
available quantitative information on health effects that have been observed in animals after dermal 
exposure to organotin compounds. 
3.2.3.1 Death 
Inorganic Tin Compounds.  No studies were located regarding death in humans or animals after dermal 
exposure to inorganic tin compounds. 
Organotin Compounds. The death of a female worker accidentally drenched in phenyltin and other 
unidentified compounds was described in Section 3.2.1.1.  Second and third degree burns developed 
12 hours following the accident (NIOSH 1976). 
Dermal LD50 values in animals are available for a number of organotin compounds (Smith 1978).  A 
dermal LD50 in rabbits was reported to be 11,700 mg/kg bis(tributyltin) oxide (Elsea and Paynter 1958).  
For rats, an LD50 of 605 mg/kg is given (Smith 1978).  Despite variations in values for other compounds 
such as benzoates, naphthenates, and fluorides, the acute dermal toxicity of organotin compounds is 
generally less than by the oral route.  The LD50 values for representative species in the acute- and 
intermediate-duration category are recorded in Table 3-9.  Doses are expressed as mg/kg/day of the 
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Table 3-9 Levels of Significant Exposure to Tributyltins - Dermal (continued) 
Exposure/ LOAEL 
Duration/ 
Species Frequency Reference 
(Strain) (Route) System NOAEL Less Serious Serious Chemical Form 
Systemic 
(Hartley) 
Gn Pig 50 d 
1 x/d Renal 10 M 
mg/kg/day 
(tubule degeneration) 
Mori et al 1984 
TBT 
Bd Wt 10 M 
mg/kg/day 
(decreased body weight 40 M 
mg/kg/day 
(severe decrease in body 
weight) 







Bd Wt = body weight; (C) = capsule; d = day(s); F = Female; (G) = gavage; Gn pig = Guinea pig; hr = hour(s); LD50 = lethal dose, 50% kill; LOAEL = lowest-observed-adverse-effect 
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3.2.3.2 Systemic Effects 
Inorganic Tin Compounds.  No studies were located regarding respiratory, cardiovascular, 
gastrointestinal, hematological, musculoskeletal, hepatic, or renal effects in humans or animals after 
dermal exposure to inorganic tin compounds. 
Organotin Compounds. No studies were located regarding respiratory, cardiovascular, gastrointestinal, 
hematological, musculoskeletal, or renal effects in humans after dermal exposure to organotin
compounds. 
No studies were located regarding respiratory, cardiovascular, gastrointestinal, hematological,
musculoskeletal, or hepatic effects in animals after dermal exposure to organotin compounds. 
The highest NOAEL values and reliable LOAELs are recorded in Table 3-9. 
Hepatic Effects. Signs of hepatic injury, as judged by increased serum AST and ALT activities, were
reported in a case of acute dermal exposure to triphenyltin acetate (Colosio et al. 1991).  The patient, a 
36-year-old man, spilled powder of a 19% formulation of triphenyltin acetate on exposed skin on his 
arms.  The acute rise in transaminase activities was followed by a gradual decrease for the next 18 days. 
Twelve days after poisoning, echotomography showed a generalized enlargement of the liver.  Three days
later, examination of a liver needle biopsy showed slight and nonspecific inflammatory abnormalities.  
Slight hepatomegaly persisted when the patient was discharged 21 days after poisoning. 
Renal Effects. Doses of 10 or 40 mg tributyltin oxide/kg/day were applied to the shaved skin of male 
guinea pigs for 50 days (Mori et al. 1984).  Swelling, degeneration, and destruction of tubular epithelium
were observed, but there were no changes in the glomerulus.  There was also an increased excretion of 
sodium, chloride, phosphate, glucose, and amino acids in the urine.  In serum, the concentrations of 
phosphate and certain amino acids were low reflecting the excessive loss in the urine.  According to the 
authors, these findings were consistent with a secondary Fanconi syndrome.  These renal tubular changes 
are similar to those seen with inorganic tin compounds after oral exposure (see Section 3.2.2.2) and 
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Dermal Effects.    
Inorganic Tin Compounds.  No studies were located regarding dermal effects in humans after dermal 
exposure to inorganic tin compounds. 
Stannous fluoride (0.25 and 0.5%) and stannous chloride (1 and 2%) produced leukocyte pustules in 
rabbit skin along the area adjacent to an abdominal epidermal scratch (Stone and Willis 1968).  
Infiltration of the tissue with polymorphonuclear and mononuclear leukocytes was present in the absence 
of pustules at a stannous chloride concentration of 0.5% and a stannous fluoride concentration of 0.1%. 
Organotin Compounds.  It is known that organotins are skin irritants in humans (Sheldon 1975).  Direct 
skin contact with triphenyltin fluoride produced an irritant contact folliculitis in a male worker (Andersen 
and Petri 1982). Patch tests were performed in human subjects, as well as in guinea pigs and rabbits, but 
the dermatitis could not be reproduced.  An irritant contact dermatitis was also seen in workers using a 
paint containing tributyltin oxide (Goh 1985).  Sensitization was not observed in any of the referenced 
studies or in a separate study of tributyltin oxide-based paints (Gammeltoft 1978).  Lyle (1958) described 
the following time-course of events in five volunteers who had undiluted tributyltin chloride painted on 
the skin of the back of the hand.  Reddening and swelling of the mouths of the hair follicles appeared after 
2–3 hours; this was followed by progressively intense follicular inflammation.  The pruritus was confined 
to the tested area and persisted for 2 or 3 days.  Pustules appeared on the second day and remained small 
until they dried up on the third or fourth day.  On the fifth day, resolution was well advanced and, after a 
week, all that remained was faint punctate erythema with a little perifollicular scaling. 
Tributyltin oxide is a severe irritant to the skin in rabbits (Sheldon 1975).  By contrast, tributyltin fluoride 
and triphenyltin fluoride produced only minimal skin irritation (Sheldon 1975).  Other acute studies have 
likewise demonstrated the skin irritating potential of tributyltin oxide and triphenyltin acetate in rats and 
mice (Corsini et al. 1996a; Klimmer 1969; Pelikan and Cerny 1968). 
Dermal exposure of rats to doses of 80 mg/kg of dipropyltin dichloride, diisopropyltin dichloride, or 
diethyltin dichloride for 5 consecutive days produced necrosis, edema, and inflammation of the skin 
(Barnes and Stoner 1958).  The same dose of dimethyltin dichloride produced dermal necrosis with black 
scar formation; dibutyltin dichloride produced little superficial damage to the skin and some edema of 
subcutaneous tissues. Dihexyltin dichloride and dioctyltin dichloride did not produce skin lesions 
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each of three levels tested (14, 27, and 68 mg/kg/day tributyltin fluoride) (Sheldon 1975). Deaths 
occurred in 7 of 10 rabbits at 68 mg/kg, but surviving animals eventually returned to normal a few days
after exposure was terminated. The authors stated that a dose of 14 mg/kg (65 applications) was a 
NOAEL despite local irritation at the application sites.  In view of the exaggerated daily contact with the 
rabbit skin, this value seems reasonable since such high levels of daily exposure would not be the case in 
humans.  However, a detailed report of this study was not available for review. 
A study in guinea pigs did not find tributyltin oxide to be a contact sensitizer (Schweinfurth and Gunzel 
1987). 
Ocular Effects.    
Inorganic Tin Compounds.  No studies were located regarding ocular effects of inorganic tin in humans 
or animals following dermal exposure. 
Organotin Compounds. Lyle (1958) described the case of a worker who was not wearing protective 
goggles and splashed an unspecified butyltin compound on the face and both eyes were affected.  
Lachrimation and intense suffusion of the conjunctiva appeared within minutes and, despite immediate 
lavage, persisted for 4 days.  Tributyltin oxide, tributyltin fluoride and triphenyltin fluoride are extreme 
irritants to rabbits’ eyes (Sheldon 1975).
3.2.3.3 Immunological and Lymphoreticular Effects 
Inorganic Tin Compounds.  No studies were located regarding immunological and lymphoreticular 
effects in humans or animals following dermal exposure to inorganic tin.  
Organotin Compounds. Colosio et al. (1991) reported that a man who spilled a powder pesticide 
formulation containing 19% triphenyltin acetate over exposed skin on his arm developed severe genital 
edema and urticarial eruptions on his trunk.  In addition, on day 11 after the accident his serum IgE was 
elevated. Although patch tests conducted with the entire formulation and with each single component of 
the formulation gave negative results, the investigators attributed the findings to poisoning with
triphenyltin.  Tributyltin oxide induced contact sensitization in mice applied the test material for 3 days
and challenged with it 3 days later (Stringer et al. 1991).  The lowest concentration tested, 0.25% by 
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3.2.3.4 Neurological Effects 
Inorganic Tin Compounds.  No studies were located regarding neurological effects in humans or animals 
following dermal exposure to inorganic tin. 
Organic Tin Compounds.  The only relevant information is that from the case of a man who spilled a 
powder pesticide formulation containing 19% triphenyltin acetate on his exposed arms, and 10 days after 
the accident, his EEG showed alterations consisting of generalized paroxysmal abnormalities and 
bradyrhythmia (Colosio et al. 1991).  Four months after the accident, the EEG showed slight anomalies 
during hyperpnea. 
No studies were located regarding the following effects in humans or animals after dermal exposure to 
inorganic tin or organotin compounds: 
3.2.3.5 Reproductive Effects 
3.2.3.6 Developmental Effects 
3.2.3.7 Cancer 
Inorganic Tin Compounds.  No studies were located regarding cancer effects in humans or animals after 
dermal exposure to inorganic tin compounds. 
Organotin Compounds. No studies were located regarding cancer effects in humans after dermal 
exposure to organotin compounds. 
In a limited evaluation of carcinogenicity, tributyltin fluoride was applied to the shaved backs of male 
white mice 3 times/week for a period of 6 months.  Treated mice received 15 mg of 5 or 10% of the 
compound in propylene glycol.  Hyperplastic skin changes were observed in the 5% group, but not in the 
10% group (Sheldon 1975).  Carcinogenic effects were not observed in this study, which was only of 
intermediate duration.  No other studies were located regarding cancer effects in animals after dermal 
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3.2.4 Other Routes of Exposure 
This section provides brief examples of effects of tin compounds that have been studied primarily by
exposing the animals by a route other than inhalation, oral, or dermal. 
A considerable number of studies have evaluated the developmental effects of both trimethyltin and 
triethyltin following perinatal exposure by intraperitoneal injection of animals, and some studies have 
demonstrated that some alterations persist until adulthood.  For example, a single intraperitoneal dose of 
trimethyltin hydroxide (4–6 mg/kg) to rat pups on Pnd 5 reduced growth and impaired performance on 
rope descent when tested on Pnd 20 and 21 (Ruppert et al. 1983).  Motor activity in a figure-eight maze 
was increased at 57 days of age and at 120 days of age.  The response to acoustic startle was decreased 
during preweaning and as adults.  At termination (Pnd 120), whole brain weight and weight of olfactory 
bulbs decreased at 4, 5, and 6 mg/kg, whereas the hippocampus weight was decreased at 5 and 6 mg/kg.  
Similar results were obtained following a single intraperitoneal injection of triethyltin bromide (3 or 
6 mg/kg) also on Pnd 5 (Reiter et al. 1981).  Barone et al. (1995) showed that some behavioral alterations 
that can be detected on Pnd 23 after a single injection of triethyltin on Pnd 5, which were no longer 
apparent 3 or 12 months postdosing, became apparent again in 24-month-old rats, suggesting an 
unmasking effects by the natural aging process. 
Chang (1984a, 1984b) did not observe lesions in the hippocampal formation of rats injected 
intraperitoneally with 6 mg/kg trimethyltin chloride between Pnd 1 and 4, but increasing damage to 
Ammon’s horn was seen when dosing occurred between the ages of Pnd 5 and 15.  This was followed by 
an apparently reduced sensitivity after Pnd 20.  Since the pathological patterns were well-correlated with 
the development and functional maturity of the hippocampal neurons, Chang (1984a, 1984b, 1990) 
postulated that the production of lesions, particularly those in subfield CA3, require functionally mature 
and intact granule cells and their fibers, the mossy fibers.  It has also been shown that the day of exposure 
greatly influences the magnitude of cognitive deficits and neuropathology associated with exposure to 
triethyltin (Freeman et al. 1994). 
Trimethyltin and triethyltin have induced ototoxicity in rodents.  A single intraperitoneal injection of 4– 
6 mg trimethyltin/kg produced a frequency-dependent loss of auditory sensitivity in rats that was severe 
in the high frequency range (Eastman et al. 1987; Ruppert et al. 1984).  Subsequent studies showed that 
the alterations were long-lasting and consisted of a high-frequency hearing loss characterized by elevated 
thresholds in the auditory startle response test detected 11 weeks postdosing (Crofton et al. 1990).  
Thresholds for the brainstem auditory evoked response were also elevated in treated rats 9 weeks 
 
   
 
160 TIN AND TIN COMPOUNDS 
3. HEALTH EFFECTS 
postdosing. Microscopic examination of the cochlea from base to apex showed dead outer hair cells 
preferentially in regions associated with high-frequency hearing, in a dose-related manner.  A study in 
guinea pigs treated intraperitoneally with a single dose of 2 mg of trimethyltin chloride/kg showed high-
frequency impairment, which improved throughout a 6-week period of testing (Fechter and Carlisle 
1990). As seen in the rat, hair cell loss occurred in a portion of the cochlea responsible for encoding high-
frequency sound.  There also was a marked increase in the diameter of the vessels of the stria vascularis 
(an area containing one of the primary vascular networks in the cochlea) along with signs of atrophy in 
the stria vascularis. However, since the increases in vessel diameter were not confined to the basal 
portion of the cochlea, and were greater in the middle and apical regions than in the base, it seemed that 
the strial pathology was not directly related to hair cell loss or functional impairment.  In a different study, 
both trimethyltin and triethyltin were shown to severely disrupt (increase) the compound action potential 
(CAP) threshold in guinea pigs within 30–60 minutes of dosing, but had no significant effect on the 
cochlear microphonic (CM) potential (Clerici et al. 1991).  The CAP is generated by the release of 
neurotransmitters from the inner hair cells and the subsequent depolarization of spiral ganglion cells, 
whereas CM reflects electromechanical function of the outer hair cells.  In a further study, trimethyltin 
was shown to reduce CAP sensitivity and CM amplitude (Fechter et al. 1992). The effect was relatively
broad across test frequencies 6 hours after dosing and gradually became restricted to higher frequencies.  
The effect of trimethyltin appears to be a direct effect on the cochlea, as disruption of sound-evoked 
cochlear action potentials can be observed after direct application of trimethyltin to the round window of 
guinea pigs (Liu and Fechter 1995).  The results of these and other studies were thought to be consistent 
with the hypothesis that trimethyltin disrupts function at the synapse between the inner hair cell and the 
Type I spiral ganglion cell, possibly by damaging the hair cells or ganglia from uncontrolled production 
of reactive oxygen species (ROS) (Clerici 1996; Fechter and Liu 1994). 
A series of publications from Merkord and coworkers have described the effects of dibutyltin dichloride 
on the pancreas from rats following intravenous injection of the chemical.  Earlier studies described an 
acute interstitial pancreatitis in rats developing 24 hours after a single dose followed by a more severe 
pancreatitis with mononuclear cell infiltrates 4–6 days later (Merkord and Hennighausen 1989).  In a 
more recent study, the time-course of the pancreatic alterations was followed for up to 28 days with 
interim sacrifices at various intervals after a single dose of 6 mg dibutyltin dichloride/kg (Merkord et al. 
1997).  The findings suggested an initial cytotoxic effect on the biliopancreatic duct epithelium leading to 
epithelial necrosis with obstruction of the duct.  This was followed by hematogenic effects directly
injuring pancreatic cells followed by interstitial edema and inflammation.  A tendency to a chronic course 
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showed that an active inflammatory process persisted for up to 60 days after dosing (Sparmann et al. 
1997).  A study of repeated administration of a slightly lower dose of dibutyltin dichloride (4 mg/kg) at 
intervals of 3 weeks, reported the development of acute pancreatitis and biliopancreatic lesions after 
6 weeks and pancreatic fibrosis and liver lesions after 9–12 weeks (Merkord et al. 2001).  In rats followed 
for up to 1 year after a single injection of 6 mg dibutyltin dichloride/kg, the permanent obstruction of 
biliopancreatic secretion and chronic cholestasis led to the formation of deposits inside the dilated duct, 
occasionally with bacterial infiltration and growth.  Considerable amounts of tin were detected inside the 
bacterially infected deposits (Jonas et al. 2002). 
3.3 GENOTOXICITY 
In vitro studies with inorganic tin have provided mixed results (Table 3-10). DNA damage was noted in 
Chinese hamster ovary cells incubated with stannous chloride in the absence of metabolic activation, but 
the results for stannic chloride were negative (McLean et al. 1983).  Cytogenetic studies also gave 
positive responses with stannous chloride for chromosomal aberrations and sister chromatid exchanges in 
Chinese hamster ovary cells with or without metabolic activation (Gulati et al. 1989).  Ganguly et al. 
(1992) incubated peripheral lymphocytes from 27 healthy male volunteers with stannic chloride and 
observed a significant increase in the frequency of chromosomal aberrations.  In K562 cells (a cell line 
derived from a chronic myelogenic human leukemia), stannous chloride reduced viability and induced 
DNA damage, as determined by the comet assay (Dantas et al. 2002).  The investigators (Dantas et al. 
2002) proposed that genetic damage is produced by ROS generated by the reduction of hydrogen 
peroxide by stannous ions.  Earlier research from this group had demonstrated that ROS scavengers and 
metal-ion chelators could prevent, at least partially, the inactivation of Escherichia coli cultures treated 
with stannous chloride (Dantas et al. 1996).  Stannous chloride has also been reported to rapidly convert 
hydroperoxy thymidine to mutagenic hydroxymethyl deoxyuridine species in vitro, suggesting a redox 
component in the genotoxic potential of stannous chloride in vivo (Tofigh and Frenkel 1989). 
Table 3-11 presents data on the genotoxicity of organotin compounds in in vitro assays.  Hamasaki et al. 
(1993) tested 14 different organotin compounds in two strains of Salmonella typhimurium, TA98 and 
TA100, without metabolic activation.  All but dibutyltin dichloride gave negative results in TA98.  In 
TA100, the monobutyltins, dibutyltins, and tributyltin compounds gave positive results.  Results from
assays in mammalian cells for a number of trialkyl organotins, with and without metabolic activation, 
showed mostly negative results (Davis et al. 1987; Sasaki et al. 1993).  However, other studies have 
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Table 3-10. Genotoxicity of Inorganic Tin Compounds In Vitro 
Results 
With Without 
Species (test system) End point activation activation Form Reference 
Prokaryotic organisms: 
Bacillus subtilis Rec-assay No data – Stannous chloride Nishioka 1975 
B. subtilis Rec-assay No data – Stannic oxide Nishioka 1975 
Salmonella typhimurium Reverse No data – Stannic chloride Hamasaki et 
TA100, TA98 mutation al. 1993 
Escherichia coli MBL50 DNA damage No data + Stannous chloride Cabral et al. 
1998 
Mammalian cells: 
Chinese hamster ovary DNA damage No data + Stannous chloride McLean et al. 
cells 1983 
Chinese hamster ovary DNA damage No data – Stannic chloride McLean et al. 
cells 1983 
Chinese hamster ovary Sister + + Stannous chloride Gulati et al. 
cells chromatid 1989 
exchanges 
Chinese hamster ovary Chromosomal + + Stannous chloride Gulati et al. 
cells aberrations 1989 
K562 cell line DNA damage No data + Stannous chloride Dantas et al. 
2002 
Human peripheral Chromosomal No data + Stannic chloride Ganguly et al. 
lymphocytes aberrations 1992 
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Table 3-11. Genotoxicity of Organotin Compounds In Vitro 
Results 






Bacillus subtilis TBTO Rec-assay No data – Davis et al. 1987 
Klebsiella 
pneumoniae 
TBTO Fluctuation test No data – Davis et al. 1987 
Salmonella 
typhimurium
TBTO Plate assay – – Davis et al. 1987 
S. typhimurium TBTO Hepatocyte – No data Davis et al. 1987 
S. typhimurium TBTO Mediated assay – No data Davis et al. 1987 
S. typhimurium TBTO Fluctuation test + – Davis et al. 1987 
S. typhimurium TA98 MBTO Reverse mutation No data – Hamasaki et al. 
1993 
S. typhimurium TA98 MBTC Reverse mutation No data – Hamasaki et al. 
1993 
S. typhimurium TA98 DBTC Reverse mutation No data + Hamasaki et al. 
1993 
S. typhimurium TA98 TBTC Reverse mutation No data – Hamasaki et al. 
1993 
S. typhimurium TA98 TBTO Reverse mutation No data – Hamasaki et al. 
1993 
S. typhimurium TA98 TeBT Reverse mutation No data – Hamasaki et al. 
1993 
S. typhimurium TA98 MPhTC Reverse mutation No data – Hamasaki et al. 
1993 
S. typhimurium TA98 DPhTC Reverse mutation No data – Hamasaki et al. 
1993 
S. typhimurium TA98 TPhTC Reverse mutation No data – Hamasaki et al. 
1993 
S. typhimurium TA98 TePhT Reverse mutation No data – Hamasaki et al. 
1993 
S. typhimurium TA98 MMTC Reverse mutation No data – Hamasaki et al. 
1993 
S. typhimurium TA98 DMTC Reverse mutation No data – Hamasaki et al. 
1993 
S. typhimurium TA98 TMTC Reverse mutation No data – Hamasaki et al. 
1993 














164 TIN AND TIN COMPOUNDS 
3. HEALTH EFFECTS 
Table 3-11. Genotoxicity of Organotin Compounds In Vitro 
Results 
With Without 
Species (test system) Compound End point activation activation Reference 
S. typhimurium MBTC Reverse mutation No data + Hamasaki et al. 
TA100 1993 
S. typhimurium DBTC Reverse mutation No data + Hamasaki et al. 
TA100 1993 
S. typhimurium TBTC Reverse mutation No data + Hamasaki et al. 
TA100 1993 
S. typhimurium TBTO Reverse mutation No data + Hamasaki et al. 
TA100 1993 
S. typhimurium TeBT Reverse mutation No data – Hamasaki et al. 
TA100 1993 
S. typhimurium MPhTC Reverse mutation No data – Hamasaki et al. 
TA100 1993 
S. typhimurium DPhTC Reverse mutation No data – Hamasaki et al. 
TA100 1993 
S. typhimurium TPhTC Reverse mutation No data – Hamasaki et al. 
TA100 1993 
S. typhimurium TePhT Reverse mutation No data – Hamasaki et al. 
TA100 1993 
S. typhimurium MMTC Reverse mutation No data – Hamasaki et al. 
TA100 1993 
S. typhimurium DMTC Reverse mutation No data + Hamasaki et al. 
TA100 1993 
S. typhimurium TMTC Reverse mutation No data – Hamasaki et al. 
TA100 1993 
S. typhimurium TeMT Reverse mutation No data – Hamasaki et al. 
TA100 1993 
Eukaryotic organisms: 
Saccharomyces TBTO Forward mutation – – Davis et al. 1987 
pombe 
Saccharomyces TBTO Mitotic gene – – Davis et al. 1987 
cerevesiae conversion 
Mammalian cells: 
Chinese hamster TBTO 8-Azaguanine and – – Davis et al. 1987 
cells ovarian resistance 
Chinese hamster TBTO 6-Thioguanine – – Davis et al. 1987 
cells resistance 
Mouse lymphoma TBTO 6-Thioguanine and No data – Davis et al. 1987 
cells Buer resistance 
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Table 3-11. Genotoxicity of Organotin Compounds In Vitro 
Results 










– Davis et al. 1987 
Chinese hamster 
cells 
TBTO Inhibition of 
metabolic 
cooperation 
No data – Davis et al. 1987 
Chinese hamster 
cells 
TPhTH Gene mutation – – Oshiro et al. 1991 
Chinese hamster 
cells 
TPhTH Micronucleus + – Oshiro et al. 1991 
Chinese hamster 
cells 
TPhTH Micronucleus + + Chao et al. 1999 
Chinese hamster 
cells 






















Chao et al. 1999 
Chao et al. 1999 















No data – Sasaki et al. 1993 
Chinese hamster 
cells 










No data – Sasaki et al. 1993 
Chinese hamster 
cells 
TMTC Spindle inhibition No data + Jensen et al. 1991b 
Chinese hamster 
cells  
TBTC Spindle inhibition No data + Jensen et al. 1991b 
Chinese hamster 
cells 
DMTC Spindle inhibition No data + Jensen et al. 1991b 
Chinese hamster 
cells 
TPhTC Spindle inhibition No data + Jensen et al. 1991b 
Chinese hamster 
cells 
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Table 3-11. Genotoxicity of Organotin Compounds In Vitro 
Results 
With Without 
Species (test system) Compound End point activation activation Reference 
Human peripheral TMTC Chromosomal No data + Ghosh et al. 1991 
lymphocytes aberrations 
Human peripheral TMTC Sister chromatid No data + Ganguly et al. 1992 
lymphocytes exchange 
Human peripheral TMTC Micronucleus No data + Ghosh et al. 1990 
lymphocytes
+ = positive result; – = negative result; DBTC = di-n-butyltin dichloride; DMTC = dimethyltin dichloride; 

DPhTC = diphenyltin dichloride; MBTC = n-butyltin trichloride; MBTO = mono-n-butyltin oxide; MMTC = methyltin 

trichoride; MPhTC = phenyltin trichloride; TBTC = tri-n-butyltin chloride; TBTF = tributyltin fluoride; 

TBTO = bis(tributyltin)oxide; TeBT =tetra-n-butyltin; TeMT = tetramethyltin; TePHT = tetraphenyltin; 
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peripheral lymphocytes obtained from healthy individuals and incubated with trimethyltin chloride 
(Ganguly et al. 1992; Ghosh et al. 1990, 1991).  Triphenyltin compounds were positive in tests for 
induction of micronuclei and sister chromatid exchanges in Chinese hamster cells (Chao et al. 1999;
Oshiro et al. 1991). 
A limited number of studies have examined the in vivo genotoxic effects of organotins administered in 
animals (Table 3-12).  In vivo micronucleus tests for tributyltin oxide in mice have produced mixed 
results. Neither tributyltin oxide nor triphenyltin chloride injected in doses up to 100 mg/kg in mice 
increased the incidence of micronuclei in blood reticulocytes (Yamada and Sasaki 1993).  Similar results 
were reported by Schweinfurth and Gunzel (1987) after administration of a single dose of 125 mg/kg of 
tributyltin oxide to mice.  In contrast, Davis et al. (1987) reported an increase in micronuclei in mice 
treated with a single dose of 60 mg/kg tributyltin oxide.  According to Schweinfurth and Gunzel (1987), 
the difference between their results and those of Davis et al. (1987) may be due to a higher number of 
polychromatic erythrocytes per animal that were scored in Schweinfurth and Gunzel (1987). Sagelsdorff 
et al. (1990) treated male and female rats with a single gavage dose (approximately 3.5 mg/kg) of 
14C-dioctyltin dichloride and isolated DNA from thymus and liver 96 hours later to determine possible 
adduct formation.  They detected radioactivity incorporated to all DNA fractions via biosynthesis, but 
there was no adduct formation.  Gavage administration of three doses of 2 mg/kg of triphenyltin acetate to 
mice or a single dose of 12.5 mg/kg significantly increased the incidence of micronucleated reticulocytes; 
a similar significant increase occurred following a single dose of 2.5 mg/kg of triphenyltin hydroxide 
(Chao et al. 1999). Intraperitoneal treatment of mice with 0.25–1 mg/kg of trimethyltin significantly




The results of toxicity studies suggest that inorganic tin compounds are not readily absorbed after oral or 
inhalation exposure and show only limited effects after dermal exposure.  Organotin compounds are more 
readily absorbed than inorganic tin compounds by these three routes of exposure. 
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Table 3-12. Genotoxicity of Organotin Compounds In Vivo 
Species 
(test system) Compound End point Results Reference 
Insect system: 
Drosophilia TBTO Test for sex-linked recessive – Davis et al. 1987 
melanogaster lethal mutations 
Mammalian system: 
Mice TBTO Micronucleus test; single dose + Davis et al. 1987 
60 mg/kg body weight 
Mice TBTO Micronucleus test; cytotoxic – Schweinfurth and Gunzel 
doses; highest 125 mg/kg body 1987 
weight 
Mice TPhTA Micronucleus; single 12.5 mg/kg + Chao et al. 1999 
oral dose 
TPhTH Micronucleus test; single + Chao et al. 1999 
2.5 mg/kg oral dose 
Rat DOTC Liver and thymus DNA adduct – Sagelsdorff et al. 1990 
single oral gavage ~3.5 mg/kg 
Mice TMTC Chromosomal aberrations; + Ganguly 1994 
three intraperitoneal doses 0.25– 
1 mg/kg 
Mice	 TBTO Micronucleus; single oral dose – Yamada and Sasaki 1993 
100 mg/kg TPhTC 
+ = positive result; – = negative result; DNA = deoxyribonucleic acid; DOTC = dioctyltin dichloride; 
TBTO = bis(tributyltin)oxide; TMTC = trimethyltin chloride; TPhTA = triphenyltin acetate; TPhTC = triphenyltin 
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3.4.1.1 Inhalation Exposure 
No quantitative studies were located regarding absorption in humans or animals after inhalation exposure 
to inorganic tin or organotin compounds.  However, limited data summarized in Section 3.2.1 suggest that 
absorption of organotins by the inhalation route is possible, as occurred for example in cases for subjects 
who exhibited serious neurological effects after accidental exposure to vapors of a trimethyltin (Feldman 
et al. 1993; Fortemps et al. 1978; Rey et al. 1984; Ross et al. 1981; Saary and House 2002; Yanofsky et 
al. 1991).  Dermal exposure may have also occurred in these cases.
3.4.1.2 Oral Exposure 
Inorganic Tin Compounds.  Johnson and Greger (1982) conducted a balance study in eight healthy adult 
males, who were placed on diets containing either 0.1 mg Sn/day (basal diet) or 50 mg Sn/day
(supplemented with stannous chloride). Subjects were placed on the diets for 20 days and intakes and 
excretion were measured daily in two 6-day periods (following a 6-day adjustment to the diets).  Average 
fecal excretion was 55% of the daily intake in the basal group and 97% in the supplemented group, 
suggesting net absorption of 45 and 3%, respectively. Average urinary excretion was 26% of the daily
intake in the basal group and 2.4% in the supplemented group.  Estimates of absorption in individuals 
ranged from -4 to 71% of the daily intake in the basal group and from -7 to 9% in the supplemented 
group. These observations suggest that gastrointestinal absorption of tin, in humans, decreases with 
increasing dose. An alternative explanation for the differences in absorption of tin in the basal and 
supplemented diets is that tin naturally incorporated into food may be more readily absorbed than tin 
added as stannous chloride to food.  Consistent with the former explanation are observations from
Calloway and McMullen (1966).  In this study, nine healthy adults were placed on diets for 24 days
consisting of either fresh food (10 mg Sn/day), canned food that had been stored for 20 months at 1 qC 
(26 mg Sn/day), or canned foods that had been stored for 20 months at 37 qC (163 mg Sn/day).  Tin was 
not detected in the urine in this study, and the amount excreted in the feces was the same as the amount 
ingested. Thus, net absorption of tin could not be detected at these higher levels of intake, in contrast to 
the observations made at lower intakes (0.1 mg Sn/day; Johnson and Greger 1982). 
Studies conducted in animals suggest that fractional absorption of ingested inorganic Sn[II] is higher, by a 
factor of approximately 4, than Sn[IV]; however, the associated anion appears to have little or no effect 
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rats, after a single oral dose of 113Sn[II]citrate or 113Sn[IV]citrate (20 mg Sn/kg), respectively (Hiles 
1974). Fractional absorption of tin after single oral doses (20 mg Sn/kg) of stannous pyrophosphate 
(113Sn[II]2P2O7), stannous fluoride (113Sn[II]F2), or stannic fluoride (113Sn[IV]F4) appeared to be similar to 
that of 113Sn[II]citrate and 113Sn[IV]citrate (i.e., <5%), based on comparisons of tissue and excreta levels 
(Hiles 1974).  Furchner and Drake (1976) concluded, from comparisons of tissue retention kinetics after 
oral gavage and intravenous injection of stannous chloride (113SnCl2), that gastrointestinal absorption of 
Sn[II] was similar (less than 5%) in dogs, mice, rats, and monkeys. 
Organotin Compounds. No quantitative estimates of absorption of organotin compounds in humans 
were located. The detection of butyltin compounds in blood and in postmortem human liver samples 
indicates that butyltin compounds are absorbed in humans (Kannan et al. 1999; Nielsen and Strand 2002).  
Also, numerous deaths occurred in a poisoning episode with presumably accidental ingestion of 
triethyltin in France in 1954 (WHO 1980) indicating that absorption occurred.  In addition, Kreyberg et 
al. (1992) described the case of a woman who ingested an unknown amount of trimethyltin and died 
6 days after consuming the chemical. 
Methyltin Compounds.  Quantitative estimates of absorption of methyltin compounds after ingestion 
were not located. Tin levels in brain, kidney, and liver were similar in neonatal rats that received oral 
doses of 1 mg/kg trimethyltin hydroxide (0.66 mg Sn/kg) or triethyltin sulfate (0.44 mg Sn/kg), 
suggesting that both compounds may be absorbed similarly (Mushak et al. 1982).
Ethyltin Compounds. Rats administered a single oral dose of approximately 25 mg/kg ethyltin 
trichloride (12 mg Sn/kg) excreted 92% (range 89–95%) of the dose in feces and 1.2% (range 1–2%) in 
urine, suggesting that at least 8% of the dose had been absorbed (Bridges et al. 1967).  This is a minimum 
estimate of absorption, since absorbed ethyltin compounds are secreted in bile and excreted in feces (see 
Section 3.4.4.4). 
Butyltin Compounds.  Mice administered a single oral dose of approximately 180 μmol/kg, respectively, 
of mono-, di-, or tributyltin (23 mg Sn/kg) excreted, approximately 2, 20, or 35% of the dose in urine 
within 96 hours following dosing (Ueno et al. 1994).  These values are minimum estimates of the 
absorption of the ingested dose because they do not account for absorbed tin excreted by other routes 
(e.g., bile-fecal pathway; see Section 3.4.4.4).  However, these results indicate that the fraction of an 
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moieties, suggesting that more-highly butylated tin compounds may be absorbed to a greater extent 
(Kimmel et al. 1977). 
Phenyltin Compounds.  Quantitative estimates of absorption of phenyltin compounds after ingestion 
were not located. Urinary excretion of tin compounds (as total tin) over a 96-hour period following a 
single oral dose of tri-, di-, or monophenyltin (15.5 mg Sn/kg) was <1% of the administered dose of tin 
(Ohhira and Matsui 1993a).  This is a minimum estimate of the absorbed fraction as it does not account 
for excretion by other routes or retention of tin. 
3.4.1.3 Dermal Exposure 
Inorganic Tin Compounds.  No studies were located regarding absorption in humans or animals after 
dermal exposure to inorganic tin compounds. 
Organotin Compounds. No studies were located regarding absorption in humans after dermal exposure 
to organotin compounds. 
Quantitative estimates of dermal absorption of organotin compounds in animals were not located.  
Organotin compounds, including trimethyltin, triethyltin, tributyltin, and triphenyltin, have produced 
systemic toxicity in animals after dermal exposure, indicating that dermal exposures can result in 
systemic absorption of tin (Mori et al. 1984; Stoner 1966). 
3.4.2 Distribution 
The human body has been estimated to contain less than 17 mg of tin, with approximately 6 mg in soft 
tissues and the remaining fraction associated with skeletal tissues (ICRP 1981a).  In a survey of tin 
concentrations in postmortem human tissues collected from several hundred subjects, the highest 
concentrations occurred in the kidney, liver, lung, and bone (Kehoe et al. 1940; Schroeder et al. 1964; see 
Table 3-13). Tin was not detected in brain tissue (Kehoe et al. 1940). In kidney and liver, the highest 
concentrations (kidney 57–60 mg/kg, liver 48–61 mg/kg) were observed at ages 1–10 years; 
concentrations were 20–40 mg/kg thereafter; tin was not detected in kidney or liver at birth (Schroeder et 
al. 1964).  In the lungs, tin appeared to increase with age, with the highest levels (53–64 mg tin/kg) at 
ages 51–84 (Schroeder et al. 1964).  Although, these data indicate trends in tin accumulation in human 
tissues, wide variations in tissue concentrations were observed, most likely reflecting variation in  
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Table 3-13. Mean Tin Levels in Human Tissuesa 









Gastrointestinal tract 0.1–0.5 
ND = Not detected 






173 TIN AND TIN COMPOUNDS 
3. HEALTH EFFECTS 
exposures and, possibly the health/exposure history of the tissue donors (Tipton and Cook 1963; Tipton et 
al. 1963).  Additional information regarding tin and organotin levels in human tissues and fluids is 
presented in Table 6-5. 
When fresh human whole blood was incubated with triethyl[113Sn]tin chloride, the red blood cell:plasma 
tin ratio was 1.9 (Rose and Aldridge 1968). This ratio was substantially different from the ratio observed 
in rat blood (19), and similar to that in other rodent species (range, 1–5).  Interspecies differences have 
been attributed to variable binding of tin (or triethyltin) to hemoglobin (Rose 1969) and may also be 
applicable to trimethyltin, which also shows a pronounced accumulation in rat red blood cells (Brown et 
al. 1984; see Section 3.4.2.2 for further discussion). 
3.4.2.1 Inhalation Exposure 
No studies were located regarding distribution in humans or animals after inhalation exposure to 
inorganic tin or organotin compounds. 
3.4.2.2 Oral Exposure 
Inorganic Tin Compounds.  No studies were located regarding distribution in humans after oral exposure 
to inorganic tin compounds; however, data are available on tissue levels of tin in general populations 
(Schroeder et al. 1964; see Section 3.4.2). 
Consistent with observations made of the tissue distribution of tin in humans, bone, kidney, and liver are 
major sites of deposition of tin in rats and mice, after oral administration of inorganic tin compounds 
(Hiles 1974; NTP 1982; Schroeder et al. 1968; Yamaguchi et al. 1980).  Levels of tin in bone, kidney, and 
liver were 0.02–1% of the administered dose of 113Sn in rats that received a single oral dose of 20 mg
Sn/kg/day as stannous pyrophosphate (113Sn[II]2P2O7), stannous fluoride (113Sn[II]F2), stannic fluoride 
(113Sn[IV]F4), 113Sn[II]citrate, or 113Sn[IV]citrate (Hiles 1974).  Levels in blood were 0.01% (or less) of 
the administered dose.  In rats that received 20 mg Sn/kg/day of stannous fluoride (113Sn[II]F2) or stannic 
fluoride (113Sn[IV]F4), for a period of 28 days, levels of tin in kidneys and liver were approximately the 
same as after a single oral dose (Hiles 1974); however, levels in bone were higher after multiple dosing, 
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Accumulation of tin in bone has also been observed in rats and mice exposed to stannous chloride 
(Sn[II]Cl2) (NTP 1982; Yamaguchi et al. 1980).  Tissue concentration ratios were approximately 43 for 
bone:kidney and 32 for bone:liver after 90 days of oral (gavage) doses of stannous chloride; the 
bone:tissue ratios increased with increasing doses of 0.3, 1, or 3 mg/kg/day (Yamaguchi et al. 1980).  
Chronic exposures of rats, at much higher doses (60–70 mg/kg/day, 1,000 ppm in diet), resulted in tissue 
concentration ratios of approximately 0.5 for bone:kidney and 55 for bone:liver; increasing the dose by a 
factor of approximately 2, resulted in a proportional increase bone:kidney and bone:liver ratios (NTP 
1982).  Chronic exposures of mice (230–280 mg/kg/day, 1,000 ppm in diet), resulted in tissue
concentration ratios of approximately 30 for bone:kidney and 60 for bone:liver (NTP 1982).  Bone:kidney 
and bone:liver ratios, in rats and mice, were similar in female and males (NTP 1982).  These studies 
indicate a dose-dependence and possible species differences (i.e., mice compared to rats) in the tissue 
distribution of tin after exposures to stannous chloride.  However, it should be noted that the dosages 
administered in the NTP (1982) study resulted in gastrointestinal tract toxicity, which may have affected 
absorption of administered tin. 
Schroeder et al. (1968) chronically exposed rats to 5 ppm stannous chloride in drinking water and found 
relatively high concentrations of tin in spleen.  Tissue concentration ratios (spleen:tissue) were: 
kidney, 11; liver, 5; heart, 2; and lung, 3.  Tin concentrations in brain were approximately twice that of 
blood in rats exposed to stannous chloride (Sn[II]Cl2, 100, 250, or 500 mg/L, 63, 156, or 313 mg Sn/L) 
for up to 18 weeks, and appeared to increase with increasing duration of exposure, suggesting the 
possibility of accumulation of tin in brain with prolonged exposure to stannous chloride (Savolainen and 
Valkomen 1986). 
Animal studies in which absorbed tin was measured in tissues following parenteral injection of 
Sn[II]chloride (113SnCl2), confirmed the above observations; i.e., that bone, kidney, and liver are major 
sites of deposition of absorbed Sn[II] (see Section 3.4.4.4). 
Tin was not detected in the uterine horns or combined fetuses and placentas in rats following daily
ingestion of 20 mg Sn/kg/day as 113SnF2, or 113SnF4 beginning on the day of conception (Hiles 1974).
However, on Gd 21, fetuses of dams administered 20 mg Sn/kg/day as SnF2 (approximately 100 mg Sn 
cumulative dose) contained approximately 0.2 μg Sn/g, or approximately 0.2% of the cumulative 
administered dose (detection limit, 0.1 μg/g). This suggests the possibility that, in the rat, tin 
administered orally as stannous chloride may be transferred to the fetus. 
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No studies on transfer of tin to breast milk following oral exposure (or exposure by other routes) to 
inorganic tin compounds were located. 
Organotin Compounds. No studies were located regarding distribution in humans after oral exposure to 
organotin compounds.  
Methyltin Compounds.  Studies conducted in animals indicate that ingested methyltin compounds 
distribute to soft tissues, with the highest levels usually observed in liver.  Species differences in the 
tissue distribution of trimethyltin have been observed.  In marmosets, 1–13 days following a single oral 
dose of 3–4.5 mg/kg trimethyltin chloride (1.8–2.4 mg Sn/kg), brain:blood concentration ratios ranged 
from 6 to 10; whereas, in rats, 5 days following an oral dose of 10 mg/kg (6 mg Sn/kg), blood:brain ratios 
were approximately 38 (Brown et al. 1979, 1984). Mushak et al. (1982) also observed relatively high 
blood:tissue ratios of tin in neonatal rats that received oral doses of trimethyltin hydroxide (0.66 mg
Sn/kg/day, Pnds 2–29): brain, 42; kidney, 22; and liver, 8.  Following multiple oral doses of 4 mg/kg 
(2.4 mg Sn/kg) for 7 days, blood:brain ratios in the rat ranged from 30 to 48 (Brown et al. 1979).  The 
relatively high blood levels of tin in rats, compared to other species, have been attributed to a more 
pronounced accumulation of trimethyltin in red blood cells.  When samples of blood from rats were 
incubated with trimethyltin, the blood:plasma concentration ratio was approximately 67, compared to 
approximately 1 in the marmoset, gerbil, and hamster (Brown et al. 1984).  The mechanism for the 
difference has not been elucidated. 
Ethyltin Compounds.  In animals, ingested ethyltin, along with five dealkylation products, distribute to 
soft tissues, including brain, kidney and liver.  In rats, following 5 oral doses of 10 mg/kg/day triethyltin 
(5.8 mg Sn/kg/day), tissue:blood concentration ratios of triethyltin were approximately: brain, 8; kidney, 
4; and liver, 0.5 (Iwai et al. 1982b).  Following the same dose of tetraethyltin (5.1 mg Sn/kg/day), both 
tetra- and triethyltin were detected in tissues, reflecting dealkylation of tetraethyltin (see Section 3.4.3). 
The brain:blood ratio of tetraethyltin was <1 whereas the brain:blood ratio of triethyltin was >8.  In 
neonatal rats that received oral doses of triethyltin sulfate (0.44 mg Sn/kg/day, Pnds 2–29), tissue:blood 
tin concentration ratios were: 0.7, brain; kidney, 0.8; liver, 3. 4 (Mushak et al. 1982).  The higher 
liver:blood ratio of total tin, compared to that of triethyltin, following ingestion of triethyltin, also may
reflect the dealkylation of trimethyltin in the liver (see Section 3.4.3). 
Butyltin Compounds. Similar to ethyltin compounds, ingested butyltin compounds and their dealkylation 
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10 mg/kg tributyltin (5.8 mg Sn/kg), tissue:blood concentration ratios of tributyltin were approximately: 
brain, <1; kidney, 2–4; and liver 1–2 (Iwai et al. 1982b).  Following the same dose of tetrabutyltin, 
tissue:blood concentration ratios of tetrabutyltin were approximately: brain, <1; kidney, 10–12; and 
liver, 20.  In rats given a single oral dose of 40 mg/kg tributyltin fluoride (15 mg Sn/kg), transient 
elevations in tributyltin, dibutyltin, monobutyltin, and inorganic tin were observed in brain and liver over 
the 8-day period following the dose, indicating that dealkylation had occurred (Iwai et al. 1981, see 
Section 3.4.3). In neonatal rats that received oral doses of tributyltin acetate (1.0 mg Sn/kg/day, Pnds 2– 
29), tissue:blood tin concentration ratios(possibly limited by the detection limit for blood tin) were: 
brain, 2.6; kidney, 19; and liver, 24 (Mushak et al. 1982).  
In rats exposed to tributyltin oxide in the diet (0.25, 1, 4, or 16 mg/kg/day; 0.1, 0.4, 1.6, or 6.4 mg
Sn/kg/day) for 4 weeks, total tin in kidney, liver, and brain increased with increasing dosage, and were 
similar in females and males (Krajnc et al. 1984).  Levels in the brain and adipose tissue were 10–20% of
the kidney and liver levels. 
Twenty-four hours after administration of a single dose of 22 mg dibutyltin diacetate/kg to pregnant rats 
on Gd 8, dibutyltin and monobutyltin were detected in maternal blood and liver, and in the embryos, 
indicating placental transfer (Noda et al. 1994).  In the embryos, the concentration of dibutyltin was 6– 
7 times higher than that of monobutyltin.  Nakamura et al. (1993) had also detected dibutyltin in fetuses 
on Gd 18 after administration of the chemical to the pregnant rats on Gd 7–17. 
Phenyltin Compounds. Studies conducted in animals indicate that ingested phenyltin compounds and 
dearylated metabolites (see Section 3.4.3) distribute to soft tissues, including brain, kidney, liver, and 
pancreas. In hamsters and rats, following a single oral dose of 50 mg triphenyltin chloride (15 mg Sn/kg), 
triphenyltin and dearylated metabolites, including inorganic tin, were detected in brain, blood, kidney, 
liver and pancreas (Ohhira and Matsui 1996).  The highest concentrations of triphenyltin and metabolites 
were found in liver and kidney.  In rats, tissue:blood ratios for triphenyltin, 48 hours after the dose, were 
approximately: brain, 10; kidney, 21; liver, 17; and pancreas, 4.  Similar ratios were observed in hamsters: 
brain, 9; kidney, 11; liver, 21; and pancreas, 11.  In neonatal rats that received oral doses of triphenyltin 
acetate (0.87 mg Sn/kg/day, Pnds 2–29), tissue:blood tin concentration ratios (based on the detection limit 







177 TIN AND TIN COMPOUNDS 
3. HEALTH EFFECTS 
In rats, following a single oral dose of 55.4 mg/kg tetraphenyltin (15 mg Sn/kg), tetraphenyltin, and the 
dearylated metabolites (tri-, di-, and monophenyltin) were detected in kidney and liver (Ohhira and 
Matsui 2003). 
3.4.2.3 Dermal Exposure 
No studies were located regarding distribution in humans or animals after dermal exposure to inorganic 
tin or organotin compounds. 
3.4.2.4 Other Routes of Exposure 
Inorganic Tin Compounds. Animal studies, in which absorbed tin was measured in tissues following 
parenteral injection of Sn[II]chloride (113SnCl2), confirm observations from oral exposure studies 
(Section 3.4.2.3) that bone, kidney, and liver are major sites of deposition of absorbed Sn[II] (Furchner 
and Drake 1976; Hiles 1974). In rats that received an intraperitoneal injection of stannous chloride 
(113Sn[II]Cl2, 0.006 μg/kg), tissue levels (percent of body burden) 1 day after dosing were: bone, 50%, 
kidney, 3.5%; liver, 6%; and skeletal muscle, 20%; thus, muscle also appears to a major site of deposition 
of Sn[II] (Furchner and Drake 1976). 
Organotin Compounds. Animal studies, in which organotin compounds were administered parenterally
confirm observations made following oral exposures; organotin compounds distribute to soft tissues, 
including brain, kidney, and liver. 
Methyltin Compounds. In rats administered a single intraperitoneal dose of 6 mg/kg trimethyltin (4.3 mg
Sn/kg), tin distributed to brain, heart, kidney, and liver, with levels in brain (ng/g protein) that were 15– 
50% of that in other tissues (Cook et al. 1984a).  Tin distribution was uniform across the brain regions, 
cerebellum, medulla-pons, hypothalamus, hippocampus, and striatum (Cook et al. 1984a).  Tin in brain, 
kidney, and liver were lower after a dose of 6 mg/kg trimethyltin (4.3 mg Sn/kg) than after a dose of 
6 mg/kg triethyltin (2.5 mg Sn/kg).  
Ethyltin Compounds. In rats, 5 days following a single intravenous dose of 10 mg/kg triethyl[113Sn]tin 
chloride (5 mg Sn/kg), tissue:blood tin ratios were: liver, 1.3; kidney, 0.6; brain, 0.2; skeletal muscle, 
0.15; and spinal cord, 0.1; levels were similar in brain stem cerebellum, cerebrum, and cortex (Rose and 






   
 
 
178 TIN AND TIN COMPOUNDS 
3. HEALTH EFFECTS 
intraperitoneal dose of 6 mg/kg triethyltin (3.5 mg Sn/kg), similar levels of tin were observed in heart, 
kidney, and liver, and levels in brain were 15–25% of that of kidney and liver.  Increasing the intravenous 
dose of triethyltin from approximately 0.6 to 5 mg/kg (0.3–2.5 mg Sn/kg) in rats resulted in proportional 
increases in levels of tin in blood, brain, kidney, and liver, with no evidence of a limitation in capacity for 
deposition in these tissues (Rose and Aldridge 1968). 
Species differences in deposition of tin in red blood cells have been observed following parenterally­
administered triethyltin to animals (Rose and Aldridge 1968).  In rats, 4–5 hours following a single 
intravenous dose of 10 mg/kg triethyl[113Sn]tin chloride (5 mg Sn/kg), substantially higher levels of tin in 
blood (relative to other tissues) were observed, compared to the hamster and guinea pig, although the 
distribution to other tissues was similar among rodent species.  When samples of whole blood from rats 
were incubated with triethyl[113Sn]tin chloride, the red blood cell:plasma tin concentration ratio was 19; 
ratios observed in blood from other rodent species were considerably lower (1–5) and, in human blood, 
the ratio was 1.9, suggesting that the mechanism for the species differences in red blood cell:plasma ratios 
involved uptake and/or retention of triethyltin (or tin derived from triethyltin) in red blood cells (Rose and 
Aldridge 1968). Rat hemoglobin bound more 113Sn when incubated with triethyl[113Sn]tin than 
hemoglobins isolated from other rodents, or from humans (Rose and Aldridge 1968). 
3.4.3 Metabolism 
Inorganic Tin Compounds. No studies were located in humans or animals on metabolism of inorganic 
tin after inhalation, oral, or dermal exposure. 
Organotin Compounds. No studies were located in humans on metabolism after inhalation, oral, or 
dermal exposure to organotin compounds.  Microsomes prepared from human liver dealkylate tributyltin 
to form di- and monobutyltin metabolites, suggesting that similar pathways may be active in humans, in 
vivo (Ohhira et al. 2003). This would be consistent with the detection of dibutyltin and monobutyltin in
postmortem human liver samples (Nielsen and Strand 2002) and with the more substantial evidence for 
dealkylation of alkyltins, including butyltins, in various nonhuman species (see below). 
Ethyltin Compounds.  Studies conducted in rats indicate that tetra-, tri- and diethyltin undergo 
dealkylation to ethyltin compounds (Bridges et al. 1967; Cremer 1958).  Dealkylation and hydroxylation 
of the ethyl moieties are catalyzed by microsomal monooxygenase(s) of liver, and possibly other tissues 
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Butyltin Compounds.  Studies conducted in rats indicate that tributyltin undergoes dealkylation to di- and 
monobutyltin compounds (Iwai et al. 1981, 1982; Matsuda et al. 1993; Ueno et al. 1994).  The butyl 
moieties are also oxidized at carbon 3 to yield 3-hydroxybutyl and 3-oxobutyl metabolites; and at carbon 
4, to yield the 4-hydroxybutyl and 3-carboxy metabolites (Matsuda et al. 1993).  The simple dealkylation 
products were the principal metabolites detected in blood and brain following a 2 mg/kg oral dose of 
tributyltin chloride, whereas in kidney and liver, hydroxy-, carboxy-, and oxo-metabolites were the 
dominant metabolites (Matsuda et al. 1993).  Dealkylation and hydroxylation are catalyzed by
microsomal monooxygenase(s) (Kimmel et al. 1977; Ohhira et al. 2003).  The alkyl products of 
dealkylation are conjugated with glutathione and further metabolized to mercapturic acid derivatives 
(Suzuki et al. 1999b). 
Phenyltin Compounds.  Studies conducted in hamsters and rats indicate that tetra-, tri-, di-, and 
monophenyltin compounds are dearylated.  The dearylated metabolites, including inorganic tin, can be 
found in kidney and liver after an oral exposure to phenyltin compounds (Ohhira and Matsui 1993a, 
1993b, 2003; Ohirra et al. 1996).  Dearylation of phenyltin compounds is catalyzed by microsomal 
monooxygenase(s) in liver, and possibly in other tissues (Ohhira et al. 2003).  A recent study of CYP 
isoforms in rat hepatocytes showed that CYP2B1 had a small metabolic capacity for triphenyltin, but the 
principal CYP for triphenyltin metabolism in rats was CYP2C6 (Ohhira et al. 2004).  Support for this 
finding was provided by experiments in which anti-rat CYP2C6 antibodies and cimetidine, a selective 
CYP2C6 inhibitor, inhibited triphenyltin dearylation activity in the hepatic microsomes of rats (Ohhira et 
al. 2004). 
3.4.4 Elimination and Excretion 
3.4.4.1 Inhalation Exposure 
Inorganic Tin Compounds.  No studies were located regarding excretion in humans or animals after 
inhalation exposure to inorganic tin. 
Organotin Compounds. No studies were located regarding excretion in humans or animals after 
inhalation exposure to inorganic tin, although tin was detected in the urine from a fatal inhalation case 
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3.4.4.2 Oral Exposure 
Inorganic Tin Compounds. Feces and urine are major routes of excretion of ingested tin in humans 
(Calloway and McMullen 1966; Johnson and Greger 1982, see Section 3.1.4.2).  In eight healthy adult 
males who were placed on diets (for 20 days) containing 0.1 mg Sn/day (basal diet) or 50 mg Sn/day
(supplemented with stannous chloride), average fecal excretion was 55% of the daily intake in the basal 
group and 97% in the supplemented group (Johnson and Greger 1982).  Average urinary excretion was 
26% of the daily intake in the basal group and 2.4% in the supplemented group, suggesting that urine was 
a major route of excretion of absorbed tin.  These and other observations (Calloway and Mullen 1966) 
also suggest that gastrointestinal absorption of tin in humans may decrease with increasing dose, possibly
reflecting a tight homeostatic control of tin absorption (see Section 3.4.1.2). 
In dogs, mice, rats, and Rhesus monkeys, tin ingested as Sn[II] or Sn[IV] compounds is excreted 
primarily in feces; however, urine and bile appear to be major routes of excretion of absorbed Sn[II] (see 
Section 3.4.4.4).  In rats, 48 hours after dosing (20 mg Sn/kg/day), 95% of the administered 113Sn (as Sn 
[II], Sn [IV] citrate, Sn[II]2P2O7, Sn[II]F2, or Sn[IV]F4) was recovered in feces, while <1% was detected 
in urine (Hiles 1974).  Similar results were obtained in dogs, mice, rats, and Rhesus monkeys (Furchner 
and Drake 1976). 
Whole body and tissue retention kinetics have been measured in mice, monkeys, rats, and dogs after an 
oral gavage dose of stannous chloride (Sn[II]Cl2) (Furchner and Drake 1976). Whole-body elimination 
kinetics of absorbed Sn[II] were similar in all four species and could be described with 1- or 
2-compartment models in which 96–100% of the initial body burden is eliminated with a half-time of 
0.2–0.4 days.  In Rhesus monkeys (dose, 0.0004 μg/kg), approximately 96% of the body burden was 
eliminated with a half-time of 0.3 days (reflecting mainly excretion of unabsorbed tin in feces), and 4% 
was eliminated with a half-time of 3 days.  
Organotin Compounds. No studies were located regarding excretion in humans after oral exposure to 
organotin compounds. 
Methyltin Compounds. In rats, after a single oral dose of 3 mg/kg (1.8 mg Sn/kg; Brown et al. 1984), 
blood concentrations of trimethyltin decreased by one-half in approximately 3 days and, in brain, in 
approximately 2 (or less) days.  Information identifying the relative contributions of various excretory
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Ethyltin Compounds. Studies in rats indicate that urine and feces are the major routes of excretion of 
ethyltin following oral exposures to ethyltin compounds (Bridges et al. 1967).  Over a 3-day period 
following a single oral dose of approximately 25 mg/kg ethyltin trichloride (12 mg Sn/kg), rats excreted 
92% (range 89–95%) of the dose in feces and 1.2% (range 1–2%) in urine (Bridges et al. 1967).  
Following absorption, ethyltin is excreted predominantly in urine, whereas absorbed diethyltin and 
triethyltin are excreted to a greater extent in feces (See Section 3.4.4.4). 
Butyltin Compounds.  In mice that received a single oral dose of 1.2 mg/kg tri[14C]butyltin acetate, 
approximately 16% of the 14C dose was excreted in urine in 5 days, 53% was excreted in feces, and 22% 
was exhaled as [14C]CO2 (Kimmel et al. 1977). Following a similar dose di[14C]butyltin diacetate the 
excretion pattern (% of dose) was: urine, 10%; feces, 66%; and carbon dioxide, 7% (Kimmel et al. 1977).  
In mice, the amount of tin excreted in urine following an oral dose of different butyltins also increased 
with the number of butyl groups.  Five days following a single oral dose of 180 μmol/kg of tri-, di-, or 
monobutyltin, urinary excretion of tin (percent of dose) was approximately: tributyltin, 5%; dibutyltin, 
3%; and butyltin, 0.3% (Ueno et al. 1994). These differences may reflect real differences in urinary
excretion of absorbed tin compounds, or greater absorption of the tin compounds having a larger number 
of butyl groups. 
Phenyltin Compounds.  Information or the rates or relative contributions of various excretory routes for 
elimination of phenyltin compounds was not located. 
3.4.4.3 Dermal Exposure 
No studies were located regarding excretion in humans or animals after dermal exposure to inorganic tin 
or organotin compounds. 
3.4.4.4 Other Routes of Exposure 
Inorganic Tin Compounds.  Studies in which inorganic tin compounds have been parenterally injected 
into animals have shown that absorbed inorganic tin is excreted in urine and bile.  Forty-eight hours after 
an intravenous injection to rats of 2 mg Sn/kg, as 113Sn [II] citrate, 35% of the administered radioactivity
was excreted in urine and approximately 12% was (2 mg Sn/kg, as 113Sn [II] citrate) was excreted in the 
feces. In bile-duct cannulated rats, 23% was excreted in the urine, 11% in bile, and 2% in the feces.  
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The biliary contribution to excretion of Sn[IV] was less than that of Sn[II], and after intravenous injection 
of 2 mg Sn/kg, as 113Sn [IV] citrate, 40% of the administered radioactivity was excreted in urine and 3% 
in feces. Following the same intravenous dose administered to rats that had bile duct cannulas, 25% of 
the administered dose was excreted in urine and 0.5% in bile (Hiles 1974).  Urine-feces excretion ratios 
after intravenous injection of stannous chloride were approximately 10 in dogs, 3 in mice and rats, and 
5 in Rhesus monkeys (Furchner and Drake 1976). 
Rates of elimination of absorbed inorganic tin have been measured in mice, monkeys, rats, and dogs after 
intravenous or intraperitoneal injection of stannous chloride (Sn[II]Cl2) (Furchner and Drake 1976). 
Whole-body elimination kinetics of absorbed Sn[II] were similar in all four species and could be 
described with similar 4-compartment models.  In Rhesus monkeys (dose, 0.0004 μg/kg), approximately
39% of the body burden was eliminated with a half-time of 0.6 days, 11% was eliminated with a half-time 
of 5 days, 8% eliminated with a half-time of 24 days, and 42% was eliminated with a half-time of 
88 days.  The pseudo-first order elimination half-times (all components combined) were approximately
7 days in monkeys and 1–2 days in dogs, mice, and rats; the difference reflects the larger contribution of 
the slow compartment in the monkey (42%) compared to the other three species (20–30%).  
Measurements of the elimination kinetics of absorbed Sn[II], from individual tissues in rats (dose, 
0.006 μg/kg), suggested that bone was a major contributor to the slowest compartment, comprising 
approximately 50% of the body burden 1 day after dosing, and approximately 70–75% of the body burden 
from days 6–113 after dosing.  Elimination rates were similar in all soft tissues measured (blood, brain, 
kidney, liver, spleen).  These observations are consistent with the observations of accumulation of tin in 
bone with repeated exposures to Sn[II] compounds (Hiles 1974; NTP 1982; Yamaguchi et al. 1980). 
Methyltin Compounds. The elimination kinetics of tin from tissues, following parenteral injection of 
trimethyltin has been investigated in the rat.  Cook et al. (1984a) administered single intraperitoneal doses 
of 6 mg/kg trimethyltin bromide (4.4 mg Sn/kg) to rats and measured tissue tin over 22 days following the 
dose. The pseudo-first order elimination half-times for tin were: blood, 10 days; brain, 10 days; heart, 
11 days; kidney, 12 days; and liver, 15 days.  These rates were slower than those estimated for tin 
following a dose of triethyltin (Cook et al. 1984a).  Ekuta et al. (1998) derived empirical, single-
compartment models of the kinetics of 14C in blood of four inbred mouse strains following single 
intraperitoneal injections of tri[14C]methyltin.  Elimination half-times were 28.5 hours (AKR/J), 
31.3 hours (BalbcByJ), 30.0 hours (C57Bi6J), and 57.4 hours (DBA/2J). 
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Ethyltin Compounds. Following absorption, ethyltin is excreted predominantly in urine, whereas 
absorbed diethyltin is excreted to a much greater extent in feces.  In rats, during the 72-hour period 
following an intraperitoneal dose of 12.7 mg/kg ethyltin trichloride (6 mg Sn/kg), 73% of the dose was 
excreted in urine and none in feces; approximately 4% of the dose was secreted into bile (Bridges et al. 
1967). Biliary secretion appears to be quantitatively more important in the excretion of absorbed 
diethyltin, compared to ethyltin.  During the 72 hours following an intraperitoneal dose of 10 mg/kg 
[14C]diethyltin dichloride (5 mg Sn/kg), approximately 64% of the administered dose of tin was excreted 
in feces and 31% in urine (fecal:urine ratio, 2.2); 32% of the administered 14C was excreted in feces and 
19% in urine (fecal:urine ratio, 1.8).  In rats in which the bile duct had been cannulated, 56% of an 
intraperitoneal dose of [14C]diethyltin was secreted into bile; essentially all of the 14C secreted into bile 
was identified as diethyltin.  Biliary secretion of triethyltin has also been observed in hamsters and guinea 
pigs, following intraperitoneal injection of 10 mg/kg triethyl[113Sn]tin chloride (5 mg Sn/kg) (Rose and 
Aldridge 1968). 
In rats, absorbed tetraethyltin appears to be excreted primarily as the trialkyltin metabolite.  During the 
3 days following a subcutaneous dose of 10 mg/kg triethyltin in rats, approximately 0.20% of the dose 
was excreted in urine and 0.08% in feces (urine:feces ratio, 2.5; Iwai et al. 1982b).  During the 3 days
following a subcutaneous dose of 10 mg/kg tetraethyltin in rats, approximately 0.13% of the dose was 
excreted in urine and 0.07% in feces (urine:feces ratio, 1.9); however, no tetraethyltin was detected in 
excreta. 
The elimination kinetics of tin from tissues, following parenteral injection of triethyltin has been 
investigated in the rat. Cook et al. (1984a) administered single intraperitoneal doses of 6 mg/kg triethyltin 
as the bromide salt (3.5 mg Sn/kg) to rats and measured tissue tin levels over 22 days following the dose.  
The pseudo-first-order elimination half-times for tin were: blood, 2.5 days; brain, 4.6 days; heart, 
3.4 days; kidney, 5.6 days; and liver, 6.1 days.  These estimates are consistent with rates of decline in tin 
levels measured in blood, brain, kidney, and liver 1–5 days following a single intravenous dose of 
10 mg/kg triethyl[113Sn]tin chloride (5 mg Sn/kg) in rats (Rose and Aldridge 1968). 
Butyltin Compounds. In rats, absorbed tetrabutyltin appears to be excreted as the trialkyltin metabolite.  
In rats, during the 3 days following a subcutaneous dose of 10 mg/kg tributyltin, approximately 0.18% of 
the dose was excreted in urine and 0.04% in feces (urine:feces ratio, 4.5; Iwai et al. 1982b).  Following 
the same subcutaneous dose of tetrabutyltin, approximately 0.12% of the dose was excreted in urine and 
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3.4.5 Physiologically Based Pharmacokinetic (PBPK)/Pharmacodynamic (PD) Models 
Physiologically based pharmacokinetic (PBPK) models use mathematical descriptions of the uptake and 
disposition of chemical substances to quantitatively describe the relationships among critical biological 
processes (Krishnan et al. 1994). PBPK models are also called biologically based tissue dosimetry
models.  PBPK models are increasingly used in risk assessments, primarily to predict the concentration of 
potentially toxic moieties of a chemical that will be delivered to any given target tissue following various 
combinations of route, dose level, and test species (Clewell and Andersen 1985).  Physiologically based 
pharmacodynamic (PBPD) models use mathematical descriptions of the dose-response function to 
quantitatively describe the relationship between target tissue dose and toxic end points.  
PBPK/PD models refine our understanding of complex quantitative dose behaviors by helping to 
delineate and characterize the relationships between: (1) the external/exposure concentration and target 
tissue dose of the toxic moiety, and (2) the target tissue dose and observed responses (Andersen et al. 
1987; Andersen and Krishnan 1994).  These models are biologically and mechanistically based and can 
be used to extrapolate the pharmacokinetic behavior of chemical substances from high to low dose, from
route to route, between species, and between subpopulations within a species.  The biological basis of 
PBPK models results in more meaningful extrapolations than those generated with the more conventional 
use of uncertainty factors. 
The PBPK model for a chemical substance is developed in four interconnected steps: (1) model 
representation, (2) model parametrization, (3) model simulation, and (4) model validation (Krishnan and 
Andersen 1994). In the early 1990s, validated PBPK models were developed for a number of 
toxicologically important chemical substances, both volatile and nonvolatile (Krishnan and Andersen 
1994; Leung 1993).  PBPK models for a particular substance require estimates of the chemical substance-
specific physicochemical parameters, and species-specific physiological and biological parameters.  The 
numerical estimates of these model parameters are incorporated within a set of differential and algebraic 
equations that describe the pharmacokinetic processes. Solving these differential and algebraic equations 
provides the predictions of tissue dose.  Computers then provide process simulations based on these 
solutions. 
The structure and mathematical expressions used in PBPK models significantly simplify the true 
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adequately described, however, this simplification is desirable because data are often unavailable for 
many biological processes.  A simplified scheme reduces the magnitude of cumulative uncertainty.  The 
adequacy of the model is, therefore, of great importance, and model validation is essential to the use of 
PBPK models in risk assessment. 
PBPK models improve the pharmacokinetic extrapolations used in risk assessments that identify the 
maximal (i.e., the safe) levels for human exposure to chemical substances (Andersen and Krishnan 1994).  
PBPK models provide a scientifically sound means to predict the target tissue dose of chemicals in 
humans who are exposed to environmental levels (for example, levels that might occur at hazardous waste 
sites) based on the results of studies where doses were higher or were administered in different species.  
Figure 3-9 shows a conceptualized representation of a PBPK model. 
If PBPK models for tin and tin compounds exist, the overall results and individual models are discussed 
in this section in terms of their use in risk assessment, tissue dosimetry, and dose, route, and species 
extrapolations. 
ICRP (1981b, 2001) Tin Biokinetics Model 
Description of the model. 
The ICRP (1981b, 2001) model is based on an empirical model developed by Furchner and Drake (1976)
(Figure 3-10).  The fraction of ingested tin that is absorbed from the gastrointestinal tract (uptake to 
blood) is assumed to be 0.02.  Absorbed tin is assumed to enter the blood from where 50% is immediately
transferred to excreta (specific routes not specified in the model), 35% is transferred to bone mineral, and 
15% is uniformly distributed to all other tissues.  Tin in any tissue or organ is retained with elimination 
half-times of 4 (20% of tissue burden), 25 (20%), and 400 (60%) days. 
ICRP (1981b, 2001) also provides classifications for clearance of inhaled tin compounds in the
respiratory tract, for use in the ICRP (1994) inhalation model.  Sulphides, oxides, hydroxides, halides, and 
nitrates of tin, and stannic phosphate are assigned Type M; all other compounds of tin are assigned to 
Type F. For Type F compounds, rapid 100% absorption is assumed to occur within 10 minutes of 
material deposition in the bronchi (BB) bronchiole (bb), and alveolar interstitial (AI) regions.  Fifty 
percent of Type F compounds deposited in extrathoracic region transfer to the gastrointestinal tract (ET2). 
During nose breathing, there is rapid absorption of approximately 25% of the tin deposited in the  
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Figure 3-9. Conceptual Representation of a Physiologically
 
Based Pharmacokinetic (PBPK) Model for a
 
Hypothetical Chemical Substance 

Source: adapted from Krishnan et al. 1994 
Note: This is a conceptual representation of a physiologically based pharmacokinetic (PBPK) model for a hypothetical 
chemical substance.  The chemical substance is shown to be absorbed via the skin, by inhalation, or by ingestion, 
metabolized in the liver, and excreted in the urine or by exhalation. 
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Figure 3-10.  ICRP (1981b, 2001) Tin Biokinetic Model 
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extrathoracic region, and 50% absorption during mouth breathing. For Type M compounds, 
approximately 70% of the tin deposited in AI eventually is transferred to blood and there is rapid 
absorption of about 10% of the tin deposited in BB and bb, and 5% of tin deposited in ET2. During nose 
breathing, approximately 2.5% of the deposit in ET is rapidly absorbed and 5% is rapidly absorbed during 
mouth breathing.  
Validation of the model. 
The extent to which the ICRP model has been validated is not described in ICRP (1981b). 
Risk assessment. 
The model has been used to establish radiation dose equivalents (Sv/Bq) of ingested and inhaled 
radioactive tin isotopes for ages 1 day to 50 years (ICRP 2001). 
Target tissues. 
The model is designed to calculate intake limits for radioactive tin, based on radiation dose to all major 
organs, including the bone surfaces, bone marrow, and liver, to which the highest doses would be 
expected. 
Species extrapolation. 
The model is designed for applications to human dosimetry and cannot be applied to other species without
modification. 
Interroute extrapolation. 
The ingestion model (ICRP 1981b, 2001), together with the respiratory tract model (ICRP 1994) are 
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3.5 MECHANISMS OF ACTION 
3.5.1 Pharmacokinetic Mechanisms 
Absorption.    The mechanism(s) of absorption of inorganic and organotin compounds have not been 
elucidated. In rats, following five oral doses of 10 mg/kg/day of tetra- or triethyltin, or tetra- or 
tributyltin, the alkyltin in the gastrointestinal tract tissue was primarily associated with the duodenum and 
jejunum indicating that these may be sites of absorption (Iwai et al. 1982b).  A recent study with the 
Caco-2 human intestinal cell-line suggested that, in general, butyltins have a low in vivo permeability
(Azenha et al. 2004).  The study also showed that the permeability pattern correlated with the in vivo 
toxicity (trialkyltin ! dialkyltin ! monoalkyltin).  However, the accumulation pattern (dialkyltin ! 
trialkyltin ! monoalkyltin) was different than that of permeability, presumably due to the strong affinity
of dibutyltin for dithiol groups.  Finally, the permeability of monobutyltin and dibutyltin, but not that of 
tributyltin, was found to be dependent of the paracellular route status. 
Distribution.    Inorganic tin deposits in bone mineral; however, the mechanisms for the uptake and 
retention in bone have not been elucidated.  
Species differences have been demonstrated in the distribution of methyltin and ethyltin compounds 
within whole blood.  Rats show higher red blood cell:plasma concentration ratios than other species, 
including humans and nonhuman primates (Brown et al. 1984; Rose and Aldridge 1968).  Uptake and 
retention of methyltin and ethyltin in red blood cells has been attributed to binding to hemoglobin; 
however, the mechanism for the difference has not been elucidated. When hemoglobin from rat red blood 
cells is incubated with triethyl[113Sn]tin, radioactivity was bound to hemoglobin with an apparent affinity
constant of approximately 3.5x105 M-1 (Rose 1969). The pH-dependence of binding is consistent with 
involvement of histidine residues in hemoglobin (Rose 1969).  
The subcellular distribution of tin, following parenterally-administered trimethyltin or triethyltin, has 
been examined in rats and guinea pigs (Cook et al. 1984a; Rose and Aldridge 1968).  Fractionation of 
brain tissue from animals that received a single intraperitoneal dose of 6 mg/kg trimethyltin (4.3 mg
Sn/kg), revealed that tin was associated with the crude mitochondrial and microsomal fractions and, 
within the crude mitochondrial fraction, tin was associated with myelin, synaptosomes, and mitochondria 
(Cook et al. 1984b). The concentration in the mitochondrial fraction increased over time, reaching a 
maximum of 5 days after the dose.  Subcellular concentrations of tin were 4–20 times lower after the 
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The subcellular distribution of tin in kidney and liver was similar in rats and guinea pigs following a 
parenteral dose of triethyltin; however, differences were observed between the distribution in rat brain 
compared to kidney and liver (Rose and Aldridge 1968).  In rats, 2 hours following a single intravenous 
dose of 10 mg/kg triethyl[113Sn]tin chloride (5 mg Sn/kg), approximately 60% of the 113Sn was associated 
with the 40,000 x g supernatant (cytosolic) fraction and approximately 13% was associated with the 
heavy mitochondrial fraction.  In brain, approximately 32% was associated with the supernatant fraction 
and 40% with the heavy mitochondrial fraction.  Cook et al. (1984b) also found tin associated with the 
crude mitochondrial (13,000 x g) fraction of rat brain after a single intraperitoneal dose of 6 mg/kg 
triethyltin bromide (2.5 mg Sn/kg).  Subfractionation of the crude mitochondrial fraction on a Ficoll 
gradient revealed tin associated with the myelin, synaptosomes, and mitochondria. 
In a comparative study with rats, mice, and guinea pigs, the susceptibility to develop liver damage 
followed the order: mice ! rats ! guinea pigs (Ueno et al. 2003b). This appeared to be partly due to 
differences in metabolism of tributyltin and in the distribution of dibutyltin within cell organelles.  In 
hepatocytes of mice treated with dibutyltin chloride, 41% of the dibutyltin was found in organelles 
compared to 27% in rats and 9% in guinea pigs (Ueno et al. 2003b). 
Metabolism.    No information on speciation of inorganic tin after absorption was located; therefore, the 
extent to which Sn[II] and Sn[IV] are interconverted is unknown.  The major metabolic pathways for 
alkyltin compounds include dealkylation and hydroxylation and further oxidation of the alkyl moieties 
(see Section 3.4.3). These reactions have been found to occur in the microsomal fraction of liver 
(including human liver), are dependent on reduced nicotinamide adenosine dinucleotide phosphate 
(NADPH), and are inhibited by carbon monoxide, suggesting involvement of cytochrome P-450 (Kimmel 
et al. 1977; Ohhira et al. 2003).  For triphenyltin, CYP2C6 constitutes the principal CYP for dearylation 
in hepatic microsomes of rats (Ohhira et al. 2004). 
Several studies have examined the involvement of metabolism in the toxicity of some organotin
compounds.  Cases have been described in which metabolism can either increase or decrease the toxicity
of these compounds.  For example, studies in hamsters showed that pretreatment of the animals with the 
cytochrome P-450 inducer, phenobarbital (PB), suppressed the diabetogenic effects of triphenyltin 
compared to PB-untreated hamsters (Ohhira et al. 1999).  Pretreatment with the CYP1A and 2A inducers 
E-naphthoflavone and 3-methylcholanthrene, was not as effective as PB in preventing the organotin­
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P-450 inhibitor, SKF-525A, increased the diabetogenic effects of triphenyltin (Ohhira et al. 2000).  
Overall, these findings suggested that the hyperglycemic toxicity of triphenyltin is due primarily to 
accumulation of the parent compound, triphenyltin, in the pancreas, and not to a metabolite.  Studies by
Ueno et al. (1995, 1997) showed that the liver toxicity of tributyltin chloride could be prevented by
treatment of the mice with the cytochrome P-450 inhibitor SKF-525A and that pretreatment with the 
P-450 inducer, PB increased the toxicity of tributyltin.  These results suggested that the liver toxicity of 
tributyltin is due to a metabolite, most likely dibutyltin.  
Excretion.    Bile, feces, and urine are major routes of elimination of absorbed inorganic and organotin 
compounds (see Section 3.4.4.4).  Information on the mechanisms of biliary secretion and urinary
excretion of tin compounds was not located. 
3.5.2 Mechanisms of Toxicity 
Studies in laboratory animals have shown that exposure to tin and tin compounds can produce a wide 
array of effects, but it is unknown whether exposure of humans to levels of tin compounds found in the 
environment will cause similar effects.  General mechanisms of neurotoxicity and immunotoxicity of 
organotin compounds are briefly discussed below, as effects on these two systems may cause the most 
concern following potential exposures of humans to these substances.  Although exposure to toxic 
amounts of neurotoxic organotins is somewhat unlikely, studies with trimethyltin and triethyltin in 
animals have shown a very steep dose-response curve for these substances and similar severe effects have 
been observed following acute high exposure of humans.  Exposure to immunotoxic organotins, such as 
tributyltin, is much more likely because of substances’ use and, environmental prevalence, based on 
monitoring data. 
Neurotoxicity. Trimethyltin has been shown to produce degenerative lesions in the hippocampus and 
associated structures of the limbic system (e.g., dentate gyrus) in nonhuman primates and in several 
rodent species (see Section 3.2.2.4; Koczyk 1996).  The lesions have been characterized as neuronal cell 
apoptosis and are accompanied with astrocyte swelling and reactive gliosis (Aschner and Aschner 1992; 
Fiederowicz et al. 2001; Haga et al. 2002; Koczyk and Oderfeld-Nowak 2000; McCann et al. 1996; 
Monnet-Tschudi et al. 1995a, 1995b). The glial response may be secondary to the primary neuronal 
lesion or a direct effect of trimethyltin on glial cell activation.  Glial cell activation has been observed in 
primary cultures of rat cortical astrocytes (Mizuhashi et al. 2000a, 2000b; Röhl et al. 2001) and in primary
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neuronal cells (Figiel and Fiedorowicz 2002; Monet-Tschudi et al. 1995a, 1995b), suggesting direct 
effects of trimethyltin on microglia.  Glial cell activation could contribute to neuronal cell degeneration 
by local release of pro-inflammatory cytokines, tumor necrosis factor-Į, and/or interleukins (Bruccoleri et 
al. 1998; Harry et al. 2002; Maier et al. 1995; McPherson et al. 2003).  Trimethyltin has also been shown 
to induce apoptosis (and necrosis at higher exposure concentrations) in primary cell cultures of rat 
neuronal cells and in other cell models, suggesting possible direct effects on neuronal cells (Gunasekar et 
al. 2001; Jenkins and Barone 2004; Thompson et al. 1996; Viviani et al. 1998).  Specific gene products, 
stannin and calcitonin gene-related peptide, may render neurons more vulnerable to trimethyltin-induced 
apoptosis (Bulloch et al. 1999; Thompson et al. 1996; Toggas et al. 1992).  Astrocyte swelling may be 
related to perturbation of the regulation of transmembrane potassium (or other solute) gradients (Aschner 
et al. 1992; Brand et al. 1997). 
Numerous functional disturbances, at the cellular level, have been observed in association with the 
trimethyltin neuropathology.  These effects may be contributing mechanisms to the primary lesion or may
represent secondary phenomena associated with neuronal cell loss.  Trimethyltin has been shown to 
stimulate the neuronal release of and/or to decrease neuronal cell uptake of neurotransmitters in brain 
tissue, including aspartate, GABA, glutamate, norepinephrine, and serotonin (Aschner et al. 1992; Costa 
1985; Dawson et al. 1995; Doctor et al. 1982; Earley et al. 1992; Gass? et al. 2000; Naalsund and 
Fonnum 1986; Patterson et al. 1996).  Such effects could give rise to imbalances in neuronal inhibition 
and excitation; however, their contributions as either primary or secondary mechanisms of trimethyltin­
induced neuronal degeneration and/or neurological impairment have not been established. 
In mice, exposure to trimethyltin decreases the expression of neural cell adhesion molecule (NCAM) and 
depresses NCAM levels in the hippocampus (Dey et al. 1994, 1997).  NCAM functions by establishing 
intercellular contact between neurons (e.g., synaptogenesis) and in cell migration during the development 
of the nervous system.  In mature mice, NCAM continues to be expressed in the hippocampus, where it 
appears to function in the acquisition and consolidation of memory.  Thus, altered NCAM expression may
contribute to trimethyltin-induced impairments in learning and memory. 
At doses of trimethyltin that produce loss of hippocampal neurons, expression of several neuropeptides 
(e.g., dynorphin, enkephalin, neuropeptide Y, somatostatin) and neuropeptide receptors (e.g., neuro­
peptide Y) are altered in affected areas of the brain (Ishikura et al. 2001, 2002; Sadamatsu et al. 1998; 
Tsunashima et al. 1998).  Altered expression of enkephalin and dynorphin may be contributing 
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shown to alter various factors in the lymbic system associated with the pathophysiology of Alzheimer’s 
disease (Nilsberth et al. 2002). 
Triethyltin induces an edema that is largely restricted to brain white matter (intramyelinic edema) in 
animal models without a prominent gliosis, in contrast to the reactive gliosis observed in trimethyltin 
toxicity (see Section 3.2.2.4).  The mechanism for the intramyelinic edema observed in triethyltin 
neurotoxicity has not been established.  Altered expression of myelin basic protein is an early event in the 
intralamellar vacuolization that precedes the development of intramyelinic edema (Veronesi et al. 1991a, 
1991b). Increased expression of various pro-inflammatory cytokines in affected areas also appears to 
coincide with vacuolization; these include tumor necrosis factor-, interleukin-1 , and monocyte 
chemoattractant protein 1- (Mehta et al. 1998). Results from a study with cultured oligodendrocytes, the 
myelin-forming cells of the central nervous system, suggested that triethyltin causes the onset of 
programmed cell death in oligodendrocytes, as indicated by DNA fragmentation (Stahnke and Richter-
Landsberg 2004). Programmed cell death was accompanied by induction of a heat shock protein, HSP32, 
an indicator of oxidative stress, and ERK1,2, a signal-regulated kinases known to be activated under 
conditions similar to those that induce HSP32 transcription. 
Immunotoxicity. Thymic atrophy produced by certain organotins, such as triphenyltin, tributyltin, 
dibutyltin, and dioctyltin compounds, involves a decrease in the number of cortical thymocytes, resulting 
in reduced thymus weight (see Section 3.2.2.3, Seinen and Willems 1976; Seinen et al. 1977a, 1977b).  
With prolonged exposure, T-cell-mediated immune responses are suppressed (Seinen et al. 1977b).  Loss 
of thymocytes appears to involve suppression of proliferation of immature thymocytes and, at higher 
dosages, apoptosis of mature thymocytes (Bollo et al. 1996; Raffay and Cohen 1993).  These appear to be 
direct effects on the thymus as both cytotoxicity and apoptosis have been observed in thymocyte cell 
cultures exposed to di- or tributyltin (Gennari et al. 1997, 2000, 2002a; Raffay et al. 1993; Umebayashi et 
al. 2004) and triphenyltin (Dacasto et al. 2001; Stridh et al. 1999b).  Cytotoxicity of butyltin compounds 
in thymocyte cultures involves suppression of DNA and protein synthesis (Gennari et al. 2002a; Raffay et 
al. 1993), and also induction of the expression of genes involved in apoptosis, such as nur77, a 
transcription factor member of the steroid/thyroid hormone receptor superfamily (Gennari et al. 2002b). 
An early and, possibly, the initiating event of apoptosis is a rise in cytosolic ionized calcium (Ca2+) 
concentration, caused both by intracellular calcium stores as well as by disruption of calcium transport at 
the cell membrane (Chow et al. 1992; Corsini et al. 1997; Gennari et al. 2000; Oyama et al. 1991, 1994, 
2003). Disruption of the regulation of intracellular calcium levels and, possibly, direct effects on energy
metabolism of mitochondria either contributes to or gives rise to the uncontrolled production of reactive 
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oxygen species, release of cytochrome c to the cytosol, and the proteolytic and nucleolytic cascade of 
apoptosis (Gennari et al. 2000; Okada et al. 2000).  Modification of the cytoskeleton through 
Ca2+-independent disruption of F-actin may also contribute to DNA fragmentation (Chow and Orrenius 
1994. 
Alkyltin compounds, in particular butyltin compounds, suppress T-cell-mediated immune responses, 
including antibody formation against foreign antigens, delayed hypersensitivity reactions, and allograft 
rejection (see Section 3.2.2.3). These effects appear to result from suppression of proliferation of 
immature thymocytes (CD4-CD8+) which would, otherwise, differentiate into mature T-cells possessing 
the complete antigen-recognizing T-cell receptor complex, resulting in lower numbers of circulating 
functional T-cells (Pieters et al. 1994b, 1994c).  Suppression of lymphoproliferative responses to T- and 
B-cell mitogens also has been demonstrated for triphenyltin (Dacasto et al. 1994b, 2001a, 2001b). 
Direct effects on lymphocyte function may also contribute certain aspects of immune suppression 
observed in animals exposed to butyltin compounds, including decreased natural killer cell activity. In
vitro, butyltin compounds suppress cytotoxic activity of human natural killer cells that function in the 
immune response to tumors and virally-infected cells (Whalen et al. 1999, 2000, 2002a, 2003).
Mechanisms for suppression of killer cells appear to involve loss of cell surface receptors important for 
binding to target cells (Odman-Ghazi et al. 2003; Whalen et al. 2002b), possibly secondary to a loss of 
regulation of intracellular cAMP (Whalen and Loganathan 2001), and disruption of the transcription of 
genes for the cytotoxic proteins granzyme B and perforin (Thomas et al. 2004), which are proteins 
contained in granules released by NK cells. 
3.5.3 Animal-to-Human Extrapolations 
Although information is available to support development of models of toxicokinetics for various tin 
compounds in rodents and nonhuman primates (e.g., Rhesus monkey, marmoset), evaluation of such 
models for applications to predicting the toxicokinetics of tin in humans would be highly uncertain 
because of the near complete lack of observations in humans (see Section 3.12.2).  In addition, studies 
conducted in animals suggest differences between nonhuman primates and rats in certain important 
features of the toxicokinetics of tin compounds.  For example, the elimination kinetics of absorbed 
inorganic tin occurs more slowly in Rhesus monkeys than in rodents; this difference appears to be the 
result of a larger fraction of the tin body burden associated with the slowest kinetic compartment 




195 TIN AND TIN COMPOUNDS 
3. HEALTH EFFECTS 
in red blood cells to a much greater extent in rats than in other species, including nonhuman primates 
(Brown et al. 1984; Rose and Aldridge 1968).  Also, studies of several rodent species showed different 
sensitivities to liver toxicity induced by tri- and dibutyltin which were related to the subcellular 
distribution of dibutyltin in hepatocytes (Ueno et al. 2003a, 2003b).  The susceptibilities followed the 
order: mice ! rats ! guinea pigs. Another case in which extrapolation from rats or mice to humans may
not be appropriate is that represented by the biliary duct necrosis produced by some organotins.  Bile duct 
necrosis following administration of dibutyltin occurred in rats, mice, and hamsters, species which unlike 
man, have common bile duct systems, but did not occur in rabbits, guinea pigs, hens, and cats, which 
have separate bile duct and pancreatic duct systems (Boyer 1989; Kimbrough 1976).  Thus, some 
toxicities of organotins in some animal species are not directly extrapolatable to humans. 
3.6 TOXICITIES MEDIATED THROUGH THE NEUROENDOCRINE AXIS 
Recently, attention has focused on the potential hazardous effects of certain chemicals on the endocrine 
system because of the ability of these chemicals to mimic or block endogenous hormones.  Chemicals 
with this type of activity are most commonly referred to as endocrine disruptors. However, appropriate 
terminology to describe such effects remains controversial.  The terminology endocrine disruptors, 
initially used by Colborn and Clement (1992), was also used in 1996 when Congress mandated the EPA 
to develop a screening program for “...certain substances [which] may have an effect produced by a 
naturally occurring estrogen, or other such endocrine effect[s]...”.  To meet this mandate, EPA convened a 
panel called the Endocrine Disruptors Screening and Testing Advisory Committee (EDSTAC), and in 
1998, the EDSTAC completed its deliberations and made recommendations to EPA concerning endocrine 
disruptors. In 1999, the National Academy of Sciences released a report that referred to these same types 
of chemicals as hormonally active agents. The terminology endocrine modulators has also been used to 
convey the fact that effects caused by such chemicals may not necessarily be adverse.  Many scientists 
agree that chemicals with the ability to disrupt or modulate the endocrine system are a potential threat to 
the health of humans, aquatic animals, and wildlife.  However, others think that endocrine-active 
chemicals do not pose a significant health risk, particularly in view of the fact that hormone mimics exist 
in the natural environment.  Examples of natural hormone mimics are the isoflavinoid phytoestrogens 
(Adlercreutz 1995; Livingston 1978; Mayr et al. 1992).  These chemicals are derived from plants and are 
similar in structure and action to endogenous estrogen.  Although the public health significance and 
descriptive terminology of substances capable of affecting the endocrine system remains controversial, 
scientists agree that these chemicals may affect the synthesis, secretion, transport, binding, action, or 
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development, and/or behavior (EPA 1997).  Stated differently, such compounds may cause toxicities that 
are mediated through the neuroendocrine axis. As a result, these chemicals may play a role in altering, 
for example, metabolic, sexual, immune, and neurobehavioral function.  Such chemicals are also thought 
to be involved in inducing breast, testicular, and prostate cancers, as well as endometriosis (Berger 1994; 
Giwercman et al. 1993; Hoel et al. 1992). 
In recent years, concern has been raised that many pesticides and industrial chemicals are endocrine-
active compounds capable of having widespread effects on humans and wildlife (Crisp et al. 1998; Daston 
et al. 1997; Safe et al. 1997).  Particular attention has been paid to the possibility of these compounds 
mimicking or antagonizing the action of estrogen and exhibiting antiandrogenic properties.  Estrogen 
influences the growth, differentiation, and functioning of many target tissues, including female and male
reproductive systems, such as mammary gland, uterus, vagina, ovary, testes, epididymis, and prostate.  
Another way that endocrine-active compounds can affect development is by acting on thyroid hormones.  
Thyroid hormones are essential for the normal development of the nervous system, lung, skeletal muscle, 
and possible other organs.  The fetus is dependent on maternal thyroid hormones at least until the fetal 
thyroid begins to produce T4 and triiodothyronine (T3), which occurs in humans at approximately 16– 
2 weeks of gestation. 
Thus far, there is no evidence that tin and tin compounds are endocrine disruptors in humans at the levels 
found in the environment. 
No studies were located regarding endocrine disruption in humans following exposure to tin or tin 
compounds or regarding effects in animals following exposure to inorganic tin.
Inorganic Tin Compounds.  The only relevant information located regarding inorganic tin is that 
stannous chloride induced the growth of MCF-7 breast cancer cells in vitro, decreased the steady-state 
amount of estrogen receptor protein and mRNA, induced the two estrogen-regulated genes, progesterone 
receptor and pS2, and activated the estrogen receptor in transient transfection experiments (Martin et al. 
2003).  Tin exhibited 1/3 to 1/4 the estrogenic potency of estradiol when measured in MCF-7 cells 
transiently transfected with the luciferase reporter construct.  
Organotin Compounds.  Intermediate- and chronic-oral studies with dibutyltin in rats and mice did not 
show alterations in the weight or in microscopic appearance of endocrine glands (Gaunt et al. 1968; NCI 
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pre- and postimplantation loss and resorptions in rats when administered during pregnancy (Ema et al. 
1991b, 1995b, 1997b; Noda et al. 1991a, 1992). In all cases, the highest incidence of effects was 
observed when the chemicals were administered on Gds 7–9 (Ema et al. 1992, 1997a, 1999a).  It was 
suggested that implantation loss that occurs after dosing the pregnant animals early during gestation is 
caused by an organotin-induced suppression of the uterine decidual cell response and decrease in 
progesterone levels (Ema and Miyawaki 2002; Ema et al. 1999b; Harazono and Ema 2000, 2003). 
Male ICR mice treated with 10 mg tributyltin oxide/kg 2 times/week for 4 weeks showed significantly
reduced sperm counts (Kauasaka et al. 2002).  In addition, light microscopy of the testis revealed 
disorganized seminiferous tubules with vacuolization of Sertoli cells and some loss of germ cells.  No 
effects were seen on spermatogonia, spermatocytes, spermatids, Leydig cells, or the basement membrane 
of the seminiferous tubules; the study NOAEL was 2 mg/kg/day.  A 2-year study with tributyltin oxide 
did not report histopathological alterations in endocrine glands from male and female rats treated with up 
to 2.1 mg/kg/day, except for a decrease in thyroid follicular epithelial cell height observed at 12 and 
24 months (Wester et al. 1990).  However, no significant alterations were observed at 12 and 24 months 
in serum levels of TSH, LH, FSH, insulin, T4, or FT4.  Chronic-duration studies with dibutyltin diacetate 
found no significant histopathological alterations in endocrine glands from rats and mice treated with 
dietary doses of up to 6.7 and 19.8 mg/kg/day, respectively, for 78 weeks (NCI 1978a).  However, a long-
term study with triphenyltin hydroxide reported an increase in Leydig cell hyperplasia and tubular atrophy
of the testes in rats dosed with 5.2 mg/kg/day for 2 years (Tennekes et al. 1989b).  This was not seen in 
rats dosed with up to 9.8 mg/kg/day or in mice dosed with up to 3.8 mg/kg/day for 78 weeks (NCI 
1978b). 
In male Fischer-344 rats treated with a single dose of 100 mg/kg of tributyltin oxide, there was an 
increase in serum cortisol and adrenal hypertrophy (Funahashi et al. 1980).  Tributyltin oxide also 
significantly reduced serum T4 and TSH, but at the same time increased the stainability of TSH cells, 
suggesting that tributyltin oxide inhibited TSH release, which caused thyroid hypofunction.  Since the 
decrease in circulating T4 was much more pronounced than that of TSH, Funahashi et al. (1980) 
suggested that tributyltin oxide also has a direct effect on the thyroid.  Most acute effects appeared to be 
reversible within 14 days.  Treatment of rats with 6 mg/kg/day for 26 weeks increased adrenal and 
hypophysis weight and also caused signs of thyroid hypofunction (Funahashi et al. 1980).  In an 
additional intermediate-duration study with tributyltin oxide, treatment of Wistar rats with doses of 
approximately 4 mg/kg/day significantly decreased serum levels of T4 and TSH, and increased LH 
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hormone (FSH) and corticosterone.  Release of TSH after administration of thyrotropin-releasing 
hormone (TRH) was slightly reduced at 4 mg/kg/day, but releases of both LH and FSH were enhanced.  
Light microscopy revealed flattening of the epithelial lining of the thyroid follicles at 4 mg/kg/day, but 
not at lower doses. In the pituitary, treatment with 4 mg/kg/day tributyltin oxide reduced the number of 
TSH-immunoreactive cells and the staining intensity, increased the number of cells staining for LH, and 
had no significant effect in the staining for GH-, FSH-, or ACTH-producing cells.  Krajnc et al. (1984)
concluded that their results suggested that treatment with tributyltin oxide for 6 weeks did not stimulate 
the pituitary-adrenal axis. 
In a 2-generation reproductive toxicity study in female Wistar rats, there was suggestive evidence that 
tributyltin chloride may alter developmental landmarks controlled by sex hormones.  Doses of 
10 mg/kg/day significantly delayed the day of eye opening in F2 pups (Ogata et al. 2001). Anogenital 
distance was significantly increased in F1 and F2 females on Pnds 1 and 4 and on Pnd 1 in F1 pups at 
2 mg/kg/day.  The day of vaginal opening was significantly delayed (6 days) with 10 mg/kg/day in F1 and 
F2 groups. Analysis of the estrous cycles between Pnds 71 and 92 showed no alterations in F1 rats, but the 
number of cycles was significantly decreased in F2 rats. Also, the percentage of normal cycles was 
decreased F1 and F2 rats dosed with 10 mg/kg/day.  
A study of similar design with tributyltin chloride was conducted to evaluate the development of 
reproductive parameters in male Wistar rats (Omura et al. 2001).  The doses tested were 0.4, 2, and 
10 mg/kg/day.  Anogenital distance (measured on Pnds 1 and 4) was not significantly altered in F1 or F2 
males and neither was the day of testes descent.  The day of eye opening was significantly delayed in 
mid- and high-dose F1 rats and in high-dose F2 rats. Effects on the weight of the sex organs included: 
decreased absolute testis weight in all F1 groups (dose-related); decrease absolute epididymis weight in 
low- and high-dose F1 groups; decrease absolute testis and epididymis weight in high-dose F2 groups and 
in relative prostate weight in mid- and high-dose F2 groups. The only sperm parameters that were 
significantly altered were sperm count in high-dose F2 rats and spermatid count in mid- and high-dose F2 
rats and high-dose F1 rats. Histological examination of the testes revealed minimal alterations in high-
dose F1 rats, but were more frequent and severe in F2 rats and were considered abnormal in this group.
These effects consisted of vacuolization of the seminiferous epithelium, spermatid retention, and delayed 
spermiation.  Serum testosterone was increased and estradiol was decreased in high-dose F1 rats; serum
estradiol was decreased and LH was increased in high-dose F2 rats. 
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The information available is insufficient to ascertain whether organotins cause endocrine disruption in 
laboratory mammals, but the studies of Ogata et al. (2001) and Omura et al. (2001) suggest that tributyltin 
may have such a property. In addition, assays in vitro support this hypothesis.  A brief summary of some
recent in vitro studies is presented below. 
A commonly used test of potential endocrine-disruption activity is the assay of aromatase activity.  
Aromatase cytochrome P-450 is an enzyme that catalyzes the conversion of androgens to estrogens. 
Because estrogens are involved in processes including development of female secondary characteristics, 
regulation of bone density, menstruation cycle, and spermatogenesis, interference with their metabolism
can have widespread consequences. Using human term placenta as source of enzymes, Heidrich et al. 
(2001) evaluated the aromatase activity of a series of organotins.  The results showed that tributyltin 
chloride was a partial competitive inhibitor of aromatase activity.  Dibutyltin dichloride was a less potent 
inhibitor, whereas tetrabutyltin and monobutyltin trichloride had no significant effect.  In contrast, 
tributyltin had only moderate inhibitory activity toward 3E-HSD type I activity, an enzyme that converts 
dehydroepiandrosterone to androstenedione.  None of the other butyltins tested inhibited 3E-HSD type I 
activity.  Cooke (2002) found that tributyltin chloride and dibutyltin dichloride inhibited aromatase 
activity (a commercial preparation), but not monobutyltin or mono-, di-, or trioctyltins.  
Tributyltin chloride inhibited human 5D-reductase type1 and 5D-reductase type 2 (Doering et al. 2002), 
enzymes that mediate the activation of androgens, suggesting that this organotin could potentially disturb 
normal male reproductive physiology.  5D-Reductase type 2 also was inhibited by dibutyltin dichloride 
and neither enzyme was affected by monobutyltin trichloride or by tetrabutyltin, which suggested that at 
least two butyl groups bound to tin are required for the interaction with these enzymes.  Triphenyltin 
chloride also was found to be a significant inhibitor of human sex steroid hormone metabolism by
interacting with critical cysteine residues of the enzymes (Lo et al. 2003).  McVey and Cooke (2003) 
examined the effects of organotins on the activity of 3E-hydroxysteroid dehydrogenase (3E-HSD), 
17-hydroxylase (17-OHase), and 17E-hydroxysteroid dehydrogenase (17E-HSD), enzymes that catalyze 
steps in the synthesis of steroids. In microsomes from rat testes, tributyltin chloride inhibited 17-OHase 
and 3E-HSD, whereas monooctyltin trichloride inhibited only 3E-HSD. 17E-HSD activity was unaffected 
by mono-, di-, or tributyltin, or mono-, di-, or trioctyltin.  Triphenyltin chloride, tributyltin chloride, and 
dibutyltin dichloride suppressed testosterone production in Leydig cells in vitro from neonatal pig testes 
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3.7 CHILDREN’S SUSCEPTIBILITY 
This section discusses potential health effects from exposures during the period from conception to 
maturity at 18 years of age in humans, when all biological systems will have fully developed.  Potential 
effects on offspring resulting from exposures of parental germ cells are considered, as well as any indirect 
effects on the fetus and neonate resulting from maternal exposure during gestation and lactation.  
Relevant animal and in vitro models are also discussed. 
Children are not small adults.  They differ from adults in their exposures and may differ in their 
susceptibility to hazardous chemicals.  Children’s unique physiology and behavior can influence the 
extent of their exposure.  Exposures of children are discussed in Section 6.6, Exposures of Children. 
Children sometimes differ from adults in their susceptibility to hazardous chemicals, but whether there is 
a difference depends on the chemical (Guzelian et al. 1992; NRC 1993).  Children may be more or less 
susceptible than adults to health effects, and the relationship may change with developmental age 
(Guzelian et al. 1992; NRC 1993).  Vulnerability often depends on developmental stage.  There are 
critical periods of structural and functional development during both prenatal and postnatal life and a 
particular structure or function will be most sensitive to disruption during its critical period(s).  Damage 
may not be evident until a later stage of development.  There are often differences in pharmacokinetics 
and metabolism between children and adults.  For example, absorption may be different in neonates 
because of the immaturity of their gastrointestinal tract and their larger skin surface area in proportion to 
body weight (Morselli et al. 1980; NRC 1993); the gastrointestinal absorption of lead is greatest in infants 
and young children (Ziegler et al. 1978).  Distribution of xenobiotics may be different; for example, 
infants have a larger proportion of their bodies as extracellular water and their brains and livers are 
proportionately larger (Altman and Dittmer 1974; Fomon 1966; Fomon et al. 1982; Owen and Brozek 
1966; Widdowson and Dickerson 1964).  The infant also has an immature blood-brain barrier (Adinolfi 
1985; Johanson 1980) and probably an immature blood-testis barrier (Setchell and Waites 1975).  Many
xenobiotic metabolizing enzymes have distinctive developmental patterns.  At various stages of growth 
and development, levels of particular enzymes may be higher or lower than those of adults, and 
sometimes unique enzymes may exist at particular developmental stages (Komori et al. 1990; Leeder and 
Kearns 1997; NRC 1993; Vieira et al. 1996).  Whether differences in xenobiotic metabolism make the 
child more or less susceptible also depends on whether the relevant enzymes are involved in activation of 
the parent compound to its toxic form or in detoxification.  There may also be differences in excretion, 
particularly in newborns who all have a low glomerular filtration rate and have not developed efficient 
tubular secretion and resorption capacities (Altman and Dittmer 1974; NRC 1993; West et al. 1948).  
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Children and adults may differ in their capacity to repair damage from chemical insults.  Children also 
have a longer remaining lifetime in which to express damage from chemicals; this potential is particularly
relevant to cancer. 
Certain characteristics of the developing human may increase exposure or susceptibility, whereas others 
may decrease susceptibility to the same chemical.  For example, although infants breathe more air per 
kilogram of body weight than adults breathe, this difference might be somewhat counterbalanced by their 
alveoli being less developed, which results in a disproportionately smaller surface area for alveolar 
absorption (NRC 1993). 
No studies were located that specifically addressed exposure to inorganic tin in children.  Data in adults 
regarding exposure to inorganic tin are derived from occupational exposure settings (a nonrelevant 
exposure scenario for children) and from ingesting food items contaminated with tin.  This has produced 
nausea, vomiting, and diarrhea (WHO 1980, 2003) and it is expected that children would experience the 
same types of effects if exposed to high amounts of inorganic tin in the same manner.  In a small number 
of studies available, exposure of rodents to inorganic tin during gestation did not result in embryotoxicity 
or teratogenicity (FDA 1972; Theuer et al. 1971). 
No specific information was found regarding exposure of children to organotins.  The only information 
that involves exposure to children is that from a report by Wax and Dockstader (1995) indicating that all 
members of a family of five, including three children, complained of nausea, vomiting, headache, sore 
throat, burning nose, and wheezing 24 hours after a room in their home had been painted with a paint 
containing tributyltin oxide for mildew control. 
Studies in animals indicate that tributyltins, dibutyltins, and dioctyltins are mainly immunotoxic, whereas 
trimethyltins and triethyltins are neurotoxic.  No studies of immunotoxicity in humans exposed to 
organotins have been conducted.  A study in rats observed that the immunological effects produced by
dibutyltin dichloride were more pronounced in rats exposed in the developmental phase of the lymphoid 
system (Seinen et al. 1977b).  The neurotoxic effects of trimethyltin, triethyltin, and triphenyltin observed 
in experimental animals have been observed in adult humans accidentally exposed to these substances 
(Colosio et al. 1991; Feldman et al. 1993; Fortemps et al. 1978; Lin et al. 1998; Ross et al. 1981; Wu et 
al. 1990; Yanofsky et al. 1991) and it is reasonable to assume that similar types of effects would occur in 
children acutely exposed to high amounts of these substances.  Studies with trimethyltin in rats showed 
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age period is between Pnds 9 and 15 (Chang 1984a, 1984b).  Organotins are also known to be skin and 
eye irritants in adult humans (Goh 1985; Lyle 1958; Sheldon 1975) and similar effects would be expected 
in exposed children. 
There are no developmental studies of organotins in humans.  However, studies in animals have shown 
that triphenyltin, dibutyltin, and tributyltin administered to rodents during pregnancy induce adverse 
developmental effects and that the severity of the effects depends of the specific day(s) of gestation when 
treatment occurs (Baroncelli et al. 1995; Ema et al. 1991a, 1991b, 1992, 1995b, 1997b; Faqi et al. 1997;
Farr et al. 2001; Harazono et al. 1998; Noda et al. 1991a, 1991b).  The most commonly seen 
malformations are facial malformations, particularly cleft plate.  These studies also showed that 
organotins can induce adverse reproductive effects such as pre- and postimplantation losses, resorptions, 
and fetal deaths. One key issue not yet resolved is whether these effects occur secondary to maternal 
toxicity or can occur in the absence of maternal toxicity. 
Perinatal administration of organotins can cause neurodevelopmental (neurochemical and behavioral) 
effects in animals, which vary with the age at treatment and can persist until adulthood.  This has been 
studied mostly with triethyltin and trimethyltin with the chemicals administered parenterally (Barone 
1993; Barone et al. 1995; Freeman et al. 1994; Miller and O’Callaghan 1984; O’Callaghan and Miller 
1988a; Reiter et al. 1981; Stanton 1991; Stanton et al. 1991). 
There is no information regarding the pharmacokinetics of tin and tin compounds in children. Studies in 
animals have shown that both inorganic tin (Theuer et al. 1971) and organotin compounds (Nakamura et 
al. 1993; Noda et al. 1994) can cross the placenta and reach the developing organism.  There are no data 
on tin and tin compounds in human breast milk and no animal studies that have conclusively 
demonstrated transfer of tin and tin compounds to the offspring via maternal milk.  Recently, Cooke et al. 
(2004) found negligible transfer of tributyltin and dibutyltin from rats dosed during lactation with up to 
2.5 mg tributyltin/kg/day to the pups via the milk. 
In two multi-generation studies in rats, exposure to tributyltin chloride induced slight alterations in 
developmental landmarks in male and female animals, suggesting the possibility that this substance 
possesses endocrine modulatory properties in mammals (Ogata et al. 2001; Omura et al. 2001).  However, 
no comprehensive testing has been done with tributyltin or other organotins in laboratory mammals.  
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male and female sex hormones, which could affect the balance of androgens and estrogens in the body of 
developing mammals (Cooke 2002; Doering et al. 2002; Heidrich et al. 2001; McVey and Cooke 2003).  
3.8 BIOMARKERS OF EXPOSURE AND EFFECT 
Biomarkers are broadly defined as indicators signaling events in biologic systems or samples.  They have 
been classified as markers of exposure, markers of effect, and markers of susceptibility (NAS/NRC 
1989). 
Due to a nascent understanding of the use and interpretation of biomarkers, implementation of biomarkers 
as tools of exposure in the general population is very limited.  A biomarker of exposure is a xenobiotic 
substance or its metabolite(s) or the product of an interaction between a xenobiotic agent and some target 
molecule(s) or cell(s) that is measured within a compartment of an organism (NAS/NRC 1989).  The 
preferred biomarkers of exposure are generally the substance itself or substance-specific metabolites in 
readily obtainable body fluid(s) or excreta.  However, several factors can confound the use and 
interpretation of biomarkers of exposure.  The body burden of a substance may be the result of exposures 
from more than one source.  The substance being measured may be a metabolite of another xenobiotic 
substance (e.g., high urinary levels of phenol can result from exposure to several different aromatic 
compounds).  Depending on the properties of the substance (e.g., biologic half-life) and environmental 
conditions (e.g., duration and route of exposure), the substance and all of its metabolites may have left the 
body by the time samples can be taken.  It may be difficult to identify individuals exposed to hazardous 
substances that are commonly found in body tissues and fluids (e.g., essential mineral nutrients such as 
copper, zinc, and selenium).  Biomarkers of exposure to tin and tin compounds are discussed in 
Section 3.8.1.
Biomarkers of effect are defined as any measurable biochemical, physiologic, or other alteration within an 
organism that, depending on magnitude, can be recognized as an established or potential health 
impairment or disease (NAS/NRC 1989).  This definition encompasses biochemical or cellular signals of 
tissue dysfunction (e.g., increased liver enzyme activity or pathologic changes in female genital epithelial 
cells), as well as physiologic signs of dysfunction such as increased blood pressure or decreased lung 
capacity.  Note that these markers are not often substance specific.  They also may not be directly 
adverse, but can indicate potential health impairment (e.g., DNA adducts).  Biomarkers of effects caused 
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A biomarker of susceptibility is an indicator of an inherent or acquired limitation of an organism's ability
to respond to the challenge of exposure to a specific xenobiotic substance.  It can be an intrinsic genetic or 
other characteristic or a preexisting disease that results in an increase in absorbed dose, a decrease in the 
biologically effective dose, or a target tissue response.  If biomarkers of susceptibility exist, they are 
discussed in Section 3.10 “Populations that are Unusually Susceptible.” 
3.8.1 Biomarkers Used to Identify or Quantify Exposure to Tin and Tin Compounds 
Absorbed inorganic tin distributes to soft tissues and bone (see Sections 3.4.2.2 and 3.4.2.4).  Elimination 
of inorganic tin from blood and other soft tissues is relatively rapid (half-time, 1–3 days in monkeys); 
therefore, acute exposure may be detectable as an elevation in blood tin levels only for a few days (see 
Section 3.4.4.4).  Blood measurements may be suitable for detecting exposures of intermediate or chronic 
duration.  Models that would support quantitative estimates of exposure, based on blood tin levels, have 
not been developed.  Inorganic tin is retained in bone for much longer periods (half-time, 2–3 months in 
monkeys); however, noninvasive methods for measuring elevations in bone tin levels are not available.  
Absorbed inorganic tin is excreted primarily in urine (see Section 3.4.4.4); therefore, measurements of 
urinary tin may allow detection of long-term exposures to tin; however, models for translating this 
information into quantitative estimates of exposure have not been developed. 
Detection of exposures to specific organotin compounds requires measurements of the specific compound 
(and metabolites). Organic tin compounds (alkyltin compounds) appear to be eliminated relatively 
rapidly from blood and other soft tissues (half-times, 2–15 days in rats); therefore, detection of exposure 
from measurements of alkyltin compounds in blood would require measurements made within a few days
of an acute exposure (see Section 3.4.4.4).  Models for estimating exposure levels from blood 
measurements have not been developed.  Since absorbed alkyltin compounds are excreted in urine, 
urinary measurements may provide a means for detecting exposures.  Methods for determining tin and tin 
compounds in biological materials are discussed in Section 7.1. 
3.8.2 Biomarkers Used to Characterize Effects Caused by Tin and Tin Compounds 
There are no specific biomarkers of effects for inorganic tin compounds.  Certain organotin compounds 
do produce more specific effects than inorganic tin compounds.  For example, studies in animals have 
shown that trimethyltin and triethyltin are primarily neurotoxic and affect specific areas or morphological 
substrates in the central nervous system (Aschner and Aschner 1992; Chang 1990).  The structural 
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alterations observed in the brain from intoxicated animals (hippocampal lesions, intramyelinic edema) 
have also been observed in humans acutely exposed to high amounts of trimethyltin and triethyltin 
(Feldman et al. 1993; Foncin and Gruner 1979; Kreyberg et al. 1992; Yanofsky et al. 1991). Certain 
behavioral alterations seen in intoxicated animals, such as memory deficits and aggressive behavior, also 
have been observed in humans acutely exposed to high amounts of trimethyltin.  While the neurological 
effects induced by these substances cannot be considered specific biomarkers of exposure for this group 
of chemicals, their manifestation can direct trained professionals to investigate potential exposure.  
Studies with other organotins, such as tributyltin, dibutyltin, and dioctyltin, in animals have reported 
effects on the bile duct and liver, immune system (thymus and lymphoid organs), kidneys, and blood, but 
these effects are not specific for organotin compounds. 
3.9 INTERACTIONS WITH OTHER CHEMICALS 
Tin is an element that affects the metabolism of various essential minerals such as zinc, copper, and iron 
by mechanisms not totally elucidated, but that may involve effects on absorption and retention.  For 
example, Yamaguchi et al. (1979) reported that the increase in serum calcium concentration that occurred 
in rats following administration of a single oral dose of calcium chloride was significantly inhibited by 
previous administration of tin as stannous chloride (30 mg/kg every 12 hours for 3 days).  Since calcium
in the duodenal mucosa was reduced and the activity of alkaline phosphatase was also reduced in the 
mucosa, Yamaguchi et al. (1979) suggested that tin inhibited the duodenal active transport of calcium.  In 
a study in volunteers, consumption of a diet that provided approximately 5 times more tin (0.65 mg
Sn/kg/day) than a control diet (0.14 mg Sn/kg/day) for 20 days had no significant effect on fecal losses, 
urinary losses, apparent retention, and serum levels of calcium (Johnson and Greger 1982). 
Administration of tin (as stannous chloride) in the diet (200 ppm for 21 days) to rats resulted in reduced 
concentration of zinc in the tibias, reduced retention of zinc in the kidneys, and increased amounts of zinc 
in the feces (Greger and Johnson 1981).  In addition, the copper content of the kidneys and liver of the 
animals fed the diet with added tin was significantly lower than in rats fed a control diet.  Also in the 
Greger and Johnson (1981) study, tin had no effect on the retention of iron in the kidneys or in fecal 
losses of iron, but the concentration of iron in the livers from treated rats was significantly higher than in 
livers from control rats.  The effect on zinc appeared to be, at least in part, due to reduced absorption of 
zinc since food intake was not depressed in the treated rats.  In contrast, the effect of tin on copper status 
seemed to be caused by a different mechanism based on the fact that the tin diet did not increase fecal 
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improvement in the iron nutritional status of the rats or impairment in the rat’s abilities to mobilize iron 
from the liver.  They further hypothesized that the effect of tin on iron metabolism may have been a 
reflection of the effect of tin on copper metabolism because ceruloplasmin, a copper metalloenzyme, is 
one enzyme involved in mobilization of iron from the liver.  In a subsequent study, the same group of
investigators showed that feeding rats diets containing >500 ppm tin reduced plasma copper levels to 13% 
of those in control rats and also depressed copper levels in kidneys and liver (Johnson and Greger 1985).  
Similar results regarding the effects of tin on copper and zinc metabolism were reported by Rader et al. 
(1990). The results of these studies are consistent with the findings of De Groot (1973), who observed 
that supplementation of a high-tin diet with copper and iron could reduce signs of anemia in rats, but 
could not correct the reduced growth, and reduced growth is a common symptom of zinc deficiency
(Rader et al. 1990). Tin was also found to interact with zinc metabolism in humans; individuals fed diets 
with excess tin lost significantly more zinc in their feces and less zinc in the urine than those fed a control 
diet (Johnson et al. 1982). 
In a study in rats, Noda et al. (1994) examined the effect of pretreatment of pregnant animals with carbon 
tetrachloride on the teratogenic activity of dibutyltin dichloride.  Pregnant rats were treated 
subcutaneously with carbon tetrachloride on Gds 6 and 7 and orally with various dose levels of dibutyltin 
dichloride on Gd 8; sacrifices were conducted on Gd 20.  Pretreatment with carbon tetrachloride 
significantly increased the incidence of external and skeletal malformations caused by the organotin 
alone. Moreover, pretreatment with carbon tetrachloride increased the concentration of dibutyltin in 
embryos, maternal liver, and blood.  Carbon tetrachloride caused maternal hepatotoxicity (increased 
serum transaminases) and decreased the activity of hepatic microsomal drug-metabolizing enzymes, 
suggesting that dibutyltin itself (and not a metabolite) was teratogenic. 
Makita et al. (2003, 2004) studied the effects of the simultaneous administration of tributyltin chloride 
and p,p’-DDE on developmental end points in rats. Rats were treated orally with tributyltin 
chloride/kg/day alone (2 mg/kg/day) or tributyltin chloride plus p,p’-DDE (10 mg/kg/day) during 
gestation and lactation.  Developmental parameters examined in the pups at various times up to 6 weeks 
of age included gender and gross malformations, body and sex organ weights, anogenital distance, eye 
opening, nipple retention (in males), vaginal opening, vaginal opening, preputial separation, and serum
testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH).  Tributyltin significantly
depressed growth rate of the pups from Pnd 7 to 28, but simultaneous administration of p,p’-DDE 
prevented this effect.  Sex organs’ weights were not affected by tributyltin, except for prostate weight 
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was increased in the combination group relative to the tributyltin alone group.  Serum testosterone was 
not affected in any group and serum LH was reduced in the tributyltin group, but not in the combination 
group.  Tributyltin did not affect anogenital distance, nipple retention, or vaginal opening, but delayed eye 
opening (not observed in the combination group).  The mechanism of interaction between tributyltin and 
p,p’-DDE is unknown. 
3.10 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE
A susceptible population will exhibit a different or enhanced response to tin and tin compounds than will 
most persons exposed to the same level of tin and tin compounds in the environment.  Reasons may
include genetic makeup, age, health and nutritional status, and exposure to other toxic substances (e.g., 
cigarette smoke).  These parameters result in reduced detoxification or excretion of tin and tin 
compounds, or compromised function of organs affected by tin and tin compounds.  Populations who are 
at greater risk due to their unusually high exposure to tin and tin compounds are discussed in Section 6.7, 
Populations with Potentially High Exposures. 
There are no specific populations that have been identified as being unusually susceptible to inorganic tin 
compounds with respect to health effects.  However, studies in animals and humans indicate that 
inorganic tin affects the metabolism of various essential trace elements.  For example, levels of dietary tin 
much higher than those in normal diets reduce zinc absorption, which reduces growth, and reduces 
plasma copper levels, and may lead to anemia.  Therefore, children or adults who consume diets already
poor in these minerals may be at higher risk of developing signs of lack of zinc or copper if their dietary
tin is excessive (as in a canned-food-based diet).  However, it is important to note that >90% of tin-lined 
cans used for food today are lacquered. 
No population has been identified that is unusually susceptible to the effects of exposure to organotin 
compounds.  
3.11 METHODS FOR REDUCING TOXIC EFFECTS 
This section will describe clinical practice and research concerning methods for reducing toxic effects of 
exposure to tin and tin compounds.  However, because some of the treatments discussed may be 
experimental and unproven, this section should not be used as a guide for treatment of exposures to tin 
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toxicologists should be consulted for medical advice.  No texts were found that provided specific 
information about treatment following exposures to tin and tin compounds.  
Human exposure to tin may occur by inhalation, ingestion, or dermal contact (see Chapter 6).  
Gastrointestinal effects have been observed following ingestion of inorganic tin compounds and 
inhalation, ingestion or dermal exposure to some organotin compounds may cause neurological effects 
(see Section 3.2). Inorganic tin salts and organotins are reported to be skin and eye irritants (WHO 1980). 
The information below has been extracted from HSDB (2003). 
3.11.1 Reducing Peak Absorption Following Exposure 
Usually, it is unnecessary to induce emesis in cases of ingestion of inorganic tin compounds, and induced 
emesis may be dangerous in patients who have ingested caustic tin compounds such as stannic chloride.  
Emesis is contraindicated following ingestion of trimethyltin.  Immediate dilution with 4–8 ounces of 
milk or water is recommended after oral exposure, as well as administration of activated charcoal slurry
(240 mL water/30 g charcoal).  Following inhalation exposure, the patient should be moved to fresh air.  
In cases of dermal exposure, contaminated clothing should be removed and the exposed area should be 
washed thoroughly with soap and water.  Irrigation with copious amounts of tepid water (or preferably a 
physiologically-balanced eye wash solution) for at least 15 minutes is recommended in cases of eye 
exposure. Gastric lavage can be considered after ingestion of a potentially life-threatening amount of a 
tin compound if it can be performed soon after ingestion (generally within 1 hour).  Caution should be 
used to protect the airway by placement in Trendelburg and left lateral decubitus position or by 
endotracheal intubation. 
3.11.2 Reducing Body Burden 
No specific information was located to reduce the body burden of tin and compounds following exposure. 
3.11.3 Interfering with the Mechanism of Action for Toxic Effects 
Information summarized in HSDB (2003) describes standard measures to support vital functions 
following exposure. There are specific measures to interfere with the mechanism of toxicity of tin and 
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(2,3-dimercaptopropanol) has been suggested as an antidote, based on studies in animals, but it was not 
effective against trialkyltins or tetraalkyltins.  DMPS (2,3-dimercaptopropane-1-sulfonic acid) and DMSA 
(meso-2,3-dimercaptosuccinic acid) were effective in reducing the bile duct, pancreas, and liver lesions in 
rats, but were less effective against thymus atrophy (Merkord et al. 2000). 
3.12 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the 
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether 
adequate information on the health effects of tin and tin compounds is available.  Where adequate 
information is not available, ATSDR, in conjunction with the National Toxicology Program (NTP), is 
required to assure the initiation of a program of research designed to determine the health effects (and 
techniques for developing methods to determine such health effects) of tin and tin compounds. 
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that if met would 
reduce the uncertainties of human health assessment.  This definition should not be interpreted to mean 
that all data needs discussed in this section must be filled.  In the future, the identified data needs will be 
evaluated and prioritized, and a substance-specific research agenda will be proposed. 
3.12.1 Existing Information on Health Effects of Tin and Tin Compounds 
The existing data on health effects of inhalation, oral, and dermal exposure of humans and animals to tin 
and tin compounds are summarized in Figures 3-11 and 3-12.  The purpose of this figure is to illustrate 
the existing information concerning the health effects of tin and tin compounds.  Each dot in the figure 
indicates that one or more studies provide information associated with that particular effect.  The dot does 
not necessarily imply anything about the quality of the study or studies, nor should missing information in 
this figure be interpreted as a “data need”.  A data need, as defined in ATSDR’s Decision Guide for 
Identifying Substance-Specific Data Needs Related to Toxicological Profiles (Agency for Toxic 
Substances and Disease Registry 1989), is substance-specific information necessary to conduct 
comprehensive public health assessments.  Generally, ATSDR defines a data gap more broadly as any 
substance-specific information missing from the scientific literature.
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Figure 3-11 provides the information for inorganic tin compounds.  There are case reports that describe 
acute and chronic effects of inhaled inorganic tin compounds on humans.  There are also reports of 
humans that developed health effects after oral exposure to food and drink from tin cans.  No other 
studies were located regarding health effects in humans after inhalation, oral, or dermal routes of 
exposure. The most relevant route of exposure to inorganic tin for humans is the oral route. 
The health effects of inorganic tin compounds have been chiefly studied in animals after oral exposure, as 
shown in Figure 3-11.  The figure also shows that no inhalation studies and only a few dermal studies 
were located regarding health effects from inorganic tin compounds. 
Figure 3-12 provides health effects information on humans and animals after exposure to organotin 
compounds.  The database for these compounds as a class is much more complete than for the inorganic 
tin compounds.  There are case reports that describe deaths and other effects associated with inhalation, 
oral, and dermal routes of exposure.  In addition to acute-duration inhalation studies and acute and 
intermediate dermal studies, there are reports of neurobehavioral effects in humans after inhalation, oral, 
and dermal exposures. The main route of exposure to organotins for humans is the oral route.
The extent of the database on health effects in animals resulting from exposure to organotin compounds is 
shown in Figure 3-12. Except for genotoxic studies, there are oral studies that describe all the other 
toxicological end points considered in this profile.  By contrast, the information is more limited for the 
inhalation and dermal routes of exposure. 
3.12.2 Identification of Data Needs 
Acute-Duration Exposure.    There are no data in humans following acute inhalation exposure to 
inorganic tin and the data in animals are limited mostly to death (Igarashi 1959; Schweinfurth and Gunzel 
1987).  Therefore, an acute-duration inhalation MRL was not derived for inorganic tin.  For organic tin 
compounds, limited acute inhalation data exist for death in humans (Rey et al. 1984) and in animals 
(Igarashi 1959; Schweinfurth and Gunzel 1987), systemic effects in humans (Rey et al. 1984; Saary and 
House 2002; Wax and Dockstader 1995) and in animals (Igarashi 1959), and neurological effects in 
humans (Feldman et al. 1993; Rey et al. 1984; Ross et al. 1981; Saary and House 2002; Yanofsky et al. 
1991). The information provided in these studies is inadequate for derivation of acute-duration inhalation 
MRLs for inorganic tin or organotins largely because of lack of quantitative data.  Oral exposure is the 
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provide information on lethality in animals (NTP 1982), on reproductive/developmental effects in rodents 
(FDA 1972), and on systemic effects in humans (Boogaard et al. 2003; WHO 1980, 2003). In the case of 
organotins, data exist for lethality in humans (Kreyberg et al. 1992; WHO 1980) and in animals (WHO 
1980), systemic effects in humans (Lin and Hsueh 1993; Lin et al. 1998; WHO 1980; Wu et al. 1990) and 
in animals (Barnes and Magee 1958; Pelikan and Cerny 1970; Raffray and Cohen 1993; Funahashi et al. 
1980; Seinen et al. 1977a; Takagi et al. 1992; Ueno et al. 1994, 1995, 1997, 2003a, 2003b), immuno­
logical effects in animals (Seinen et al. 1977a; Smialowicz et al. 1989, 1990; Snoeij et al. 1985), neuro­
logical effects in humans (Kreyberg et al. 1992; Lin et al. 1998; WHO 1980; Wu et al. 1990) and in 
animals (Baroncelli et al. 1990, 1995; Brown et al. 1984; Chang and Dyer 1983; Chang et al. 1983; Davis 
et al. 1987; Ema et al. 1991a; Magee et al. 1957; Squibb et al. 1980), and reproductive and developmental 
effects in animals (Ema and Harazono 2000; Ema et al. 1991b, 1992, 1997b, 1999b, 1999c, 2003; Farr et 
al. 2001; Harazono and Ema 2003; Noda et al. 1991a, 1992b).  Again, the data for inorganic tin were 
insufficient for derivation of an acute oral MRL.  The data for organotins were either insufficient or 
inadequate in that no NOAELs were available and most LOAELs were serious LOAELs, thus precluding 
derivation of acute oral MRLs.  Acute dermal data were limited to a lethal human case (NIOSH 1976) and 
several reports in animals (Smith 1978) exposed to organotins, information on hepatic effects in humans 
(Colosio et al. 1991), and dermal and ocular effects in humans and animals (Barnes and Stoner 1958; Goh 
1985; Klimmer 1969; Lyle 1958; Sheldon 1975).  Excessive acute exposure to inorganic tin is unlikely to
occur unless there is consumption of unusually high amounts of canned foods in a short period of time.  
Further acute studies with inorganic tin are unlikely to provide new key information.  The decision to 
expand the database for acute exposure to some organotin compounds should be based on the results of a 
case-by-case evaluation of the likelihood of potential exposure to high concentrations of these substances 
for people living near waste sites. It is unlikely that the general population will be acutely exposed to 
high amounts of organotins. 
Intermediate-Duration Exposure. There are currently no data concerning the effects of inorganic 
tin or organotin compounds on humans for this exposure duration for the inhalation, oral, or dermal routes 
of exposure. No data were available regarding effects in animals after intermediate-duration exposure to 
inorganic tin by the inhalation route.  Studies of inorganic tin in rodents, primarily rats and mice, treated 
orally demonstrated effects in the gastrointestinal tract, the blood, the kidney, the liver, and bile ducts 
(Chmielnicka et al. 1993; De Groot et al. 1973; Dreef-van der Meulen et al. 1974; Janssen et al. 1985;
NTP 1982; Schroeder et al. 1968).  Very limited information was located regarding reproductive and 
developmental effects of inorganic tin compounds in animals (Theuer et al. 1971).  The study by
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inorganic tin.  Few studies were located that tested organotin compounds by the inhalation route in 
animals.  These studies provided some information on respiratory, hepatic, renal, and reproductive effects 
but lacked enough detail to be considered for MRL derivation (Gohlke et al. 1969; Igarashi 1959; 
Iwamoto 1960).  Intermediate-duration oral exposure studies with organotins provide information on 
lethality in various species (Magee et al. 1957; NCI 1978b; Seinen et al. 1977b) and on a variety of end 
points (hematological, body weight, endocrine, hepatic, renal, immunological, neurological, reproductive, 
and developmental in rodents (Adeeko et al. 2003; Barnes and Magee 1958; Bouldin et al. 1981; Bressa et 
al. 1991; Carthew et al. 1992; Cooke et al. 2004; Dacasto et al. 1994a; Funahashi et al. 1990; Gaunt et al. 
1968; Graham and Gonatas 1973; Jang et al. 1986; Krajnc et al. 1984; Noland et al. 1982; Ogata et al. 
2001; Omura et al. 2001; Purves et al. 1991; Seinen and Willems 1976; Seinen et al. 1977a, 1977b; Smith 
1973; Snoeij et al. 1985; Tryphonas et al. 2004; Verdier et al. 1991; Vos et al. 1990).  Most of these 
studies tested dibutyltin, dioctyltin, tributyltin, triethyltin, trimethyltin, and/or triphenyltin.  Adequate 
information was available for derivation of an intermediate-duration oral MRL for dibutyltin dichloride 
based on altered humoral immune responses in rats (Seinen et al. 1977b) and for tributyltin oxide, also 
based on immunotoxicity (Vos et al. 1990).  Information regarding effects following intermediate-
duration dermal exposure was restricted to a study by Sheldon (1975), who described skin alterations in 
rabbits during a 90-day exposure period.  Oral exposure is the main route of exposure to inorganic tin for 
humans; therefore, inhalation and dermal exposure studies seem unnecessary.  Also, further oral studies 
are unlikely to provide new information.  The effects of some organotins (i.e., trimethyltin, triethyltin, 
tributyltin, dibutyltin) are well characterized.  Still, the information available for trimethyltin and 
triethyltin was inadequate for MRL derivation, largely because of the steepness of the dose-response 
curve for these compounds.  The decision to conduct additional intermediate-duration studies designed to 
define NOAELs should rest on results of monitoring studies for these compounds in the environment and 
on the identification of populations potentially exposed to them. 
Chronic-Duration Exposure and Cancer.    Data on chronic exposure to inorganic tin were limited 
to cases of occupational exposures in which the main effects were respiratory effects (Cutter et al. 1949; 
Dundon and Hughes 1950; Pendergrass and Pryde 1948; Stewart and Lassiter 2001).  Inhalation is 
assumed to have been the main route of exposure in these cases.  Affected individuals showed a benign 
form of pneumoconiosis, or stannosis.  Information regarding health effects in animals following chronic-
duration exposure to inorganic tin is restricted to a 2-year oral bioassay in rats and mice (NTP 1982), a 
42-month oral study in rats (Schroeder et al. 1968), and an 18-month oral study in mice (Schroeder and 
Balassa 1967), all with stannous chloride.  While there were no compound-related nonneoplastic effects 
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well as decreased longevity in rats exposed to doses approximately 100 times lower than those tested by
NTP (1982). There is no apparent explanation for this discrepancy except that the NTP (1982) study was 
a dietary study, while Schroeder et al. (1968) administered the compound in the drinking water.  Studies 
comparing the bioavailability of tin in solid food vs. water may provide useful information.  No chronic 
oral MRL was derived for inorganic tin because the lowest dose from Schroeder et al. (1968) was a 
serious LOAEL. The need to conduct inhalation and dermal chronic-duration studies with inorganic tin is 
less clear since the main route of exposure for humans to inorganic tin is the oral route.  No data were 
located regarding health effects in humans following chronic exposure to organotin compounds.  Long-
term bioassays have been conducted for dibutyltin diacetate in rats and mice (NCI 1978a), triphenyltin 
hydroxide in rats and mice (NCI 1978b; Tennekes et al. 1989a, 1989b), and tributyltin oxide in rats 
(Wester et al. 1990). In addition, an 18-month study of the immunotoxicity of tributyltin oxide in rats is 
available and was used as basis for deriving a chronic-duration oral MRL for tributyltin oxide (Vos et al. 
1990). No chronic oral MRL was derived for dibutyltin because a relative low dose in the NCI (1978a) 
study caused significant early mortality in rats.  For the same reason, no chronic oral MRL was derived 
for triphenyltin (Tennekes et al. 1989b).  Research to produce chronic oral data for other organotins that 
may be present in hazardous waste sites and represent a potential source of exposure for those living in 
the vicinity may be warranted.  However, a comprehensive evaluation of 90-day studies should be 
conducted first.  Environmental monitoring information suggests that the inhalation and dermal routes of 
exposure to organotins are much less relevant to humans than the oral route and, therefore, may be given 
lower priority.  
There is no information regarding cancer in humans exposed to inorganic tin or organic tin compounds.  
An oral bioassay for stannous chloride in rats and mice provided no evidence of carcinogenicity at the 
levels tested (NTP 1982). Similar negative results were found for dibutyltin diacetate in rats and mice, 
although technical problems did not allow for a complete evaluation of uterine tumors in female rats (NCI 
1978a). A bioassay for triphenyltin hydroxide in rats and mice also gave negative results (NCI 1978b), 
but studies with higher doses did find triphenyltin hydroxide to induce pituitary and testicular tumors in 
rats (Tennekes et al. 1989b) and hepatocellular carcinomas in mice (Tennekes et al. 1989a).  A bioassay
with tributyltin oxide in rats yielded questionable results (Wester et al. 1990), which led the EPA (IRIS 
2005) to assign this chemical to a group for which “there is inadequate information to assess carcinogenic 
potential.” Since the observed tumors were considered to have high incidence in the strain of rat used 
(Wistar), it may be necessary to repeat the study in a different strian of rat.  An oral bioassay seems more
relevant than inhalation or dermal studies since these two routes of exposure are less relevant for humans.  
Further studies concerning the fates of the organic and tin moieties from these compounds and the 
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contribution of each moiety to mechanisms of carcinogenicity are needed in order to evaluate the role of 
tin in the tumorigenic response. 
Genotoxicity.    There are no human data regarding the genotoxic potential of inorganic tin or organotin
compounds after inhalation, oral, or dermal exposures.  The limited in vitro data for inorganic tin consist 
mostly of studies with stannous chloride and stannic chloride.  The results in prokaryotic organisms have 
been mostly negative (Hamasaki et al. 1993; Nishioka 1975), but the opposite has been observed in tests 
conducted with mammalian cells (Dantas et al. 2002; Ganguly et al. 1992; Gulati et al. 1989).  Further 
studies are unlikely to add new key information.  Tests of many organotin compounds in S. typhimurium 
gave predominantly negative results (Hamasaki et al. 1993) and tests conducted in mammalian cells in 
vitro also gave predominantly negative results (Chao et al. 1999; Davis et al. 1987; Oshiro et al. 1991; 
Sasaki et al. 1993). Studies of organotin compounds in vivo, mostly in mice, have given mixed results 
(Chao et al. 1999; Davis et al. 1987; Ganguly 1994; Yamada and Sasaki 1993).  Further genotoxicity
studies with organotin compounds do not seem warranted at this time. 
Reproductive Toxicity. No studies were located regarding reproductive effects of inorganic tin in 
humans following inhalation, oral, or dermal exposure or in animals following inhalation or dermal 
exposure. The only information available regarding oral exposure of animals to inorganic tin is that from
Theuer et al. (1971), FDA (1972), and De Groot et al. (1973).  FDA (1972) reported no reproductive 
effects (number of corpora lutea and of implantation and resorption sites) in rats, mice, and hamsters 
administered up to 0.31 mg tin/kg/day (as stannous chloride) during gestation (Gds 6–15 for rats and 
mice, Gds 6–10 for hamsters) (FDA 1972).  Theuer et al. (1971) reported that administration of tin, as tin 
fluoride or sodium pentachlorostannite, to rats in the diet during gestation had no significant effect on the 
number of resorptions or placental weight.  De Groot et al. (1973) observed moderate testicular 
degeneration in rats dosed for 9 weeks with approximately 315 mg tin/kg/day. Most rats in this group 
were moribund and had to be sacrificed; therefore, the biological significance of the testicular finding is 
unclear. The limited data available suggest that the reproductive system is not a target for inorganic tin 
toxicity at the levels commonly found in the environment.  No data were available regarding reproductive 
effects in humans following exposure to organotin compounds by any route or in animals after dermal 
exposure. Reduced fertility was reported in female rats following inhalation exposure to a mixture of 
tributyltin bromide and dibutyltin dibromide for periods ranging from a few weeks to a few months 
(Iwamoto 1960).  Numerous studies in rodents have examined the effects of organotins (mostly 
dibutyltin, tributyltin, and triphenyltin) on reproductive parameters such as pregnancy rates, pre- and 
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Harazono 2000; Ema et al. 1991b, 1992, 1999c; Faqi et al. 1997; Harazono et al. 1998; Noda et al. 1991a, 
1992b) and found that the highest incidence of resorptions and postimplantation losses occurred when the 
chemicals were administered on Gds 7–9 (Ema et al. 1992, 1997a, 1999a).  Most long-term studies have 
not reported histopathological alterations in reproductive organs from rats or mice (NCI 1978a, 1978b; 
Wester et al. 1990) with the exception of Tennekes et al. (1989b), who reported an increase in Leydig cell 
hyperplasia and tubular atrophy of the testes in rats treated with triphenyltin.  The mechanism by which 
some organotins affect reproduction is not known, but there is evidence that suppression of uterine 
decidualization may be a cause of preimplantation losses (Ema and Miyawaki 2002; Ema et al. 1999b; 
Harazono and Ema 2003). It would be helpful to elucidate whether effects such as pre- and 
postimplantation loss occur secondary to maternal toxicity or can happen independent of maternal 
toxicity.  Since direct effects on reproductive organs do not seem to have an important role (except for the 
findings of Tennekes et al. 1989b), further research should focus on the effects of organotins on the 
endocrine control of reproductive functions in adult animals and on the hormonally-controlled 
development of reproductive organs in animals exposed in utero and early in life.  Numerous studies in 
vitro have shown that organotins can affect the activities of enzymes involved in the synthesis of steroid 
hormones, with potentially widespread consequences (i.e., Cooke 2002; Doering et al. 2002; Heidrich et 
al. 2001; McVey and Cooke 2003).  Additional tests to evaluate the potential endocrine disrupting ability
of organotins in mammals should be conducted.  Pilot studies in primates would be valuable to reduce the 
uncertainty of extrapolating observations in animals to human health. 
Developmental Toxicity. No studies were located regarding developmental effects of inorganic tin 
in humans following inhalation, oral, or dermal exposure, or in animals following inhalation or dermal 
exposure. Limited oral data on inorganic tin showed that treatment of rats, mice, and hamsters with up to 
31 mg tin/kg/day by gavage in water during gestation (Gds 6–15 for mice and rats, Gds 6–10 for 
hamsters) has no significant effect on fetal weight, the number of live of dead fetuses, or the incidence of 
external and internal malformations (FDA 1972).  Also, tin, in the form of tin fluoride or sodium
pentachlorostannite, administered to rats during pregnancy had no significant effect on average fetal 
weight or the number of live fetuses per litter (Theuer et al. 1971).  This study also showed that tin from
inorganic compounds can cross the placenta and reach the fetus.  There are no studies of developmental 
effects in humans following inhalation, oral, or dermal exposure to organotins. Several studies in 
animals, mostly rats and mice, have shown that oral exposure to some organotin compounds (mostly
tributyltin, dibutyltin, and triphenyltin) during pregnancy induces external and skeletal malformations, the 
most common of which were cleft jaw and ankyloglossia (Ema and Harazono 2000; Ema et al. 1991b, 
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incidence of malformations occurred when the chemicals were administered on Gds 7–9 (Ema et al. 
1992). Limited data in rats indicate that dibutyltin can cross the placenta and reach the embryo 
(Nakamura et al. 1993; Noda et al. 1994).  A study in rats that included maternal exposure to tributyltin 
chloride during lactation showed that little, if any, tributyltin or dibutyltin is transferred to the suckling 
pups via the maternal milk (Cooke et al. 2004).  A companion paper reported subtle alterations in 
immunological parameters in pups from rats that were exposed during pregnancy during lactation, and 
then the pups were exposed directly until 90 days of age (Tryphonas et al. 2004).  As with reproductive 
effects, the role of maternal toxicity in the manifestation of adverse developmental effects is not totally
clear. The mechanism responsible for the teratogenic activity of organotins is not known and studies 
should continue to investigate the events at the molecular level that may be affected.  The use of in vitro 
systems (i.e., cultured rat embryos) may be preferable to studies in the whole animal, as the experimental 
conditions in the former are easier to manipulate than in the latter.  Two studies in rats exposed to 
tributyltin chloride suggested that perinatal exposure can affect some developmental landmarks (Ogata et 
al. 2001; Omura et al. 2001). Whether this is a result of endocrine disrupting ability of these compounds 
or from other mechanisms is important to know.  Triethyltins and trimethyltins are neurotoxic to humans 
and animals and have been extensively used as tools to investigate the relationship between localized 
lesions within the central nervous system and behavioral alterations.  Continued research in this area is 
important to determine susceptible developmental periods during which alterations of neuronal structures 
will cause long-lasting effects or accelerate specific aspects of the normal aging processes.  
Immunotoxicity.    There currently is no information available in humans or animals suggesting that 
the immune system is a major target of inorganic tin toxicity, or that the immune system is a target of 
organic tin toxicity in humans.  However, there is considerable information on the immunotoxic effects of 
some organotins administered to animals orally or by injection, and from in vitro tests systems.  Studies 
have compared various organotins for several animal species (Seinen et al. 1977a, 1977b; Snoeij et al. 
1985).  The immunotoxic effect is characterized by reduced thymus weight and size and lymphocyte 
depletion (Krajnc et al. 1984; Seinen and Willems 1976; Seinen et al. 1977a, 1977b; Smialowicz et al. 
1989, 1990; Snoeij et al. 1985).  While dialkyltins appear to interfere directly with the proliferation of 
lymphocytes, tributyltin oxide has a direct action on lymphocytes in the thymus (Boyer 1989).  The 
results of a study that reported alterations in the humoral immune response in rats exposed orally to 
dibutyltin dichloride were used as basis for derivation of an intermediate-duration oral MRL for dibutyltin 
dichloride (Seinen et al. 1977b).  Long-term studies with tributyltin oxide in rats showed alterations in 
parameters of specific and nonspecific resistance (Vos et al. 1990).  The results from this study were used 
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reasonable to assume that similar effects would occur in animals exposed to sufficiently high amounts of 
organotins by the inhalation and dermal routes.  Future research should continue to focus on determining 
the basis for interspecies differences including pharmacokinetic differences, and differences at the cellular 
and molecular levels.  It would be valuable to determine whether primates exhibit responses similar to 
rodents and if so, whether subtle alterations in immune parameters alter resistance to challenges with 
pathogens. A recent study evaluated immunocompetence in rats exposed during gestation and as 
juveniles and found subtle alterations of unknown toxicological significance (Tryphonas et al. 2004).  
Replication of these findings would be valuable. 
Neurotoxicity.    There are no studies in humans regarding neurotoxic effects after inhalation, oral, or 
dermal exposure to inorganic tin compounds.  Limited animal data suggest that oral exposures to high 
concentrations of inorganic tins may induce effects on the central nervous system (WHO 1980), but the 
nervous system is not a sensitive target for inorganic tin toxicity. 
Neurotoxic effects have been reported in humans after inhalation (Feldman et al. 1993; Rey et al. 1984;
Ross et al. 1981; Saary and House 2002; Yanofsky et al. 1991), oral (Foncin and Gruner 1979; Kreyberg 
et al. 1992; Lin et al. 1998; Wu et al. 1990), and dermal (Colosio et al. 1991) exposure to organotins and 
in animals after oral exposure (i.e., Bouldin et al. 1981; Brown et al. 1984; Eto et al. 1971; Graham and 
Gonatas 1973; Magee et al. 1957; Snoeij et al. 1985; Squibb et al. 1980) to these compounds.  Among the 
organotins, trimethyltin and triethyltin have been the most widely studied in acute- and intermediate-
duration oral studies.  These organotins are highly toxic and their effects are well characterized and are 
expected to occur across routes of exposure.  Trimethyltin induces neuronal necrosis, particularly in the 
hippocampal region, whereas triethyltin produces intramyelinic edema (Chang 1990).  Case studies of 
humans acutely exposed (accidentally or intentionally) to high amounts of trimethyltin or triethyltin and 
studies in animals reported morphological changes in the central nervous system as well as behavioral 
changes that may persist for a long time after the poisoning episode.  One typical manifestation of 
trimethyltin intoxication in both humans and animals is aggressive behavior.  Both trimethyltin and 
triethyltin have become important research tools for the study of brain function, in particular, to examine 
the association between damage to specific brain structures, such as the hippocampus or brain cell groups 
and behavioral alterations.  Additional studies using nerve cells in vitro can provide more information on 
possible mechanisms of action of these organotins at the cellular and molecular levels.  Also, studies on 
the effects of tin compounds on glial function, both during neurodevelopment and adulthood, would be 
useful. Studies of the potential effects of long-term exposure to low levels of trimethyltin or triethyltin, as 
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Epidemiological and Human Dosimetry Studies.    The general population is exposed to 
inorganic tin compounds through consumption of contaminated food, in industrial settings, and 
potentially at hazardous waste sites through contact with contaminated air, water, and soil.  Organotin 
compounds are also used in agricultural and other uses with potential exposure of people by different 
routes, although the main route of exposure is also the oral route.  Only limited case reports of human 
exposure and no retrospective or prospective epidemiological studies are available.  Occupational studies 
of inorganic tin exposure provide information mostly on respiratory effects in workers exposed 
chronically (Cutter et al. 1949; Dundon and Hughes 1950).  In contrast, the neurotoxic effects of some
organotins are well documented in workers and members of the general population exposed by all routes 
(Colosio et al. 1991; Feldman et al. 1993; Kreyberg et al. 1992; Lin et al. 1998; Rey et al. 1984; Ross et 
al. 1981; WHO 1980; Wu et al. 1990; Yanofsky et al. 1991).  These cases have generally involved 
accidental or intentional exposure to high amounts of organotins. Should populations with past or 
ongoing exposure to organotins be identified, emphasis should be placed on the evaluation of organs and 
systems that have appeared to be particularly sensitive in animal studies.  For example, evaluation of 
immunocompetence should have high priority in people exposed to tributyltin, dibutyltin, or dioctyltin, 
whereas neurobehavioral tests should be conducted in those known to have been exposed or are exposed 
to trimethyltin or triethyltin. 
Biomarkers of Exposure and Effect.    
Exposure. The development of models that would support quantitative estimates of exposure to tin and 
tin compounds based on blood or urine levels of tin, or a specific organotin or metabolite, would be 
valuable. 
Effect.  There are no biomarkers of effect specific for tin or tin compounds.  Research to identify reliable 
biomarkers for exposure to tin and tin compounds in humans would be useful in order to evaluate the 
prevalence and magnitude of exposure in an at-risk population. 
Absorption, Distribution, Metabolism, and Excretion.    The toxicokinetics of tin compounds 
have not been adequately characterized to support the development of predictive PBPK models in humans 
(see Section 3.4). Existing models are based entirely on observations in animals (ICRP 2001).  No 
quantitative estimates of absorption of inhaled inorganic or organotin compounds are available, for either 
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gastrointestinal absorption in humans that suggest considerable interindividual variability and, possibly,
dose dependence (Calloway and McMullen 1966; Johnson and Greger 1982).  Estimates of gastro­
intestinal absorption of organotin compounds in humans are not available.  Studies in animals suggest that 
redox state (i.e., Sn[II] vs. Sn[IV]) (Hiles 1974) and number of alkyl moieties affect gastrointestinal 
absorption of tin compounds (Bridges et al. 1967; Kimmel et al. 1977; Mushak et al. 1982; Ohhira and 
Matsui 1993a; Ueno et al. 1994) thus, studies in humans that address these potential variables would be 
particularly useful.  Information on the distribution of absorbed tin compounds in humans derives from
analyses of human cadaver tissues (Kehoe et al. 1940; Schroeder et al. 1964).  These studies, together 
with studies conducted in animals, suggest that the major sites of deposition of tin in humans appear to be 
similar to those in animals exposed to inorganic tin compounds; however, they provide no information on 
the distribution of specific inorganic or organotin compounds in humans.  Quantitative estimates of the 
elimination rates of absorbed tin in humans are not available.  Studies in animals indicate that elimination 
rates vary with chemical form and across species, for given tin compounds (Bridges et al. 1967; Brown 
1984; Furchner and Drake 1976; Kimmel et al. 1977; Ueno et al. 1994). 
Available information on the toxicokinetics in animals, while providing abundant information on the 
distribution and elimination kinetics of tin, do not provide adequate information for extrapolation of doses 
from one route of exposure to another (e.g., oral-to-dermal, oral-to-inhalation), for which health effects 
studies are lacking. The major information deficit, in this regard, is insufficient characterization of the 
extents and rates of absorption of tin from major potential routes of exposure (i.e., no information is 
available for the inhalation and dermal routes) and insufficient characterization of the effects of dose on 
gastrointestinal absorption. 
Comparative Toxicokinetics.    As noted in Section 3.5.2, information on the toxicokinetics of tin 
compounds in humans is sufficiently limited to preclude comparisons with other species (see Section 3.4). 
Studies in animals are also insufficient for comparisons of the absorption of tin compounds across 
species, from inhalation, oral, or dermal routes (see Section 3.4.1).  Several studies have compared rates 
of elimination of tin, administered in various inorganic forms or as organotin compounds, in various 
animal species (Furchner and Drake 1976; Hiles 1974; NTP 1982).  These studies demonstrate species 
differences in elimination kinetics that may be germane to extrapolations to humans.  For example, the 
elimination kinetics of absorbed inorganic tin occurs more slowly in Rhesus monkeys than in rodents; this 
difference appears to be the result of a larger fraction of the tin body burden associated with the slowest 
kinetic compartment (presumably bone) in monkeys (Furchner and Drake 1976).  Organotin compounds, 
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other species, including nonhuman primates (Brown 1984; Rose 1969; Rose and Aldridge 1968).  Species 
differences to the hepatotoxic effects of some organotins have been described.  Comparative studies with 
tributyltin and dibutyltin in rats, mice and guinea pigs showed the susceptibilities for liver toxicity
followed the order: mice ! rats ! guinea pigs (Ueno et al. 2003b). Kinetic studies showed that the 
differences in susceptibility appeared to be partly due to differences in metabolism of tributyltin and in 
the distribution of dibutyltin within cell organelles.  These observations suggest that a more complete 
characterization of inter-species variability in the toxicokinetics of tin would be useful for extrapolating 
doses across species, in particular, from rats to other species, including humans. 
Information is available to support the development of models of toxicokinetics of various tin compounds 
in rodents and nonhuman primates (e.g., Rhesus monkey, marmoset); however, the current lack of 
observations on the toxicokinetics of tin compounds in humans makes evaluation of such models for 
applications to predicting the toxicokinetics of tin in humans highly uncertain.  Useful types of 
observations in humans to support toxicokinetic model development would include:  (1) quantifying 
extent and rates of absorption of tin compounds in humans from the inhalation, oral, and dermal 
pathways; (2) quantifying the relative contribution of various excretory routes to elimination of tin 
compounds in humans, including bile, urine, feces, and milk; (3) time course for the concentrations of tin 
in blood and blood plasma (or other tissues) following a single dose or during repeated exposures; 
(4) observing of blood:tissue and/or plasma:tissue concentration ratios for tin; and (5) identifying 
pathways and rates of metabolism of tin compounds. 
Methods for Reducing Toxic Effects.    Recommended methods for the mitigation of effects of 
acute exposure to tin compounds include standard treatments and measures to support vital functions 
(HSDB 2003). No information was located concerning mitigation of effects of lower-level or longer-term
exposure to tin.  This, in part, may reflect the fact that no population has been identified as having been 
subjected or currently undergoing exposure to excessive amounts of tin and compounds.  Attempts to 
propose studies of specific methods to reduce possible adverse effects do not appear warranted at this 
time. 
Children’s Susceptibility.    Data needs relating to both prenatal and childhood exposures, and 
developmental effects expressed either prenatally or during childhood, are discussed in detail in the 
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There are no studies that specifically addressed exposure to inorganic tin in children.  Workers exposed to 
tin in the air experienced respiratory effects (Cutter et al. 1949; Dundon and Hughes 1950; Pendergrass 
and Pryde 1948) and ingestion of excessive inorganic tin caused gastrointestinal effects (WHO 1980, 
2003). It is reasonable to assume that children exposed in similar manners will experience similar effects.  
Dermal contact with some organotins such as tributyltin can cause skin irritation and exposure by any
route to trimethyltin or triethyltin can cause serious neurological effects.  There is no reason to believe 
that children exposed to these chemicals would exhibit a different response.  There is no information on 
whether the developmental process is altered in humans exposed to tin and compounds.  Limited evidence 
with tributyltin chloride in rats suggests that this substance may alter developmental events controlled by
hormones (Ogata et al. 2001; Omura et al. 2001), but further studies are necessary on this issue.  The 
possibility that organotin compounds may have endocrine-disrupting ability in mammals has not been 
systematically studied. 
There are no data to evaluate whether pharmacokinetics of tin and tin compounds in children are different 
from adults.  There is limited information indicating that inorganic tin can cross the placenta (Theuer et 
al. 1971), and also that dibutyltin can do so and reach the fetus (Nakamura et al. 1993; Noda et al. 1994).  
Administration of dibutyltin and other organotins, such as tributyltin and triphenyltin, to pregnant rodents 
has caused malformations in the fetuses (Ema et al. 1991a, 1991b, 1992, 1995b, 1997b; Faqi et al. 1997;
Farr et al. 2001; Harazono et al. 1998; Noda et al. 1991a, 1991b), indirectly suggesting that organotins (or 
metabolites) other than dibutyltin also can cross the placenta.  There are no studies on whether tin 
compounds can be transferred from mother to offspring through maternal milk.  Cross-fostering studies 
can provide important information regarding the role of in utero vs. lactation exposure to tin compounds 
in normal development.  There is evidence that acute perinatal exposure to some organotins results in 
altered behavioral responses in rodents tested as adults (i.e., Barone et al. 1995; Reiter et al. 1981; 
Ruppert et al. 1983). Research efforts should continue to focus on the possible underlying mechanisms
that are responsible for such long-lasting postexposure toxicities.  There are no data to permit an 
evaluation of whether metabolism of tin and compounds is different in children than in adults. 
Research into the development of sensitive and specific biomarkers of exposures and effects for tin 
compounds would be valuable for both adults and children.  There are no data on the interactions of tin 
with other chemicals in children; however, studies in humans and in animals have shown that dietary tin 
can influence the metabolism of zinc (Greger and Johnson 1981; Johnson and Greger 1982; Rader et al. 
1990), which is essential for normal growth.  There are no pediatric-specific methods to reduce peak 
absorption for tin and compounds, to reduce body burdens, or to interfere with the mechanisms of action.  
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Based on the information available, it is reasonable to assume that the supportive methods recommended 
for maintaining vital functions in adults will also be applicable to children. 
Child health data needs relating to exposure are discussed in Section 6.8.1, Identification of Data Needs:  
Exposures of Children. 
3.12.3 Ongoing Studies 
The following ongoing studies concerning health effects associated with tin and tin compounds were 
identified in the Federal Research in Progress database (FEDRIP 2004). 
Dr. W.D. Atchison, from Michigan State University, East Lansing, Michigan, plans to examine the 
process by which environmental chemicals, such as some organotins, can destroy distinct populations of 
neurons in the brain, especially during development.  Specifically, Dr. Atchison will study the effect of 
trimethyltin on the generation of mechanical tension in developing hippocampal pyramidal neurons in 
primary culture, or transformed neuronal cells.  This research is sponsored by the National Institute of 
Environmental Health Sciences. 
Dr. M.L. Billingsley, from Penn State University, Hershey, Pennsylvania, plans to use molecular biologic 
approaches to address specific mechanisms that may explain the selective actions of organotin toxicants.  
The first aim will be to investigate the normal function of stannin (a protein isolated from organotin­
sensitive tissues) and to use targeted gene disruptions to determine the consequences of loss of stannin on 
the elaboration of organotin toxicity.  The second aim will use in vivo antisense disruption of stannin 
expression to determine whether this protein is needed for the elaboration of organotin toxicity.  This 
research is sponsored by the National Institute of Environmental Health Sciences. 
Dr. A.Z. Mason, from California State University, Long Beach, California, proposes to determine the sub­
lethal model of toxicity of tributyltin (TBT) and assess whether it and other toxicological analogues could 
constitute an environmental hazard to humans.  A series of in vivo and in vitro experiments using the 
TBT-sensitive mollusk, Nucella emarginata, and human prostate cancer and hepatoma cell lines have 
been designed to specifically test each of the identified mechanisms of action and determine if TBT acts 
via perturbing aromatase activity, androgen conjugation, and elimination or by potentiation gonadotropin 
neuropeptide release.  This research is sponsored by the National Institute of General Medical Sciences. 
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Dr. K.R. Pennypacker, from the University of South Florida, Tampa, Florida, proposes that brain injury
leads to activation of NF-kB (nuclear factor kB) in neurons surviving injury and that this activation 
induces the transcription of growth factors that have a decisive role in promoting cell survival.  NF-kB 
expression and activity in the rat hippocampus in response to injury caused by excitotoxicity (kainite), 
ischemia (middlecerebral arterial occlusion), and neurotoxicity (trimethyltin) will be examined to 
determine whether activation of NF-kB is a common event in injury to the brain.  This research is 
sponsored by the National Institute of Neurological Disorders and Stroke. 
Dr. C.R. Rice, of Mississippi State University, Mississippi State, Mississippi, plans to evaluate the 
immunotoxicity of mixtures of halogenated hydrocarbons (a co-planar PCB) and organotin (TBT) using 
channel catfish and mice as comparative vertebrate models, using the guidelines of the National 
Toxicology Program.  Early studies will be devoted to establishing dose-dependent indices of toxicity that 
will be used to monitor the relative immunotoxicity of a co-planar PCB and TBT.  Subsequent research 
will be devoted to evaluating the effects of the co-planar PCB and TBT, alone and in combination, on 
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4.1 CHEMICAL IDENTITY 
Tin is a naturally occurring element that appears in group 14 (4A) of the periodic table at the boundary
between the metals and nonmetals. Tin can form various compounds, both inorganic and organic.  
Inorganic tin compounds do not contain a tin-carbon bond, whereas organotin compounds contain at least 
one tin-carbon bond (Kroschwitz and Howe-Grant 1997; Lide 2000).  The divalent and tetravalent 
oxidation states can be designated using the names stannous and stannic, respectively, in the name of the 
compound. Another commonly encountered nomenclature system, the Stock Oxidation-Number system, 
denotes the oxidation state in Roman numerals in parentheses following the metal’s name:  tin(II) and 
tin(IV) (Smith 1996).  Table 4-1 lists common synonyms and other pertinent identification information 
for tin and representative inorganic and organic tin compounds. 
4.2 PHYSICAL AND CHEMICAL PROPERTIES 
Tin is a silver-white metal that is malleable and somewhat ductile.  It has a highly crystalline structure 
and exists in two allotropic forms at normal pressures.  Gray or Į tin exists below 13.2 °C and has a cubic 
structure. At 13.2 °C, gray tin is converted to white or ȕ tin, which has a tetragonal structure.  In 
compounds, tin can exist in the +2 or +4 oxidation state.  Industrially important organotin compounds 
include the dimethyltin, dibutyltin, tributyltin, dioctyltin, triphenyltin, and tricyclohexyltin families.  
Organotin compounds that are industrially important contain tin in the +4 oxidation state (Kroschwitz and 
Howe-Grant 1997; Lide 2000).  Table 4-2 lists important physical and chemical properties of tin and 
representative inorganic and organic tin compounds. 
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Table 4-1. Chemical Identity of Tin and Tin Compoundsa 
Characteristic Tin Tin(II) chloride Tin(IV) oxide 
Synonyms Metallic tin; silver matt Stannous chloride; tin Stannic oxide; tin oxide; 
powder; tin flake dichloride; tin protochloride stannic anhydride 
Trade name No data No data No data 
Chemical formula Sn SnCl2 SnO2 
Chemical structure Sn SnCl2 SnO2 
Identification numbers: 
CAS registry 7440-31-5 7772-99-8 18282-10-5 
NIOSH RTECS XP7320000b XP8700000b XQ4000000b 
EPA hazardous No data No data No data 
waste 
DOT/UN/NA/ IMCO No data No data No data 
shipping 
HSDB 5035 582 5064 
NCI No data C02722 No data 
EINECS 231-141-8 231-868-0 242-159-0 
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Table 4-1. Chemical Identity of Tin and Tin Compoundsa 
Monomethyltin 
Characteristic Tin(II) fluoroborate Tin(II) fluoride trichloride 
Synonyms	 Tetraflurorborate(1-), Stannous fluoride; easygel; Trichloromethyl 
tin(2+) (2:1); tin fluoristan; Gel-Kam; Gel- stannane; methyltin 
bis(tetrafluoroborate) Tin trichloride 
Trade name No data No data No data 
Chemical formula SnB2F8 SnF2 CH3Cl3Sn 
Chemical structure	 Sn(BF4)2 SnF2 Cl 
H3C Sn Cl 
Cl 
Identification numbers: 
CAS registry 13814-97-6 7783-47-3 993-16-8 
NIOSH RTECS No data XQ3450000b WH8585500b 
EPA hazardous No data No data No data 
waste 




HSDB No data 783 No data 

NCI No data No data No data 

EINECS 237-487-6 231-999-3 213-608-8
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Table 4-1. Chemical Identity of Tin and Tin Compoundsa 
Characteristic Dimethyltin dichloride Trimethyltin chloride 
Monobutyltin 
trichloride 








Trade name No data No data No data 
Chemical formula C2H6Cl2Sn C3H9ClSn C4H9Cl3Sn 
Chemical structure Cl CH3 Cl 




CAS registry 753-73-1 1066-45-1 1118-46-3 
NIOSH RTECS WH7245000b WH6850000b WH678000b 
EPA hazardous No data No data No data 
waste 
DOT/UN/NA/ IMCO No data No data No data 
shipping 
HSDB No data 6413 6073 
NCI No data No data No data 
EINECS 212-039-2 213-917-8 214-263-6 
231 TIN AND TIN COMPOUNDS 
4. CHEMICAL AND PHYSICAL INFORMATION 
Table 4-1. Chemical Identity of Tin and Tin Compoundsa 
Characteristic Dibutyltin dichloride Tributyltin chloride Monobutyltin hydride 
Synonyms Dibutyltin chloride; Chlorotributylstannane; tri­ n-Butyltin; 
dichlorodibutyltin; n-butyltin chloride butylstannane; butyltin 
dichlorodibutylstannane trihydride 
Trade name No data No data No data 
Chemical formula C8H18Cl2Sn C12H27ClSn C4H12Sn 
Identification numbers: 
CAS registry 683-18-1 1461-22-9 2406-65-7 
NIOSH RTECS WH7100000b WH6820000b No data 
EPA hazardous No data No data No data 
waste 
DOT/UN/NA/ IMCO No data No data No data 
shipping 
HSDB 6071 No data No data 
NCI No data No data No data 
EINECS 211-670-0 215-958-7 No data 
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Table 4-1. Chemical Identity of Tin and Tin Compoundsa 
Characteristic Monobutyltin ion Dibutyltin hydride Tributyltin hydride 
Synonyms No data	 Di-n-butyltin; Tributylstannane; 
dibutylstannane; dibutyltin tributyltin; Tributylstannic 
dihydride hydride 
Trade name No data No data No data 
Chemical formula C4H8Sn C8H20Sn C12H28Sn 





CAS registry 78763-54-9 1002-53-5 688-73-3 
NIOSH RTECS No data WH6883600b WH8675000b 
EPA hazardous No data No data No data 
waste 




HSDB No data No data 6362
 
NCI No data No data No data 

EINECS No data No data 211-704-4
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Table 4-1. Chemical Identity of Tin and Tin Compoundsa 





Lastanox Q; Biomet TBTO; 
oxybis(tributyltin) 
Bromotriethyl-stannane 
TBTOc No data 
Chemical formula C16H36Sn C24H54OSn2 C6H15BrSn 
Chemical structure 
Sn 
Sn O Sn 
Sn Br 
Identification numbers: 
CAS registry 1461-25-2 56-35-9 2767-54-6 
NIOSH RTECS WH8605000b JN8750000b WH6740000b 
EPA hazardous No data No data No data 
waste 
DOT/UN/NA/IMCO No data No data No data 
shipping 
HSDB 6074 6505 No data 
NCI No data No data No data 
EINECS 215-960-8 200-268-0 220-443-5 
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Table 4-1. Chemical Identity of Tin and Tin Compoundsa 
Characteristic Triphenyltin Triphenyltin hydroxide Triphenyltin chloride 






stannane; Aquatin; fentin 
chloride 
Trade name No data No data No data 




Sn OH Sn Cl 
Identification numbers: 
CAS registry 668-34-8 76-87-9 639-58-7 
NIOSH RTECS No data WH8575000b WH6860000b 
EPA hazardous No data No data No data 
waste 
DOT/UN/NA/ IMCO No data No data No data 
shipping 
HSDB No data 1784 6404 
NCI No data C00260 No data 
EINECS No data 200-990-6 211-358-4 
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Table 4-1. Chemical Identity of Tin and Tin Compoundsa 
Mono-n-octyltin 
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Table 4-1. Chemical Identity of Tin and Tin Compoundsa 






































aAll information obtained from HSDB 2003 and ChemID 2003, except where noted. 
bRTECS 2003 
cTomlin 1997 
CAS = Chemical Abstracts Service; DOT/UN/NA/IMCO = Department of Transportation/United Nations/North 
America/International Maritime Dangerous Goods Code; EINECS = European Inventory of Existing Chemical 
Substances; EPA = Environmental Protection Agency; HSDB = Hazardous Substances Data Bank; NCI = National 
Cancer Institute; NIOSH = National Institute for Occupational Safety and Health; RTECS = Registry of Toxic Effects 





237 TIN AND TIN COMPOUNDS 
4. CHEMICAL AND PHYSICAL INFORMATION 
Table 4-2. Physical and Chemical Properties of Tin and Tin Compoundsa 
Property Tin	 Tin(II) chloride Tin(IV) oxide Tin(II) fluoride 
Molecular weight 118.69 189.60 150.71 156.71 
Color Silver-white White White White 
Physical state Solid Solid Solid Solid 
Melting point 231.9 °C 246 °C 1,630 °C 213 °C 
Boiling point 2,507 °C 623 °C Sublimes 1,800– 850 °C 
1,900 °C 
Density (g/cm3) 7.265 (white tin) 3.90 6.95 4.57 at 25 °C 
5.769 (gray tin) 
Odor Odorless Odorless No data No data 
Odor threshold: 
Water  No data No data No data No data 
Air No data No data No data No data 
Solubility: 
Water Insoluble 90 g/100 g water at Insoluble 30–39% in water at 
20 °C 20 °C 
Other solvents Soluble in Very soluble in Insoluble in alcohol, Practically insoluble 
hydrochloric acid, hydrochloric acid; cold acids; slowly in ethanol, ether, 
sulfuric acid, aqua soluble in alcohol, soluble in hot and chloroform 
regia, alkali, slightly ethyl acetate, concentrated 
soluble in dilute glacial acetic acid, potassium or sodium 
nitric acid sodium hydroxide hydroxide solution 
solution 
Partition coefficients: 
Log octanol/water No data No data No data No data 
Log Koc No data No data No data No data 
Vapor pressure 	 8x10-3 mm Hg at 25 mm Hg at No data No data 
1,224 °C 427.9 °C 
Henry’s law constant No data No data No data No data 
Autoignition No data No data No data No data 
temperature 
Flashpoint No data No data No data No data 
Flammability limits No data No data No data No data 
Explosive limits No data No data No data No data 
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Table 4-2. Physical and Chemical Properties of Tin and Tin Compoundsa 
Monomethyltin Dimethyltin Trimethyltin Monobutyltin 
Property trichloride dichloride chloride trichloride 
Molecular weight 240.08b 219.67b 199.26 282.17 
Color Colorlessb Colorlessb Colorless Colorless 
Physical state Solidb Solidb Solid Liquid 
Melting point 43 °Cb 90 °C (107 °C)b 37.5 °C -63 °C
Boiling point 171 °Cb 185–190 °Cb 154–156 °C 102 °C at 12 mm Hg 
Density (g/cm3) No data No data No data 1.71 at 25 °C 
Odor No data No data No data No data 
Odor threshold: 
Water  No data No data No data No data 
Air No data No data No data No data 
Solubility: 




Miscible with water Sparingly soluble in 
water 
Other solvents Soluble in organic 
solventsb 
Soluble in organic 
solventsb 
Soluble in organic 
solvents 
Soluble in organic 
solvents 
Partition coefficients: 
Log octanol/water No data No data No data No data 
Log Koc No data No data No data No data 
Vapor pressure No data No data No data No data 
Henry’s law constant No data No data No data No data 
Autoignition No data No data No data No data 
temperature 
Flashpoint 105 °F (40 °C)c No data 207 °F (97 °C)c No data 
Flammability limits No data No data No data No data 
Explosive limits No data No data No data No data 
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Table 4-2. Physical and Chemical Properties of Tin and Tin Compoundsa 
Dibutyltin Bis(tributyltin)
 
Property dichloride oxide Tributyltin chloride Tributyltin hydride 

Molecular weight 303.85 596.11 325.49d 291.09 
Color White Slightly yellow Colorlessd No data 
Physical state Solid Liquid Liquidd Liquid 
Melting point 43 °C <-45 °Ce No data No data 
Boiling point 135 °C at 10mmHg 180°C at 2 mm Hg 145–147 °C at 5 mm 
Hge 
112.5-113.5 °C at 8 
mm Hg 
Density (g/cm3) 1.36 at 24 °C 1.17 at 25 °C 1.20e 1.103 at 20 °C 
Odor No data Weak odor No data No data 
Odor threshold: 
Water  No data No data No data No data 
Air No data No data No data No data 
Solubility: 
Water Insoluble in cold 
water 
4 mg/L at pH 7, 
20 °C 
Insoluble in cold 
waterd 
No data 
Other solvents Soluble in ether Miscible with Soluble in No data 




Log octanol/water 0.97 No data No data No data 
Log Koc No data No data No data No data 
Vapor pressure 2 mm Hg at 100 °C 7.5x10-6 mm Hg at 
20 °Cf 
No data No data 
Henry’s law constant No data No data No data No data 
Autoignition No data No data No data No data 
temperature 
Flashpoint 335 °F (168 °C) >212 °F (100 °C) >230 °F (110 °C)c 104 °F (40 °C)c 
Flammability limits No data No data No data No data 
Explosive limits No data No data No data No data 
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Table 4-2. Physical and Chemical Properties of Tin and Tin Compoundsa 
Triethyltin Triphenyltin Triphenyltin 
Property Tetrabutyltin bromide hydroxide chloride 
Molecular weight 347.16 285.79b 367.03 385.48 
Color Colorless or slightly Colorlessb White White 
yellow 
Physical state Oily liquid Liquidb Solid Solid 
Melting point -97 °C -13.5 °Cb 119 °C 103.5 °C 
Boiling point 145 °C at 10 mm 223–224 °Cb No data 240 °C at 
Hg 13.5 mmHg 
Density (g/cm3) 1.054 at 20 °C 1.630 g/mLb 1.54 at 20 °C No data 
Odor Distinct, No data Odorless No data 
characteristic 
Odor threshold: 
Water  No data No data No data No data 
Air No data No data No data No data 
Solubility: 
Water Insoluble in water Very slightly 1.2 mg/L at 20 °C 40 mg/L at 20 °C 
soluble in cold 
waterb 
Other solvents Soluble in organic 
solvents 
Soluble in organic 
solventsb 
Slightly soluble in 
toluene, alcohol 
Moderately soluble 
in organic solvents 
Partition coefficients: 
Log octanol/water No data No data 3.53 4.19 
Log Koc No data No data No data No data 
Vapor pressure No data No data 3.53x10-7 mm Hg at No data 
25 °C 
Henry’s law constant No data No data No data No data 
Autoignition No data No data No data No data 
temperature 
Flashpoint 225 °F (107 °C)c 211 °F (99 °C)c 211 °F (99 °C)c No data 
Flammability limits No data No data No data No data 
Explosive limits No data No data No data No data 
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Table 4-2. Physical and Chemical Properties of Tin and Tin Compoundsa 
Property Tetraoctylstannane 
Molecular weight 571.59b 
Color No data 
Physical state No data 
Melting point No data 
Boiling point 268 °C at 10 mm Hgb 
Density (g/cm3) 0.9605b 
Odor No data 
Odor threshold: 
Water  No data 

Air No data 

Solubility: 
Water No data 
Other solvents No data 
Partition coefficients: 
Log octanol/water No data 
Log Koc No data 
Vapor pressure No data 
Henry’s law constant No data 
Autoignition No data 
temperature 
Flashpoint No data 
Flammability limits No data 
Explosive limits No data 















243 TIN AND TIN COMPOUNDS 
5. PRODUCTION, IMPORT/EXPORT, USE, AND DISPOSAL 
5.1 PRODUCTION 
No information is available in the TRI database on facilities that manufacture or process tin or tin 
compounds because these chemicals are not required to be reported under Section 313 of the Emergency
Planning and Community Right-to-Know Act (Title III of the Superfund Amendments and 
Reauthorization Act of 1986) (EPA 1997). 
The earth's crust contains about 2–3 ppm tin, comprising 0.0006% of the earth's crust (Budavari 2001; 
Bulten and Meinema 1991).  The most important tin containing mineral is cassiterite, SnO2. Other tin 
minerals are stannite, teallite, cylindrite, and canfieldite.  After tin-containing ores are mined, they
undergo further separation processing resulting in concentrates containing 70–77% tin by weight, which 
is almost pure cassiterite, and are ready for smelting (Gaver 1997). 
The world's largest producer of tin in 2003 was Indonesia (33% of the world total), followed by China 
(24%), Peru (19%), Bolivia (7%), Brazil (7%), and Australia (3%).  Of the 20 countries that mine tin, 
these six account for 93% of the world total of 2.09x105 metric tons.  Tin has not been mined in the 
United States since 1993. Production of tin stopped in 1989 at the only U.S. tin smelter at Texas City, 
Texas. However, the United States is believed to be the world's largest producer of secondary tin.  In 
2003, about 11,000 metric tons of tin from old and new scrap were recycled at 3 detinning plants and 
70 secondary nonferrous-metal processing plants.  The Defense Logistics Agency, which manages the 
National Defense Stockpile, sold 8,876 metric tons of pig tin from the stockpile in 2003.  The Steel 
Recycling Institute stated that the steel can (tin-plated) recycling rate in the United States in 2003 was 
60%. Tin is recovered, in addition to steel, in can recycling (Carlin 2003b, 2004).  Production of 
organotin compounds was 5,000 tons in 1955 and approximately 35,000 tons in 1985 (Fent 1996).  More 
recent production numbers for organotin compounds could not be located.  Thirty one organotin 
compounds (e.g., bis(tributyltin) oxide, triphenyltin hydroxide, dibutyltin dichloride) are included on the 
U.S. High Production Volume (HPV) chemicals lists for 1990 and 1994.  HPV chemicals are those that 
are manufactured in or imported into the United States in quantities one million pounds per year (EPA 
2004).  Current U.S. manufacturers of selected tin compounds are given in Table 5-1. 
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Table 5-1. Current U.S. Manufacturers of Selected Tin Compoundsa 
Company Location 
Inorganic tin compounds 
Tin(II) chloride 









Engelhard Corporation, Appearance and Performance - Technologies Elyria, Ohio 





Atotech USA Inc. Rock Hill, South Carolina 
General Chemical Corporation Claymont, Delaware 
OMG Fidelity, Inc. Newark, New Jersey 
Solvay Fluorides Inc. St. Louis, Missouri 
Methyltin compounds 
Dimethyltin dineodecanoate 
Gelest, Inc. Tullytown, Pennsylvania 
Tetramethyltin 
Clariant Life Science Molecules (America) Inc. Gainesville, Florida 
Gelest, Inc. Tullytown, Pennsylvania 
Butyltin compounds 
Dibutyltin acetylacetonate 
MacKenzie Company Bush, Louisiana 
Dibutyltin bis(2,4-pentanedionate) 
Gelest, Inc. Tullytown, Pennsylvania 
Dibutyltin bis(2-ethylhexanoate); Dibutyltin bis(isooctyl) maleate; Dibutyltin 
bis(isooctyl mercaptoacetate); Dibutyltin bis(isopropyl maleate); Dibutyltin 
bis(n-lauryl mercaptide); Dibutyltin dibutoxide; Dibutyltin dimethoxide; 
Dibutyltin disalicylate; Dibutyltin mercaptopropionate; Dibutyltin sulfide; 
Tributyltin fluoride 
ATOFINA Chemicals, Inc. Specialty Chemicals Division Carrollton, Kentucky 
Dibutyltin chloride; Dibutyltin oxide; Bis(tributyltin) oxide 




ATOFINA Chemicals, Inc. Specialty Chemicals Division Carrollton, Kentucky 





ATOFINA Chemicals, Inc. Specialty Chemicals Division Carrollton, Kentucky 
Atotech USA Inc. Rock Hill, South Carolina 
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ATOFINA Chemicals, Inc. Specialty Chemicals Division Carrollton, Kentucky 











ATOFINA Chemicals, Inc. Specialty Chemicals Division Carrollton, Kentucky 












Gelest, Inc. Tullytown, Pennsylvania 
Johnson Matthey, Inc. Alfa Aesar Ward Hill, 
Massachusetts 







ATOFINA Chemicals, Inc. Specialty Chemicals Division Axis, Alabama 

Octyltin compounds 
Dioctyltin S,S'-bis(isooctylmercaptoacetate); Dioctyltin dichloride; Dioctyltin 
maleate 
ATOFINA Chemicals, Inc. Specialty Chemicals Division Carrollton, Kentucky 
Dioctyltin dilaurate 
ATOFINA Chemicals, Inc. Specialty Chemicals Division Carrollton, Kentucky 
Gelest, Inc. Tullytown, Pennsylvania 
Dioctyltin oxide 
ATOFINA Chemicals, Inc. Specialty Chemicals Division Carrollton, Kentucky; 
Axis, Alabama 
Tetraoctyltin 
ATOFINA Chemicals, Inc. Specialty Chemicals Division Axis, Alabama 
Phenyltin compounds 
Diphenyltin chloride; Diphenyltin oxide; Triphenyltin fluoride 

ATOFINA Chemicals, Inc. Specialty Chemicals Division Carrollton, Kentucky 

aDerived from SRI 2004.  SRI reports production of chemicals produced in commercial quantities (defined as 





246 TIN AND TIN COMPOUNDS 
5. PRODUCTION, IMPORT/EXPORT, USE, AND DISPOSAL 
5.2 IMPORT/EXPORT 
U.S. consumption of primary and secondary tin was 34,000 and 5,830 metric tons, respectively, in 2002, 
and is estimated as 36,000 and 8,460 metric tons, respectively, for 2003. U.S. imports of refined tin in 
2002 totaled 42,200 metric tons and were mainly from Peru, followed by China, Bolivia, Brazil, and 
Indonesia. Tin imports for 2003 are estimated at 37,000 metric tons.  Major imports of tin include 
unwrought metal, waste and scrap, and unwrought tin alloys.  Tin exports of refined tin were 2,940 metric 
tons in 2002, and are estimated at 4,020 metric tons for 2003 (Carlin 2004).  U.S. imports for 
consumption of dibutyltin oxide, tetrabutyltin, and other organotin compounds were approximately 447,
611, and 2,070 metric tons, respectively in 2003, and were approximately 266, 649, and 1,680 metric tons, 
respectively, through August 2004 (ITA 2004). 
5.3 USE 
The major uses of tin in 2003 were: cans and containers, 27%; electrical, 23%; construction, 10%; 
transportation, 10%; and others 30% (Carlin 2004).  Tinplate is used in food packaging, aerosol 
containers, and decorative applications. Various tin alloys are important, including bronze and pewter.  
Tin readily forms alloys with other metals and imparts hardness and strength.  Tin is an important 
component of solders, since it wets the base metal by alloying with it (Gaver 1997). 
Inorganic tin compounds are used in the glass industry, where they are added to strengthen the glass.  
Inorganic tin compounds also serve as the base for the formulation of colors, as catalysts, and in perfumes 
and soaps (WHO 1980). Tin(IV) oxide (SnO2) is used in the ceramics and glass industries, as well as a 
polishing agent and as a catalyst (Kroschwitz and Howe-Grant 1997).  It is also used to produce milky or 
colored glass and in the formulation of fingernail polish (Windholz 1983).  Tin(IV) chloride (SnCl4) is 
often used as the starting material for the production of organotin compounds.  Tin(II) fluoride (SnF2) is 
added to toothpastes as an anticaries agent. Tin(II) chloride (SnCl2) is the most important inorganic tin 
compound.  It is used as an industrial reducing agent and in tin electroplating.  Tin(II) chloride is also 
used as a food additive, (e.g., as a preservative and a color-retention agent). Tin(II) fluoroborate 
(Sn(BF4)2), which is not isolated as a solid but is only found in solution, is an important chemical in 
electroplating. The consumption of inorganic tin compounds is lower than that of organotin compounds 
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Examples of commercially important organotin compounds include tetraorganotins (R4Sn), triorganotins 
(R3SnX), diorganotins (R2SnX2), and monoorganotins (RSnX3). The organotin compounds of 
commercial importance have R groups equal to methyl, butyl, octyl, cyclohexyl, phenyl, or neophyl.  The 
anionic X groups are commonly halides, oxide, hydroxide, carboxylates, or mercaptides.  Tetraorganotin 
compounds are mainly used in the production of tri-, di-, and monoorganotin compounds.  Tri- and 
diorganotin compounds are the most important classes of organotin compounds.  Triorganotin compounds 
are used as industrial biocides, agricultural chemicals, wood preservatives, and marine antifouling agents. 
Diorganotin compounds are used as polyvinyl chloride (PVC) stabilizers and as polyurethane foam and 
esterification catalysts.  Monoorganotin compounds are also used as PVC stabilizers, as well as in the 
treatment of glass (Batt 2004; Kroschwitz and Howe-Grant 1997). 
The major commercial applications for which organotin compounds are used are as PVC heat stabilizers, 
biocides, catalysts, agrochemicals, and glass coatings, accounting for approximately 20,000 tons of tin 
consumption per year (Batt 2004).  The major use of organotin compounds is for heat stabilization of 
PVC, which represents approximately two-thirds of the global consumption (Sadiki and Williams 1999).  
It was estimated that in 1981, the U.S. consumption of organotin compounds as PVC stabilizers was 
10,650 tons, approximately 27% of the world market (Kroschwitz and Howe-Grant 1997).  Organotin 
compounds used as PVC stabilizers include butyl-, octyl-, and methyltin compounds.  Octyl- and 
methyltin compounds are used in PVC for food packaging.  In the United States, the organotin 
compounds that are used predominantly as PVC stabilizers are methyltins (about 50% of the market) and 
butyltins (40%), with octyltin compounds making up the remainder.  In Asia, methyltins (50%) and 
octyltins (40%) and in Europe, octyltins (60%) and butyltins (30%) are the most widely used organotin 
compounds as PVC stabilizers (Leaversuch 1999).  Tributyltin compounds are also used as slimicides on 
masonry, as disinfectants, and as biocides for cooling systems, power station cooling towers, pulp and 
paper mills, breweries, leather processing, and textile mills (WHO 1990). 
The use of triorganotin compounds as marine antifoulants has been restricted by the Organotin 
Antifouling Paints Control Act (June 16, 1988), which limits the type of vessel on which these paints can 
be used, and limits the use of tributyltin paints to those that have laboratory tested release rates of 
4 μg/cm2/day (Cardwell et al. 1999a). France was the first country to adopt restrictions in 1982, and 
now the majority of industrialized countries have adopted restrictions on the use of tributyltin containing 
paints on vessels <25 meters in length, and include, in addition to France and the United States, the 
United Kingdom, Canada, New Zealand, Australia, and the European Union (Birchenough et al. 2002).  
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on the Control of Harmful Anti-fouling Systems on Ships, which prohibits the use of harmful organotin 
compounds in anti-fouling paints on ships and established a mechanism to prevent the potential future use 
of other harmful substances as anti-fouling systems (IMO 2004).  
5.4 DISPOSAL
Tin-containing wastes in the form of salts, slags, and muds are generated as a result of smelting, refining, 
and detinning processes. Solid wastes containing tin are generated by both domestic and industrial users 
of containers. Tin-containing wastes may be incinerated or disposed of in landfills (WHO 1980). 
Inorganic and organic tin compounds may be disposed of in sealed containers in a secured sanitary
landfill (NIOSH/OSHA 1981). 
Tin is not listed as a hazardous waste constituent by the EPA and therefore, its disposal is not restricted 
by federal land disposal restrictions.  No data were located regarding the amounts of tin disposed of by
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6.1 OVERVIEW
Tin and organotin compounds have been identified in at least 214 and 8 sites, respectively, of the 
1,662 hazardous waste sites that have been proposed for inclusion on the EPA National Priorities List 
(NPL) (HazDat 2004).  However, the number of sites evaluated for tin and organotin compounds is not 
known. The frequency of these sites can be seen in Figures 6-1 and 6-2, respectively.  All sites where tin 
and organotin compounds were found are located in the United States.  
Tin occurs naturally in the earth's crust with a concentration of approximately 2–3 ppm (Budavari 2001).  
Tin compounds are found in various environmental media in both inorganic and organic forms.  Tin may
be released to the environment from natural and anthropogenic sources.  Tin is a component of many soils 
and inorganic tin compounds may be released in dusts from wind storms, roads, and agricultural 
activities. Releases of tin to environmental media may occur from the production and use of tin and tin 
compounds.  Gases, dusts, and fumes containing tin may be released from smelting and refining 
processes, industrial uses of tin, waste incineration, and burning of fossil fuels (Byrd and Andreae 1986; 
Senesi et al. 1999; WHO 1980). In general, organotin compounds are released to the environment from
anthropogenic sources; however, methyltin compounds can be produced in the environment by 
biomethylation of inorganic tin and can occur naturally (Fent 1996).  Antifouling paints containing 
tributyltin are applied as a finish coat to the immersed sections of boats and floating structures.  As the 
paint releases tributyltin into the water, it creates an environment that repels the organisms that may
attach to the surface of submerged objects. Use of antifouling paints represents the major source of 
tributyltin into the coastal environment (Alzieu 1998).  The use of tributyltin compounds as slimicides on 
masonry, disinfectants, and biocides for cooling systems, power station cooling towers, pulp and paper 
mills, breweries, leather processing, and textile mills (WHO 1990) may result in their release to the 
environment.  Triphenyltin enters the environment directly from its use as a pesticide.  To a lesser extent, 
organotin compounds may also enter the environment by leaching to soil and groundwater from consumer 
products containing organotin compounds disposed of in landfills (Fent 1996).  
Tin may exist in either divalent (Sn2+) or tetravalent (Sn4+) cationic (positively charged) ions at 
environmental conditions.  Tin(II) dominates in reduced (oxygen-poor) water, and will readily precipitate 
as a sulfide (SnS) or as a hydroxide (Sn(OH)2) in alkaline water. Tin(IV) readily hydrolyzes, and can 
precipitate as a hydroxide.  In general, tin(IV) would be expected to be the only stable ionic species in the 
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weathering cycle (Wedepohl et al. 1978).  Tin in water may partition to soils and sediments.  Cations such 
as Sn2+ and Sn4+ will generally be adsorbed by soils to some extent, which reduces their mobility.  Tin is 
generally regarded as being relatively immobile in the environment (Gerritse et al. 1982; WHO 1980).  
Organotin compounds are generally only sparingly soluble in water and are likely to partition to soils and 
sediments.  Most commercially used organotin compounds are relatively immobile in environmental 
media due to their low vapor pressures, low water solubilities, and high affinities for soil and organic 
sediments (Blunden et al. 1984).  For example, nearly all of the tributyltin found in the water column is 
bound to suspended particles, with a small portion associated with dissolved organic matter and organic 
and inorganic ligands (Gadd 2000). Tributyltin that is associated with particles in the water column may
settle out, which is an important process in its removal from the water column.  Tributyltin sorption 
coefficients to sediments can range from 100 to 10,000 (Anderson et al. 2002).  Degradation of organotin 
compounds involves breaking the tin-carbon bond and can occur in the environment by ultraviolet (UV) 
irradiation, or biological or chemical cleavage (Blunden et al. 1984).  Rates of photodegradation and 
biodegradation of organotins in water are dependent upon environmental conditions.  In sediment, 
organotins are generally persistent.  Organotin compounds may be significantly bioconcentrated by
aquatic organisms.  Cleavage of the tin-carbon bond by hydrolysis is not a significant environmental fate 
process under environmental conditions (WHO 1990). 
Occupational exposure to tin may be significant in some industrial environments.  Ambient environ­
mental levels of tin are generally quite low, except in the vicinity of pollution sources.  Humans may be 
exposed to tin by inhalation, ingestion, or dermal absorption.  However, typical human exposure to tin is 
primarily by ingestion of food.  Tin-lined cans used to package food constitute the most important 
contribution to tin intake in the diet (Biégo et al. 1999).  While there is evidence that tin is essential for 
the normal growth of rats, there is no evidence that tin is essential for other animals, including humans 
(WHO 1980). Exposure to organotin compounds may occur by the ingestion of seafood and contact with 
consumer products that contain organotin compounds.  Household commodities made up of polyurethane, 
plastic polymers, and silicons contain butyltin concentrations in the parts per million range (Kannan et al. 
1999). Mono- and dimethyltin and mono- and dibutyltin compounds have been detected in drinking 
water in Canada where polyvinyl chloride (PVC) pipes, containing these organotin compounds, are used 
in the distribution of drinking water (Sadiki and Williams 1996, 1999; Sadiki et al. 1996).  Organotin 
compounds were detected in household dust in the United Kingdom (Santillo et al. 2003). 
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6.2 RELEASES TO THE ENVIRONMENT 
The Toxics Release Inventory (TRI) data should be used with caution because only certain types of 
facilities are required to report (EPA 1997). Manufacturing and processing facilities are required to report 
information to the TRI only if they employ 10 or more full-time employees; if their facility is classified 
under Standard Industrial Classification (SIC) codes 20–39; and if their facility produces, imports, or 
processes 25,000 pounds of any TRI chemical or otherwise uses >10,000 pounds of a TRI chemical in a 
calendar year (EPA 1997).
There is no information on releases of tin and tin compounds from manufacturing and processing 
facilities because these releases are not required to be reported (EPA 1997). However, releases of tin to 
environmental media may occur from the production and use of tin and tin compounds.  
Tin and organotin compounds have been identified in a variety of environmental media (air, surface 
water, leachate, groundwater, soil, and sediment) collected at 214 and 8 sites, respectively, of the 
1,662 current or former NPL hazardous waste sites (HazDat 2004).  
6.2.1 Air 
There is no information on releases of tin and tin compounds to the atmosphere from manufacturing and 
processing facilities because these releases are not required to be reported (EPA 1997). 
Tin has been identified in air collected at 6 of the 214 current or former NPL hazardous waste sites where 
it was detected in some environmental media.  No organotin compounds were found in air at the eight 
current or former NPL hazardous waste sites where organotin compounds were detected in some 
environmental media (HazDat 2004). 
Tin may be released to the atmosphere from both natural and anthropogenic sources.  Tin is a component 
of many soils and may be released in dusts from wind storms, roads, and agricultural activities.  Gases, 
dusts, and fumes containing tin may be released from smelting and refining processes, industrial uses of 
tin, waste incineration, and burning of fossil fuels (Byrd and Andreae 1986; Senesi et al. 1999; WHO 
1980). Davison et al. (1974) reported that the tin content of airborne fly ash from coal-burning power 
plants ranged from 7 to 19 μg/g. Worldwide emissions of tin to the atmosphere from coal and oil 
combustion, refuse incineration, and copper/nickel production facilities were estimated at 1,470– 
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10,810 metric tons in 1983 (Nriagu and Pacyna 1988).  Organotin compounds may be released to air by 
agricultural spraying, volatilization, antifouling paint sprays, incineration of materials treated or stabilized 
with organotin compounds, and glass coating operations.  Incineration of organotin containing material is 
unlikely to be a significant source of organotin compounds to air, since these compounds will be 
decomposed to inorganic tin during combustion (Blunden et al. 1984).  Releases of organotin compounds 
to air are not significant due to their low vapor pressures and rapid photodegradation (Blunden et al. 1984; 
Fent 1996). 
6.2.2 Water 
There is no information on releases of tin and tin compounds to water from manufacturing and processing 
facilities because these releases are not required to be reported (EPA 1997). 
Tin has been identified in groundwater and surface water at 78 and 36 sites, respectively, of the 214 NPL 
hazardous waste sites where it was detected in some environmental media.  Organotin compounds were 
found in surface water at one of the eight current or former NPL hazardous waste sites where they were 
detected in some environmental media; organotin compounds were not found in groundwater at these 
sites (HazDat 2004). 
Releases of tin to water may occur from industrial facilities smelting, refining, or using tin (WHO 1980).  
Antifouling paints containing tributyltin are applied as a finish coat to the immersed sections of boats and 
floating structures. As the paint releases tributyltin into the water, it creates an environment that repels 
the organisms that may attach to the surface of submerged objects.  Use of antifouling paints represents 
the major source of tributyltin into the coastal environment.  It has been estimated that one boat releases 
1–10 μg tributyltin/cm2 of hull surface daily to ensure antifouling protection.  This corresponds to 0.2– 
2 g/day for a small sailboat and up to 50–500 g/day for an average sized merchant ship (Alzieu 1998).  
The use of triorganotin compounds as marine antifoulants has been restricted by the Organotin 
Antifouling Paints Control Act (June 16, 1988), which limits the type of vessel on which these paints can 
be used, and limits the use of tributyltin paints that have laboratory tested release rates of 4 μg/cm2/day 
(Cardwell et al. 1999a). Most industrialized countries, in addition to the United States, have adopted 
similar restrictions on the use of tributyltin containing paints.  These countries include the United 
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Organotin compounds may also be released to water from overspray and land runoff from agricultural 
applications, industrial processes, and leaching from organotin-stabilized polyvinyl chloride (PVC) 
(Blunden et al. 1984). The use of tributyltin compounds as slimicides on masonry, disinfectants, and 
biocides for cooling systems, power station cooling towers, pulp and paper mills, breweries, leather 
processing, and textile mills may result in their release to the environment (WHO 1990).  Triphenyltin 
acetate and triphenyltin hydroxide are used as fungicides, algicides, and molluscicides (WHO 1999).  
Timber treatment facilities can be as a significant source of tributyltin in freshwater systems from
seepage, accidental spills, and intentional releases.  Minor sources of organotin compounds in freshwater 
can be seepage from landfill sites and agricultural runoff, due to the use of contaminated sewage sludge or
organotin containing pesticides (Demora and Pelletier 1997).  Monthly samples of influent, effluent, and 
sludges were collected from July 1990 to January 1991 from sewage treatment plants in five Canadian 
cities. Monobutyltin was detected in all influent samples.  Dibutyl- and tributyltin were only detected 
infrequently, and octyltin species were not detected. A significant reduction, 40% on average, in the 
concentration of monomethyltin was found after passage through the sewage treatment plants, due to 
degradation and adsorption to sludge.  No butyltin or octyltin species were found in five landfill leachate 
samples in southern Ontario, Canada (Chau et al. 1992). 
6.2.3 Soil 
There is no information on releases of tin and tin compounds to soil from manufacturing and processing 
facilities because these releases are not required to be reported (EPA 1997). 
Tin has been identified in soil at 121 sites and in sediment at 49 sites collected from 214 NPL hazardous 
waste sites, where it was detected in some environmental media.  Organotin compounds were found in 
sediment and soil at four sites and one site, respectively, of the eight current or former NPL hazardous 
waste sites where they were detected in some environmental media (HazDat 2004). 
Tin may be released to soil from organotin pesticide usage and landfilling of tin-containing wastes, 
including used cans and organotin-containing plastics (WHO 1980).  The application of pre-treated 
municipal sludge and urban refuse as soil amendments may also introduce tin to soils.  Concentrations of 
tin in sewage sludges from countries in Europe and North America ranged from 40 to 700 mg/kg dry 
weight. Manures and poultry wastes contained tin at concentrations of 3.7–7.4 and 2.0–4.1 mg/kg dry
weight, respectively.  Other incidental point sources that may introduce tin to soil are corrosion of metal 








256 TIN AND TIN COMPOUNDS 
6. POTENTIAL FOR HUMAN EXPOSURE 
be released to soil through agricultural applications and burial of organotin-containing waste material 
(Blunden et al. 1984). An estimated 5,200 tons of organotin compounds were released, primarily to
landfills in the United States in 1976 (Laughlin and Linden 1985).  No current data were found regarding 
releases of organotin compounds to soil.
6.3 ENVIRONMENTAL FATE
6.3.1 Transport and Partitioning 
Tin may be transported in the atmosphere by the release of particulate matter derived from the 
combustion of fossil fuels and solid wastes.  The vapor pressure of elemental tin is negligible (Cooper and 
Stranks 1966), and inorganic tin compounds are nonvolatile at environmental conditions.  Airborne 
particles may travel long distances before deposition depending on the type of emitting source, physical 
form and properties (e.g., size, density), physical or chemical changes that may occur during transport, 
adsorption processes, and meteorological conditions (Senesi et al. 1999).  
Tin may exist in either divalent (Sn2+) or tetravalent (Sn4+) cationic (positively charged) ions at 
environmental conditions.  Tin(II) dominates in reduced (oxygen-poor) water, and will readily precipitate 
as a sulfide (SnS) or as a hydroxide (Sn(OH)2) in alkaline water. Tin(IV) readily hydrolyzes, and can 
precipitate as a hydroxide. The solubility product of Sn(OH)4 has been measured at approximately
10-56 g/L at 25 °C. In general, tin(IV) would be expected to be the only stable ionic species in the 
weathering cycle (Wedepohl et al. 1978). 
Tin in water may partition to soils and sediments.  Cations such as Sn2+ and Sn4+ will generally be 
adsorbed by soils to some extent, which reduces their mobility.  Tin is generally regarded as being 
relatively immobile in the environment (Gerritse et al. 1982; WHO 1980).  However, tin may be 
transported in water if it partitions to suspended sediments (Cooney 1988), but the significance of this 
mechanism has not been studied in detail.  Transfer coefficients for tin in a soil-plant system were 
reported to be 0.01–0.1 (Senesi et al. 1999). 
A bioconcentration factor (BCF) relates the concentration of a chemical in plants and animals to the 
concentration of the chemical in the medium in which they live.  It was estimated that the BCFs of 
inorganic tin were 100, 1,000, and 3,000 for marine and freshwater plants, invertebrates, and fish, 
respectively (Thompson et al. 1972).  Marine algae can bioconcentrate tin(IV) ion by a factor of 








257 TIN AND TIN COMPOUNDS 
6. POTENTIAL FOR HUMAN EXPOSURE 
Approximately 95% of tributyltin in the water column was found to be bound to suspended particles and 
the remainder was associated with dissolved organic matter and organic and inorganic ligands (Gadd 
2000).  Tributyltin that is associated with particles in the water column may settle out, which is an 
important process in the removal of tributyltin from the water column.  Tributyltin sorption coefficients to 
sediments can range from 100 to 10,000 (Anderson et al. 2002).  A partition coefficient of about 2,180 at 
20 °C was calculated by Maguire et al. (1985) to estimate the adsorption of tributyltin ions by lake 
sediments.  These investigations also concluded that the half-life of the desorption reaction was about 
10 months, indicating that tributyltin can be strongly retained by sediments.  The adsorption behavior of 
Sn4+ ion and eight organotin species (tri-, di-, and monobutyltin; tri-, di-, and monomethyltin; and tri- and 
diphenyltin) were studied in a water-sediment system using artificial seawater and estuarine sediment.  
Adsorption coefficients varied from 100.5 to 104.5 and showed the trend of Sn4+ > mono > di > tri in the 
same substituent series. Larger absorption coefficients were found for aromatic compounds than for 
aliphatic compounds (Sun et al. 1996).  Sediment-water partition coefficients for tributyltin ranged from
240 to 65,000 in sediments of the coast of southwestern Spain.  Similar values were found for 
monobutyltin.  Dibutyltin was found to have higher affinity for sediment (Gomez-Ariza et al. 2001).
At ambient temperatures, the solubilities of organotin compounds range from 0.0001 to about 50 mg/L 
(Laughlin and Linden 1985; WHO 1980).  Organotin compounds may partition from water to aquatic 
organisms. An octanol/water partition coefficient (Kow) describes the partitioning of an organic chemical 
between octanol and water. Octanol is believed to best imitate the fatty structures in plant and animal 
tissues (Kenaga and Goring 1980). The Kow of tributyltin at pH 6 was reported to be about 1,585 by
Maguire et al. (1983).  The most accurate Kow for tributyltin in seawater was 5,500 (Laughlin and Linden 
1985). 
There is no evidence of biomagnification of tributyltin in marine ecosystems, but accumulation may
occur, resulting in high tissue concentrations in some organisms (Meador 2000).  Rüdel (2003) reported 
that, based on a review of the literature, the bioavailability of organotin compounds via the food chain 
appears to be of minor importance for tributyltin and triphenyltin when compared to uptake via the water 
phase. Measured BCF values for bis(tributyltin)oxide with marine oysters were found to range from
2,300 to 11,400 (Waldock and Thain 1983).  A BCF of 30,000 was estimated by Maguire et al. (1984) for 
the bioconcentration of tributyltin cation by freshwater green algae.  Seven-day BCF values were derived 
for dibutyltin dichloride, dibutyltin dilaurate, tributyltin chloride, bis(tributyltin) oxide, and triphenyltin 
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from 12 in muscle to 5,012 in liver.  For all organotin compounds, liver had the highest BCF values.  The 
highest BCFs were found for the tributyltin compounds (Tsuda et al. 1986).  BCF values for 
bis(tributyltin) oxide for red sea bream (Pagrus major), mullet (Mugil cephalus), and filefish (Rudarius 
erodes) were 9,400–11,000, 2,400–3,000, and 3,200–3,600, respectively, determined in an 8-week flow-
through aquarium system.  Larger BCF values were obtained when fish were reared in seawater 
containing lower concentrations of tributyltin.  BCF values for triphenyltin chloride for P. major and 
R. erodes were 3,100–3,300 and 4,100, respectively, and were independent of the concentration of 
triphenyltin in the rearing water (Yamada and Takayanagi 1992).  The log BCFs for tributyltin in fish 
from the Port of Osaka and the Yodo River, Japan were 3.6–4.2 and 2.9–3.5, respectively (Harino et al. 
2000).  After 50 days of exposure to water containing a constant concentration of tributyltin (500 ng/L), 
whole body concentrations in tilapia did not reach a plateau, and the 50-day BCF was 12,300.  
Enrichment of tributyltin was highest in the viscera, followed by gill, and then muscle (Hongxia et al. 
1998). A BCF of 10,500 was found for tributyltin uptake from seawater in marine mussels (Mugil 
graynus) during the 56-day accumulation phase (Suzuki et al. 1998).  BCFs were 17,000–350,000, 2,000– 
70,000, and 1,000–70,000 for tri-, di-, and monobutylin, respectively, in mollusks living in southwest 
Spain, showing a decrease in BCF with decreasing lipophilicity for the butyltin compounds (Gomez-
Ariza et al. 2001). 
Bioconcentration as a function of pH was studied for triphenyltin and tributyltin in a freshwater sediment 
organism, Chironomus ripaius. At pH 5 and 8, respectively, the BCFs were 310 and 170 for tributyltin, 
and 680 and 510 for triphenyltin.  While the difference in BCF at the two pHs was statistically significant 
for tributyltin, it was not for triphenyltin.  This may be explained by the speciation differences for each of 
these compounds as pH varies.  The acid dissociation constant (pKa) of tributyltin is 6.25, and at pH 5, the 
fraction of tributyltin hydroxide is approximately 5%, with the tributyltin cation as the predominant 
species in solution. The pKa for triphenyltin is 5.2, and at pH 5, approximately 40% is present as 
triphenyltin hydroxide with the remainder as triphenyltin cation.  The differences in the observed pH 
dependence between triphenyltin and tributyltin may indicate that the neutral hydroxide species is the 
predominant form taken up by the organism.  BCF values of 1,500 and 1,200 at pH 5 and 8, respectively, 
were determined for tetrabutyltin ion, which cannot undergo ionization and was used as a control 
compound.  The difference between these BCF values for tetrabutyltin at pH 5 and 8 was not statistically
significant (Looser et al. 1998). 
Releases of organotin compounds to air from various surfaces are, in general, not significant due to their 
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methylation of inorganic and organotin compounds, such as di- and tributyltin, are likely to occur in 
sediments, producing potentially volatile organotin compounds.  This process may lead to mobilization of 
tin species into the water column and possibly into the atmosphere.  However, there is currently no 
significant evidence of losses of organotin compounds to the atmosphere (Amouroux et al. 2000).  There 
was no indication that tributyltin in water partitioned to the air during a 62-day period, whereas 20% of 
the water evaporated (Maguire et al. 1983). 
6.3.2 Transformation and Degradation 
6.3.2.1 Air 
No information was located on the transformation or degradation of tin compounds in the atmosphere. 
6.3.2.2 Water 
Inorganic tin cannot be degraded in the environment, but may undergo oxidation-reduction, ligand 
exchange, and precipitation reactions (HSDB 2003). It has been established that inorganic tin can be 
transformed into organometallic forms by microbial methylation (Hallas et al. 1982).  Inorganic tin may
also be converted to stannane (H4Sn) in extremely anaerobic (oxygen-poor) conditions by macroalgae 
(Donard and Weber 1988). 
The speciation of organotin compounds is pH-dependent.  At lower pHs, the cationic form will be the 
primary form, and as the pH is increased, the neutral hydroxide compounds will be the predominant 
species. In the environmentally relevant pH range (pH 5–9), the predominant organotin species will be 
the neutral hydroxide compounds (i.e., R3SnOH, R2Sn(OH)2, and RSn(OH)3). High concentrations of 
chloride favor the formation of chloro species.  The pKa values for trimethyltin, triethyltin, tributyltin, and 
triphenyltin cations are approximately 6.60, 6.81, 6.25, and 5.2, respectively (Blunden et al. 1984; Fent 
1996; Meador 2000). 
Degradation of organotin compounds involves the breaking of the tin-carbon bond, which may occur by
UV irradiation, or by biological or chemical cleavage (Blunden et al. 1984).  In water, tributyltin can be 
degraded by photochemical and biological processes relatively rapidly; however, adsorption onto 
suspended particulate material in water followed by sedimentation is a key removal process (De Mora and 
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and light; it is generally estimated to be in the range of 1 day to a few weeks (Alzieu 1998).  
Biodegradation is the major process in seawaters rich in suspended solids, but photolysis, in surface 
waters, exceeds biodegradation in clean seawater.  Calculated half-lives range from 6 days in summer­
time waters rich in suspended particles to 127 days in clean winter waters (Watanabe et al. 1992).  
Tributyltin can be degraded by microbial, microalgal, and fungal populations, as well as by some higher 
organisms, such as fish (Anderson et al. 2002).  Cleavage of the tin-carbon bond by hydrolysis is not an 
important fate process under environmental conditions (WHO 1990). 
6.3.2.3 Sediment and Soil 
Inorganic tin cannot be degraded in the environment, but may undergo oxidation-reduction, ligand 
exchange, and precipitation reactions (HSDB 2003). Degradation of organotin compounds in sediments 
is much slower than in water, and half-lives have been estimated to be several years (Alzieu 1998).  In 
addition to dealkylation of organotin compounds, methylation of tin and organotin compounds by 
chemical and/or biological means may occur.  The contribution of methylation by biotic and abiotic 
mechanisms is not clear. This pathway may result in fully substituted and volatile tin compounds.  
Methylated butyltin compounds, such as tributylmethyltin and dibutyldimethyltin, have been found in 
contaminated harbor sediments and in surface waters (Amouroux et al. 2000; Cooney 1988).  Methylation 
of tin in sediments was found to be positively correlated with increasing organic content in sediment and 
to follow predominately a biotic pathway (Hadjispyrou et al. 1998).
6.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT 
Reliable evaluation of the potential for human exposure to tin and tin compounds depends in part on the 
reliability of supporting analytical data from environmental samples and biological specimens.  
Concentrations of tin and tin compounds in unpolluted atmospheres and in pristine surface waters are 
often so low as to be near the limits of current analytical methods.  In reviewing data on tin and tin 
compounds levels monitored or estimated in the environment, it should also be noted that the amount of 
chemical identified analytically is not necessarily equivalent to the amount that is bioavailable.  The 
analytical methods available for monitoring tin and tin compounds in a variety of environmental media 
are detailed in Chapter 7. 
Environmental monitoring studies may report concentrations of organotin compounds in various 
environmental media in two formats, either as mass of tin per unit mass or volume of media, or as mass of 
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organotin ion per unit mass or volume of media.  To convert mass on a tin basis to mass on an organotin 
cation basis, multiply by the ratio of the formula weight of the organotin cation to the atomic weight of 
tin. Conversions are provided in Table 6-1 for various organotin cations.  For example, a tributyltin 
(TBT) concentration in sediment reported as 122 ng TBT/g would correspond to 50 ng Sn/g, since 
tributyltin ion has a mass that is 2.44 times greater than that of tin. 
6.4.1 Air 
Tin is detected in air infrequently and at low concentrations, except in the vicinity of industrial sources. 
Air concentrations in U.S. cities ranged from below the detection limit to 0.8 μg/m3 in several studies. 
Average concentrations are generally <0.1 μg/m3, with higher concentrations near some industrial 
facilities (EPA 1982a; WHO 1980). In some studies, tin was not detected in 40–>50% of samples.  
Atmospheric tin is associated with particulate matter, and peak concentrations were found on smaller 
respirable particles (1–3 μm) (WHO 1980).  Samples of airborne inhalable particulate matter were 
collected in two urban/industrial areas in Illinois, southeast Chicago and East St. Louis, over a 2-year 
period. Average tin concentrations in the fine (<2.5 μm) and coarse (2.5–10 μm) particulate fractions 
were <0.007 and 0.012 μg /m3 for East St. Louis, respectively, and <0.007  μg /m3 for both the fine and 
course fractions in samples from southeast Chicago and a rural site in Bondville, Illinois (Sweet and 
Vermette 1993). The average tin concentration in highway tunnel exhaust aerosol in the Elbtunnel in 
Hamburg, Germany between August 1988 and January 1989 was 10.9 μg/m3 (Dannecker et al. 1990).  
Tin concentrations in the particulate matter in the ambient air at art glass manufacturing plants measured 
by personal samples from oven-charger and batch-mixer workers ranged from 0.1 to 3.5 μg/m3 from three 
plants that use arsenic as a fining agent (a fining agent is added to disperse air bubbles in glass).  Tin was 
not detected in the particulate matter in the air at three other plants that use antimony compounds instead 
of arsenic (Apostoli et al. 1998).  No monitoring data for concentrations of organotin compounds in air 
were found. 
6.4.2 Water 
Tin occurs in trace amounts in natural waters.  However, it is seldom measured and only infrequently
detected, since concentrations are often below the detection limit (NAS 1977; WHO 1980). In surface 
waters, tin was detected in only 3 of 59 samples from 15 U.S. and Canadian rivers at concentrations 
ranging from 1.3 to 2.1 μg/L, and not detected in 119 samples from 28 U.S. rivers.  A mean tin 
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Table 6-1. Conversion Between Mass on a Tin Basis to 
Mass on an Organotin Cation Basis 
To convert from mass on a tin To: Multiple by: 
basis: 
mass on a TBT cation 2.44 
basis
mass on a DBT cation 1.96 
basis
mass on a MBT cation 1.48 
basis
mass on a TMT cation 1.38 
basis
mass on a DMT cation 1.25 
basis
mass on a MMT cation 1.13 
basis
mass on a TPT cation 2.95 
basis
mass on a DPT cation 2.30 
basis
mass on a MPT cation 1.65 
basis
DBT = dibutyltin; DMT = dimethyltin; DPT = diphenyltin; MBT = monobutyltin; MMT = monomethyltin; 
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concentrations in public water supplies ranged from 1.1 to 2.2 μg/L in 42 U.S. cities and from 0.8 to 
30 μg/L in 32 of 175 water supplies in Arizona (NAS 1977; WHO 1980).  Tin concentrations in drinking 
water have been reported at <10 μg/L (WHO 2003). Tin is present in seawater at about 0.2–3 μg/L (NAS 
1977; WHO 1980).  Tin concentration in fresh snow from the French Alps collected in 1998 at different 
altitudes ranged from 157 to 436 pg/g (Veysseyre et al. 2001). 
Concentrations of tributyltin (TBT) were found to range from 20 to 1,800 ng TBT/L in the Chesapeake 
Bay area, Maryland (Hall 1988).  In surface waters from San Diego Bay, California in 1986–1989, 
tributyltin levels averaged 4.7–13 ng TBT/L in the north bay, 1.3–9.9 ng TBT/L in the south bay, 3.5– 
14 ng TBT/L in U.S. Navy pier regions, and 19–120 ng TBT/L in yacht harbors.  Tributyltin 
concentrations in bottom waters in the San Diego Bay area ranged from 8.8 to 61 ng TBT/L.  The mean 
tributyltin concentrations in regional surface waters from Pearl Harbor, Hawaii from 1986 to 1989 were: 
0.0–6.8 ng TBT/L in channels; 0.0–4.9 ng TBT/L in outlying regions; 2.4–31 ng TBT/L in Southeast 
Loch; and 6.7–130 ng TBT/L in a small marina.  Tributyltin concentrations in bottom waters in Pearl 
Harbor ranged from 0.0 to 9.7 ng TBT/L.  In Honolulu harbor, surface and bottom water tributyltin 
concentrations were 4.8–580 and 2.6–170 ng TBT/L, respectively (Grovhoug et al. 1996).  Tributyltin 
concentrations in surface water from the harbor area of Osaka City, Japan ranged from 2 to 33 ng TBT/L 
(Harino et al. 1998). Butyltin compounds were detected in 32 of the 63 seawater samples (0.5 m depth) 
that were collected from 18 areas along the Japanese coast from 1997 to 1999.  Average butyltin 
concentrations were 4.6 ng MBT/L, 4.5 ng DBT/L, and 6.8 ng TBT/L from sampling stations for each of 
the four areas: the Pacific coast of northern Japan, the coast along the Sea of Japan, Tokyo Bay and the 
adjacent area, and western Japan. The highest concentrations in these four areas were found in western 
Japan with concentrations of 5.9 ng MBT/L, 6.9 ng DBT/L, and 20.1 ng TBT/L (Takeuchi et al. 2004).  
The seasonal variations in tributyltin concentrations in marinas on Lake Ontario were studied from April 
to December 1998.  The marinas were at Toronto, Mississauga, Oakville, Hamilton, and Fifty Point, 
Canada. Approximately 150–200 pleasure boats were in each marina in the summer.  Tributyltin 
concentrations increased with increased boat activity, with a maximum concentration of 14 ng Sn/L 
reported in late August at Fifty Point.  Concentrations of tributyltin varied at the marinas, peaking 
between June and September, but were always higher in the marinas compared to a reference site, 
Burlington, Canada, that was far from any marinas (Yang and Maguire 2000).  Similar seasonal variations 
were seen in seawater collected from marinas and harbors from southwestern Spain.  Tri-, di-, and 
monobutyltin concentrations were significantly higher in water collected in May and August compared to 
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areas with poor water turnover. Tributyltin concentrations ranged from <0.5 to 31 ng Sn/L.  Analysis for 
phenyltin compounds was performed, but none were found (Gomez-Ariza et al. 2001).
While many studies reported on the occurrence of organotin compounds in marine environments fewer 
studies reported the occurrence of organotin compounds in freshwater.  A study investigating the levels of 
di- and tributyltin in fresh surface waters from nine sites across the United States found that, at most sites, 
di- and tributyltin were not detected (detection limits were 970 and 180 ng butyltin ion/L for dibutyltin 
and tributyltin, respectively).  The highest dibutyltin concentrations were found in water sampled in 1998 
from the Neuse River, North Carolina and Contentnea Creek, North Carolina at 140 and 160 ng DBT/L, 
respectively.  Tributyltin was only detected in the Little Missouri River, North Dakota and Flat River, 
North Carolina at concentrations of 265 and 600 ng TBT/L, respectively (Jones-Lepp et al. 2004).  
Bancon-Montigny et al. (2004) reported a monitoring study involving sampling along 11 rivers in 
southwest France from February to October 2001.  Sites were chosen to represent specific industrial or 
agricultural activities. Organotin compounds were detected in most water samples; butyltin compounds 
were most frequently detected with concentrations generally ranging from below the detection limit 
(0.2 ng Sn/L) to 30 ng Sn/L.  Phenyltin compounds were also detected at concentrations generally ranging 
from below the detection limit (0.2 ng Sn/L) to 20 ng Sn/L.  High phenyltin concentrations were detected 
during the spring and the end of the summer and likely are derived from agricultural sources.  
Monophenyltin concentrations from over 400 up to 700 ng Sn/L were detected at four sampling sites.  
Octyltin compounds were detected as well; however, concentrations were generally lower, ranging from
below the detection limit (0.2 ng Sn/L) to 15 ng Sn/L (Bancon-Montigny et al. 2004). 
Mono- and dimethyltin and mono- and dibutyltin compounds have been detected in Canadian drinking 
water. Drinking water in Canada is distributed through PVC pipes stabilized with methyl- and butyltin 
compounds.  Methyl- and butyltin compounds were detected at concentrations up to 22 and 43.6 ng Sn/L,
respectively, in distributed water samples from six municipalities in Canada (Sadiki and Williams 1996).  
Tap water in 10 of 22 homes collected in February 1995 from five Canadian municipalities contained 
monomethyltin and dimethyltin compounds at concentrations of 0.5–257 and 0.5–6.5 ng Sn/L,
respectively.  No organotin compounds were detected in the tap water from the other 12 houses.  No 
organotin compounds were detected in raw water or in water just after leaving the treatment plant, 
suggesting that the source of these organotin compounds was from some component of the distribution 
system (Sadiki et al. 1996).  Canadian drinking water samples collected during the winter–spring 1996 
from 28 sites and autumn 1996 from 21 sites were found to contain monomethyltin, dimethyltin, 
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respectively.  These compounds were detected with a frequency of 84, 80, 16, and 12% in the winter– 
spring survey and 100, 57, 7, and 7% in the autumn survey, respectively.  A summer 1996 survey of 
locations with the highest organotin concentrations in the winter–spring survey showed a decrease in 
mono- and dimethyltin concentration in 89% of the samples.  This finding was consistent with laboratory
studies that showed organotin release from PVC into water decreases after a few days. PVC pipe/tubing 
contains organotin compounds consistent with the organotin patterns found in the distributed water 
samples.  Octyltin compounds, which are not used as stabilizers in the PVC used to distribute drinking 
water, were not detected in drinking water samples.  Octyltin compounds are used instead as heat 
stabilizers in PVC for food packaging. Except for one treated water sample, no organotin compounds 
were detected in raw or treated water collected at the water treatment plant or in distributed water 
supplied through polyethylene pipes (Sadiki and Williams 1999).  
Organotin compounds were measured in precipitation and fog in the forested catchment in Northeast 
Bavaria, Germany during 2001–2002. Mono-, di-, and tri methyl and butyl derivatives, as well as mono- 
and dioctyltin compounds were detected in precipitation samples collected in this study.  The median total 
organotin concentrations in bulk precipitation, throughfall, and fog were 5.83, 14.6, and 57.1 ng Sn/L,
respectively, over the year-long monitoring study.  Monoalkyl tin compounds were the dominant species 
found in precipitation, with concentrations up to 192 ng Sn/L for monobutyltin in fog (Huang et al. 2004).
6.4.3 Sediment and Soil 
Tin concentrations in soil are generally low, except in areas where tin containing minerals are present 
(Bulten and Meinema 1991).  Tin concentrations in the earth's crust are approximately 2–3 mg/kg 
(Budavari 2001). Tin concentrations in soil can range from 2 to 200 mg/kg, but in areas of high tin 
deposits, levels of 1,000 mg/kg may occur (Schafer and Fembert 1984; WHO 1980).  The mean 
background soil concentration in the United States is 0.89 mg/kg (Eckel and Langley 1988).  Tin 
concentrations in topsoil (0–7.6 cm) from the western end of East St. Louis, Illinois ranged from <13 to 
1,130 mg/kg.  East St. Louis has a history of industrial facilities including smelters of ferrous and 
nonferrous metals, a coal-fired power plant, chemical producing companies, and petroleum refineries 
(Kaminski and Landsberger 2000a).  Sediment cores collected in January 1996 from Central Park Lake in 
New York City, New York contained average tin concentrations ranging from 4.0 mg/kg at 44–47 cm
depth to 67 mg/kg at 22–24 cm depth.  The average tin concentration in surface sediments (0–2 cm depth) 
in Central Park Lake was 32 mg/kg.  The similarities between the history of municipal solid waste 
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appear to be consistent with incineration being the major source of several metals to the New York City
atmosphere (Chillrud et al. 1999).  Tin concentrations in sediments from the Wah Chang Ditch and the 
northeast corner of Swan Lake, an area that received runoff from a Texas tin smelter during the 1940s and 
1950s, were found to be as high as 8,000 mg/kg (Park and Presley 1997). 
Organotin concentrations in sediment are summarized in Table 6-2.  While tributyltin concentrations in 
water have declined since restrictions on tributyltin use in paints have been in place, concentrations of 
tributyltin in sediments have remained relatively high.  Degradation of tributyltin in sediment is much 
slower than in the water column.  Recent surveys of tributyltin concentrations in harbors and marinas in 
various countries show concentrations ranging from hundreds of parts per billion (μg/kg) to low parts per 
million (mg/kg) (Meador 2000).  Tributyltin concentrations in sediment samples from the harbor area of 
Osaka City, Japan ranged from 0.002 to 0.966 mg TBT/kg dry weight (Harino et al. 1998).  Sediment in 
southwestern Spain during November 1993–February 1994 and May–August 1994 were analyzed for the 
presence of butyl- and phenyltin compounds.  No phenyltin species were found in sediment, but mono-, 
di-, and tributyltin were found at all stations sampled, with concentrations of tributyltin ranging from
<0.0006 to 0.16 mg Sn/kg dry weight.  Increased concentrations of organotin concentration during 
summer months were not observed in the sediment, as they were in water and biota, and may be due to 
vertical mixing of the sediment layers by natural and boating activities (Gomez-Ariza et al. 2001).  Tri-, 
di-, and monobutyltin were detected in superficial sediment samples from five river estuaries (Deba, 
Urola, Oria, Oiartzun, and Bidasoa) of Gipuzkoa, North Spain at concentrations of 0.05–5.48, 0.15–0.71, 
and 0.86–2.87 mg Sn/kg dry weight, respectively.  Except for one sampling point, monobutyltin, a 
degradation product of tributyltin, accounted for the largest percentage of total butyltin (>47%) 
(Arambarri et al. 2003).  Sediments collected in November 1997 from three sites near Nuuk, Greenland 
contained tributyltin concentrations ranging from <0.001 to 0.171 mg Sn/kg dry weight (Jacobsen and 
Asmund 2000).  Tributyltin concentrations were measured in sediment collected in 1997 and 1999 from
transects along and perpendicular to the shipping lanes in the Sound (Øresund) and the 
Kattegat/Skagerrak region, an important shipping strait between Denmark and Sweden.  Tributyltin 
concentrations ranged from 0.0015 to 0.0188 mg TBT/kg dry weight in the Sound and were below the 
detection limit (<0.001 mg TBT/kg dry weight) in the Kattegat region.  A strong correlation was observed 
between tributyltin concentration and the organic fraction in sediment samples from the Sound (Strand et 
al. 2003). 
Bancon-Montigny et al. (2004) reported a monitoring study involving sampling along 11 rivers in 
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Table 6-2. Organotin Levels in Sediment 
Nature/location of Concentration of organotin Reported 
sediment compound Units as Reference 
Central-west Greenland, near Nuuk Harbor, surface sediment 
TBT DBT MBT mg Sn/kg dw Mean 
Sandkaj 0.0097 0.0039 <0.001 Jacobsen and 
Asmund 2000 
Havnen 0.171 0.0096 <0.001 
Hundeøen <0.001 <0.001 <0.001
St. Lawrence River in the Quebec City area, surface sediments 
TBT DBT MBT DPT mg Sn/kg dw Mean Regoli et al. 2001 
Portneuf 0.097 0.286 0.989 <0.001 
Sillery 0.146 0.165 0.087 <0.001 
Quai Lévis 0.173 0.496 0.123 0.015 
Bassin Louise 0.888 0.997 0.203 <0.001 
Outside Bassin 0.807 0.634 0.185 <0.001 
Louise 
St. Charles River 0.330 0.579 0.165 <0.001 
St. Lawrence Marina 0.209 0.389 0.004 0.101 
Île d'Orléans East 0.211 0.045 0.006 <0.001 
Superficial sediments from five river estuaries (Deba, Urola, Oria, Oiatzun, and Bidasoa) of Gipuzkoa, 
North Spain, October 2000
TBT DBT MBT mg Sn/kg dw Range Arambarri et al. 
2003 
0.05–5.48 0.15–0.71 0.86–2.87 
Huelva coast, southwest Spain 
(November 1993– TBT DBT MBT mg Sn/kg dw Average Gomez-Ariza et 
February 1994) al. 2001 
Canela 0.0067 0.017 0.0032 
Pinillos 0.0009 0.0026 0.0015 
Carreras River 0.0140 0.080 0.015 
Idla Cristana harbor 0.090 0.090 0.035 
Cantil marina 0.100 0.270 0.080 
Punta Caiman 0.0028 0.0037 0.0012 
Isla Cristina <0.0006 <0.0007 0.0034 
breakwater (inner 
part) 
Terron harbor 28.0 46.0 45.0 
Palo 2.0 3.6 8.0 
Rompido marina 130.0 40.0 24.0 
Pino 0.8 0.7 0.9 
Punta Umbria harbor 16.0 69.0 13.0 
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Table 6-2. Organotin Levels in Sediment 
Nature/location of Concentration of organotin Reported 
sediment compound Units as Reference 
Six sites from the lowermost Tennessee River and Kentucky Lake, United States,  
surface sediments (0–5 cm) 
MBT DBT TBT mg/kg dwa Range Loganathan et al. 
1999 
<0.003– <0.001– 0.0053– 
0.320 0.014 0.356 
Thirteen sites in the Sound (Øresund) between Denmark and Sweden, surface sediments, 1997 
NR NR 0.0015– mg/kg dwa Range Strand et al. 
0.0188 2003 
Twenty-four sites from Coddington Cove, Newport, Rhode Island, United States,  
surface sediments (0–2 cm), 1993 and 1994 
NR NR 0.032–0.372 mg Sn/kg dw Range Wade et al. 2004 
Eighteen sites from 11 rivers in southwest France, surface sediments, July 2001 
0.016– 0.001– 0.0013– mg Sn/kg dw Range Bancon-Montigny 
0.125 0.087 0.089 et al. 2004 
Eighteen sites from 11 rivers in southwest France, surface sediments, September 2001 
0.001– ND– ND–0.020 mg Sn/kg dw Range Bancon-Montigny 
0.048 0.037 et al. 2004 
aConcentration reported as mg butyltin ion/kg sediment. 
DBT = dibutyltin; DPT = diphenyltin; dw = dry weight; MBT = monobutyltin; ND = not detected; NR = no data 
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agricultural activities. Mono-, di-, and tributyltin were present in nearly all surface sediment samples 
with concentrations ranging from 0.001 to 0.125, not detected to 0.087, and not detected to 
0.089 mg Sn/kg dry weight, respectively.  Mono-, di-, and triphenyltin and mono-, di-, and trioctyltin 
were also detected in some sediment samples, but with less frequency and generally at lower 
concentrations than the butyltin compounds (Bancon-Montigny et al. 2004). 
Tri-, di-, and monobutyltin were detected in all sediment samples collected in the Quebec City harbor area 
of the St. Lawrence River with concentrations of 0.097–0.888, 0.045–0.997, and 0.004–0.989 mg Sn/kg 
dry weight, respectively.  Diphenyltin was detected in two sites at concentrations of 0.015 and 0.101 mg
Sn/kg dry weight.  The organotin contamination found in this study was more comparable to levels 
reported for Canadian marine harbor sites than to freshwater harbor sites (Regoli et al. 2001). Tributyltin 
and dibutyltin concentrations in surface sediments (0–2 cm) collected in 1990 and 1992 from intertidal 
sites in Portland and Boothbay Harbor, Maine ranged from 0.024 to 12.4 mg TBT/kg and from 0.015 to 
2.23 mg DBT/kg dry weight (Page et al. 1996).  Tributyltin was detected in all 24 surface sediment (0– 
20 cm) samples collected from Coddington Cove, Newport, Rhode Island on November 3, 1993 and June 
13, 1994; concentrations ranged from 0.032 to 0.372 mg Sn/kg dry weight with a mean concentration of 
0.146 mg Sn/kg dry weight.  Sediment cores of varying depth (up to 18 cm) were obtained from seven 
stations. Tributyltin was detected in all of these samples and ranged from 0.0073 to 0.225 mg Sn/kg dry
weight. No consistent trends were observed in the tributyltin concentrations with depth, suggesting that 
mixing is an important process in the sediment column (Wade et al. 2004).  Kentucky Lake constitutes the 
northernmost end of a shipping route for large barges and small ships between the Gulf of Mexico and the 
Ohio River. The lowermost Tennessee River receives industrial waste water from several industries in 
the Calvert City Industrial Complex.  Total butyltin (BT) concentrations in the sediments of the 
lowermost Tennessee River and Kentucky Lake ranged from 0.0068 to 0.356 mg BT/kg dry weight 
(Loganathan et al. 1999). 
6.4.4 Other Environmental Media 
Tin and tributyltin concentrations found in foods are summarized in Tables 6-3 and 6-4, respectively.  Tin 
concentrations of vegetables, fruits and fruit juices, nuts, dairy products, meat, fish, poultry, eggs, 
beverages, and other foods not packaged in metal cans are generally <2 mg/kg.  Tin concentrations in 
pastas and breads have been reported to range from <0.003 to 0.03 mg/kg.  Mean tin concentrations 
ranging from <1 to 1,000 mg/kg have been found in foods packaged in unlacquered or partially lacquered 
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Table 6-3. Tin Levels in Fooda 
Food item Concentration (mg/kg) Reported as 
Dietary intake in a French adult 
Preserved foods in unlacquered cans 




Mushrooms (n=3) 34 (24–45) 

Pineapples (n=5) 82 (44–136) 

Fruit cocktail (n=2) 97 (88–107) 

Peaches (n=3) 44 (27–71) 









Preserved foods in lacquered cans
Bean (n=1) 2.4 Mean, range
Tomatoes (n=2) 6.0 (3.2–8.8)
Asparagus (n=2) 3.9 (1.4–6.5) 
Garden peas (n=1)  1.0 
Mushrooms (n=2) 6.9 (0.4–13.4)
Apricot (n=1) 5.8 
Cherry (n=1) 0.5 
Strawberry (n=1) 0.6 
Papaya (n=1) 2.9 
Meats (n=4) 4.5 (1.1–9.4)
Fishes (n=4) 0.7 (0.3–0.9) 
Fresh foods 












Potatoes (n=5) 0.1 (0.1–0.2) 

Salad (n=4) 0.02 (0.01–0.03) 

Tomatoes (n=4) 0.05 (0.04–0.06) 

Lentils (n=2) 0.13 (0.09–0.17) 

Bananas (n=3) <0.003 

Oranges (n=3) 0.07 (0.06–0.08) 

Pears (n=3) 0.07 (0.06–0.08) 

Apples (n=4) 0.04 (0.02–0.07) 

Apricots (n=2) 0.07 (0.06–0.08) 
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Table 6-3. Tin Levels in Fooda 
Food item Concentration (mg/kg) Reported as 
Mineral waters (n=5) <0.003 
Nonalcoholic beverages (n=10) 0.04 (<0.003–0.13) 
Fishes and crustaceans (n=10) <0.003
Breads (n=6) <0.003
Pasta (n=12) <0.003 
Meats (n=15) <0.003
Cooked pork meats (n=10) <0.003
Milk (n=10) <0.003
Dairy products (n=10) <0.003 
Sugar (n=5) <0.003 
Chocolate (n=1) <0.003 
Oil (n=4) <0.003 
aSource: Biego et al. 1999 
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Table 6-4. Tributyltin (TBT) Levels in Food 
Food item Concentration (ng TBT/g) wet weight 
Seafood from eight markets worldwidea Reported as mean 
Ulsan, Korea 

Mussel, soft tissue 115
 




Shrimp, tail only 19
 






European squid, muscle 655
 
European squid, common cuttlefish, elegant 376
 
cuttlefish, muscle 
Mediterranean mussel, soft tissue 87 
Red tuna, muscle 56 
Common cuttlefish, muscle 14 
Elegant cuttlefish, muscle 13 
Green crab, muscle 3.6 
Lemon sole, Senegalse sole, muscle Not detected 
Galveston, Texas, United States 





Shrimp, whole body 12
 
Shrimp, tail only 11
 
Southern flounder, tropical flounder, muscle 6
 
Oyster, soft tissue 4.6
 






Bigeye tuna, muscle 20
 
Mitre squid, muscle 12
 
Short-necked clam, soft tissue 5.6
 








Atlantic herring, muscle 36
 
Common mussel, blue mussel, soft tissue 22
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Table 6-4. Tributyltin (TBT) Levels in Food 
Food item Concentration (ng TBT/g) wet weight 
Sydney, Australia 

Slimy mackerel, muscle 13
 
Sydney rock oyster, soft tissue 9.2
 
Butterfly fan lobster, muscle (tail) 7.2
 
Arrow squid, cuttlefish, muscle 7
 
Tiger flathead, muscle 6
 
Yellowtail kingfish, muscle 5.3 





Longfin inshore squid, muscle 8.9
 
Cock shrimp, whole body 7.7
 
Common mussel, soft tissue 5.6
 
Witch flounder, muscle 2.7
 
Atlantic salmon, muscle Not detected 















Mussel, soft tissue 5.9
 
Seafood from six markets in the United Statesb Reported as mean summer, winter 
San Pedro, California 

Bottom fish 7.1, 1.7 

Crustaceans 1.2, 1.1 





Bottom fish 2.1, 1.4 

Crustaceans 1.0, 1.4 









Bottom fish 1.3, 1.2 





Bottom fish 1.3, 23 

Crustaceans 1.2, 1.0 

Mollusks 3.3, 0.54 
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aKeithly et al. 1999 
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(WHO 2003).  Data from the Can Manufacturers Institute (CMI 1988) indicate that >90% of tin-lined 
cans used for food today are lacquered.  Only light colored fruit and fruit juices are packed in unlacquered 
cans, since tin helps maintain the color of the fruit. Tin content in foods stored in opened metal cans 
increases over time, since tin can rapidly dissolve in the presence of oxygen.  Acidic foods are more
aggressive to the tin coating in metal cans, and canned acidic foods have higher tin contents.  Tin 
concentrations of canned foods increase with storage time and temperature (WHO 2003). 
Tin concentrations in various foods were determined in a dietary tin intake study for adults in France.  
Foods in lacquered cans generally were found to contain tin concentrations below 10 mg/kg, and tin 
concentrations ranged from 24 to 156 mg/kg in food from unlacquered cans.  The average tin 
concentration in fresh foods was 0.03 mg/kg (Biégo et al. 1999).  Canned vegetables and fruit products 
were found to have mean tin concentrations of 44 and 17 mg/kg fresh weight, respectively, in a 1994 total 
diet study in the United Kingdom (Ysart et al. 1999).  A study of metal concentration in canned milk 
products in Lithuania showed that the content of tin in canned milk exceeded the concentration in raw 
milk, which, in 1990–1992, was on average 0.22 mg/kg.  Mean tin concentrations in evaporated sterilized 
milk, concentrated sterilized milk, and sweetened condensed milk were 85, 89, and 40 mg/kg, 
respectively.  Tin concentrations in canned milk were shown to increase during storage (Ramonaiytơ 
2001). Local and imported edible seaweeds obtained in British Columbia were found to contain tin in
concentrations ranging from 0.01 to 0.46 mg/kg dry weight (van Netten et al. 2000). 
Samples of fish, crustaceans, cephalopods (i.e., squid), and bivalve mollusks were purchased from
markets in Stockholm, Sweden; London, England; Marseille, France; Singapore; Ulsan, Korea; Sydney,
Australia; Galveston, United States; and Halifax, Canada during August and September 1997 and 
analyzed for tributyltin content.  Average tributyltin concentrations for bivalves, pelagic fish, pelagic 
invertebrates, and flatfish were 40, 16, 7.4, and 4.6 μg TBT/kg, respectively.  It was noted that the high 
concentrations in bivalves were expected.  The lower concentrations of tributyltin found in flatfish were 
unexpected, since flatfish live on sediment and consume mostly benthic prey.  Sediment is considered a 
sink for tributyltin in aquatic environments (Keithly et al. 1999).  In a similar study, seafood was 
purchased in August 1989 and January 1990, representing a summer and winter sample, from Boston, 
Massachusetts; Baltimore, Maryland; Seattle, Washington; Pensacola, Florida; San Pedro, California; and 
Chicago, Illinois. These locations represented major fishing and aquaculture areas on the coasts of the 
United States and the Great Lakes. Categories of seafood sampled were bottom fish, crustacea, 
freshwater fish, mollusks, and maricultured fish.  Tributyltin was detected in 35% of samples analyzed.  




276 TIN AND TIN COMPOUNDS 
6. POTENTIAL FOR HUMAN EXPOSURE 
compared to seafood purchased in the winter in 10 of the 15 instances where the same or similar species 
were sampled from the same location during the summer and winter surveys.  Elevated tributyltin 
concentrations in seafood sampled during the summer were believed to be consistent with increased 
recreational boat activity in the summer. Mean tributyltin summer concentrations for bottom fish, 
crustaceans, and mollusks were 0.98–7.1, 1.0–2.4, and 2.0–13 μg TBT/kg, respectively.  Mean tributyltin 
winter concentrations for the same seafood categories were 1.0–23, 1.0–1.4, and 0.54–6.3 μg TBT/kg, 
respectively.  The respective summer and winter mean concentrations of tributyltin were 5.9 and 3.2 μg 
TBT/kg in freshwater fish from Chicago, Illinois and 5.2 and 14 μg TBT/kg for pen-reared fish from
Seattle, Washington (Cardwell et al. 1999b).  
Tributyltin and triphenyltin concentrations were determined in foods in a market basket study.  About 
100 kinds of foods were purchased every year in 1990–1993 in Shiga Prefecture, Japan.  Foods were 
divided into 13 groups: I, rice; II, cereals, grains, and potatoes; III, sugar and cakes; IV, fats and oils; V, 
bean products; VI, fruits; VII, green vegetables; VIII, other vegetables and seaweeds; IX, seasonal 
beverages; X, fish, mollusks, and crustaceans; XI, meats and eggs; XII, milk and dairy products; and XIII, 
cooked meats (curry and hash).  Tributyltin and triphenyltin (TPT) were only detected in group X (fish, 
mollusks, and crustaceans) and group VIII (vegetables and seaweeds), with higher levels in group X 
(5.2 μg TBT and 0.4 μg TPT), than in group VIII (0.2 μg TBT and 0 μg TPT) (Tsuda et al. 1995).  
Twenty-two samples of gin, martini, cognac, red wine, and sherry that were stored in plastic containers, 
used in Canada for storage of alcoholic beverages, were analyzed for dioctyltin compounds, dioctyltin 
bis(maleate), and dioctyltin S,S'-bis(isooctyl mercaptoacetate).  Beverages tested contained <40 μg/L tin. 
While these plastic containers contained up to 1,700 μg Sn/g, and these dioctyltin compounds were 
soluble in alcohol (64.7 and 150 μg/mL, respectively), there was no evidence of leaching in any samples 
analyzed (Méranger 1975). 
Tin and organotin concentrations found in human tissues and fluids are summarized in Table 6-5.  Tin 
was detected in nine human adipose tissue samples during the 1982 National Human Adipose Tissue 
Survey at concentrations ranging from 4.6 to 15 μg/g (Stanley 1986).  Urine samples were selected from
the available archived urine specimens from participants in the National Health and Nutrition 
Examination Survey (NHANES) III, conducted from 1988 to 1994.  The 500 samples were chosen to 
represent a broad range of the U.S. population. Tin was detected in 89% of samples (detection limit, 
0.1 μg/L) and had a 95th upper percentile concentration of 20.1 μg/L (Paschal et al. 1998).  Tissue samples 
from various organs were obtained from 20 deceased individuals (15 men and 5 women), who, at the time 
of their death, lived in Terragona, Spain and the surrounding areas for at least 10 years.  No known 
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Table 6-5. Tin and Organotin Levels in Human Tissues and Fluids 
Human tissue or fluid Concentration Units Reported as Reference 
Tin 
Adipose tissue, (n=9) 4.6–15 μg/g Range Stanley 1986 
Urine, NHANES, (n=500) 20.1 μg/L 95th upper Paschal et al. 1998 
percentile 
Urine (n=14) occupationally 1.8 (1.0–2.7) μg/L Mean (range) Schramel et al. 1997 
non-exposed men and women, 
Germany 
Terragona, Spain (n=20) 
Brain 0.98 (0.28–4.57) μg/g ww Mean (range) Llobet et al. 1998 
Bone 6.18 (2.72–17.32) 
Kidney 1.54 (0.68–3.04) 
Liver 4.44 (1.84–10.16) 
Lung 1.74 (0.67–6.54) 
Terragona, Spain (n=78) 
Brain 0.27 (0.23–0.74) μg/g ww Mean (range) García et al. 2001 
Bone 0.47 (0.45–0.76) 
Kidney 0.25 (0.23–0.43) 
Liver 0.16 (0.09–0.27) 









Total butyltin 0.0024–0.0110 μg/g wwa Range Kannan and Falandysz 
(MBT+DBT+TBT) 1997 
Denmark (n=18) 






Monobutyltin 0.018 (0.012–0.022) μg/g wwa Mean (range) Takahashi et al. 1999 
Dibutyltin 0.066 (0.045–0.078) 
Tributyltin <0.0020 
aConcentrations of organotins are reported in μg organotin species/g or mL. 
DBT = dibutyltin; MBT = monobutyltin; TBT = tributyltin; ww = wet weight
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occupational exposure to metals was found for these subjects based on a questionnaire sent to relatives.  
Tin concentrations were lowest in brain tissue and highest in bone at 0.98 and 6.18 μg/g wet weight, 
respectively.  No significant differences in tin concentrations were noted based on gender or age (Llobet 
et al. 1998). In a similar study, samples of liver, lung, kidney, brain, and bone were collected from
78 adult subjects (57 men and 21 women) autopsied between 1997 and 1999 who at the time of death 
lived in Tarragona County, Spain or in the surroundings for the last 10 years.  Autopsy records included 
data on gender, age, occupation, residence, and smoking and drinking habits.  No occupational exposure 
to heavy metals was found in this group.  Ages ranged from 36 to 76 years, 55% were considered 
smokers, and 24% were considered drinkers.  An individual was considered a smoker if he or she smoked 
more than one pack of cigarettes per day for at least 1 year of his or her life.  Men who consumed more
than 280 g of alcohol per week (168 g for women) were considered drinkers.  Place of residence was 
divided into three areas: (a) near the petrochemical industry, (b) near the petroleum refineries and 
municipal solid waste incinerator, and (c) urban area (downtown).  For tin concentrations in the tissues 
studied, no significant differences between sex, smoking and drinking habits, or places of residence were 
found. One exception was in the kidney, where tin concentrations were slightly higher in drinkers (García 
et al. 2001). 
Butyltin compounds were measured in human blood collected in July 1998 in central Michigan from
17 male and 15 female individuals.  Mono-, di-, and tributyltin were detected in 53, 81, and 70% of the 
samples.  Mono-, di-, and tributyltin concentrations ranged from below the detection limit to maximum
concentrations of 0.027, 0.016, and 0.085 μg organotin ion/mL, respectively.  Total butyltin 
concentrations ranged from below the detection limit to 0.101 μg BT/mL (Kannan et al. 1999).  Human 
liver samples from nine individuals, aged 45–83, obtained from the Gdansk School of Medicine, Poland 
in March 1994, were found to contain total butyltin (mono-, di-, and tributyltin) concentrations ranging 
from 0.0024 to 0.011 μg BT/g wet weight (Kannan and Falandysz 1997).  Four human liver samples 
obtained by autopsy in Ehime University Hospital, Japan in 1997 and 1998 were found to contain average 
concentrations of mono-, di-, tributyltin, and total butyltin of 0.018, 0.066, <0.002, and 0.084 μg 
organotin ion/g wet weight, respectively (Takahashi et al. 1999).  Liver samples from 18 deceased Danish 
men aged 21–82 were collected from December 1999 to January 2000 at the Institute for Forensic 
Medicine, SDU, Odense University. Concentrations of tributyltin and triphenyltin were all below the 
detection limit, <0.0003 μg TBT/g and <0.003 μg TPT/g.  Mean concentrations (and ranges) of mono- 
and dibutyltin were 0.0016 (0.0003–0.0047) μg MBT/g and 0.009 (0.0008–0.0283) μg DBT/g wet weight.  
A large interperson variability was noted for this sample with a more than 25-fold difference between the 
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Ten individual indoor dust samples were collected from 10 regions from the United Kingdom in 2002.  
Samples were collected primarily from private households, but also included some businesses.  Samples 
were analyzed for various chemicals including eight organotin compounds, mono-, di-, tri-, and 
tetrabutyltin, mono- and dioctyltin, tricyclohexyltin, and triphenyltin.  Mono-, di- and tributyltin, and 
mono- and dioctyltin were found in all pooled regional samples, and mean concentrations were 1.375,
0.563, 0.1445, 0.4506, and 0.1292 μg organotin ion/g, respectively.  Triphenyltin was found in only one 
pooled sample, at a concentration of 0.0069 μg TPT/g.  Tetrabutyltin and trihexyltin were not detected.  
Detection limits were 0.001 μg organotin ion/g dry weight.  Possible sources of these organotin 
compounds in the home may be from the use of butyl- and octyltin compounds as stabilizers in PVC.  In 
addition, tributyltin is used as a fungicide and as treatment against dust-mites in carpets and textiles.  Dust 
samples from Denmark, Finland, France, Spain, and Sweden showed similar patterns of organotin 
contents as found in the United Kingdom samples (Santillo et al. 2003). 
Tin concentrations in the kidneys of mink collected from the Kootenay River and lower Fraser River in 
British Columbia, Canada were 6.25 and 5.5 μg/g dry weight.  Tin concentrations in the livers of mink 
from the upper and lower Fraser River were 5.53 and 5.17 μg/g dry weight, respectively. Tin 
concentrations in the livers of otters were <4 μg/g dry weight collected from the Kootenay, lower and 
upper Columbia, and upper Fraser Rivers, and 2.67 μg/g from the lower Fraser River (Harding et al. 
1998).  Tin concentrations in mantle muscle and liver samples of juvenile Japanese common squid, 
Todarodes pacificus, collected from three locations in and near Japanese coasts, were 0.042–0.050 and 
0.077–0.13 μg/g wet weight, respectively (Ichihashi et al. 2001). 
Concentrations of butyltin (mono-, di-, and tributyltin) compounds were determined in the kidney and 
liver of 18 species of seabirds collected between the mid-1980s and mid-1990s from Japan, Korea, the 
North Pacific Ocean, and the southern Indian Ocean. The highest mean total butyltin concentrations were 
found in the kidney and liver of inland and coastal birds.  The highest mean concentrations of butyltins 
(BT) were found in common cormorants from Lake Biwa, Japan at 0.300 and 0.280 μg BT/g wet weight, 
in kidney and liver, respectively.  Among the open sea birds, the Laysan albatross from the North Pacific 
Ocean had the highest total butyltin concentrations in the liver at 0.043 μg BT/g wet weight (Guruge et al. 
1997).
Concentrations of tributyltin and triphenyltin were measured in the muscle of 11 species of fish from the 
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from 0.011 to 0.182 μg TBT/g and from <0.001 to 0.130 μg TPT/g wet weight.  In addition, mono- and 
dibutyltin and diphenyltin were detected in all samples.  Monophenyltin was detected in all but one 
sample from the Port of Osaka and none of the samples from the Yoda River (<0.001 μg MPT/g wet 
weight). Concentrations of organotin compounds were higher in fish from sea areas than those from the 
river (Harino et al. 2000). Ueno et al. (2004) determined butyltin concentrations in the liver of skipjack 
tuna (Katsuwonus pelamis) collected from Asian offshore waters, off-Seychelles (west African coast), 
off-Brazil (west South American coast), and in open seas (North Pacific) during 1996–2001. High 
concentrations of butyltins were found in skipjack tuna from offshore waters around Japan with 
concentrations up to 0.400 μg BT/g wet weight.  Tributyltin was detected a relatively higher 
concentrations in all locations, with mean concentrations ranging from 0.0049 to 0.200 μg TBT/g wet 
weight in the North Pacific and the East China Sea, respectively.  Monobutyltin concentrations were 
below the detection limit (0.0018 μg MBT/g) for four samples from the South China Sea, off-Indonesia, 
off-Seychelles, and off-Brazil, and ranged up to 0.017 μg MBT/g wet weight in the East China Sea (Ueno 
et al. 2004). 
Concentrations of di- and tributyltin were studied in whole-body fish samples from six freshwater sites 
across the United States (Jones-Lepp et al. 2004).  Di- and tributyltin were not detected in 8 and 9 of the 
13 fish samples, respectively, that were collected from these sites (detection limits were 0.00097 and 
0.0018 μg/g for di- and tributyltin, respectively).  The highest concentrations were reported in largemouth 
bass (Micropterus salmoides) from Red Bank Creek, South Carolina at 0.221 μg DBT/g , and in 
shorthead rosehorse (Moxostoma macrolepidotum) from the Little Missouri River, North Dakota at 
0.389 μg TBT/g (Jones-Lepp et al. 2004).  
Strand and Asmund (2003) studied the concentrations of butyltins in bivalves collected between 1999 and 
2000 from six areas along the west coast of Greenland.  The highest tributyltin concentration, 0.254 μg 
TBT/g wet weight, was found in mussels (Mytilus edulis) sampled inside Nuuk harbor, the largest harbor 
in West Greenland. Tributyltin could only be detected in two of the six areas outside of the harbor areas 
at concentrations of 0.001 and 0.0027 μg TBT/g wet weight, in Chlamys islandica and Nuculana pernula, 
respectively.  Di- and monobutyltin concentrations ranged from <0.0005 to 0.025 and from <0.0005 to 
0.0041 μg organotin ion/g wet weight, respectively, in M. edulis in the harbor sites.  Di- and monobutyltin 
were not detected in C. islandica from open water sites, and were detected in N. pernula from open water 
at 0.0016 and 0.0012 μg organotin ion/g wet weight, respectively.  Triphenyltin could not be detected in 
any samples (<0.005 μg TPhT/g wet weight) (Strand and Asmund 2003).  M. edulis, clams (Mercenaria 
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Rhode Island were found to contain tributyltin concentrations ranging from 0.0092 to 0.977 μg Sn/g wet 
weight. Tributyltin concentrations in lobsters from the same area were all below the detection limit 
(<0.006 μg Sn/g) (Wade et al. 2004).  Tributyltin concentrations were measured in benthic mollusks 
(N. pernula, Nucula sulcata, Nucula tenuis, Artica islandica, Musculus niger, Cardium echinatum, 
Buccinum undatum, and Neptunea antiqua) collected in 1997 and 1999 from transects along and 
perpendicular to the shipping lanes in the Sound (Øresund) and the Kattegat/Skagerrak region, an 
important shipping strait between Denmark and Sweden.  Di- and tributyltin were detected in all mollusk 
samples, and ranged from 0.011 to 0.267 μg DBT/g and from 0.0081 to 1.316 μg TBT/g dry weight 
(Strand et al 2003). Tributyltin was found in mussels (Mytilus galloprovincialis) from Portuguese coastal 
waters at concentrations of 0.011–0.789 μg Sn/g dry weight and was detected at all 17 sites sampled 
between May and July 2000.  Mono- and dibutyl tin were also found in most samples with concentrations 
ranging from not quantifiable to 0.605 and from not quantifiable to 0.345 μg Sn/g dry weight, 
respectively.  Di- and triphenyltin concentrations were not quantifiable in all but one sample, with a 
triphenyltin concentration of 0.016 μg Sn/g dry weight (Barroso et al. 2004). 
Tributyltin, dibutyltin, and monobutyltin concentrations were determined in the liver, kidney, and brain 
tissues of adult southern sea otters (Enhydra lutris nereis) found dead along the coast of California during 
1992–1996. The mean and range of liver, kidney, and brain concentrations for total butyltin compounds 
were 1.320 (0.040–9.2), 0.160 (0.004–0.43), and 0.061 (0.0027–0.14) μg BT/g wet weight, respectively.  
The accumulation of butyltin compounds in sea otters was explained by their bottom-feeding habit and a 
diet that consists exclusively of invertebrates such as mollusks and gastropods (Kannan et al. 1998a).  
Butyltin concentrations in the liver, kidney, and brain tissues of southern sea otters (E. lutris nereis) found 
dead on the California coast during 1992–1996 were 0.040–5.3, 0.004–0.265, and 0.0039–0.140 μg BT/g 
wet weight, respectively (Kannan et al. 2004). 
Berge et al. (2004) studied the concentrations of organotin compounds in samples of harbor porpoise 
(Phocoena phocoena), common seal (Phoca vitulina), ringed seal (Phoca hispida), and glaucous gull 
(Larus hyperboreus) from Norwegian territories without any obvious point sources of tributyltin.  Most 
samples were collected between 1998 and 2000; however, some of the porpoise samples were collected in 
1988, which is prior to the restriction on the use of tributyltin on smaller boats.  The highest 
concentrations of mono-, di-, and tributyltin were found in harbor porpoise samples in Northern Norway
in 1988, especially in liver tissue with mean concentrations of 0.0345, 0.285, and 0.098 μg Sn/g wet 
weight, respectively.  In general, mono-, di-, and tributyltin concentrations were lower in harbor porpoise 
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glaucous gulls from Bear Island.  Concentrations of phenyltins in blubber, kidney, and brain of common 
seals were below the detection limit (generally <0.001 μg Sn/g wet weight). Mono-, di-, and triphenyltin 
were detected in the liver, muscle, and kidney of harbor porpoises samples in 1999; mono- and 
diphenyltin were dominant in liver and muscle with mean concentrations of 0.0164 and 0.0192 μg Sn/g 
wet weight, respectively (Berge et al. 2004).  
Ciesielski et al. (2004) measured the organotin concentrations in liver tissue of marine mammals found 
between 1999 and 2003 from the Polish coast of the Baltic Sea.  The mammals studied included 14 harbor 
porpoises (P. phocoena), 2 striped dolphins (species not specified), 1 ringed seal (P. hispida), and 2 grey
seals (Halichoerus grypus). Tributyltin was detected in all samples and ranged from 0.044 to 1.488 μg 
Sn/g dry weight in grey seal and striped dolphin, respectively.  Dibutyltin was not detected in the two 
grey seal liver samples, but was detected in all other samples ranging from 0.071 to 3.295 μg Sn/g dry 
weight in ringed seal and striped dolphin, respectively.  Monobutyltin was not detected in one of the grey
seal samples, but was detected in all other samples ranging from 0.021 to 2.915 μg Sn/g dry weight for 
grey seal and striped dolphin, respectively (Ciesielski et al. 2004). 
6.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE 
Human exposure to tin may occur by inhalation, ingestion, or dermal contact.  However, exposure of the 
general population occurs primarily by ingestion of food (NAS 1977; WHO 1980).  The daily intake from
air is unlikely to exceed 0.5 μg based on concentrations of tin in air that have been estimated to be in the 
range of 0.002–0.03 μg/m3 (Biégo et al. 1999).  Tinplate, which is steel coated with a thin layer of
metallic tin, has been used to line cans for food.  Some of these cans are also coated with a lacquer.  
While new canning techniques have decreased the amount of tin contamination of foods over the years, 
metal cans still are the main source of tin in the diet (WHO 2003). Tin(II) chloride is used as a food 
additive and has U.S. FDA Generally Regarded As Safe (GRAS) approval.  It is used as a preservative for 
canned soda water, a color retention agent in canned asparagus, and a component in food packaging 
materials (Kroschwitz and Howe 1997).  Tin exposure may occur from dental preparations, since tin(II) 
fluoride (0.41%) is an approved fluoride source in dentifrices (Pader 1993).  In a laboratory study to 
determine the amount of tin and other metals leached into water from copper piping with four types of 
lead-free solders, which contain 94–95.5% tin, no significant leaching of tin was observed (Subramanian 
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Estimates of daily dietary tin intake ranged from 1 mg, for diets consisting mainly of fresh meats, 
vegetables, and cereals, to 38 mg for diets including a high proportion of canned foods (Schafer and 
Femfert 1984; WHO 1980).  The average daily tin intake of an adult in the United States was estimated at 
4.003 mg (4 mg from food and 0.003 mg from air), and with undetectable levels contributed by drinking 
water (EPA 1987a; WHO 1980).  Other estimates of human daily intake range from 0.2 to 17 mg
(Klaassen et al. 1986; Krigman and Silverman 1984).  Tin levels in drinking water have been reported at 
<0.010 mg/L.  If daily intake of water is assumed to be 2 L/day, then intake of tin from water would be 
0.012–0.020 mg/day (WHO 2003).  The tin contents in fresh food or food packaged in lacquered or 
unlacquered cans were determined to estimate the daily tin intake in an adult in France.  From this study, 
it was found that canned foods, while representing 6–7% of the daily consumed foods, represented >95% 
of the total tin intake. The estimated tin intake by an adult in France was determined to be 0.04 mg/kg 
body weight (Biégo et al. 1999).  In a 1994 total diet study in the United Kingdom, the canned vegetables 
group and fruit product group contributed 66 and 31%, respectively, to the total average exposure of tin, 
which was estimated as 2.4 mg/day.  From this study, an upper range exposure to tin of 7.9 mg/day was 
estimated. Population dietary exposure to tin from total diet studies in the United Kingdom from 1976 to 
1994 ranged from 1.7 mg/day in 1985 to 5.4 mg/day in 1991 (Ysart et al. 1999). 
Little is known about the extent of exposure of humans to butyltin compounds (Kannan et al. 1999).
Occupational exposure represents the greatest exposure to tributyltin; nonoccupational exposure to 
tributyltin is usually slight, with diet as the most important means of exposure (Demora and Pelletier 
1997). Dermal absorption is a significant route of occupational exposure for certain organotin 
compounds (Stewart and Lassiter 2001).  Household commodities made of polyurethane, plastic 
polymers, and silicons contain butyltin concentrations in the ppm range.  Butyltin compounds are also 
found in seafood (Cardwell et al. 1999b; Kannan et al. 1999; Keithly et al. 1999).  The daily intakes of 
tributyltin and triphenyltin in Japan were estimated to be 4.7 and 0.7 μg in 1991 and 2.2 and 0.7 μg in 
1992, respectively, based on a duplicate portion study.  In this study, cooked meals were collected for 
3 days from women in Shiga Prefecture, Japan in 1991 and 1992, and were homogenized and frozen.  In a 
separate market basket study in Shiga Prefecture, Japan, daily intakes of tributyltin and triphenyltin in 
Japan were estimated to be 6.9 and 5.4 μg in 1991 and 6.7 and 1.3 μg in 1992, respectively. Of the food 
groups analyzed in the market basket study, 95% of the daily intakes of tributyltin and triphenyltin came 
from the fish, mollusks, and crustaceans food group (Tsuda et al. 1995).  Human dietary exposure to 
butyltins by food in order of importance may be regarded as: marine food > animal-origin foods (dairy
and meat) > farm products (rice, and sunflower and peanut oil) (Kannan et al. 1995).  Other routes of 
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materials, which have led to contamination of food, drinking water, and municipal sewage sludges, as 
suggested in some studies.  Dibutyltin and octyltin compounds have been found in some textiles products.  
It has been demonstrated that butyltin compounds in siliconized baking parchment can be transferred to 
food baked on this type of baking parchment (Takahashi et al. 1999).  Organotin compounds were found 
in household dust in a U.K. study (Santillo et al. 2003). 
Occupational exposures to tin may be substantial.  Inhalation or dermal exposure to triphenyltin leachate, 
used in fungicides and insecticides, may occur during both manufacturing and application (NAS 1977; 
WHO 1980).  Workers in the numerous industries producing or using inorganic tin or organotin
compounds (Section 5.3) may also be exposed.  NIOSH estimated that 730,000 workers in the United 
States were potentially exposed to tin in the workplace in 1980 (NOES 1989). The National Occupational 
Exposure Survey (NOES) database does not contain information on the frequency, concentration, or
duration of exposure to workers to tin or any of its compounds.  These surveys provide only estimates of 
number of workers potentially exposed to chemicals in the workplace. 
6.6 EXPOSURES OF CHILDREN 
This section focuses on exposures from conception to maturity at 18 years in humans.  Differences from
adults in susceptibility to hazardous substances are discussed in Section 3.7, Children’s Susceptibility. 
Children are not small adults.  A child’s exposure may differ from an adult’s exposure in many ways. 
Children drink more fluids, eat more food, breathe more air per kilogram of body weight, and have a 
larger skin surface in proportion to their body volume.  A child’s diet often differs from that of adults.  
The developing human’s source of nutrition changes with age:  from placental nourishment to breast milk 
or formula to the diet of older children who eat more of certain types of foods than adults.  A child’s 
behavior and lifestyle also influence exposure.  Children crawl on the floor, put things in their mouths, 
sometimes eat inappropriate things (such as dirt or paint chips), and spend more time outdoors.  Children 
also are closer to the ground, and they do not use the judgment of adults to avoid hazards (NRC 1993). 
Exposure to tin and tin compounds for children will be similar to adults and will occur primarily through 
the diet. In a 7-day duplicate diet study of 97 pre-school aged (1.75–2.2 years) children from the 
Birmingham area in the United Kingdom, the average daily intake of tin was 1.78 mg/kg.  In this study,
mothers were asked to collect and weigh duplicate samples of all food and drink (including water) 
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amount of canned food consumed and the concentration of tin in the diet (Smart et al. 1987). Children 
living in institutional settings may be served more canned foods due to their ease of storage and 
economical price, and may be exposed to higher levels of tin than the general population (WHO 2003). 
In a joint World Health Organization (WHO) and International Atomic Energy Agency (IAEA) 
collaborative study published in 1989 on minor and trace elements in breast milk, median tin 
concentrations were 2.81 and 0.24 μg/L in breast milk from women in Guatemala and Zaire, respectively, 
3 months after giving birth (WHO/IAEA 1989).  No data were located regarding current concentrations of 
tin or tin compounds in human breast milk in the United States.  Other possible exposures to tin by
children may occur from the clothing of other household members with occupational exposure (Rinehart 
and Yanagisawa 1993). 
6.7 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES 
People eating a high percentage of their diet from canned foods will be exposed to higher amounts of tin 
than the general population.  For example, people living in intuitional settings, such as nursing homes, 
boarding schools, or prisons, or people with lower incomes may be served or choose canned foods due to 
their ease of storage and economical price (WHO 2003).  
Potentially high inhalation exposures to tin and its compounds may occur in the workplace or from
agricultural uses of tin compounds. A study of the tin and lead concentrations in house dust from the 
homes of nine electrical-cable splicers employed by a large power company found higher tin 
concentrations in house dust from the splicers' homes compared to house dust from control homes.  Tin 
concentrations in house dust from the homes of splicers and the controls were 117 and 14 ppm in laundry 
areas, and in other areas concentrations were 66 ppm and not detected (<10 ppm), respectively.  In one of 
the control homes occupied by a person who soldered copper water pipes in his home using lead-tin 
solder, tin concentrations in dust were 5 times higher than levels found in dust from homes of either the 
control or splicer groups (Rinehart and Yanagisawa 1993).  In a 1994 study of heavy metal exposure in a 
Bolivian smelter, personal breathing zone air samples were collected by 15 workers, representing 12 job 
categories during one shift according to NIOSH Method 7300.  Tin exposure was below the occupational 
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6.8 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the 
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether 
adequate information on the health effects of tin and tin compounds is available.  Where adequate 
information is not available, ATSDR, in conjunction with NTP, is required to assure the initiation of a 
program of research designed to determine the health effects (and techniques for developing methods to 
determine such health effects) of tin and tin compounds. 
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that if met would 
reduce the uncertainties of human health assessment.  This definition should not be interpreted to mean 
that all data needs discussed in this section must be filled.  In the future, the identified data needs will be 
evaluated and prioritized, and a substance-specific research agenda will be proposed. 
6.8.1 Identification of Data Needs 
Physical and Chemical Properties. Table 4-2 and Section 4.2 summarize many of the relevant 
physical and chemical properties of tin and many of its compounds.  There are adequate data for the 
physical and chemical properties of tin and inorganic tin compounds.  The chemical behavior of most of 
the common organotin compounds in environmentally-relevant media is not well known.  There is a need 
to measure the solubility and vapor pressure of the more important organotin compounds in order to 
provide a more reliable basis for predicting their fate in the environment. 
Production, Import/Export, Use, Release, and Disposal.    According to the Emergency 
Planning and Community Right-to-Know Act of 1986, 42 U.S.C. Section 11023, industries are required 
to submit substance release and off-site transfer information to the EPA.  The TRI, which contains this 
information for 2001, became available in May of 2004.  This database is updated yearly and should 
provide a list of industrial production facilities and emissions. 
Production volumes and uses of tin are well-documented (Carlin 2003b, 2004). While data were 
available on the uses of many organotin compounds, current production volumes could not be located.  
Data on releases, disposal practices, and possible environmental contamination from uses of tin and its 
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constituent, current data are not available on industrial releases or disposal practices. Information on 
releases or disposal practices, and current quantitative data on leaching of inorganic and organic forms of 
tin into foods from tin-lined cans and PVC packaging materials would be useful in assessing potential 
human exposure to tin compounds. 
Environmental Fate. From the information available, it appears likely that both inorganic and 
organotin will partition to soils and sediments, and will not volatilize from water (Blunden et al. 1984;
Cooney 1988; Fent 1996; Maguire et al. 1983, 1985; WHO 1980).  Research on physical and biological 
processes in water and at sediment-water interfaces would be particularly helpful to more accurately
predict the fate of tin compounds released to the environment.  Methyltin compounds can be produced in 
the environment by biomethylation of inorganic tin (Fent 1996).  It has been suggested that methylation 
of butyltin compounds in sediment may lead to mobilization of tin species into the water column and 
possibly to the atmosphere.  However, there is currently no significant evidence of losses of organotin 
compounds to the atmosphere (Amouroux et al. 2000). 
Bioavailability from Environmental Media.    Inorganic tin is not well absorbed after inhalation, 
oral, and dermal exposure.  Organotin compounds are somewhat better absorbed by both the inhalation 
and oral routes (Hiles 1974; Mori et al. 1984).  Dermal absorption is a significant route of occupational 
exposure for certain organotin compounds (Stewart and Lassiter 2001).  The daily intakes of tin from air, 
food, and water are small (WHO 1980).  Further study of human intake of organotin compounds from
food and water would also be useful. The pH may be an important consideration for the bioavailability of 
organotin compounds.  Bioconcentration studies by Looser et al. (1998) indicated that as pH increases, 
uptake of organotin compounds increases. 
Food Chain Bioaccumulation. It has been established that organotins can be bioconcentrated by
aquatic organisms in marine environments (Gomez-Ariza et al. 2001; Harino et al. 2000; Hongxia et al. 
1998; Laughlin and Linden 1985; Looser et al. 1998; Maguire et al. 1984; Meador 2000; Suzuki et al. 
1998; Tsuda et al. 1986; Waldock and Thain 1983; Yamada and Takayanagi 1992).  Similar information 
for terrestrial ecosystems would be useful.  Inorganic tin compounds may also be bioconcentrated, but 
data are limited (Seidel et al. 1980; Thompson et al. 1972).  There is no information available on the 
potential transfer of inorganic tin or organotin compounds from lower trophic levels to higher levels.  
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Exposure Levels in Environmental Media. Reliable monitoring data for the levels of tin and tin 
compounds in contaminated media at hazardous waste sites are needed so that the information obtained 
on levels of tin and tin compounds in the environment can be used in combination with the known body 
burden of tin and tin compounds to assess the potential risk of adverse health effects in populations living 
in the vicinity of hazardous waste sites. 
Data were obtained regarding tin levels in air (Dannecker et al. 1990; EPA 1982a, 1988c; NAS 1977; 
Sweet and Vermette 1993; WHO 1980).  No monitoring data for concentrations of organotin compounds 
in air were found.  Inorganic tin levels in water are limited to data obtained in the early 1980s (NAS 1977; 
WHO 1980) and more recent data were not found.  Due to its use in marine paints, tributyltin levels, as 
well as di- and monobutyltin, levels are monitored in water (Gomez-Ariza et al. 2001; Grovhoug et al. 
1996; Hall 1988; Harino et al. 1998; Sadiki and Williams 1996, 1999; Sadiki et al. 1996; Yang and 
Maguire 2000). There have only a few surveys reported that monitor the occurrence of organotin 
compounds in U.S. freshwaters (Bancon-Montigny et al. 2004; Jones-Lepp et al. 2004).  Additional 
information on inorganic and organotin concentrations in all media, especially air, water, and soil at 
hazardous waste sites, determined by the most sensitive analytical methods, would be useful in evaluating 
human exposure to tin. 
Several estimates concerning the human daily intake of tin have been reported (Biégo et al. 1999; EPA 
1987c; Klaassen et al. 1986; Krigman and Silverman 1984; WHO 1980; Ysart et al. 1999).  Data on the 
intake of organotin compounds from food are limited (Cardwell et al. 1999b; Keithly et al. 1999; 
Méranger 1975; Tsuda et al. 1995).  
Exposure Levels in Humans. Tin has been detected in human adipose tissue (Stanley 1986), urine 
(Paschal et al. 1998; Schramel et al. 1997), and brain, bone, kidney, liver, and lung (García et al. 2001; 
Llobet et al. 1998). Butyltin compounds have been detected in blood (Kannan et al. 1999) and liver 
(Kannan and Falandysz 1997; Nielsen and Strand 2002; Takahashi et al. 1999). These reports are for 
populations without documented high exposures to tin and tin compounds and should represent 
background levels in human tissues.  Biological monitoring data, especially for populations near 
hazardous waste sites, would help to assess human exposure to tin and tin compounds. 
This information is necessary for assessing the need to conduct health studies on these populations. 
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Exposures of Children. Very little data were found regarding the exposure of children to tin and tin 
compounds (Smart et al. 1987; WHO 2003; WHO/IAEA 1989).  Like adults, the major route of exposure 
to tin will be through the diet, particularly a diet high in canned foods.  Levels of tin and organotin 
compounds in the tissue and body fluids of children have not been found.  Levels of tin in human breast 
milk have been reported (WHO/IAEA 1998); however, more recent tin concentrations in human breast 
milk have not been found. 
Child health data needs relating to susceptibility are discussed in Section 3.12.2, Identification of Data 
Needs: Children’s Susceptibility. 
Exposure Registries. No exposure registries for tin and tin compounds were located.  Tin and tin 
compounds are not currently substances for which a sub-registry has been established in the National 
Exposure Registry. Tin and tin compounds will be considered in the future when chemical selection is 
made for sub-registries to be established.  The information that is amassed in the National Exposure 
Registry facilitates the epidemiological research needed to assess adverse health outcomes that may be 
related to exposure to these substances. 
6.8.2 Ongoing Studies 
The Federal Research in Progress (FEDRIP 2004) database provides additional information obtainable 
from a few ongoing studies that may fill in some of the data needs identified in Section 6.8.1.  These 
studies are summarized in Table 6-6. 
The Organotin Environmental Programme (ORTEP) Association is an international non-profit 
organization of producers of organotin compounds established in 1978 by companies from the United 
States, Europe, and Japan. The goals of the ORTEP Association include the promotion and 
encouragement of the dissemination of scientific and technical information on the environmental effects 
of organotin compounds (ORTEP 2004).  The International Tin Research Institute (ITRI) tin producers 
announced, in October 20, 2004, a project that will begin in January 2005 that will generate information 
to increase the understanding of the tin industry, and the applications of tin, as well as the interactions of 
tin with humans and the environment, including increased scientific understanding of the environmental 
fate of tin during its use and recycling (Tin Technology 2004).  
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Table 6-6. Ongoing Studies on Organotin Compoundsa 
Investigator Affiliation Research description Sponsor 
Eng G University of the 
District of 
Columbia 
Investigation of the environmental fate of triorganotins 
that leach in the aerobic and anaerobic sediments of 
D.C. waterways and determination of the toxicity of 
these compounds on the aquatic biota. 
Department of 
Agriculture 
Pannell KH University of 
Texas at El Paso 
The investigators propose to continue their initially 
successful study concerning the synthesis and 
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The purpose of this chapter is to describe the analytical methods that are available for detecting,  
measuring, and/or monitoring tin and tin compounds, their metabolites, and other biomarkers of exposure 
and effect to tin and tin compounds.  The intent is not to provide an exhaustive list of analytical methods.  
Rather, the intention is to identify well-established methods that are used as the standard methods of 
analysis.  Many of the analytical methods used for environmental samples are the methods approved by 
federal agencies and organizations such as EPA and the National Institute for Occupational Safety and 
Health (NIOSH).  Other methods presented in this chapter are those that are approved by groups such as 
the Association of Official Analytical Chemists (AOAC) and the American Public Health Association 
(APHA). Additionally, analytical methods are included that modify previously used methods to obtain 
lower detection limits and/or to improve accuracy and precision. 
Tin is usually determined as the total metal, but it may also be measured as specific organotin 
compounds.  Flame atomic absorption analysis is the most widely used and straightforward method for 
determining tin; furnace atomic absorption analysis is used for very low analyte levels and inductively 
coupled plasma atomic emission analysis is used for multianalyte analyses that include tin. 
The preferred separation technique for organotin compounds is gas chromatography (GC) due to its high 
resolution and detector versatility.  Analysis of organotin compounds usually consists of four steps:  
(1) extraction; (2) formation of volatile derivative; (3) separation; and (4) detection and quantification.  
First, the organotin compounds must be extracted from the sample using organic solvents, ion exchange 
resins, or adsorption onto a solid support.  For biological materials, a general clean-up step is needed, 
such as purification using Florisil, silica gel, alumina, or ion exchange resin.  The extracted organotin 
compounds must then undergo derivatization to a volatile form to be able to separate them by GC.  
Derivatization methods include the formation of alkyl (methyl or pentyl) derivatives using a Grinard 
reagent, formation of ethyl derivatives using sodium tetraethylborate, or by formation of hydrides 
(RnSnH4-n) using sodium borohydride.  Separation of these derivatives may be done using differences in 
their boiling points or by GC.  Finally, detection and quantification can be performed using a flame 
photometric detector, atomic absorption spectroscopy (AAS), or mass spectrometry (MS) (Takeuchi et al. 
2000; WHO 1990).
High performance liquid chromatography (HPLC) has also been used in the analysis of organotin 
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Most separations are based on ion exchange or reversed phase separations using gradient elution.  AAS, 
inductively coupled plasma mass spectrometry (ICP-MS), and fluorometric detection can be used.  HPLC 
coupled with AAS is commonly used for speciation of organotin compounds (Takeuchi et al. 2000).  
7.1 BIOLOGICAL MATERIALS 
Tin and its compounds can enter the human body through inhalation, ingestion, or penetration through the 
skin. Levels of tin and tin compounds in the body can be estimated by analysis of body fluids, excreta, or 
tissues. Methods for the determination of tin in biological materials are summarized in Table 7-1.  
Normally, for determination in biological samples, the sample is digested in an oxidizing acid mixture 
followed by atomic spectrometric determination.  Determination of organotin compounds in biological 
materials will require extraction, derivatization, separation, and detection, as described above.  Human 
exposure to elemental tin and organotin compounds may be determined by analysis of blood or urine.  
Whole blood samples are typically analyzed by spectrophotometry and photometry.  Urine samples may
be acid digested to destroy organic matter and to oxidize tin to the tin(IV) state (Stewart and Lassiter 
2001).
7.2 ENVIRONMENTAL SAMPLES 
Methods for determination of tin in environmental samples are summarized in Table 7-2. 
Tin is readily measured in multielement analyses of air, water, and solid waste samples by inductively 
coupled plasma-atomic emission spectroscopy (ICP-AES).  For samples that are free of particulate matter, 
such as drinking water, direct aspiration atomic absorption spectroscopy, such as EPA Method 7870, may
be used. Other samples, such as groundwater, industrial wastes, soils, sediments, sludges, and other solid 
wastes, require digestion prior to analysis to determine total and acid leachable metal (EPA 1992).  EPA 
Method 3050B, which describes acid digestion of sediments, sludges, and soils, does not list tin as an 
analyte; however, it states other elements and matrices may be analyzed by this method if performance is
demonstrated for that analyte in that matrix at the concentrations of interest (EPA 1996b). 
The APHA methods using either a flame atomic absorption method (3111B) or electrochemical atomic 
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Table 7-1. Analytical Methods for Determining Inorganic Tin and Organotin 
Compounds in Biological Materials 
Sample 













Digest in oxidizing 
acid, extract ketone 












Urine Extraction with 
polydithiocarbamate 
resin, which is ashed 
ICP-AES 2 μg/L 100±10% 
recovery 
Kneip and Crable 
1988 
Urine Extract with resin, 
ash resin 
ICP-AES 0.1 μg 100±10% NIOSH 1984a 
Food Digest in oxidizing 
acid 
AAS No data No data AOAC 1990a 
Urine Extract with resin, 
ash resin 
ICP-AES 0.1 μg/sample 100% NIOSH 1994a 
Blood Wet ashing with nitric 
and perchloric acids 
AAS 2.5 ng/mL No data Chiba et al. 1994 
Urine Acidified with nitric 
acid 




















Elution stepwise on 
silica gel column 
AAS 1.5 ng Sn 72.7±9.3% Iwai et al. 1981 
Human liver Acidified tissue 
extracted with 0.1% 
tropolone-acetone, 
derivatization with 
GC-FPD 5 ng/g (TBT) 
1 ng/g (DBT, 
MBT) 








GC-FPD 4.0 ng/g (TBT) 
3.0 ng/g (DBT) 
2.0 ng/g (MBT) 
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Table 7-1. Analytical Methods for Determining Inorganic Tin and Organotin 
Compounds in Biological Materials 
Sample Analytical Sample Percent 
matrix Preparation method method detection limit recovery Reference 
Human liver Acid digestion, GC-PFPD 0.3 ng/g (TBT) No data Nielson and 
derivatization with 3 ng/g (DBT, Strand 2002 
sodium MBT) 
tetraethylborate 
aA digestion procedure for metals in biological materials applicable to most metals, including tin. 

bEstimated from sensitivity and linearity data. 

cFluorescence detection after derivitization with Morin reagent. 

AAS = atomic absorption spectroscopy; DBT = dibutyltin; FPD = flame photometric detector; GC = gas 

chromatography; HCl = hydrochloric acid; HPLC = high performance liquid chromatography; ICP-AES = inductively
 
coupled plasma-atomic emission spectroscopy; ICP-MS = inductively coupled plasma mass spectrometryl; 
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Table 7-2. Analytical Methods for Determining Inorganic Tin and Organotin 
Compounds in Environmental Samples 
Sample 
Analytical detection Percent 
Sample matrix Preparation method method limit recovery Reference 
Total inorganic tin 
Environmental Digested in oxidizing acid ICP-MS 0.04–50 ng/g 103±3% Brzezinska-
Paudyn and 
Van Loon 1988 
Water Generate hydride with AAS 0.02 μg/L No data Rains 1982 
sodium borohydride or
electrolytically, sweep into 
silica cell heated to 700 °C 
Water Generate hydride with AAS 0.5 μg/L No data Thompson and 
(aqueous sodium borohydride or Thomerson 
solution) electrolytically, sweep into 1974 
silica cell heated to 700 °C 
Water Acidify with nitric acid AAS (direct 0.8 mg/L No data APHA 1998a 
aspiration) 
Water Acidify with nitric acid AAS (furnace 5 μg/L No data APHA 1998b 
technique) 
Watera Acidify with nitric acid ICP-AES No data No data APHA 1998c 
Water Acidify with nitric acid AAS (direct 0.8 mg/L No data EPA 1986b, 
aspiration) 1992, 1996b 
Pesticide Form volatile organotin GC-FID No data No data Basters et al. 
formulations derivatives 1978 
Organotins 
Pesticide Derivatize butylmagnesium GC-FID No data No data AOAC 1990a 
formulations chloride, extract with 
toluene 
Air Adsorbed onto GC-FID 0.05 μg/m3 93.3±9.3% Zimmerli and 
Chromosorb 102 Zimmermann 
desorption with ethereal 1980 
hydrochloric acid, 
methylated 
Airb Adsorption on filter and HPLC-AAS 1 μg/sample No data NIOSH 1994b 
XAD-2 resin, desorption (furnace 
technique) 
Airc Adsorption on filter and GC-FPD 0.01 μg No data NIOSH 2002
XAS-2 resin, desorption, 
derivatization with sodium 
tetraethylborate 
Water Acidified, extracted with GC-FPD 100 pg 96±4 to Maguire and 






296 TIN AND TIN COMPOUNDS 
7. ANALYTICAL METHODS 
Table 7-2. Analytical Methods for Determining Inorganic Tin and Organotin 
Compounds in Environmental Samples 
Sample 
Analytical detection Percent 
Sample matrix Preparation method method limit recovery Reference 
Water Generate hydrides with AAS 2 ng No data Hodge et al. 
sodium borohydride, 1979 
separate hydrides by 
boiling point 
Water Generate hydride AAS <0.1 μg/L No data Lee et al. 1989 
derivatives tributyltin 
Water Extract in n-hexane, Fluorescence 0.001– 91.3±0.6 to Arakawa et al. 
produce fluorescent morin 0.5 nmol/mL 99.7±0.5% 1983 
derivative recovery 
Sediment Organotin compounds are GC-MS 0.07 ng Sn/g 80–90% Muñoz et al. 
complexed with NaDCC (MBT); (MBT); 85– 2004 
and retained on a C60 0.09 ng Sn/g 95% (DBT 
column; complexes are (DBT); and TBT) 
eluted with EtOAc 0.10 ng Sn/g 
containing NaBPr4 (TBT) 
aTin not listed specifically as an analyte, but can be determined by ICP-AES. 





cThis method was developed for air monitoring of methyltin chlorides. 

AAS = atomic absorption spectroscopy; DBT = dibutyltin; EtOAc = ethyl acetate; GC-FID = gas chromatography-

flame ignition detector; GC-FPD = gas chromatography-flame photometric detector; GC-MS = gas chromatography
 
mass spectrometry; ICP-AES = inductively coupled plasma-atomic emission spectroscopy; ICP-MS = inductively
 
coupled plasma-mass spectrometry; MBT = monobutyltin; NaBPr4 = sodium tetra-n-propylborate; NaDCC = sodium 
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While tin is not specifically listed as an analyte for the ICP-MS method (3125), it may also be used in 
most cases and has lower detection limits (APHA 1998a, 1998b, 1998c). 
Organotin can be extracted from environmental samples and determined by AAS or GC methods, usually
after derivatization and separation. NIOSH Method 5504 allows for analysis of organotin compounds (as 
tin) in air and was validated using tetrabutyltin, tributyltin chloride, tricyclohexyltin hydroxide, and 
dibutyltin bis(isooctylmercaptoacetate) (NIOSH 1994b).  NIOSH Method 5526 was developed for air 
monitoring of monomethyltin trichloride, dimethyltin dichloride, and trimethyltin chloride (NIOSH 
2002). 
Muñoz et al. (2004) described a new method for the speciation of butyltin compounds where the 
compounds were complexed with sodium diethyldithiocarbamate and retained on a fullerene C60 sorbent 
column.  The neutral butyltin complexes were then eluted with ethyl acetate containing sodium tetra-
n-propylborate as a derivatizing agent, and the eluent was then analyzed using GC/MS.  By 
preconcentrating the organotin compounds on the C60 sorbent, this method allows for determination of 
mono-, di-, and tributyltin in the ng/g range.  Detection limits of 0.07, 0.09, and 0.10 ng Sn/g for mono-, 
di-, and tributyltin, respectively, were reported.  Recoveries were reported to be 80–90% for monobutyltin 
and 85–95% for di- and tributyltin.  Validation of this method was carried out by the analysis of a 
standard reference sediment (Muñoz et al. 2004). 
7.3 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the 
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether 
adequate information on the health effects of tin and tin compounds is available.  Where adequate 
information is not available, ATSDR, in conjunction with NTP, is required to assure the initiation of a 
program of research designed to determine the health effects (and techniques for developing methods to 
determine such health effects) of tin and tin compounds. 
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that if met would 
reduce the uncertainties of human health assessment.  This definition should not be interpreted to mean 
that all data needs discussed in this section must be filled.  In the future, the identified data needs will be 
evaluated and prioritized, and a substance-specific research agenda will be proposed. 
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7.3.1 Identification of Data Needs 
Methods for Determining Biomarkers of Exposure and Effect.    Sensitive and selective 
methods are available for the detection and quantitative measurement of tin after the sample matrix in 
which it is contained has been properly treated.  Atomic spectrometric techniques provide methods for the 
determination of tin with low detection limits that are highly specific are readily available (Angerer and 
Schaller 1988; AOAC 1984b; Kneip and Crable 1988; NIOSH 1984a). Methods for the determination of 
specific compounds that contain tin are more difficult and less well developed than are methods for the 
determination of total tin, but determination of specific tin compounds is an important concern because of 
the widespread use of organotin compounds as preservatives in industry and in other applications. 
Exposure. Methods exist to determine inorganic and organic tin levels in environmental samples and 
human tissues.  However, no methods have been identified that can be used to correlate the level and 
extent of exposure to tin and specific tin compounds with levels of tin in biological materials such as 
human tissues or fluids.  It would be useful to have such methods to make these correlations; however, it 
is not likely that such a method will be developed. 
Effect.  No methods have been identified that can be used to directly associate levels of tin and specific 
tin compounds in biological samples with the onset of adverse health effects.  If such methods were 
available, it would be possible to correlate the level or severity of effects with the level and extent of 
exposure. 
Methods for Determining Parent Compounds and Degradation Products in Environmental 
Media. Methods for determining tin in water, air, and waste samples with excellent selectivity and 
sensitivity are well developed and undergoing constant improvement. 
Sampling methodologies for very low level elemental pollutants such as tin continue to pose problems, 
including nonrepresentative samples, insufficient sample volumes, contamination, and labor-intensive, 
tedious extraction, and purification procedures (Green and LePape 1987). 
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7.3.2 Ongoing Studies 
No ongoing studies involving analytical techniques of tin or tin compounds were found in a search of 
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8. REGULATIONS AND ADVISORIES 

The international, national, and state regulations and guidelines regarding tin and tin compounds in air, 
water, and other media are summarized in Table 8-1.
ATSDR derived an intermediate-duration oral MRL for inorganic tin of 0.3 mg Sn/kg/day (as stannous 
chloride) based on a NOAEL of 32 mg/kg/day for hematological effects in rats in a 90-day feeding study 
(De Groot et al. 1973).  An uncertainty factor of 100 was applied to the NOAEL (10 for animal to human
extrapolation and 10 for human variability). 
ATSDR derived an intermediate-duration oral MRL of 0.005 mg/kg/day for dibutyltin chloride based on a 
LOAEL of 5 mg/kg/day for immunological effects in rats in a 4–6-week feeding study (Seinen et al. 
1977b). An uncertainty factor of 1,000 was applied to the LOAEL (10 for animal to human extrapolation, 
10 for the use of a LOAEL, and 10 for human variability).
ATSDR derived an intermediate-duration oral MRL of 0.0003 mg/kg/day for tributyltin oxide based on a 
NOAEL of 0.025 mg/kg/day for immunological effects in rats in a 4.5–6-month dietary study in rats (Vos 
et al. 1990). An uncertainty factor of 100 was applied to the NOAEL (10 for animal to human
extrapolation and 10 for human variability). 
ATSDR derived a chronic-duration oral MRL of 0.0003 mg/kg/day for tributyltin oxide based on a 
NOAEL of 0.025 mg/kg/day for immunological effects in rats in an 18-month dietary study in rats (Vos 
et al. 1990). An uncertainty factor of 100 was applied to the NOAEL (10 for animal to human
extrapolation and 10 for human variability). 
EPA (IRIS 2005) derived an oral reference dose (RfD) of 0.0003 mg/kg/day for tributyltin oxide using a 
benchmark dose analysis of immunological effects in rats in an 18-month dietary study (Vos et al. 1990).  
A 10% relative change was chosen as the benchmark response (BMR). 
EPA (IRIS 2005) has assigned tributyltin oxide to group D weight-of-evidence classification:  not 
classifiable as to human carcinogenicity, or to a group for which there is “inadequate information to 
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Table 8-1. Regulations and Guidelines Applicable to Tin and Tin Compounds 
Agency Description	 Information Reference 
INTERNATIONAL 
Guidelines: 
IARC Carcinogenicity classification 
WHO Drinking water guideline 
Tin and inorganic tin compounds 
NATIONAL 
Regulations and Guidelines: 
a. 	Air: 
ACGIH TLV (8-hour TWA) 
Tin (as Sn) 
Metal 
Oxide and inorganic compounds, 
except tin hydride 
Organic compoundsa
 STEL 
NIOSH REL (10-hour TWA) 
Tin (as Sn) 
Inorganic compounds, except tin 
oxides
 IDLH 
Organic compounds, except 
cyhexatinb
 IDLH 
 Stannous oxide 
OSHA PEL (8-hour TWA) for general 
industry 
Tin (as Sn) 
Inorganic compounds, except 
oxides 
Organic compounds 
PEL (8-hour TWA) for 
construction industry 
Tin (as Sn) 
Inorganic compounds, except 
oxides 
Organic compounds 
OSHA 	 PEL (8-hour TWA) for shipyard 
industry 
Tin (as Sn) 
Inorganic compounds, except 
oxides 
Organic compounds 

























NIOSH 2003a, 2003b 
OSHA 2003a 
29 CFR 1910.1000, 
Table Z-1 
OSHA 2003c 
29 CFR 1926.55, 
Appendix A 
OSHA 2003b 
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Table 8-1. Regulations and Guidelines Applicable to Tin and Tin Compounds 
Agency Description Information Reference 
NATIONAL (cont.)
 USNRC Occupational values 







10 CFR 20, 
Appendix B 











































10 CFR 20, 
Appendix B 
113Tin 1.0x103 5.0x10-7 






119mTin 2.0x103 1.0x10-6 
121Tin 2.0x104 6.0x10-6 
121mTin 9.0x102 4.0x10-7 
123Tin 6.0x102 3.0x10-7 
123mTin 1.0x105 5.0x10-5 
125Tin 9.0x102 4.0x10-7 
126Tin 6.0x101 2.0x10-8 
127Tin 2.0x104 8.0x10-6 
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Table 8-1. Regulations and Guidelines Applicable to Tin and Tin Compounds 
Agency Description 	 Information Reference 
NATIONAL (cont.)
 USNRC Occupational values 















EPA Drinking water standards 
c. 	Food 
FDA Direct food substances affirmed 
as GRAS in accordance with 
good manufacturing practices; 
stannous chloride (anhydrous 
and dehydrated) 
Food additives permitted for 
direct addition to food for human 
consumption; stannous chloride 
(food additive) may be safely 
used for color retention in 
asparagus packed in glass, with 
lids lined with an inert material 
Indirect food additives; 
adhesives; bis(tributyltin)oxide 
Indirect food additives; polymers; 
polyurethane resins 
Indirect food additives; resinous 
and polymeric coatings 
Indirect food additives; rubber 
articles intended for repeated 
use; stannous chloride 
Substances GRAS in 
accordance with good 
manufacturing or feeding 
practices; stannous chloride 
d. 	Other 
ACGIH Carcinogenicity classification 
EPA Carcinogenicity classification 


















Not to exceed 0.0015% 
calculated as tin for all food 
categories
Not to exceed 20 pmm 
calculated as tin 




Activators (total not to 
exceed 5% by weight of 
rubber product) 
Not to exceed 0.0015% 




10 CFR 20, 
Appendix B 
FDA 2003a 
21 CFR 184.1845 
FDA 2003b 
21 CFR 172.180 
FDA 2003d 
21 CFR 175.105(c)(5) 
FDA 2003e 
21 CFR 177.1680(b) 
FDA 2003c 
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Table 8-1. Regulations and Guidelines Applicable to Tin and Tin Compounds 
Agency Description Information Reference 
NATIONAL (cont.)
 EPA RfD
 Bis(tributyltin oxide) 
RfC
 Bis(tributyltin oxide) 
Community right-to-know; 
release reporting; effective date 
of reporting 
Bis(tributyltin)oxide 
 Triphenyltin chloride 
Emergency release notification 
Extremely hazardous 
 Trimethyltin chloride 
Reportable quantity 
Threshold planning quantity
 Triphenyltin chloride 
Reportable quantity 
Threshold planning quantity 
Municipal solid waste landfills; 
hazardous constituent; tin (total) 
Notification requirements of 
releases
Standards for owners and 
operators of hazardous waste 
TSD facilities; groundwater 
monitoring; tin (total) 









121Tin (LLI wall)d 
121Tin
 121mTin (LLI wall)d
 121mTin 
123Tin (LLI wall)d 
123Tin 
123mTin 








40 CFR 372.65 
EPA 2003c 
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Table 8-1. Regulations and Guidelines Applicable to Tin and Tin Compounds 
Agency Description Information Reference 
NATIONAL (cont.) 
















































10 CFR 20, 
Appendix B 
STATE 
a. Air No data 
b. Water 
Florida Drinking water guideline HSDB 2003 
Tin 4.2 mg/L 
Minnesota Drinking water guideline HSDB 2003 
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8. REGULATIONS AND ADVISORIES 
Table 8-1. Regulations and Guidelines Applicable to Tin and Tin Compounds 
Agency Description Information Reference 
STATE (cont.)
c. Food No data 
d. Other No data 
aSkin notation: refers to the potential significant contribution to the overall exposure by the cutaneous route, including
 
mucous membranes and the eyes, either by contact with vapors or, of probable greater significance, by direct skin 





cClass D: refers to the retention (clearance half-times of <10 days) for all compounds except those given for W. 

dWhen an ALI is defined by the stochastic dose limit, this value alone, is given. When an ALI is determined by the 

non-stochastic dose limit to an organ, the organ or tissue to which the limit applies is shown, and the ALI for the 

stochastic limit is shown in parentheses.  (Abbreviated organ or tissue designations are used: LLI wall = lower large 

intestine wall; St. wall = stomach wall; Blad wall = bladder wall; and Bone surf = bone surface.) 

eThe ALIs and DACs for inhalation are given for an aerosol with an activity median aerodynamic diameter (AMAD) of 

1 μm and for class D and W of radioactive material, which refers to their retention (clearance half-times of <10 days 

and 10–100 days, respectively) in the pulmonary region of the lung. 

fClass W: refers to the retention (clearance half-times of 10–100 days) for sulfides, oxides, hydroxides, halides, 

nitrates, and stannic phosphate. 

gA4: not classifiable as a human carcinogen 

hD: not classifiable as to human carcinogenicity
 
ACGIH = American Conference of Governmental Industrial Hygienists; ALI = annual limits on intakes; CFR = Code of 

Federal Regulations; DAC = derived air concentration; EPA = Environmental Protection Agency; FDA = Food and 

Drug Administration; GRAS = generally recognized as safe; HSDB = Hazardous Substances Data Bank;
 
IARC = International Agency for Research on Cancer; IDLH = immediately dangerous to life or health; 

IRIS = Integrated Risk Information System; LLI = lower large intestine; NIOSH = National Institute for Occupational 

Safety and Health; OSHA = Occupational Safety and Health Administration; PEL = permissible exposure limit; 

PQL = practical quantitation limit; REL = recommended exposure limit; RfC = inhalation reference concentration; 

RfD = oral reference dose; STEL = short-term exposure level; TLV = threshold limit values;  TSD = treatment, 
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10. GLOSSARY 
Absorption—The taking up of liquids by solids, or of gases by solids or liquids. 
Acute Exposure—Exposure to a chemical for a duration of 14 days or less, as specified in the 
Toxicological Profiles. 
Adsorption—The adhesion in an extremely thin layer of molecules (as of gases, solutes, or liquids) to the 
surfaces of solid bodies or liquids with which they are in contact. 
Adsorption Coefficient (Koc)—The ratio of the amount of a chemical adsorbed per unit weight of 
organic carbon in the soil or sediment to the concentration of the chemical in solution at equilibrium. 
Adsorption Ratio (Kd)—The amount of a chemical adsorbed by sediment or soil (i.e., the solid phase) 
divided by the amount of chemical in the solution phase, which is in equilibrium with the solid phase, at a 
fixed solid/solution ratio. It is generally expressed in micrograms of chemical sorbed per gram of soil or 
sediment. 
Benchmark Dose (BMD)—Usually defined as the lower confidence limit on the dose that produces a 
specified magnitude of changes in a specified adverse response.  For example, a BMD10 would be the 
dose at the 95% lower confidence limit on a 10% response, and the benchmark response (BMR) would be 
10%. The BMD is determined by modeling the dose response curve in the region of the dose response 
relationship where biologically observable data are feasible.   
Benchmark Dose Model—A statistical dose-response model applied to either experimental toxicological 
or epidemiological data to calculate a BMD. 
Bioconcentration Factor (BCF)—The quotient of the concentration of a chemical in aquatic organisms 
at a specific time or during a discrete time period of exposure divided by the concentration in the 
surrounding water at the same time or during the same period. 
Biomarkers—Broadly defined as indicators signaling events in biologic systems or samples.  They have 
been classified as markers of exposure, markers of effect, and markers of susceptibility. 
Cancer Effect Level (CEL)—The lowest dose of chemical in a study, or group of studies, that produces 
significant increases in the incidence of cancer (or tumors) between the exposed population and its 
appropriate control. 
Carcinogen—A chemical capable of inducing cancer. 
Case-Control Study—A type of epidemiological study that examines the relationship between a 
particular outcome (disease or condition) and a variety of potential causative agents (such as toxic 
chemicals).  In a case-controlled study, a group of people with a specified and well-defined outcome is 
identified and compared to a similar group of people without outcome. 
Case Report—Describes a single individual with a particular disease or exposure. These may suggest 
some potential topics for scientific research, but are not actual research studies. 
Case Series—Describes the experience of a small number of individuals with the same disease or 
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Ceiling Value—A concentration of a substance that should not be exceeded, even instantaneously. 
Chronic Exposure—Exposure to a chemical for 365 days or more, as specified in the Toxicological 
Profiles. 
Cohort Study—A type of epidemiological study of a specific group or groups of people who have had a 
common insult (e.g., exposure to an agent suspected of causing disease or a common disease) and are 
followed forward from exposure to outcome.  At least one exposed group is compared to one unexposed 
group. 
Cross-sectional Study—A type of epidemiological study of a group or groups of people that examines 
the relationship between exposure and outcome to a chemical or to chemicals at one point in time. 
Data Needs—Substance-specific informational needs that if met would reduce the uncertainties of human
health assessment. 
Developmental Toxicity—The occurrence of adverse effects on the developing organism that may result 
from exposure to a chemical prior to conception (either parent), during prenatal development, or 
postnatally to the time of sexual maturation.  Adverse developmental effects may be detected at any point 
in the life span of the organism. 
Dose-Response Relationship—The quantitative relationship between the amount of exposure to a 
toxicant and the incidence of the adverse effects. 
Embryotoxicity and Fetotoxicity—Any toxic effect on the conceptus as a result of prenatal exposure to 
a chemical; the distinguishing feature between the two terms is the stage of development during which the 
insult occurs.  The terms, as used here, include malformations and variations, altered growth, and in utero 
death. 
Environmental Protection Agency (EPA) Health Advisory—An estimate of acceptable drinking water
levels for a chemical substance based on health effects information.  A health advisory is not a legally
enforceable federal standard, but serves as technical guidance to assist federal, state, and local officials. 
Epidemiology—Refers to the investigation of factors that determine the frequency and distribution of 
disease or other health-related conditions within a defined human population during a specified period.  
Genotoxicity—A specific adverse effect on the genome of living cells that, upon the duplication of 
affected cells, can be expressed as a mutagenic, clastogenic, or carcinogenic event because of specific 
alteration of the molecular structure of the genome. 
Half-life—A measure of rate for the time required to eliminate one half of a quantity of a chemical from
the body or environmental media. 
Immediately Dangerous to Life or Health (IDLH)—The maximum environmental concentration of a 
contaminant from which one could escape within 30 minutes without any escape-impairing symptoms or 
irreversible health effects. 
Immunologic Toxicity—The occurrence of adverse effects on the immune system that may result from
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Immunological Effects—Functional changes in the immune response. 
Incidence—The ratio of individuals in a population who develop a specified condition to the total 
number of individuals in that population who could have developed that condition in a specified time 
period. 
Intermediate Exposure—Exposure to a chemical for a duration of 15–364 days, as specified in the 
Toxicological Profiles. 
In Vitro—Isolated from the living organism and artificially maintained, as in a test tube. 
In Vivo—Occurring within the living organism. 
Lethal Concentration(LO) (LCLO)—The lowest concentration of a chemical in air that has been reported 
to have caused death in humans or animals. 
Lethal Concentration(50) (LC50)—A calculated concentration of a chemical in air to which exposure for 
a specific length of time is expected to cause death in 50% of a defined experimental animal population. 
Lethal Dose(LO) (LDLo)—The lowest dose of a chemical introduced by a route other than inhalation that 
has been reported to have caused death in humans or animals. 
Lethal Dose(50) (LD50)—The dose of a chemical that has been calculated to cause death in 50% of a 
defined experimental animal population.
Lethal Time(50) (LT50)—A calculated period of time within which a specific concentration of a chemical 
is expected to cause death in 50% of a defined experimental animal population. 
Lowest-Observed-Adverse-Effect Level (LOAEL)—The lowest exposure level of chemical in a study, 
or group of studies, that produces statistically or biologically significant increases in frequency or severity 
of adverse effects between the exposed population and its appropriate control. 
Lymphoreticular Effects—Represent morphological effects involving lymphatic tissues such as the 
lymph nodes, spleen, and thymus. 
Malformations—Permanent structural changes that may adversely affect survival, development, or 
function. 
Minimal Risk Level (MRL)—An estimate of daily human exposure to a hazardous substance that is 
likely to be without an appreciable risk of adverse noncancer health effects over a specified route and 
duration of exposure. 
Modifying Factor (MF)—A value (greater than zero) that is applied to the derivation of a Minimal Risk 
Level (MRL) to reflect additional concerns about the database that are not covered by the uncertainty 
factors. The default value for a MF is 1. 
Morbidity—State of being diseased; morbidity rate is the incidence or prevalence of disease in a specific 
population. 
Mortality—Death; mortality rate is a measure of the number of deaths in a population during a specified 
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Mutagen—A substance that causes mutations.  A mutation is a change in the DNA sequence of a cell’s 
DNA. Mutations can lead to birth defects, miscarriages, or cancer.
Necropsy—The gross examination of the organs and tissues of a dead body to determine the cause of 
death or pathological conditions. 
Neurotoxicity—The occurrence of adverse effects on the nervous system following exposure to a 
chemical. 
No-Observed-Adverse-Effect Level (NOAEL)—The dose of a chemical at which there were no 
statistically or biologically significant increases in frequency or severity of adverse effects seen between 
the exposed population and its appropriate control.  Effects may be produced at this dose, but they are not 
considered to be adverse. 
Octanol-Water Partition Coefficient (Kow)—The equilibrium ratio of the concentrations of a chemical 
in n-octanol and water, in dilute solution. 
Odds Ratio (OR)—A means of measuring the association between an exposure (such as toxic substances 
and a disease or condition) that represents the best estimate of relative risk (risk as a ratio of the incidence 
among subjects exposed to a particular risk factor divided by the incidence among subjects who were not 
exposed to the risk factor). An OR of greater than 1 is considered to indicate greater risk of disease in the 
exposed group compared to the unexposed group. 
Organophosphate or Organophosphorus Compound—A phosphorus-containing organic compound 
and especially a pesticide that acts by inhibiting cholinesterase. 
Permissible Exposure Limit (PEL)—An Occupational Safety and Health Administration (OSHA) 
allowable exposure level in workplace air averaged over an 8-hour shift of a 40-hour workweek. 
Pesticide—General classification of chemicals specifically developed and produced for use in the control 
of agricultural and public health pests. 
Pharmacokinetics—The dynamic behavior of a material in the body, used to predict the fate 
(disposition) of an exogenous substance in an organism.  Utilizing computational techniques, it provides 
the means of studying the absorption, distribution, metabolism, and excretion of chemicals by the body. 
Pharmacokinetic Model—A set of equations that can be used to describe the time course of a parent 
chemical or metabolite in an animal system.  There are two types of pharmacokinetic models:  data-based 
and physiologically-based.  A data-based model divides the animal system into a series of compartments, 
which, in general, do not represent real, identifiable anatomic regions of the body, whereas the 
physiologically-based model compartments represent real anatomic regions of the body. 
Physiologically Based Pharmacodynamic (PBPD) Model—A type of physiologically based dose-
response model that quantitatively describes the relationship between target tissue dose and toxic end 
points. These models advance the importance of physiologically based models in that they clearly 
describe the biological effect (response) produced by the system following exposure to an exogenous 
substance. 
Physiologically Based Pharmacokinetic (PBPK) Model—Comprised of a series of compartments 
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variety of physiological information:  tissue volumes, blood flow rates to tissues, cardiac output, alveolar 
ventilation rates, and possibly membrane permeabilities.  The models also utilize biochemical 
information, such as air/blood partition coefficients, and metabolic parameters.  PBPK models are also 
called biologically based tissue dosimetry models. 
Prevalence—The number of cases of a disease or condition in a population at one point in time. 
Prospective Study—A type of cohort study in which the pertinent observations are made on events 
occurring after the start of the study.  A group is followed over time. 
q1*—The upper-bound estimate of the low-dose slope of the dose-response curve as determined by the 
multistage procedure.  The q1* can be used to calculate an estimate of carcinogenic potency, the 
incremental excess cancer risk per unit of exposure (usually μg/L for water, mg/kg/day for food, and 
μg/m3 for air). 
Recommended Exposure Limit (REL)—A National Institute for Occupational Safety and Health 
(NIOSH) time-weighted average (TWA) concentration for up to a 10-hour workday during a 40-hour 
workweek. 
Reference Concentration (RfC)—An estimate (with uncertainty spanning perhaps an order of 
magnitude) of a continuous inhalation exposure to the human population (including sensitive subgroups) 
that is likely to be without an appreciable risk of deleterious noncancer health effects during a lifetime.  
The inhalation reference concentration is for continuous inhalation exposures and is appropriately
expressed in units of mg/m3 or ppm. 
Reference Dose (RfD)—An estimate (with uncertainty spanning perhaps an order of magnitude) of the 
daily exposure of the human population to a potential hazard that is likely to be without risk of deleterious 
effects during a lifetime.  The RfD is operationally derived from the no-observed-adverse-effect level 
(NOAEL, from animal and human studies) by a consistent application of uncertainty factors that reflect 
various types of data used to estimate RfDs and an additional modifying factor, which is based on a 
professional judgment of the entire database on the chemical.  The RfDs are not applicable to 
nonthreshold effects such as cancer. 
Reportable Quantity (RQ)—The quantity of a hazardous substance that is considered reportable under 
the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA).  Reportable 
quantities are (1) 1 pound or greater or (2) for selected substances, an amount established by regulation 
either under CERCLA or under Section 311 of the Clean Water Act.  Quantities are measured over a 
24-hour period. 
Reproductive Toxicity—The occurrence of adverse effects on the reproductive system that may result 
from exposure to a chemical.  The toxicity may be directed to the reproductive organs and/or the related 
endocrine system.  The manifestation of such toxicity may be noted as alterations in sexual behavior, 
fertility, pregnancy outcomes, or modifications in other functions that are dependent on the integrity of 
this system. 
Retrospective Study—A type of cohort study based on a group of persons known to have been exposed 
at some time in the past.  Data are collected from routinely recorded events, up to the time the study is 
undertaken. Retrospective studies are limited to causal factors that can be ascertained from existing 
records and/or examining survivors of the cohort. 
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Risk Factor—An aspect of personal behavior or lifestyle, an environmental exposure, or an inborn or 
inherited characteristic that is associated with an increased occurrence of disease or other health-related 
event or condition. 
Risk Ratio—The ratio of the risk among persons with specific risk factors compared to the risk among 
persons without risk factors. A risk ratio greater than 1 indicates greater risk of disease in the exposed 
group compared to the unexposed group. 
Short-Term Exposure Limit (STEL)—The American Conference of Governmental Industrial 
Hygienists (ACGIH) maximum concentration to which workers can be exposed for up to 15 minutes 
continually. No more than four excursions are allowed per day, and there must be at least 60 minutes 
between exposure periods. The daily Threshold Limit Value-Time Weighted Average (TLV-TWA) may
not be exceeded. 
Standardized Mortality Ratio (SMR)—A ratio of the observed number of deaths and the expected 
number of deaths in a specific standard population. 
Target Organ Toxicity—This term covers a broad range of adverse effects on target organs or
physiological systems (e.g., renal, cardiovascular) extending from those arising through a single limited 
exposure to those assumed over a lifetime of exposure to a chemical. 
Teratogen—A chemical that causes structural defects that affect the development of an organism. 
Threshold Limit Value (TLV)—An American Conference of Governmental Industrial Hygienists 
(ACGIH) concentration of a substance to which most workers can be exposed without adverse effect.  
The TLV may be expressed as a Time Weighted Average (TWA), as a Short-Term Exposure Limit 
(STEL), or as a ceiling limit (CL). 
Time-Weighted Average (TWA)—An allowable exposure concentration averaged over a normal 8-hour 
workday or 40-hour workweek. 
Toxic Dose(50) (TD50)—A calculated dose of a chemical, introduced by a route other than inhalation, 
which is expected to cause a specific toxic effect in 50% of a defined experimental animal population. 
Toxicokinetic—The absorption, distribution, and elimination of toxic compounds in the living organism. 
Uncertainty Factor (UF)—A factor used in operationally deriving the Minimal Risk Level (MRL) or 
Reference Dose (RfD) or Reference Concentration (RfC) from experimental data.  UFs are intended to 
account for (1) the variation in sensitivity among the members of the human population, (2) the 
uncertainty in extrapolating animal data to the case of human, (3) the uncertainty in extrapolating from
data obtained in a study that is of less than lifetime exposure, and (4) the uncertainty in using lowest­
observed-adverse-effect level (LOAEL) data rather than no-observed-adverse-effect level (NOAEL) data.  
A default for each individual UF is 10; if complete certainty in data exists, a value of 1 can be used; 
however, a reduced UF of 3 may be used on a case-by-case basis, 3 being the approximate logarithmic 
average of 10 and 1. 
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APPENDIX A.  ATSDR MINIMAL RISK LEVELS AND WORKSHEETS 
The Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) [42 U.S.C. 
9601 et seq.], as amended by the Superfund Amendments and Reauthorization Act (SARA) [Pub. L. 99– 
499], requires that the Agency for Toxic Substances and Disease Registry (ATSDR) develop jointly with 
the U.S. Environmental Protection Agency (EPA), in order of priority, a list of hazardous substances most
commonly found at facilities on the CERCLA National Priorities List (NPL); prepare toxicological 
profiles for each substance included on the priority list of hazardous substances; and assure the initiation 
of a research program to fill identified data needs associated with the substances.
The toxicological profiles include an examination, summary, and interpretation of available toxicological 
information and epidemiologic evaluations of a hazardous substance.  During the development of 
toxicological profiles, Minimal Risk Levels (MRLs) are derived when reliable and sufficient data exist to 
identify the target organ(s) of effect or the most sensitive health effect(s) for a specific duration for a 
given route of exposure. An MRL is an estimate of the daily human exposure to a hazardous substance 
that is likely to be without appreciable risk of adverse noncancer health effects over a specified duration 
of exposure. MRLs are based on noncancer health effects only and are not based on a consideration of 
cancer effects.  These substance-specific estimates, which are intended to serve as screening levels, are 
used by ATSDR health assessors to identify contaminants and potential health effects that may be of 
concern at hazardous waste sites.  It is important to note that MRLs are not intended to define clean-up or 
action levels. 
MRLs are derived for hazardous substances using the no-observed-adverse-effect level/uncertainty factor 
approach. They are below levels that might cause adverse health effects in the people most sensitive to 
such chemical-induced effects.  MRLs are derived for acute (1–14 days), intermediate (15–364 days), and 
chronic (365 days and longer) durations and for the oral and inhalation routes of exposure.  Currently, 
MRLs for the dermal route of exposure are not derived because ATSDR has not yet identified a method 
suitable for this route of exposure. MRLs are generally based on the most sensitive chemical-induced end 
point considered to be of relevance to humans.  Serious health effects (such as irreparable damage to the 
liver or kidneys, or birth defects) are not used as a basis for establishing MRLs.  Exposure to a level 
above the MRL does not mean that adverse health effects will occur. 
MRLs are intended only to serve as a screening tool to help public health professionals decide where to 
look more closely.  They may also be viewed as a mechanism to identify those hazardous waste sites that 
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are not expected to cause adverse health effects. Most MRLs contain a degree of uncertainty because of 
the lack of precise toxicological information on the people who might be most sensitive (e.g., infants, 
elderly, nutritionally or immunologically compromised) to the effects of hazardous substances.  ATSDR 
uses a conservative (i.e., protective) approach to address this uncertainty consistent with the public health 
principle of prevention. Although human data are preferred, MRLs often must be based on animal studies 
because relevant human studies are lacking.  In the absence of evidence to the contrary, ATSDR assumes 
that humans are more sensitive to the effects of hazardous substance than animals and that certain persons 
may be particularly sensitive.  Thus, the resulting MRL may be as much as 100-fold below levels that 
have been shown to be nontoxic in laboratory animals. 
Proposed MRLs undergo a rigorous review process:  Health Effects/MRL Workgroup reviews within the 
Division of Toxicology, expert panel peer reviews, and agency-wide MRL Workgroup reviews, with 
participation from other federal agencies and comments from the public.  They are subject to change as 
new information becomes available concomitant with updating the toxicological profiles.  Thus, MRLs in 
the most recent toxicological profiles supersede previously published levels.  For additional information 
regarding MRLs, please contact the Division of Toxicology, Agency for Toxic Substances and Disease 
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MINIMAL RISK LEVEL WORKSHEET 
Chemical Name: Tin 
CAS Numbers: 7440-31-5 
Date:   April 2005 
Profile Status: Final Post-Public Comment 
Route: [ ] Inhalation  [X] Oral 
Duration: [ ] Acute  [X] Intermediate   [ ] Chronic 
Graph Key: 13 
Species: Rat 
Minimal Risk Level: 0.3 [X] mg/kg/day  [ ] ppm
Reference: De Groot AP, Feron VJ, Til HP. 1973. Short-term toxicity studies on some salts and oxides 
of tin in rats. Food Cosmet Toxicol 11:19-30. 
Experimental design: The effect of stannous chloride was studied in male and female Wistar rats 
(10/sex/dose level) for 13 weeks at dietary levels of 0, 300, 1,000, 3,000, and 10,000 ppm.  Using a 
conversion dietary factor of 0.05 kg food/kg body weight/day and the molecular weight of 118.69 for tin, 
it can be estimated that the diet provided approximate doses of 0, 9.5, 32, 95, or 315 mg Sn/kg/day. End 
points monitored included: survival, body weight, food intake, hematology (hemoglobin, hematocrit, total 
erythrocytes, total and differential leukocytes), serum chemistry (transaminases, alkaline phosphatase, 
bilirubin), urinalysis, organ weights (nine organs), and gross and microscopic pathology.  Tin in the 
standard diet was not determined, but the concentrations of calcium, phosphorus, iron, copper, and zinc 
were known. The concentrations of these minerals were consistent with the concentrations in standard 
rat’s diets, except for the amount of zinc, which was about 50% of that found in the standard diet. 
Effect noted in study and corresponding doses: The highest dietary level (315 mg Sn/kg/day) caused 
reduced food consumption and abdominal distension on week 1.  At week 8, loss of body weight occurred 
in males and females, and one male died.  At week 9 another three males died and the group was 
discontinued.  Rats in the 95 mg/kg/day level showed poor appetite and abdominal distension the first 
2 weeks; this was associated with decreased food consumption, but they kept growing.  At termination, no 
significant differences in body weights were seen.  Food consumption was low also at 32 mg/kg/day, but 
only on week 1.  Hemoglobin concentration was significantly reduced starting at week 4 at 95 and 
315 mg/kg/day (about 12 and 20%, respectively) and only at week 4 in 32 mg/kg/day males (3% 
reduction). Terminal hemoglobin and hematocrit were significantly reduced only in high-dose males 
(6 and 4%, respectively).  Tin had no noticeable effect on osmotic resistance of the erythrocytes or on the 
number of reticulocytes.  Serum alkaline phosphatase was significantly decreased at termination in both 
sexes but there was no significant effect on transaminases or in bilirubin.  Terminal urine samples were 
unremarkable, as were relative organ weights.  Rats from the high-dose group which had to be terminated 
early showed distended intestines, slight edema of the pancreas, and grayish-brown livers.  There was 
moderate testicular degeneration, severe pancreatic atrophy, spongy white matter in the brain, acute 
bronchopneumonia, enteritis and liver changes characterized by homogeneous appearance of the liver cell 
cytoplasm and mild proliferation of the bile duct epithelium.  In the other groups at termination, 
treatment-related effects included bile duct epithelium proliferation and homogeneous cytoplasm at 
95 mg/kg/day.  The 95 mg/kg/day dose level is considered a minimal LOAEL based on the unknown 
biological significance of a transient 12% reduction in hemoglobin concentration. 
Dose and end point used for MRL derivation: 32 mg/kg/day; decreased hemoglobin concentration. 
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Uncertainty Factors used in MRL derivation: 
[  ]  10 for use of a LOAEL 
[X]  10 for extrapolation from animals to humans 
[X]  10 for human variability
Was a conversion factor used from ppm in food or water to a mg/body weight dose? 
Yes. 
If an inhalation study in animals, list conversion factors used in determining human equivalent dose:  NA 
Was a conversion used from intermittent to continuous exposure? 
No 
Other additional studies or pertinent information that lend support to this MRL:  The effects of the 
administration of stannous chloride, stannous orthophosphate, stannous sulfate, and stannous tartrate at 
the same dietary levels as above in the diet of rats for 4 weeks are in agreement with the data from the 
13-week study (De Groot et al. 1973). The LOAELs for body weight gain, depressed hemoglobin and 
hematocrit values, and liver histopathology at 4 weeks were seen with the 3,000 ppm diet in males.  The 
NOAEL was the 1,000 ppm diet.  With the orthophosphate and tartrate salts, the differences in
hemoglobin and hematocrit were not significant with the 3,000 ppm diet, but were significant with the 
10,000 ppm diet. 
Janssen et al. (1985) reported a LOAEL of 7.9 mg/kg/day for significant decreases in hemoglobin in rats 
fed a diet containing stannous chloride for 28 days.  However, the standard diet contained only 20% of the
copper reported for the diet in the De Groot et al. (1973) study.  The lower concentrations of these 
minerals may have made the rats in the Jenssen et al. (1985) study more susceptible to the effects of tin on 
hematopoiesis.  Transient hemolytic anemia was also reported in rabbits administered 10 mg tin/kg/day
(as stannous chloride), the only dose level tested, by gavage for 4 months (Chmielnicka et al. 1993).  
However, no information was provided in that study regarding the trace mineral composition of the diet. 
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MINIMAL RISK LEVEL WORKSHEET 
Chemical Name: Dibutyltin dichloride 
CAS Number: 683-18-1 
Date:   April 2005 
Profile Status: Final Post-Public Comment 
Route: [ ] Inhalation  [X] Oral 
Duration: [ ] Acute  [X] Intermediate   [ ] Chronic 
Graph Key: 28 
Species: Rat 
Minimal Risk Level: 0.005 [X] mg/kg/day   [ ] ppm
Reference: Seinen W, Vos JG, van Krieken R, et al. 1977b.  Toxicity of organotin compounds. III.  
Suppression of thymus-dependent immunity in rats by di-n-butyltindichloride and di-n-octyltindichloride. 
Toxicol Appl Pharmacol 42:213-224. 
Experimental design:  Groups of male and female weanling Wistar rats (5–10/group) were fed diets 
containing 0, 50, or 150 ppm of the test material (>98% pure) for 4–6 weeks.  Based on a body weight of 
0.2 kg, it can be estimated that these levels provided doses of dibutyltin dichloride of approximately 0, 5, 
and 15 mg/kg/day (EPA 1988).  End points examined included body weight and parameters of humoral 
and cellular immune responses.  The humoral immune response was assessed by measuring formation of 
antibodies against SRBC and E. coli lipopolysaccharide.  Rats were immunized intraperitoneally with 
SRBC 5 days before termination of the experiments. The cellular immune response was assessed by 
examining allograft rejection (rats were grafted at week 7). 
Effects noted in study and corresponding doses: Final body weight after 4 weeks of exposure was not 
significantly altered relative to controls, but it was 28% lower than controls in the high-dose group after 
6 weeks of exposure. Allograft rejection time was significantly delayed in the high-dose group relative to 
controls. In the tests for humoral response, the number of antibody-producing cells per million spleen 
cells was not affected, but the number per whole spleen was significantly decreased in a dose-related 
manner. This response was associated with a decreased hemagglutination titer in the high-dose group. 
The antibody titers against E. coli lipopolysaccharide were slightly but not significantly lower in treated 
groups than in controls.  The dose of 5 mg/kg/day is the study LOAEL based on the reduction in 
hemagglutinating antibodies against SRBC.   
Dose and end point used for MRL derivation: 5.0 mg/kg/day; immunological effects. 
[ ] NOAEL   [X] LOAEL
Uncertainty Factors used in MRL derivation: 
[X]  10 for use of a LOAEL 
[X]  10 for extrapolation from animals to humans 
[X]  10 for human variability
Was a conversion factor used from ppm in food or water to a mg/body weight dose?
 
Yes. A food factor of 0.1 kg food/day/kg body weight was calculated using a body weight of 0.2 kg 

(from study) in an allometric equation (EPA 1988). 
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Was a conversion used from intermittent to continuous exposure? 
No 
Other additional studies or pertinent information that lend support to this MRL: Limited additional 
information was available for dibutyltin dichloride from intermediate-duration studies.  Gaunt et al. 
(1968) conducted a 90-day dietary general toxicity and histopathology study in rats and found no 
significant effects other than a slight reduction in hemoglobin with the highest dose tested 
(5.7 mg/kg/day); no effect was seen at 3.4 mg/kg/day.  Although the Gaunt et al. (1968) study defined a 
NOAEL and, possibly a minimal LOAEL, the immunological alterations reported in the Seinen et al. 
(1977b) study are preferred as basis for the intermediate-duration oral MRL because of the known 
immunotoxic properties of dibutyltins (i.e., Seinen et al. 1977a) and tributyltins (dibutyltin is a metabolite 
of tributyltin; Matsuda et al. 1993; Ueno et al. 1994).  In two acute-duration oral studies in rats, serious 
LOAELs were described at or below the 5 mg/kg/day intermediate-duration LOAEL from Seinen et al. 
(1977b). In Ema et al. (1991b), 5 mg/kg/day was a serious developmental LOAEL and in Ema and 
Harazono (2000), 3.8 mg/kg/day was a serious reproductive LOAEL.  However, in these two studies, the 
rats were treated with dibutyltin dichloride by gavage in oil, and the bolus administration may have 
contributed to the severity of the effects.
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MINIMAL RISK LEVEL WORKSHEET 
Chemical Name: Tributyltin oxide 
CAS Number: 56-35-9 
Date:   April 2005 
Profile Status: Final Post-Public Comment 
Route: [ ] Inhalation  [X] Oral 
Duration: [ ] Acute  [X] Intermediate  [ ] Chronic 
Graph Key: 66 
Species: Rat 
Minimal Risk Level: 0.0003 [X] mg/kg/day   [ ] ppm 
Reference: Vos JG, De Klerk A, Krajnc EI, et al. 1990. Immunotoxicity of bis(tri-n-butyltin)oxide in 
the rat: effects on thymus-dependent immunity and on nonspecific resistance following long-term
exposure in young versus aged rats.  Toxicol Appl Pharmacol 105:144-155. 
Experimental design:  Groups of male Wistar rats were fed a diet containing 0, 0.5, 5, or 50 ppm
tributyltin oxide (95.3% pure) for 4.5–6 months.  This diet provided approximately 0, 0.025, 0.25, and 
2.5 mg/kg/day of the tin compound.  Parameters of specific resistance evaluated included IgM and IgG 
response to ovalbumin and delayed-type hypersensitivity (DTH) response to ovalbumin and tuberculin 
after 6 months of treatment; resistance to Trichinella spiralis infection after 5.5 months; mitogenic 
response of thymus and spleen cells after 4.5 months; and surface marker analysis of mesenteric lymph 
nodes after 6 months.  Parameters of nonspecific resistance examined included clearance of Listeria 
monocytogenes from the spleen after injection at 5 months and natural cell-mediated cytotoxicity of 
spleen and peritoneal cells after 4.5 months. 
Effects noted in study and corresponding doses: Neither body weight nor spleen weight were 
significantly altered after 4.5 months of treatment, but thymus weight was reduced by 17% relative to 
controls in the high-dose group.  Neither the IgM nor IgG response to ovalbumin and T. spiralis were 
altered after 5.5 months of exposure.  The immunoglobulin E (IgE) responses to T. spiralis, as determined 
by the passive cutaneous anaphylaxis reaction, were suppressed in a dose-related manner (significant in 
the mid- and high-dose groups).  The DTH reactions to ovalbumin and tuberculin were not significantly
altered after 6 months of dosing.  There was an increase in the number of larvae T. spiralis in muscle after 
infection in the mid- and high-dose groups after 5.5 months of exposure to the tin compound.  No 
significant effect was observed on the response of spleen cells to T- and B-mitogens after 4.5 months.  
The cell surface marker analysis of mesenteric lymph node cells showed a reduction in the relative count 
of T-lymphocytes and an increase in the percentage of B-lymphocytes in the mid- and high-dose groups 
after 6 months of treatment.  The in vivo clearance of L. monocytogenes was impaired in the high-dose 
group after 5 months of treatment.  Treatment with tributyltin oxide did not induce a consistent effect on 
the natural killer cell activity of spleen and peritoneal cells after 4.5 months of exposure (decreased in the 
low- and high-dose groups, and increased in the mid-dose group).  Based on the depression of IgE titers 
and increased T. spiralis in muscle after 5.5 months of exposure to tributyltin oxide, the study LOAEL is 
0.25 mg/kg/day and the NOAEL is 0.025 mg/kg/day.  
Dose and end point used for MRL derivation: 0.025 mg/kg/day; immunological effects. 













A-8 TIN AND TIN COMPOUNDS 
APPENDIX A 
Uncertainty Factors used in MRL derivation: 
[  ]  10 for use of a LOAEL 
[X]  10 for extrapolation from animals to humans 
[X]  10 for human variability
Was a conversion factor used from ppm in food or water to a mg/body weight dose? 
Yes, conversions were done by the study authors. 
If an inhalation study in animals, list conversion factors used in determining human equivalent dose: NA 
Was a conversion used from intermittent to continuous exposure? 
No 
Other additional studies or pertinent information that lend support to this MRL:  Numerous studies in 
animals have demonstrated that the main target for some alkyltin compounds, tributyltin among them, is 
the immune system, particularly the thymus (Boyer 1989; Seinen et al. 1977a, 1977b; Snoeij et al. 1985).
Therefore, it is expected that additional intermediate-duration studies, which did not focus on the immune 
system, identified higher NOAELs.  For example, a 4-week dietary study with tributyltin oxide in rats 
observed slight hematological abnormalities at 0.25 mg/kg/day and hepatic and body weight NOAELs at 
1 mg/kg/day (Krajnc et al. 1984).  That same study found a 17% in thymus weight at 1 mg/kg/day and a 
35% decrease at 4 mg/kg/day.  An additional study with tributyltin oxide reported reduced natural killer 
cell activity in rats at 1 mg/kg/day following 6 weeks of treatment (Van Loveren et al. 1990).  In yet 
another rat study, Verdier et al. (1991) reported slight impairment in host resistance to L. monocytogenes 
following exposure to tributyltin oxide for 28 days at 5 mg/kg/day, but not at 1 mg/kg/day. 
The NOAEL of 0.025 mg/kg/day of Vos et al. (1990) is supported by recent developmental studies with 
tributyltin chloride that evaluated systemic and immunologic parameters in the offspring of rats exposed 
to tributyltin chloride in utero (Gds 8-21), through the mother’s milk, and directly as young adults until 
the age of 90 days (Cooke et al. 2004; Tryphonas et al. 2004).  The doses tested were 0, 0.025, 0.25, and 
2.5 mg/kg/day.  Neither body weights nor food consumption was affected in the dams.  No effects were 
observed on litter size, pup weight at birth, sex ratio, or survival until weaning.  Growth of the treated 
pups after weaning was slightly reduced (<10%) relative to controls and analysis of food consumption 
and weight gain showed that male pups converted feed into weight gain less effectively than females.  No 
effects were seen on the weights of pup's brain, kidney or adrenals, but there was a decrease in absolute 
and relative liver weight in 60-day-old females at 0.025 and 2.5 mg/kg/day, a decrease in absolute and 
relative liver weight in 90-day-old males at 2.5 mg/kg/day, decrease in absolute spleen weight in 30-day­
old males at 2.5 mg/kg/day and in relative spleen weight in 60-day-old females at 2.5 mg/kg/day, and a 
decrease in relative thymus weight in 60-day-old females at 0.25 and 2.5 mg/kg/day and in absolute 
thymus weight in 30-day-old males at 2.5 mg/kg/day.  No consistent treatment-related gross or 
microscopic lesions were observed in dams and pups. Clinical chemistry changes of potential biological 
importance included a decrease in serum amylase in 90-day-old males at 0.25 and 2.5 mg/kg/day and 
decreased T4, also in 90-day-old males at 2.5 mg/kg/day.  Based on the changes in pup's organ weights 
and in clinical chemistry parameters, the 0.25 mg/kg/day dose is a LOAEL and 0.025 mg/kg/day a 
NOAEL. The reduced weight gain of the pups is not considered adverse because the difference with 
controls was less than 10%. 
In the study of immunological parameters (Tryphonas et al. 2004), the only significant change in serum
immunoglobulin levels that appeared dose-related was an increase in IgG at 0.25 and 2.5 mg/kg/day in
90-day-old males.  Flow cytometric analysis of splenocytes showed a significant increase mean percent 
and absolute NK cell numbers in high-dose 30-day-old males and females, a decrease in the percentage, 
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but not in absolute numbers of CD4+8+ T cells in 60-day-old females, and an increase in the percentage 
of NK cells in 90-day-old males.  The anti-SRBC IgM response was not affected by exposure to 
tributyltin.  No significant alterations were observed in the lymphoproliferative activity of splenocytes in 
response to mitogen stimulation.  The delayed-type hypersensitivity response (DTH) was not affected in 
60-day-old females, but 90-day-old males showed a significant trend toward a decrease in DTH response 
with increasing doses of tributyltin.  The assays for L. monocytogenes infectivity and NK cell activity did 
not give dose-related responses.  Cytokine levels in serum were not affected.  Gross examination of 
lymphoid tissues was unremarkable.  The most consistent histological finding was mild to moderate 
cortical atrophy of the thymus, characterized by decreased numbers of cortical lymphocytes at 
2.5 mg/kg/day at all ages. 
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MINIMAL RISK LEVEL WORKSHEET 
Chemical Name: Tributyltin oxide 
CAS Number: 56-35-9 
Date:   April 2005 
Profile Status: Final Post-Public Comment 
Route: [ ] Inhalation  [X] Oral 
Duration: [ ] Acute  [ ] Intermediate  [X] Chronic 
Graph Key: 79 
Species: Rat 
Minimal Risk Level: 0.0003 [X] mg/kg/day   [ ] ppm 
Reference: Vos JG, De Klerk A, Krajnc EI, et al. 1990. Immunotoxicity of bis(tri-n-butyltin)oxide in 
the rat: Effects on thymus-dependent immunity and on nonspecific resistance following long-term
exposure in young versus aged rats.  Toxicol Appl Pharmacol 105:144-155. 
Experimental design:  Groups of male Wistar rats were fed a diet containing 0, 0.5, 5, or 50 ppm
tributyltin oxide (95.3% pure) for 18 months.  This diet provided approximately 0, 0.025, 0.25, and 
2.5 mg/kg/day of the test material.  Parameters of specific resistance evaluated included IgM and IgG 
response to sheep red blood cells (SRBC) after 16 months; IgM and IgG response to ovalbumin and the 
delayed-type hypersensitivity (DTH) response to ovalbumin and tuberculin after 15 months of treatment; 
resistance to T. spiralis infection after 16.5 months; mitogenic response of thymus and spleen cells after 
16.5 months; and surface marker analysis of mesenteric lymph nodes after 18 months.  Parameters of 
nonspecific resistance examined included clearance of L. monocytogenes from the spleen after injection at 
17 months and natural cell-mediated cytotoxicity of spleen and peritoneal cells after 16 months.  
Effects noted in study and corresponding doses: No information was provided regarding body weight or 
weight of the thymus and spleen at termination.  Exposure to tributyltin oxide did not affect the primary
IgM or the secondary response to SRBC after 16 months of dosing.  Neither the IgM nor IgG response to 
ovalbumin and T. spiralis were altered after 15 months of treatment, but the IgE responses to T. spiralis, 
as determined by the passive cutaneous anaphylaxis reaction, was suppressed in a dose-related manner 
(significant in the mid- and high-dose groups).  The DTH reactions to ovalbumin and tuberculin were not 
significantly altered after 16 months of dosing.  There was an increase in the number of larvae T. spiralis 
in muscle after infection in the mid- and high-dose groups after 16.5 months of exposure to the test 
material.  No significant effect was observed on the response of spleen cells to T- and B-mitogens after 
16 months.  The cell surface marker analysis of mesenteric lymph node cells showed a reduction in the 
relative count of T-lymphocytes and an increase in the percentage of B-lymphocytes in the mid- and high-
dose groups after 18 months of treatment.  The in vivo clearance of L. monocytogenes was impaired in the 
high-dose group after 17 months of treatment.  Treatment with tributyltin oxide for 16 months 
significantly reduced the natural killer cell activity of spleen and peritoneal cells, but there was no dose-
response relationship.  Based on the depression of IgE titers and increased T. spiralis in muscle after 
16.5 months of exposure to tributyltin oxide, the study LOAEL is 0.25 mg/kg/day and the NOAEL is 
0.025 mg/kg/day.
Dose and end point used for MRL derivation: 0.025 mg/kg/day; immunological effects. 
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Uncertainty Factors used in MRL derivation: 
[  ]  10 for use of a LOAEL 
[X]  10 for extrapolation from animals to humans 
[X]  10 for human variability
Was a conversion factor used from ppm in food or water to a mg/body weight dose? 
Yes, conversions were done by the study authors. 
If an inhalation study in animals, list conversion factors used in determining human equivalent dose:  NA 
Was a conversion used from intermittent to continuous exposure? 
No 
Other additional studies or pertinent information that lend support to this MRL:  The findings from the 
intermediate-duration portion of the Vos et al. (1990) study support the longer-term observations.  A 
2-year bioassay with tributyltin oxide in rats described hepatic, renal, endocrine, and body weight effects 
with a dose level of 2.1 mg/kg/day and NOAELs for these effects are approximately 0.2 mg/kg/day
(Wester et al. 1990). In that study there also were changes in immunoglobulin levels at 2.1 mg/kg/day 
throughout the study, namely: increase in IgA after 12 and 24 months, decrease in IgG in females after 
3 and 13 months, and increase in IgM after 3, 12, and 24 months.  No additional chronic-duration studies 
were located for tributyltin oxide. 
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Chapter 1 
Public Health Statement 
This chapter of the profile is a health effects summary written in non-technical language.  Its intended 
audience is the general public, especially people living in the vicinity of a hazardous waste site or 
chemical release.  If the Public Health Statement were removed from the rest of the document, it would 
still communicate to the lay public essential information about the chemical. 
The major headings in the Public Health Statement are useful to find specific topics of concern.  The 
topics are written in a question and answer format.  The answer to each question includes a sentence that 
will direct the reader to chapters in the profile that will provide more information on the given topic. 
Chapter 2 
Relevance to Public Health 
This chapter provides a health effects summary based on evaluations of existing toxicologic, 
epidemiologic, and toxicokinetic information.  This summary is designed to present interpretive, weight­
of-evidence discussions for human health end points by addressing the following questions: 
1. 	 What effects are known to occur in humans? 
2. 	 What effects observed in animals are likely to be of concern to humans? 
3. 	 What exposure conditions are likely to be of concern to humans, especially around hazardous 
waste sites? 
The chapter covers end points in the same order that they appear within the Discussion of Health Effects 
by Route of Exposure section, by route (inhalation, oral, and dermal) and within route by effect.  Human 
data are presented first, then animal data.  Both are organized by duration (acute, intermediate, chronic).  
In vitro data and data from parenteral routes (intramuscular, intravenous, subcutaneous, etc.) are also 
considered in this chapter. 
The carcinogenic potential of the profiled substance is qualitatively evaluated, when appropriate, using 
existing toxicokinetic, genotoxic, and carcinogenic data.  ATSDR does not currently assess cancer 
potency or perform cancer risk assessments.  Minimal Risk Levels (MRLs) for noncancer end points (if 
derived) and the end points from which they were derived are indicated and discussed. 
Limitations to existing scientific literature that prevent a satisfactory evaluation of the relevance to public 
health are identified in the Chapter 3 Data Needs section. 
Interpretation of Minimal Risk Levels 
Where sufficient toxicologic information is available, ATSDR has derived MRLs for inhalation and oral 
routes of entry at each duration of exposure (acute, intermediate, and chronic).  These MRLs are not 
meant to support regulatory action, but to acquaint health professionals with exposure levels at which 
adverse health effects are not expected to occur in humans. 
  
 
B-2 TIN AND TIN COMPOUNDS 
APPENDIX B 
MRLs should help physicians and public health officials determine the safety of a community living near 
a chemical emission, given the concentration of a contaminant in air or the estimated daily dose in water.  
MRLs are based largely on toxicological studies in animals and on reports of human occupational 
exposure. 
MRL users should be familiar with the toxicologic information on which the number is based.  Chapter 2, 
"Relevance to Public Health," contains basic information known about the substance.  Other sections such 
as Chapter 3 Section 3.9, "Interactions with Other Substances,” and Section 3.10, "Populations that are 
Unusually Susceptible" provide important supplemental information. 
MRL users should also understand the MRL derivation methodology.  MRLs are derived using a 
modified version of the risk assessment methodology that the Environmental Protection Agency (EPA) 
provides (Barnes and Dourson 1988) to determine reference doses (RfDs) for lifetime exposure.  
To derive an MRL, ATSDR generally selects the most sensitive end point which, in its best judgement, 
represents the most sensitive human health effect for a given exposure route and duration.  ATSDR 
cannot make this judgement or derive an MRL unless information (quantitative or qualitative) is available 
for all potential systemic, neurological, and developmental effects.  If this information and reliable 
quantitative data on the chosen end point are available, ATSDR derives an MRL using the most sensitive 
species (when information from multiple species is available) with the highest no-observed-adverse-effect 
level (NOAEL) that does not exceed any adverse effect levels.  When a NOAEL is not available, a 
lowest-observed-adverse-effect level (LOAEL) can be used to derive an MRL, and an uncertainty factor 
(UF) of 10 must be employed.  Additional uncertainty factors of 10 must be used both for human 
variability to protect sensitive subpopulations (people who are most susceptible to the health effects 
caused by the substance) and for interspecies variability (extrapolation from animals to humans).  In 
deriving an MRL, these individual uncertainty factors are multiplied together.  The product is then 
divided into the inhalation concentration or oral dosage selected from the study. Uncertainty factors used 




Tables and Figures for Levels of Significant Exposure (LSE) 
Tables and figures are used to summarize health effects and illustrate graphically levels of exposure 
associated with those effects.  These levels cover health effects observed at increasing dose 
concentrations and durations, differences in response by species, MRLs to humans for noncancer end 
points, and EPA's estimated range associated with an upper- bound individual lifetime cancer risk of 1 in
10,000 to 1 in 10,000,000.  Use the LSE tables and figures for a quick review of the health effects and to 
locate data for a specific exposure scenario.  The LSE tables and figures should always be used in 
conjunction with the text.  All entries in these tables and figures represent studies that provide reliable, 
quantitative estimates of NOAELs, LOAELs, or Cancer Effect Levels (CELs). 
The legends presented below demonstrate the application of these tables and figures.  Representative 
examples of LSE Table 3-1 and Figure 3-1 are shown.  The numbers in the left column of the legends 
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LEGEND 
See Sample LSE Table 3-1 (page B-6)
(1)	 Route of Exposure. One of the first considerations when reviewing the toxicity of a substance 
using these tables and figures should be the relevant and appropriate route of exposure.  Typically
when sufficient data exist, three LSE tables and two LSE figures are presented in the document.  
The three LSE tables present data on the three principal routes of exposure, i.e., inhalation, oral, 
and dermal (LSE Tables 3-1, 3-2, and 3-3, respectively).  LSE figures are limited to the inhalation 
(LSE Figure 3-1) and oral (LSE Figure 3-2) routes.  Not all substances will have data on each 
route of exposure and will not, therefore, have all five of the tables and figures. 
(2)	 Exposure Period. Three exposure periods—acute (less than 15 days), intermediate (15– 
364 days), and chronic (365 days or more)—are presented within each relevant route of exposure.  
In this example, an inhalation study of intermediate exposure duration is reported.  For quick 
reference to health effects occurring from a known length of exposure, locate the applicable 
exposure period within the LSE table and figure. 
(3)	 Health Effect. The major categories of health effects included in LSE tables and figures are 
death, systemic, immunological, neurological, developmental, reproductive, and cancer.  
NOAELs and LOAELs can be reported in the tables and figures for all effects but cancer.  
Systemic effects are further defined in the "System" column of the LSE table (see key number 
18). 
(4)	 Key to Figure. Each key number in the LSE table links study information to one or more data 
points using the same key number in the corresponding LSE figure.  In this example, the study 
represented by key number 18 has been used to derive a NOAEL and a Less Serious LOAEL 
(also see the two "18r" data points in sample Figure 3-1). 
(5)	 Species. The test species, whether animal or human, are identified in this column.  Chapter 2, 
"Relevance to Public Health," covers the relevance of animal data to human toxicity and 
Section 3.4, "Toxicokinetics," contains any available information on comparative toxicokinetics.  
Although NOAELs and LOAELs are species specific, the levels are extrapolated to equivalent 
human doses to derive an MRL. 
(6)	 Exposure Frequency/Duration. The duration of the study and the weekly and daily exposure 
regimens are provided in this column.  This permits comparison of NOAELs and LOAELs from
different studies. In this case (key number 18), rats were exposed to “Chemical x” via inhalation 
for 6 hours/day, 5 days/week, for 13 weeks.  For a more complete review of the dosing regimen, 
refer to the appropriate sections of the text or the original reference paper (i.e., Nitschke et al. 
1981). 
(7)	 System. This column further defines the systemic effects.  These systems include respiratory, 
cardiovascular, gastrointestinal, hematological, musculoskeletal, hepatic, renal, and 
dermal/ocular.  "Other" refers to any systemic effect (e.g., a decrease in body weight) not covered 
in these systems.  In the example of key number 18, one systemic effect (respiratory) was 
investigated. 
(8)	 NOAEL. A NOAEL is the highest exposure level at which no harmful effects were seen in the 
organ system studied.  Key number 18 reports a NOAEL of 3 ppm for the respiratory system, 
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(9)	 LOAEL. A LOAEL is the lowest dose used in the study that caused a harmful health effect.  
LOAELs have been classified into "Less Serious" and "Serious" effects.  These distinctions help 
readers identify the levels of exposure at which adverse health effects first appear and the 
gradation of effects with increasing dose.  A brief description of the specific end point used to 
quantify the adverse effect accompanies the LOAEL.  The respiratory effect reported in key
number 18 (hyperplasia) is a Less Serious LOAEL of 10 ppm.  MRLs are not derived from
Serious LOAELs. 
(10)	 Reference. The complete reference citation is given in Chapter 9 of the profile. 
(11)	 CEL. A CEL is the lowest exposure level associated with the onset of carcinogenesis in 
experimental or epidemiologic studies.  CELs are always considered serious effects.  The LSE 
tables and figures do not contain NOAELs for cancer, but the text may report doses not causing 
measurable cancer increases. 
(12)	 Footnotes. Explanations of abbreviations or reference notes for data in the LSE tables are found 
in the footnotes.  Footnote "b" indicates that the NOAEL of 3 ppm in key number 18 was used to 
derive an MRL of 0.005 ppm. 
LEGEND 
See Sample Figure 3-1 (page B-7) 
LSE figures graphically illustrate the data presented in the corresponding LSE tables.  Figures help the 
reader quickly compare health effects according to exposure concentrations for particular exposure 
periods. 
(13)	 Exposure Period. The same exposure periods appear as in the LSE table. In this example, health 
effects observed within the acute and intermediate exposure periods are illustrated. 
(14)	 Health Effect. These are the categories of health effects for which reliable quantitative data 
exists. The same health effects appear in the LSE table. 
(15)	 Levels of Exposure. Concentrations or doses for each health effect in the LSE tables are 
graphically displayed in the LSE figures.  Exposure concentration or dose is measured on the log 
scale "y" axis.  Inhalation exposure is reported in mg/m3 or ppm and oral exposure is reported in 
mg/kg/day. 
(16)	 NOAEL. In this example, the open circle designated 18r identifies a NOAEL critical end point in 
the rat upon which an intermediate inhalation exposure MRL is based.  The key number 18 
corresponds to the entry in the LSE table.  The dashed descending arrow indicates the 
extrapolation from the exposure level of 3 ppm (see entry 18 in the table) to the MRL of 
0.005 ppm (see footnote "b" in the LSE table). 
(17)	 CEL. Key number 38m is one of three studies for which CELs were derived.  The diamond 
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(18)	 Estimated Upper-Bound Human Cancer Risk Levels. This is the range associated with the upper-
bound for lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000.  These risk levels are derived 
from the EPA's Human Health Assessment Group's upper-bound estimates of the slope of the 
cancer dose response curve at low dose levels (q1*). 




















































5 6 7 8 9 10 
Systemic p p p p p p 
18 Rat 13 wk Resp 3b 10 (hyperplasia) 
5 d/wk 
6 hr/d 




38 Rat 18 mo 20 (CEL, multiple Wong et al. 1982 
5 d/wk  
7 hr/d 
organs) 
39 Rat 89–104 wk 10 (CEL, lung tumors, NTP 1982 
5 d/wk  
6 hr/d 
nasal tumors) 
40 Mouse 79–103 wk 10 (CEL, lung tumors, NTP 1982 
5 d/wk hemangiosarcomas) 
6 hr/d 
12 o	 a The number corresponds to entries in Figure 3-1. 
b Used to derive an intermediate inhalation Minimal Risk Level (MRL) of  5x10-3 ppm; dose adjusted for intermittent exposure and divided 
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ACGIH American Conference of Governmental Industrial Hygienists 
ACOEM American College of Occupational and Environmental Medicine 
ADI acceptable daily intake 
ADME absorption, distribution, metabolism, and excretion 
AED atomic emission detection 
AFID alkali flame ionization detector 
AFOSH Air Force Office of Safety and Health 
ALT alanine aminotransferase 
AML acute myeloid leukemia 
AOAC Association of Official Analytical Chemists 
AOEC Association of Occupational and Environmental Clinics 
AP alkaline phosphatase 
APHA American Public Health Association 
AST aspartate aminotransferase 
atm atmosphere 
ATSDR Agency for Toxic Substances and Disease Registry
AWQC Ambient Water Quality Criteria 
BAT best available technology 
BCF bioconcentration factor 
BEI Biological Exposure Index 
BMD benchmark dose 
BMR benchmark response 
BSC Board of Scientific Counselors 
C centigrade 
CAA Clean Air Act 
CAG Cancer Assessment Group of the U.S. Environmental Protection Agency
CAS Chemical Abstract Services 
CDC Centers for Disease Control and Prevention 
CEL cancer effect level 
CELDS Computer-Environmental Legislative Data System
CERCLA Comprehensive Environmental Response, Compensation, and Liability Act 
CFR Code of Federal Regulations 
Ci curie 
CI confidence interval 
CL ceiling limit value 
CLP Contract Laboratory Program
cm centimeter 
CML chronic myeloid leukemia 
CPSC Consumer Products Safety Commission 
CWA Clean Water Act 
DHEW Department of Health, Education, and Welfare 
DHHS Department of Health and Human Services 
DNA deoxyribonucleic acid 
DOD Department of Defense 
DOE Department of Energy
DOL Department of Labor 
























C-2 TIN AND TIN COMPOUNDS 
APPENDIX C 
DOT/UN/ Department of Transportation/United Nations/ 
NA/IMCO     North America/International Maritime Dangerous Goods Code 
DWEL drinking water exposure level 
ECD electron capture detection 
ECG/EKG electrocardiogram
EEG electroencephalogram
EEGL Emergency Exposure Guidance Level 
EPA Environmental Protection Agency
F Fahrenheit 
F1 first-filial generation 
FAO Food and Agricultural Organization of the United Nations 
FDA Food and Drug Administration 
FEMA Federal Emergency Management Agency
FIFRA Federal Insecticide, Fungicide, and Rodenticide Act 
FPD flame photometric detection 
fpm feet per minute 
FR Federal Register 




GLC gas liquid chromatography 
GPC gel permeation chromatography
HPLC high-performance liquid chromatography
HRGC high resolution gas chromatography
HSDB Hazardous Substance Data Bank 
IARC International Agency for Research on Cancer 
IDLH immediately dangerous to life and health 
ILO International Labor Organization 
IRIS Integrated Risk Information System
Kd adsorption ratio 
kg kilogram
kkg metric ton 
Koc organic carbon partition coefficient 
Kow octanol-water partition coefficient 
L liter 
LC liquid chromatography
LC50 lethal concentration, 50% kill 
LCLo lethal concentration, low 
LD50 lethal dose, 50% kill 
LDLo lethal dose, low 
LDH lactic dehydrogenase 
LH luteinizing hormone 
LOAEL lowest-observed-adverse-effect level 
LSE Levels of Significant Exposure 
LT50 lethal time, 50% kill 
m meter 
MA trans,trans-muconic acid 
MAL maximum allowable level 
mCi millicurie 
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MCLG maximum contaminant level goal 
MF modifying factor 




mmHg millimeters of mercury
mmol millimole 
mppcf millions of particles per cubic foot 
MRL Minimal Risk Level 
MS mass spectrometry
NAAQS National Ambient Air Quality Standard 
NAS National Academy of Science 
NATICH National Air Toxics Information Clearinghouse 
NATO North Atlantic Treaty Organization 
NCE normochromatic erythrocytes 
NCEH National Center for Environmental Health 
NCI National Cancer Institute 
ND not detected 
NFPA National Fire Protection Association 
ng nanogram
NHANES National Health and Nutrition Examination Survey
NIEHS National Institute of Environmental Health Sciences 
NIOSH National Institute for Occupational Safety and Health 
NIOSHTIC NIOSH's Computerized Information Retrieval System 
NLM National Library of Medicine 
nm nanometer 
nmol nanomole 
NOAEL no-observed-adverse-effect level 
NOES National Occupational Exposure Survey 
NOHS National Occupational Hazard Survey
NPD nitrogen phosphorus detection 
NPDES National Pollutant Discharge Elimination System
NPL National Priorities List 
NR not reported 
NRC National Research Council 
NS not specified 
NSPS New Source Performance Standards 
NTIS National Technical Information Service 
NTP National Toxicology Program
ODW Office of Drinking Water, EPA 
OERR Office of Emergency and Remedial Response, EPA 
OHM/TADS Oil and Hazardous Materials/Technical Assistance Data System
OPP Office of Pesticide Programs, EPA 
OPPT Office of Pollution Prevention and Toxics, EPA 
OPPTS Office of Prevention, Pesticides and Toxic Substances, EPA 
OR odds ratio 
OSHA Occupational Safety and Health Administration 
OSW Office of Solid Waste, EPA 
OTS Office of Toxic Substances 
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OWRS Office of Water Regulations and Standards, EPA 
PAH polycyclic aromatic hydrocarbon 
PBPD physiologically based pharmacodynamic 
PBPK physiologically based pharmacokinetic 
PCE polychromatic erythrocytes
PEL permissible exposure limit 
pg picogram
PHS Public Health Service 
PID photo ionization detector 
pmol picomole 
PMR proportionate mortality ratio 
ppb parts per billion 
ppm parts per million 
ppt parts per trillion 
PSNS pretreatment standards for new sources 
RBC red blood cell 
REL recommended exposure level/limit 
RfC reference concentration 
RfD reference dose 
RNA ribonucleic acid 
RQ reportable quantity
RTECS Registry of Toxic Effects of Chemical Substances 
SARA Superfund Amendments and Reauthorization Act 
SCE sister chromatid exchange 
SGOT serum glutamic oxaloacetic transaminase 
SGPT serum glutamic pyruvic transaminase 
SIC standard industrial classification 
SIM selected ion monitoring 
SMCL secondary maximum contaminant level 
SMR standardized mortality ratio 
SNARL suggested no adverse response level 
SPEGL Short-Term Public Emergency Guidance Level 
STEL short term exposure limit 
STORET Storage and Retrieval 
TD50 toxic dose, 50% specific toxic effect 
TLV threshold limit value 
TOC total organic carbon 
TPQ threshold planning quantity
TRI Toxics Release Inventory
TSCA Toxic Substances Control Act 
TWA time-weighted average 
UF uncertainty factor 
U.S. United States 
USDA United States Department of Agriculture 
USGS United States Geological Survey
VOC volatile organic compound 
WBC white blood cell 
WHO World Health Organization 
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> greater than 
 greater than or equal to 
= equal to 
< less than 








q1* cancer slope factor 
– negative 
+ positive 
(+) weakly positive result 
(–) weakly negative result 

D-1 TIN AND TIN COMPOUNDS 
APPENDIX D.  INDEX 

AAS .......................................................................................................... 291, 292, 293, 294, 295, 296, 297 

absorbed dose............................................................................................................................................ 204 

active transport.......................................................................................................................................... 205 

adipose tissue ............................................................................................................................ 176, 276, 288 

adrenal gland............................................................................................................................................. 151 

adrenals ............................................................................................................................................. 127, 147 

adsorbed ............................................................................................................................................ 252, 256 





alanine aminotransferase (see ALT) ......................................................................................................... 123 

ALT................................................................................................................................................... 123, 155 

ambient air ................................................................................................................................................ 261 

anaerobic ........................................................................................................................................... 259, 290 





antifouling agent ....................................................................................................................................... 247 

aspartate aminotransferase (see AST)....................................................................................................... 123 

AST................................................................................................................................................... 123, 155 

atomic absorption spectroscopy (see AAS) ...................................................................... 291, 292, 294, 296
 
bioavailability ........................................................................................................................... 215, 257, 287 

bioconcentration................................................................................................................................ 256, 257 

bioconcentration factor ............................................................................................................................. 256 

biodegradation................................................................................................................................... 252, 260 

biomarker .......................................................................................................................................... 203, 204 

biomarkers ................................................................................................................ 203, 204, 220, 223, 291 

blood cell count......................................................................................................................................... 119 

body weight effects ................................................................................................................................... 130 

breast milk............................................................................................................. 7, 175, 202, 284, 285, 289 

cancer .................................................................................... 5, 6, 13, 36, 149, 150, 158, 196, 201, 215, 224 

carcinogen ................................................................................................................................................. 307 

carcinogenic ................................................................................ 13, 14, 16, 23, 24, 150, 151, 152, 215, 301 

carcinogenicity........................................................................................ 6, 13, 151, 152, 158, 215, 301, 307 

carcinomas ........................................................................................................................................ 149, 215 

cardiovascular ............................................................................................................................. 30, 115, 155 

cardiovascular effects................................................................................................................................ 115 

chromosomal aberrations .................................................................................................................. 161, 167 

clearance ....................................................................................................................... 21, 22, 134, 185, 307 

cleft palate................................................................................................................................... 15, 145, 148 

crustaceans .................................................................................................................. 12, 271, 275, 276, 283 

death........................................................................................ 15, 23, 25, 112, 136, 152, 193, 212, 276, 278 

deoxyribonucleic acid (see DNA)..................................................................................................... 162, 168 

dermal effects.............................................................................................................................. 33, 129, 156 

desorption.......................................................................................................................................... 257, 295 

DNA.................................................................................................................. 161, 162, 167, 168, 193, 203 

dopamine........................................................................................................................................... 139, 147 

elimination half-time................................................................................................................. 182, 183, 185 

elimination rate ......................................................................................................................................... 221 

endocrine..................................................... 15, 126, 127, 128, 195, 196, 197, 199, 202, 214, 217, 218, 223 
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estrogen receptor....................................................................................................................................... 196 

estrogenic .................................................................................................................................................. 196 

fetus....................................................................................................................... 6, 174, 196, 200, 217, 223 

fractional absorption ................................................................................................................................. 169 

FSH ................................................................................................................................... 127, 197, 198, 206 

gas chromatography (see GC)................................................................................................... 291, 294, 296 

gastrointestinal effects .................................................................................................... 5, 31, 116, 117, 223 

GC..................................................................................................................... 291, 293, 294, 295, 296, 297 

general population................................................................................. 12, 15, 173, 203, 213, 220, 282, 285 

genotoxic............................................................................................................... 13, 23, 161, 167, 212, 216 

genotoxicity....................................................................................................................................... 161, 216 

groundwater .............................................................................................................. 249, 253, 254, 292, 305 

half-life...................................................................................................................................... 203, 257, 259 

hematological effects .................................................................................. 13, 14, 16, 17, 32, 118, 119, 301 

hepatic effects ............................................................................................. 32, 120, 121, 122, 125, 155, 213 

high performance liquid chromatography (see HPLC)............................................................................. 294
 
hippocampus ............................................................... 15, 136, 138, 147, 159, 177, 191, 192, 201, 219, 225 

HPLC ................................................................................................................................ 291, 293, 294, 295 

hydrolysis.......................................................................................................................................... 252, 260 

ICP .................................................................................................................... 292, 293, 294, 295, 296, 297 

immune system ....................................................................................................................... 5, 19, 205, 218 

immunological ...................... 14, 19, 21, 22, 23, 34, 131, 132, 135, 147, 151, 157, 201, 213, 214, 218, 301 

immunological effects......................................................... 14, 19, 21, 22, 34, 131, 132, 135, 201, 213, 301 

inductively coupled plasma (see ICP)............................................................................... 291, 292, 294, 296 

Kow ............................................................................................................................................................ 257 





limbic system ...................................................................................................................................... 15, 191 

lymphoreticular ................................................................................................................................. 132, 157 

mass spectrometry (see MS) ............................................................................................. 291, 292, 294, 296 

methylation ............................................................................................................................... 259, 260, 287 

micronuclei ....................................................................................................................................... 161, 167 

milk ................................................................................... 147, 202, 208, 218, 222, 223, 275, 276, 285, 289 

MS............................................................................................................. 291, 292, 293, 294, 295, 296, 297 

musculoskeletal effects ....................................................................................................................... 30, 120 

myelin ......................................................................................................................... 14, 137, 189, 190, 193 

neonatal ..................................................................................................................... 137, 170, 175, 176, 199 

neurobehavioral................................................................................................................... 34, 196, 212, 220 

neurochemical ........................................................................................................................................... 202 

neurodevelopmental .......................................................................................................................... 146, 202 





ocular effects....................................................................................................... 33, 114, 129, 152, 157, 213 

partition coefficients ................................................................................................................................. 257 

pharmacodynamic ..................................................................................................................................... 184 

pharmacokinetic.................................................................................. 13, 184, 185, 186, 200, 202, 219, 223 

photolysis .................................................................................................................................................. 260 

pKa.................................................................................................................................................... 258, 259 
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